Sentence,class,file
"http://dx.doi.org/10.1084/jem.184.2.78 3 Kocak, E., K. Lute, X. Chang, K.F.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-212 8 Kong, K.F., G. Fu, Y. Zhang, T. Yokosuka, J. Casas, A.J.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/ni.286 6 Krummel, M.F., and J.P. Allison.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/   jem.183.6.253 3 Lee, K.M., E. Chuang, M. Griffin, R. Khattri, D.K.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"282:2263– 2266. http://dx.doi.org/10.1126/science.282.5397.226 3 Lee, Y., A. Awasthi, N. Yosef, F.J. Quintana, S. Xiao, A. Peters, C. Wu, M.  Kleinewietfeld, S. Kunder, D.A.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/ni.241 6 Linsley, P.S., W. Brady, M. Urnes, L.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem   .174.3.56 1 Linsley, P .S., J.L.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.176.6.159 5 Liu, Z., K. Geboes, P. Hellings, P. Maerten, H. Heremans, P. Vandenberghe,  L. Boon, P. van Kooten, P. Rutgeerts, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.4049/jimmunol.167.3.183 0 Liu, S.M., A.P .",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.2002160 3 Bettelli, E., Y.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/nature0475 3 Buhlmann, J.E., S.K.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.4049/jimmunol.170.11.542 1 Bulliard, Y., R. Jolicoeur, M. Windman, S.M.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1002/eji.20032318 0 Chuang, E., K.M.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)00031- 5 Cilio, C.M., M.R.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi   .org/10.1084/jem.188.7.123 9 Dujardin, H.C., O. Burlen-Defranoux, L. Boucontet, P .",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/ni100 3 Fife, B.T., and J.A.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
http://dx.doi.org/10.1111/j.1600-065X.2008.00662.,Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1002/(SICI)1521- 4141(199903)29:03<838::AID-IMMU838>3.0.CO;2- P Freeman, G.J., G.S.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"174:625– 631. http://dx.doi.org/10.1084/jem.174.3.62 5 Freeman, G.J., D.B.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
http://dx.doi.org/10.1084/jem.178.6.218 5,Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.4049/jimmunol.182.1.27 4 Selby, M.J., J.J. Engelhardt, M. Quigley, K.A.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10   .1158/2326-6066.CIR-13-001 3 Sharpe, A.H., and G.J.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/nri72 7 Simpson, T.R., F. Li, W. Montalvo-Ortiz, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.2013057 9 Sobel, R.A., V.K.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1097/00005072-199009000-0000 2 Tai, X., M. Cowan, L. Feigenbaum, and A.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/ni116 0 Tai, X., F. Van Laethem, L. Pobezinsky, T. Guinter, S.O.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1182/blood-2011-   11-38891 8 Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi,  T.W.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.192.2.30 3 Takahashi, S., H. Kataoka, S. Hara, T. Yokosuka, K. Takase, S. Yamasaki,  W. Kobayashi, Y. Saito, and T. Saito.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1002/   eji.20032474 6 Tang, Q., K.J.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.4049/   jimmunol.171.7.334 8 Tang, Q., E.K.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi   .org/10.1002/eji.20042514 3 Tivol, E.A., F. Borriello, A.N.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10   .1016/1074-7613(95)90125- 6 Ueda, H., J.M.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/   nature0162 1 V erhagen, J., L. Gabrysová, S. Minaee, C.A.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.4049/   jimmunol.110204 2 Marengère, L.E., P. Waterhouse, G.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"272:1170– 1173. http://dx.doi.org/10.1126/science.272.5265.117 0 Metzler, B., C. Burkhart, and D.C. Wraith.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10   .1093/intimm/11.5.66 7 Odorizzi, P.M., K.E.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.2014223 7 Olsson, C., K. Riesbeck, M. Dohlsten, and E. Michaëlsson.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10   .1074/jbc.274.20.1440 0 Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.179.2.70 9 Punt, J.A., W. Havran, R. Abe, A. Sarin, and A.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.186.11.191 1 Qureshi, O.S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E.M.  Schmidt, J. Baker, L.E.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1126/   science.120294 7 Read, S., V. Malmström, and F. Powrie.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.192.2.29 5 Read, S., R. Greenwald, A. Izcue, N. Robinson, D. Mandelbrot, L. Francisco,  A.H. Sharpe, and F. Powrie.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"177:4376– 4383. http://dx.doi.org/10.4049/jimmunol.177.7.437 6 Robert, C., L. Thomas, I. Bondarenko, S. O’Day, J. Weber, C. Garbe, C.  Lebbe, J.F.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1056/NEJMoa110462 1 Rubtsov, Y.P., R.E.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1126/science.119199 6 Sage, P.T., A.M. Paterson, S.B.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1016/j.immuni.2014.12.00 5 Salomon, B., D.J.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80195- 8 Samy, E.T., K.M.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
http://dx.doi.org/10.4049/jimmunol.180.7.436 6,Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/   jem.184.5.163 1 Walker, L.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1016/   j.jaut.2013.06.00 6 Walunas, T.L., C.Y.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1084/jem.183.6.254 1 Wang, X., A. Spandidos, H. Wang, and B.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10   .1093/nar/gkr101 3 Waterhouse, P ., J.M.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1126/science.270.5238.98 5 Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z.  Fehervari, T. Nomura, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi   .org/10.1126/science.116006 2 Workman, C.J., L.W.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1007/978-1-61737-979-6_ 9 Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, J.C. Stroud,  D.L.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1016/j.cell.2006.05.04 2 Yang, S., N. Fujikado, D. Kolodin, C. Benoist, and D. Mathis.",OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1126/science.aaa701 7 Yosef, N., A.K.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
"http://dx.doi.org/10.1038/nature1198 1 Zhang, R., A. Huynh, G. Whitcher, J. Chang, J.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
http://dx.doi   .org/10.1038/nature0556 3,Non-OADS,/arxiv_data1/oa_pdf/ca/c2/JEM_20141030.PMC4577848.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/nature1303 6 Doucett, V .P ., W .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.1016/j.jim.2005.05.01 4 Ely , K.H., T .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.4049/jimmunol.176.1.53 7 Gerhard, W .",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/jem.2009041 0 Gitlin, A.D., Z. Shulman, and M.C.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/nature1330 0 Halle, S., H.C. Dujardin, N. Bakocevic, H. Fleige, H. Danzer, S. Willenzon, Y .",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.1038/ni155 2 Inamine, A., Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1093/   intimm/dxh24 1 Johnston, R.J., A.C. Poholek, D. DiT oro, I. Y usuf, D. Eto, B. Barnett, A.L.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1126/science.117587 0 Joo, H.M., Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10   .1073/pnas.080000310 5 Kaji, T., A. Ishige, M. Hikida, J. Taka, A. Hijikata, M. Kubo, T. Nagashima, Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/   jem.2012012 7 Karnowski, A., S. Chevrier, G.T.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10   .1038/nature0973 7 Keating, R., T. Hertz, M. Wehenkel, T.L.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"14:1266– 1276. http://dx.doi.org/10.1038/ni.274 1 Kim, T.S., M.M.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/jem.2009201 7 Krause, J.C., T. Tsibane, T.M.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
Online  supplemental material is available at http://www.jem.org/cgi/content/full/   jem.20142284/DC1.,Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.4049/jimmunol.120168 2 Bachmann, M.F ., B. Odermatt, H. Hengartner, and R.M.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.1084/jem.183.5.225 9 Batten, M., N. Ramamoorthi, N.M. Kljavin, C.S.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/jem.2010006 4 Baumgarth, N. 2013.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1111/imr.1209 4 Bauquet, A.T ., H. Jin, A.M. Paterson, M. Mitsdoerffer, I.C.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/ni.169 0 Boyden, A.W ., K.L.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/   10.1371/journal.pone.004073 3 Cattoretti, G., C.C.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.4049/jimmunol.176.7.434 3 Corti, D., A.L.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1172/JCI4190 2 Corti, D., J. Voss, S.J.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1126/science.120566 9 Doria-Rose, N.A., C.A.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"10:385– 393. http://dx.doi.org/10.1038/ni.171 5 Rothaeusler, K., and N. Baumgarth.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/   10.1002/eji.20093979 8 Schittek, B., and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/346749a 0 Shih, T.A., M. Roederer, and M.C.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/ni77 6 Skehel, J.J., and D.C. Wiley.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"69:531– 569. http://dx.doi.org/10.1146/annurev.biochem.69.1.53 1 Smith, K., L. Garman, J. Wrammert, N.Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/   nsmb.156 6 Takahashi, Y ., H. Ohta, and T. Takemori.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/   S1074-7613(01)00100- 5 Takahashi, Y ., A. Inamine, S. Hashimoto, S. Haraguchi, E. Y oshioka, N. Kojima,  R. Abe, and T. Takemori.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/   j.immuni.2005.06.01 0 Takahashi, Y ., H. Hasegawa, Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1086/59895 4 Tamura, S., Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.1126/science.124114 6 Taylor, J.J., K.A.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/   jem.2011169 6 Throsby, M., E. van den Brink, M. Jongeneelen, L.L.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1371/journal.pone   .000394 2 Tiller, T., C.E.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/j.jim.2009.08.00 9 T omayko, M.M., N.C. Steinel, S.M.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.4049/jimmunol   .100216 3 Tumpey, T.M., M. Renshaw, J.D.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1128/JVI.75.11.5141-   5150.200 1 Victora, G.D., and M.C.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
http://dx.doi.org/10.1146/annurev-immunol-   020711-07503 2influenza H1N1 virus hemagglutinin.,Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.10.01 0 Legge, K.L., and T.J. Braciale.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/   S1074-7613(03)00023- 2 Li, G.M., C. Chiu, J. Wrammert, M. McCausland, S.F .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi   .org/10.1038/nature1205 3 Lingwood, D., P .M.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/nature1137 1 Margine, I., R. Hai, R.A. Albrecht, G. Obermoser, A.C. Harrod, J. Banchereau,  K. Palucka, A. García-Sastre, P .",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1128/JVI.01381-1 4 Moody, M.A., R. Zhang, E.B.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1371/journal.pone   .002579 7 Moyron-Quiroz, J.E., J. Rangel-Moreno, K. Kusser, L. Hartson, F .",Non-OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1038/   nm109 1 Okuno, Y ., Y .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1093/cid/cit04 8 Purtha, W .E., T.F .",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1084/jem.2010135 2Wu, X., Z. Zhang, C.A.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1016/j.cell.2015.03.00 4 Y oshida, R., M. Igarashi, H. Ozaki, N. Kishida, D. T omabechi, H. Kida, K. Ito,  and A. Takada.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100035 0 Zammit, D.J., D.L.",OADS,/arxiv_data1/oa_pdf/42/f4/JEM_20142284.PMC4577849.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/cdd.2011.14 1 Chang, M.S., J.C. Arevalo, and M.V.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/jnr.2026 2 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 Cumano, A., K. Dorshkind, S. Gillis, and C.J.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/eji.183020100 6 Derudder, E., E.J.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/ni.173 2 Deswal, S., A. Meyer, G.J.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.4049/jimmunol.120065 3 Dhillon, A.S., S. Meikle, Z. Yazici, M. Eulitz, and W .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1093/emboj/21.1.6 4 Dingjan, G.M., S. Middendorp, K. Dahlenborg, A. Maas, F .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/   jem.193.10.116 9 Dougherty, M.K., J. Müller, D.A.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/j.molcel.2004.11.05 5 Engel, H., A. Rolink, and S. Weiss.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/(SICI)1521-4141   (199907)29:07<2167::AID-IMMU2167>3.0.CO;2- H Fleming, H.E., and C.J.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1016/S1074-7613(01)00216- 3 Gay, D., T. Saunders, S. Camper, and M. Weigert.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.177.4.99 9 Gerlach, J., S. Ghosh, H. Jumaa, M. Reth, J. Wienands, A.C. Chan, and L.  Nitschke.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10   .1002/eji.20032429 0 Gold, M.R.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/eji   .183024061 6 Gross, J.A., J. Johnston, S. Mudri, R. Enselman, S.R.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/3501011 5 Hanke, J.H., J.P. Gardner, R.L.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
http://dx.doi.org/10.1074/jbc.271.2.69 5TNP13-BSA).,OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.4049/jimmunol   .167.12.683 4 Arakawa, H., T. Shimizu, and S. Takeda.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1093/intimm/8.1.9 1 Arévalo, J.C., H. Yano, K.K.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760025 3 Bai, L., Y .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1128/MCB.02273-0 6 Brummer, T., P .E.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1093/emboj/   cdf58 8 Brummer, T ., H. Naegele, M. Reth, and Y .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/sj.onc.120718 5 Campbell, K.S., W .D.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/   10.1016/0161-5890(95)00088- 7 Castellanos, M.C., C. Muñoz, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/ni.268 5 Cesca, F ., A. Yabe, B. Spencer-Dene, A. Arrigoni, M. Al-Qatari, D. Henderson,  H. Phillips, M. Koltzenburg, F .",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/   cddis.2011.10 8 Cesca, F ., A. Yabe, B. Spencer-Dene, J. Scholz-Starke, L. Medrihan, C.H.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/ni.178 5 Martin, F ., and J.F .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/nri79 9 Mason, C.S., C.J.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1093/emboj/18.8.213 7 McGuire, K.L., and E.S.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/eji.20042552 4 Minguet, S., E.P .",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.192.2.17 1 Nemazee, D. 2006.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/   nri193 9 Neubrand, V .E., F .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1242/jcs.10276 4 Oh-hora, M., S. Johmura, A. Hashimoto, M. Hikida, and T. Kurosaki.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.2003154 7 Oi, V .T., S.L.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/   10.1038/nri265 6 Ray, R.J., A. Stoddart, J.L.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/eji.183008060 5 Richards, J.D., S.H.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.4049/jimmunol.166.6.385 5 Rodriguez-Viciana, P ., J. Oses-Prieto, A. Burlingame, M. Fried, and F .",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.03.02 7 Rolink, A., and F .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/0092-   8674(91)90032- T Rolink, A., A. Kudo, H. Karasuyama, Y .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1084/jem.2009167 3Hashimoto, A., H. Okada, A. Jiang, M. Kurosaki, S. Greenberg, E.A.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1084/jem.188.7.128 7 Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P .J.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1073/pnas.060594410 3 Hombach, J., L. Leclercq, A. Radbruch, K. Rajewsky, and M. Reth.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/343760a 0 Iglesias, T., N. Cabrera-Poch, M.P .",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1002/eji.20104051 3 Jumaa, H., B. Wollscheid, M. Mitterer, J. Wienands, M. Reth, and P .J.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"11:547– 554. http://dx.doi.org/10.1016/S1074-7613(00)80130- 2 Justement, L.B., J. Wienands, J. Hombach, M. Reth, and J.C. Cambier.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1038/nri175 0 Kraus, M., M.B.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/j.cell   .2004.05.01 4 Kurosaki, T. 1999.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1146/annurev.immunol   .17.1.55 5 Lam, K.P ., R. Kühn, and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80373- 6 Loder, F ., B. Mutschler, R.J. Ray, C.J.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.190.1.7 5 López-Menéndez, C., S. Gascón, M. Sobrado, O.G.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1242/jcs.05647 3 Mackay , F ., S.A. W oodcock, P .",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.190.11.169 7 Mandal, M., S.E.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"185:4570– 4581. http://dx.doi.org/10.4049/jimmunol.100170 8 Schamel, W .W ., and M. Reth.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)00003- 0 Shaw, A.C., W .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80261- 7 Sonoda, E., Y .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80325- 8 Sprenger, A., S. Weber, M. Zarai, R. Engelke, J.M.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1074/mcp.M112.02547 8 Srivastava, B., W .J.",Non-OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1084/jem.2005103 8 Sugawara, H., M. Kurosaki, M. Takata, and T .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1093/emboj/16.11.307 8 Takeda, S., Y .R.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1093/intimm/7.6.101 3 Tiegs, S.L., D.M.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.1084/jem.177.4.100 9 Vettermann, C., K. Herrmann, C. Albert, E. Roth, M.R.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi   .org/10.4049/jimmunol.181.5.323 2 Wheeler, M.L., M.B.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10.1126/scisignal.200418 9 Wienands, J., O. Larbolette, and M. Reth.",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
"http://dx.doi.org/10   .1038/nature0935 7 Yasuda, T., H. Sanjo, G. Pagès, Y .",OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
http://dx.doi.org/10.1016/j.immuni.2008.02.01 5,OADS,/arxiv_data1/oa_pdf/ad/dc/JEM_20141271.PMC4577850.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1084/   jem.2011020 0 Bosticardo, M., F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1182/   blood-2008-12-11525 3 Brigido, M.M., M. Polymenis, and B.D.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.4049/jimmunol.140009 8 Jackson, S.W., N.S.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1016/j.coi.2015.01.01 8 Jenks, S.A., E.M. Palmer, E.Y .",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/   10.1002/art.3813 8 Jiang, C., M.-L. Zhao, R.M.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1002/art.3023 0 Kenny, J.J., C. O’Connell, D.G.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1084/jem   .174.5.118 9 Leadbetter, E.A., I.R.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1038/416603 a Lesley, R., Y. Xu, S.L.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/S1074-7613(04)00079- 2 Levine, M.H., A.M. Haberman, D.B.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1371/journal.pone.007262 5 Matejuk, A., M. Beardall, Y. Xu, Q. Tian, D. Phillips, B. Alabyev, K. Mannoor,  and C. Chen.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .4049/jimmunol.080156 2 Meffre, E., and H. Wardemann.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/   10.1016/j.coi.2008.09.00 1 Meyer-Bahlburg, A., and D.J.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1016/j.autrev.2007.11.02 7 Meyer-Bahlburg, A., S.F.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1084/jem.2007108 8 Nemazee, D. 2006.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .1038/nri193 9 Nickerson, K.M., S.R.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.4049/   jimmunol.090259 2 Notarangelo, L.D., and H.D.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
http://dx.doi.org/10.1016/S0952-   7915(03)00112- 2on the surface of human B lymphocytes.,Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.4049/jimmunol.172.7.429 8 Cappione, A. III, J.H.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1172/JCI2417 9 Castiello, M.C., M. Bosticardo, F. Pala, M. Catucci, N. Chamberlain, M.C.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/j.jaut.2013.10.00 6 Cyster, J.G., J.I.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/   10.1172/JCI6696 3 Doyle, C.M., J. Han, M.G.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .1073/pnas.060405310 3 Eilat, D., and M. Wabl.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.4049/jimmunol   .120084 8 Fournier, E.M., M.-G. Velez, K. Leahy, C.L.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1084/jem.2012033 2 Gaudin, E., Y. Hao, M.M.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1084/   jem.2003095 5 Goodnow, C.C., J. Crosbie, S. Adelstein, T.B.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1038/334676a 0 Grillot-Courvalin, C., J.-C. Brouet, F. Piller, L.Z.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"22:1781– 1788. http://dx.doi.org/10.1002/eji.183022071 7 Grönwall, C., and G.J.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1007/s10875-014-0025- 4 Groom, J., S.L.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"204:1959– 1971. http://dx.doi.org/10.1084/jem.2006256 7 Hayakawa, K., M. Asano, S.A. Shinton, M. Gui, D. Allman, C.L.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1126/science   .285.5424.11 3 Isnardi, I., Y.-S. Ng, I. Srdanovic, R. Motaghedi, S. Rudchenko, H. von  Bernuth, S.-Y.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.09.01 5 Jackson, S.W., N.E.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"5:340. http://dx.doi.org/10.3389/fimmu.2014.0034 0 Ochs, H.D., and A.J.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/j   .jaci.2006.02.00 5 Panigrahi, A.K., N.G.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"205:2985– 2994. http://dx.doi.org/10.1084/jem.2008205 3 Pugh-Bernard, A.E., G.J.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1172/JCI20011246 2 Rawlings, D.J., M.A.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/   10.1038/nri319 0 Recher, M., S.O.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1182/blood-2011-09-37941 2 Richardson, C., A.S. Chida, D. Adlowitz, L. Silver, E. Fox, S.A. Jenks,  E. Palmer, Y. Wang, J. Heimburg-Molinaro, Q.-Z.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.4049/   jimmunol.120226 3 Schiemann, B., J.L.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .1126/science.106196 4 Schwartz, M.A., N.S.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/   10.4049/jimmunol.140079 8 Silver, K.L., T.L.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .1002/eji.20073729 3 Simon, K.L., S.M.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/j.jaci.2013   .08.05 0 Stadanlick, J.E., and M.P.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1016/j.coi.2008.03.01 5 Stadanlick, J.E., M. Kaileh, F.G. Karnell, J.L.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi   .org/10.1038/ni.166 6 Tiller, T., E. Meffre, S. Yurasov, M. Tsuiji, M.C.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/   j.jim.2007.09.01 7 Tiller, T., C.E.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1016/j.jim.2009.08.00 9 Tipton, C., C.F.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1038/ni.317 5 Wang, H., and S.H.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"171:6381– 6388. http://dx.doi.org/10.4049/jimmunol.171.12.638 1 Wardemann, H., S. Yurasov, A. Schaefer, J.W .",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10.1126/   science.108690 7 Whitcomb, E.A., B.B.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"http://dx.doi.org/10   .4049/jimmunol.180.6.370 8 Zhou, Z., H. Niu, Y.-Y.",OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
"12:7. http://dx.doi.org/10.1186/   1471-2172-12- 7 Zikherman, J., R. Parameswaran, and A. Weiss.",Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
http://dx.doi.org/10.1038/nature1131 1,Non-OADS,/arxiv_data1/oa_pdf/21/2d/JEM_20150585.PMC4577851.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/81/bmjopen-2015-007972.PMC4577868.pdf
"Global immunization data, 2014. http://www.who.int/immunization/monitoring_surveillance/global_immunization_data.pdf?ua=1 3.",OADS,/arxiv_data1/oa_pdf/7b/81/bmjopen-2015-007972.PMC4577868.pdf
May 2012. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/7b/81/bmjopen-2015-007972.PMC4577868.pdf
"WHO and UNICEF estimates of immunization coverage: 2010revision, 15 July 2011. http://www.childinfo.org/files/India_1997_2010.pdf 23. WHO and the United Nations Children ’s Fund (UNICEF).",Non-OADS,/arxiv_data1/oa_pdf/7b/81/bmjopen-2015-007972.PMC4577868.pdf
"WHO and UNICEF estimates of national immunization coverage, 2012 revision(completed July 2013), Jan 2014. http://data.unicef.org/child-health/immunization.html 24.",Non-OADS,/arxiv_data1/oa_pdf/7b/81/bmjopen-2015-007972.PMC4577868.pdf
"UNHCR, 2010. http://www.unhcr.org/3b66c2aa10.html (accessed 24Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
"World Health Organization, 2010. http://www.searo.who.int/ entity/emergencies/documents/field_manual_rh_humanitarian_ settings.pdf (accessed 25 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
http://unamid.unmissions.org/ Default.aspx?tabid=10998 (accessed 26 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
https://healthreach.nlm.nih.gov/documents/darfur_the_ culture_and_the_people_English.pdf (accessed 8 Jul 2015).21.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
"Immunization, Vaccines and Biologicals , 13 February 2008. http://www.who.int/immunization/ topics/tetanus/en/index.html (accessed 26 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
August 2011. http://reliefweb.int/sites/reliefweb.int/files/resources/MICS4_Sudan_2010.pdf (accessed 1 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
"UNFPA Sudan, Country Office, 2012. http://countryoffice.unfpa.org/filemanager/files/sudan/facts/maternal_ health.pdf (accessed 28 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
http://www.unhcr.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/bmjopen-2015-008285.PMC4577869.pdf
"SES was deﬁned by tertiles of the 2010 index of multiple depriv- ation (IMD) (http://data.gov.uk/dataset/index-of- multiple-deprivation), assessed by residential postcode.The IMD score estimates area deprivation based on indi- cators of income, health, education and employment status, where a higher score equals a higher level ofdeprivation.",OADS,/arxiv_data1/oa_pdf/ad/e5/bmjopen-2015-008383.PMC4577870.pdf
http://www.health.gov.au/internet/main/publishing.nsf/content/health-pubhlth-strateg-phys-act-guidelines#npa05 18.,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/bmjopen-2015-008383.PMC4577870.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008797).,Non-OADS,/arxiv_data1/oa_pdf/d9/e2/bmjopen-2015-008797.PMC4577874.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008656).,Non-OADS,/arxiv_data1/oa_pdf/06/a8/bmjopen-2015-008656.PMC4577876.pdf
Competing interests All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no competing interests.,Non-OADS,/arxiv_data1/oa_pdf/06/a8/bmjopen-2015-008656.PMC4577876.pdf
http://www.cso.ie/px/ pxeirestat/Statire/SelectVarVal/Define.asp?maintable=PEA01&PLanguage=0 (accessed 10 Mar 2015).,OADS,/arxiv_data1/oa_pdf/06/a8/bmjopen-2015-008656.PMC4577876.pdf
http://dx.doi .org/10.1086/507550 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10 .1002/bies.201000118 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.3201/eid1201.051254 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/j.cell.2005.10.019 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1353/bhm.2002.0022 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1038/nature08260 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Science 325:484 – 487. http://dx.doi.org/10.1126/science.1177238 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1038/nature08157 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1126/science.1176225 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Pathogenesis and transmission of swine-origin 2009 A(H1N1) inﬂuenza virus in ferrets.Science 325:481– 483. http://dx.doi.org/10.1126/science.1177127 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/j.cell.2009.05.032 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/S0140-6736(08)60627-3 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128/mBio.00445-13 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1056/NEJMoa1304459 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1126/science.1239844 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi .org/10.3310/hta14340-02 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1086/524064 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org /10.1017/S0950268810000518 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Inﬂu-enza Other Respir Viruses 6:449 – 460. http://dx.doi.org/10.1111/j.1750 -2659.2012.00342.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi .org/10.1093/infdis/jir729 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1038/nature10921 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1002/9780470942390.mo110173 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1371/journal.pone.0004857 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1586/14737159.8.4.515 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1111/j.1601-183X.2007.00335.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org /10.1128/JVI.00514-09 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/j .ajpath.2011.03.041 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128/mBio.00171-11 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/j.micinf.2011.08.008 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10 .1128/JVI.05930-11 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Biochimie 89:812– 818. http://dx.doi.org/10.1016/j .biochi.2007.04.015 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128/JVI.00546-06 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1016/j .immuni.2011.07.012 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
J Biol Chem 289:6020 – 6027. http://dx.doi.org/10.1074/jbc .M113.543892 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
J Virol85:8646 – 8655. http://dx.doi.org/10.1128/JVI.02559-10 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1371/journal.ppat.1003196 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1023/A:1018741312058 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128 /JVI.06156-11 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Brain Behav Immun 26:83– 89. http://dx.doi.org/10 .1016/j.bbi.2011.07.238 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128/JVI.01116-07 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1128/JVI.01718-06 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10 .1016/j.cyto.2008.01.013 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Genetics 190: 389 – 401. http://dx.doi.org/10.1534/genetics.111.132639 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1093/infdis/jit463 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
J Immunol 191:4740 – 4747. http://dx.doi.org/10 .4049/jimmunol.1301744 .,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.Methods 25:402– 408. http://dx.doi.org/10.1006/meth.2001.1262 .,OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
http://dx.doi.org/10.1371/journal.pone.0033180 .Inﬂuenza Virus Host Resistance October 2015 Volume 89 Number 19 jvi.asm.org 10009 Journal of Virology,Non-OADS,/arxiv_data1/oa_pdf/8e/e3/zjv9998.PMC4577889.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008032).,Non-OADS,/arxiv_data1/oa_pdf/70/9d/bmjopen-2015-008032.PMC4577926.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
http://www.health-inequalities.eu/HEALTHEQUITY/ EN/about_hi/marmot_reviews/ (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
http://www.cuore.iss.it (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
https://www.youtube.com/watch?v=Lw8E-0amEuc (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
"‘O sale mio (2), https://www.youtube.com/watch?v=9KfVHIEup6k (30 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
https://www.youtube.com/watch?v=h4Vzt-qPb1c (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
https://www.youtube.com/watch?,Non-OADS,/arxiv_data1/oa_pdf/f8/12/bmjopen-2014-007467.PMC4577927.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008277).,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/bmjopen-2015-008277.PMC4577928.pdf
"NCCN Clinical Practice Guidelines in Oncology: distress management, 2015. http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/bmjopen-2015-008277.PMC4577928.pdf
http://onlinelibrary.wiley.com/.,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/bmjopen-2015-008277.PMC4577928.pdf
http://onlinelibrary.wiley.com/.,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/bmjopen-2015-008277.PMC4577928.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008158).,Non-OADS,/arxiv_data1/oa_pdf/fd/30/bmjopen-2015-008158.PMC4577929.pdf
Data fromthe Federal Statistical Office(http://www.gbe-bund.de) as of15 December 2014 and from GEKID as of 10 December 2014.,OADS,/arxiv_data1/oa_pdf/fd/30/bmjopen-2015-008158.PMC4577929.pdf
http://www.gekid.de (accessed 10 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/fd/30/bmjopen-2015-008158.PMC4577929.pdf
"Community-speci ﬁc daily meteorological data for the same period were retrieved from the China National Weather Data Sharing System (http://cdc.cma.gov.cn/home.do), which is publicly accessible.",OADS,/arxiv_data1/oa_pdf/64/d1/bmjopen-2015-009172.PMC4577931.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008430).,Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
"Geneva, Switzerland: WHO Press, 2010. http://www.who.int/dietphysicalactivity/physical_activity-recommendations-18-64years.pdf (accessed 27 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
"Geneva, Switzerland: World Health Organisation, 2001. http://www.who.int (accessed 5 May2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
http://www.cosmin.nl (accessed 19 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
"Global Strategy on Diet, Physical Activity & Health 2010. http://www.who.int/dietphysicalactivity/strategy/en/ (accessed 4 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
"London: National Institute for Clinical Excellence, 2006. http://www.nice.org.uk/PHI002 (accessed 11 Jan 2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
"Quality of Life Research, 2011. http://www.comin.nl (accessed 6 Jul 2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/29/bmjopen-2015-008430.PMC4577932.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008290).,Non-OADS,/arxiv_data1/oa_pdf/05/a1/bmjopen-2015-008290.PMC4577933.pdf
http://eurofound.europa.eu/ewco/2006/07/NL0607019I.htm(accessed 23 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/05/a1/bmjopen-2015-008290.PMC4577933.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007396).,Non-OADS,/arxiv_data1/oa_pdf/1f/d0/bmjopen-2014-007396.PMC4577937.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/d0/bmjopen-2014-007396.PMC4577937.pdf
2013. http://www.hscic.gov.uk/catalogue/ PUB13115/nati-chil-meas-prog-eng-2012 –2013-rep.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/d0/bmjopen-2014-007396.PMC4577937.pdf
http://eppi.ioe.ac.uk/cms/LinkClick.aspx?fileticket=hQBu8y4uVwI%3d&tabid=1919&mid=6163 35.,Non-OADS,/arxiv_data1/oa_pdf/1f/d0/bmjopen-2014-007396.PMC4577937.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e8/99/atr-04-02-28013.PMC4577941.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/91/aa/atr-04-02-25299.PMC4577943.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008542).,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/bmjopen-2015-008542.PMC4577945.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008419).,Non-OADS,/arxiv_data1/oa_pdf/d9/4d/bmjopen-2015-008419.PMC4577948.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008093).,Non-OADS,/arxiv_data1/oa_pdf/7e/93/bmjopen-2015-008093.PMC4577951.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/93/bmjopen-2015-008093.PMC4577951.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008599).,Non-OADS,/arxiv_data1/oa_pdf/03/48/bmjopen-2015-008599.PMC4577953.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/03/48/bmjopen-2015-008599.PMC4577953.pdf
"Further details are available at: https://www.melbourneinstitute.com/hilda/ Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/74/59/bmjopen-2014-007052.PMC4577957.pdf
"Secondary 4364.0.55.003 —Australian Health Survey: Updated Results, 2011 –2012: Overweight and obesity 2013. http://www.abs.gov.",Non-OADS,/arxiv_data1/oa_pdf/74/59/bmjopen-2014-007052.PMC4577957.pdf
"Secondary 4364.0.55.003 — Australian Health Survey: Updated Results, 2011 –2012: MEDIA RELEASE: Health depends on where your home is 2013. http://www.abs.gov.au/ausstats/abs@.nsf/lookup/4364.0.55.003Media%20Release12011 –2012 14.",Non-OADS,/arxiv_data1/oa_pdf/74/59/bmjopen-2014-007052.PMC4577957.pdf
Latest census shows 12% of the population are born outside of Ireland (see http://www.cso.ie/en/census/census2011reports/census2011pro ﬁle6migrationanddiversity-apro ﬁleofdiversityinireland).,OADS,/arxiv_data1/oa_pdf/d8/45/bmjopen-2014-007092.PMC4577965.pdf
Translocations: Migration Soc Change 2010;6. http://www.translocations.ie/v06i01.html 13.,OADS,/arxiv_data1/oa_pdf/d8/45/bmjopen-2014-007092.PMC4577965.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/cd/bmjopen-2015-008525.PMC4577966.pdf
April 2012. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216503/dh_133511.pdf(accessed 9 Mar 2015).,OADS,/arxiv_data1/oa_pdf/fd/cd/bmjopen-2015-008525.PMC4577966.pdf
2010.http://www.nrls.npsa.nhs.uk/resources/?EntryId45=69894 (accessed23/06/2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/cd/bmjopen-2015-008525.PMC4577966.pdf
"London: Methods for development of NICE public health guidance, 2006.http://www.nice.org.uk/article/pmg4/resources/non-guidance-methods-for-the- development-of-nice-public-health-guidance-third-edition-pdf (accessed 23 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/af/55/bmjopen-2015-008346.PMC4577972.pdf
Oxford Centre for Evidence-Based Medicine.http://www.cebm.net/index.aspx?o=5653 (accessed 23 may 2015).,Non-OADS,/arxiv_data1/oa_pdf/af/55/bmjopen-2015-008346.PMC4577972.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008625).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
Some parents registered and completed the consent and parent questionnaire online (http://www.asd-uk.com).Families could also self-refer by contacting ASD-UK dir- ectly or via the website.,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
Funding We are extremely grateful to the UK autism research charity Autistica (http://www.autistica.org.uk/) for funding and supporting ASD-UK and Dasl ne.,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://autistica.org.uk/document_ downloads/Reports/Autistica-1-100-Report.PDF (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://www.hqip.org.uk/support-for-clinical-databases-and-registers(accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://www.iancommunity.,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://autismwa.org.au/2005_ report_final.pdf (accessed Apr 2015).,OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
2010. http://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/6871/1871208.pdf (accessedApr 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
2011. http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-local-authorities-in-england-and-wales/rpt-ethnicity.html (accessedApr 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://www.improvinghealthandlives.org.uk/uploads/doc/vid_8731_IHAL2010-05Autism.pdf (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
http://www.hqip.org.uk/ support-for-clinical-databases-and-registers (accessed 07 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/83/1c/bmjopen-2015-008625.PMC4577974.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008472).,Non-OADS,/arxiv_data1/oa_pdf/5d/f6/bmjopen-2015-008472.PMC4577976.pdf
"Assessment of methodological quality and data reporting The Risk of Bias Tool for Prevalence Studies developed by Hoy et al 25(see online supplementary material appen- dix S1), and the Cochrane guidelines available in ReviewManager V.5.3 (http://tech.cochrane.org/revman) will be used to assess the methodological quality and risk of bias for each study.",OADS,/arxiv_data1/oa_pdf/5d/f6/bmjopen-2015-008472.PMC4577976.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2015-000101).,Non-OADS,/arxiv_data1/oa_pdf/7d/3d/lupus-2015-000101.PMC4577980.pdf
She usually recovered from theseFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"She walked well with good arm swing.Termsarasab P, Yang AC, Frucht SJ Intermediate Phenotypes of ATP1A3 Mutations Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"1Features that are seen in the videos.Intermediate Phenotypes of ATP1A3 Mutations Termsarasab P, Yang AC, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Nat Genet 2012;44:1030– 1034, doi: http://dx.doi.org/10.1038/ng.2358.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Orphanet J Rare Dis 2014;9:15, doi: http://dx.doi.org/10.1186/1750-1172-9-15.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Mov Disord 2013;28:1457– 1459, doi: http://dx.doi.org/10.1002/mds.25396.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Mov Disord 2014;29:153–154, doi: http://dx.doi.org/10.1002/mds.25659.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Neurology 2014;82:945–955, doi: http://dx.doi.org/10.1212/WNL.0000000000000212.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Lancet Neurol 2012;11:741–743, doi: http://dx.doi.org/10.1016/ S1474-4422(12)70185-0.8.Alexoudi A, Schneider SA.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Mov Disord 2012;27:1494, doi: http://dx.doi.org/10.1002/mds.25222.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
http://evs.gs.washington.edu/EVS/ (accessed June 2015).,Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Nature 2012; 491:56–65, doi: http://dx.doi.org/10.1038/nature11632.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Nat Protoc 2009;4:1073–1081, doi: http://dx.doi.org/10.1038/nprot.2009.86.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Nat Methods 2010;7:248–249, doi: http://dx.doi.org/10.1038/nmeth0410-248.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Genet Med 2015;17:405–423, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Ann Neurol 2004;55:435–438, doi: http://dx.doi.org/10.1002/ana.20055.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Epilepsia 2015;56:82–93, doi: http://dx.doi.org/10.1111/epi.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"1Mutations in our cases.Termsarasab P, Yang AC, Frucht SJ Intermediate Phenotypes of ATP1A3 Mutations Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Lancet Neurol 2012;11:764– 773, doi: http://dx.doi.org/10.1016/S1474-4422(12)70182-5.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Biochim Biophys Acta 2014; 1842:1010–1016, doi: http://dx.doi.org/10.1016/j.bbadis.2014.03.002.",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Neurology 2009;73:400–401, doi: http://dx.doi.org/10.1212/WNL.0b013e3181 b04acd.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Brain 2007;130:828–835, doi: http://dx.doi.org/10.1093/brain/ awl340.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Pediatrics 2009;123:e534–541, doi: http://dx.doi.org/10.1542/peds.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Neurology 1993;43:2596–2602, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Acta Neuropathol 2014;128:81–98, doi: http://dx.doi.org/10.1007/s00401-014-1279-x.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"Neurology 2014;83:861–863, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"J Neurol Sci 2014; 341:133–135, doi: http://dx.doi.org/10.1016/j.jns.2014.03.034.Intermediate Phenotypes of ATP1A3 Mutations Termsarasab P, Yang AC, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",OADS,/arxiv_data1/oa_pdf/30/b2/tre-05-336-7157-2.PMC4578012.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:638-647 http://dx.doi.org/10.3904/kjim.2015.30.5.638INTRODUCTION The average age of the Korean population as well as that  in Western countries is increasing.",Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
Nursing home acquired pneumonia in the elderly www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.638tality rate for pneumonia seems to be associated with  the increased number of elderly patients [1].,Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.638within the past 30 days; or (4) attendance at a hospital  clinic or dialysis center in the last 30 days [2].",Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
Nursing home acquired pneumonia in the elderly www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.638need for mechanical ventilation was not difference be - tween the two groups.,Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.638Table 1.",Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"Nursing home acquired pneumonia in the elderly www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.638DISCUSSION Before the 2005 ATS/IDSA HCAP guidelines, NHAP was  included as a CAP category [13]; however, because some  studies performed in the early 2000s reported high iso - lation rates of PDR pathogens in patients with NHAP,  there was a disagreement over the NHAP classification  [14-16].",Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.638tween CAP and HAP [13].",OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"Nursing home acquired pneumonia in the elderly www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.638ported poor outcomes in patients with NHAP, but the  isolation rate of PDR pathogens was relatively low and  similar to that of CAP [7,8].",Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.6388.6% and 10.3%, which was higher than that reported in  other European and Asian studies.",OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
Nursing home acquired pneumonia in the elderly www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.638REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
Available from: http://kostat.go.kr/portal/korea/ index.action.,Non-OADS,/arxiv_data1/oa_pdf/4e/6c/kjim-30-5-638.PMC4578015.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:620-628 http://dx.doi.org/10.3904/kjim.2015.30.5.620 INTRODUCTION Newer P2Y12 inhibitors, such as prasugrel and ticagrelor,  have greater antiplatelet efficacy than clopidogrel [1,2].",Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
Optimal P2Y12 inhibitor in East Asians  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.620may be more vulnerable to bleeding complications.,Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.620clotting time of 250 to 300 seconds.",Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
Optimal P2Y12 inhibitor in East Asians  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.620Table 1.,Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.620DISCUSSION  The study described herein demonstrates the antiplate - let efficacy of 5 or 10 mg daily prasugrel and 90 mg twice  daily ticagrelor in Korean patients with ACS.",Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
Optimal P2Y12 inhibitor in East Asians  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.620have emerged as alternatives to clopidogrel for resolv - ing HPR [21].,Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.620used the Caucasian cut-off value of LPR to define the  therapeutic window.",Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
Optimal P2Y12 inhibitor in East Asians  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.620date on the definition of on-treatment platelet reactivity  to adenosine diphosphate associated with ischemia and  bleeding.,Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.620the incidence of venous thromboembolism.",Non-OADS,/arxiv_data1/oa_pdf/43/50/kjim-30-5-620.PMC4578016.pdf
"REVIEWKorean J Intern Med 2015;30:559-570 http://dx.doi.org/10.3904/kjim.2015.30.5.559 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgA systematic approach for the diagnosis and   treatment of idiopathic peptic ulcers Chen-Shuan Chung1, Tsung-Hsien Chiang2, and Yi-Chia Lee2 1Department of Internal Medicine,  Far Eastern Memorial Hospital,  New Taipei  City; 2Department  of Internal Medicine, National  Taiwan University Hospital, Taipei,  Taiwan Received : January 22, 2015 Accepted : June 20, 2015 Correspondence to Yi-Chia Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
560  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
"Approach and management of idiopathic peptic ulcer www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559IDIOPATHIC PEPTIC ULCER DISEASE: A DIAG - NOSIS OF EXCLUSION Because IPUD is defined as PUD that arises without an  identifiable cause, it is a diagnosis of exclusion.",Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
562  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
"Approach and management of idiopathic peptic ulcer www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559mastocytosis, amyloidosis, sarcoidosis, vasculitis, eosin - ophilic gastroenteritis, and Zollinger-Ellison syndrome  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
564  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
"Approach and management of idiopathic peptic ulcer www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559ish adults in 1982 to 1983 revealed a greater incidence  of ulcers among subjects in the highest tertile of stress  scores (3.5%) than in those in the lowest tertile (1.6%; p <  0.01) and high psychological stress has been identified  as an independent risk factor for PUD on multivariate  analysis (odds ratio, 1.12 per point increment of stress  index; 95% confidence interval [CI], 1.01 to 1.23; p = 0.03)  [76].",Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
566  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
Approach and management of idiopathic peptic ulcer www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.5594.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
Available from: http://www.iarc.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
568  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
Approach and management of idiopathic peptic ulcer www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.55952.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
570  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.559 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/kjim-30-5-559.PMC4578017.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:727-729 http://dx.doi.org/10.3904/kjim.2015.30.5.727Division of Cardiology, Department  of Internal Medicine, College of  Medicine, Daejeon St. Mary’s  Hospital, The Catholic University of  Korea, Daejeon, KoreaType 4 dual left anterior descending coronary artery Chan Joon Kim, Hee Jeoung Yoon, Sung Ho Her, Jun Han Jeon, Seung Min Jung, Eun Hee Jang,    and Seung Won Jin Received : March 4, 2008 Revised : March 25, 2008 Accepted : September 8, 2008 Correspondence to Hee Jeoung Yoon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/33/8b/kjim-30-5-727.PMC4578018.pdf
728 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.727The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/33/8b/kjim-30-5-727.PMC4578018.pdf
"729 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.727Kim CJ, et al.",OADS,/arxiv_data1/oa_pdf/33/8b/kjim-30-5-727.PMC4578018.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:739-741 http://dx.doi.org/10.3904/kjim.2015.30.5.739Departments of 1Hematology,  2Internal Medicine, and 3Pathology,  Mersin University Faculty of  Medicine, Mersin, Turkey Complete recovery of pyoderma gangrenosum   after successful treatment of underlying hairy cell  leukemia with cladribine A nı l Tomba k1, Sinan Aygün2, Ebru Serinsöz3, and Eyüp Naci Tiftik1 Received : January 21, 2014 Revised : May 22, 2014 Accepted : July 7, 2014 Correspondence to  Anil Tombak, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f7/f7/kjim-30-5-739.PMC4578019.pdf
740 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.739The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/f7/kjim-30-5-739.PMC4578019.pdf
"741 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.739Tombak A, et al.",OADS,/arxiv_data1/oa_pdf/f7/f7/kjim-30-5-739.PMC4578019.pdf
"Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTEREST Korean J Intern Med 2015;30:743-744 http://dx.doi.org/10.3904/kjim.2015.30.5.743An 85-year-old male with stage IV lung  cancer, being treated with palliative  chemo-radiotherapy for nine months,  presented with nausea, early satiety,  bilious vomiting, and abdominal pain  for 2 weeks prior to admission.",Non-OADS,/arxiv_data1/oa_pdf/ca/16/kjim-30-5-743.PMC4578020.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.743puted tomography with contrast, followed by either  upper gastrointestinal contrast-enhanced imaging or  upper endoscopy, establishes the diagnosis and rules  out other causes of gastric outlet obstruction.",Non-OADS,/arxiv_data1/oa_pdf/ca/16/kjim-30-5-743.PMC4578020.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:648-656 http://dx.doi.org/10.3904/kjim.2015.30.5.648INTRODUCTION Although previous studies have demonstrated that inten - sive glycemic control in diabetes mellitus is important  to prevent micro- and macrovascular complications  [1,2], the risk of hypoglycemia should not be overlooked.",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"Electrolytes during severe hypoglycemia www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.648been well described that a decrease in serum potassium  during insulin induced hypoglycemia is caused both by  insulin and adrenaline [9,10].",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.648RESULTS Of the 1,068 patients who visited the emergency room  with severe hypoglycemia and were screened, 219 patients  were analyzed for this study, 90 of whom were male.",OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
Electrolytes during severe hypoglycemia www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.648Hypo- Hyper-60 50 40 30 20 10 0(%) 25 201510 50(%) Normal AbnormalPotassiumPure electrolyte disturbnace Mixed electrolyte disturbance Sodium Chloride Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.648justed by age ( r = 0.167, p = 0.013).",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"Electrolytes during severe hypoglycemia www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.648ever, during severe hypoglycemia, heart rate, systolic, and  diastolic blood pressure were not significantly different  among the electrolyte subgroups (Table 3), nor did these  parameters differ significantly when examining blood  glucose levels.",OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.648than that of the aforementioned study, most likely due  to a lower number of patients treated with insulin ther - apy (21.0% vs. 51.0%).",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"Electrolytes during severe hypoglycemia www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.648severe hypoglycemia, as compared to the recovery stage.",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.648group on Hypoglycemia.",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/kjim-30-5-648.PMC4578021.pdf
"ORIGINAL ARTICLECopyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:665-674 http://dx.doi.org/10.3904/kjim.2015.30.5.665 INTRODUCTION Blood pressure (BP) is a predictor of cardiovascular and cerebrovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.665for a recent 15-year period (from 1985 to 2009) showed  that hypertension is a major cause of ESRD, and the prev - alence of hypertension would be increased by CKD itself  [5].",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"Specific time for BP measurement in CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.665Statistical analysis First, we analyzed the differences between the SBPs at  each time point and the 24-hour mSBP (Fig.",OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.665in this study (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"Specific time for BP measurement in CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.6652:00 PM, and 9:30 PM were chosen according to the or - der of decreasing difference from 24-hour mSBP.",OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.665values compared with the three previously selected time  points (7:00 AM, 2:00 PM, and 9:30 PM) (Table 4).",OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"Specific time for BP measurement in CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.665than ABPM, but few studies have examined the detailed  guidelines for the specific time points for self-BP mea - surement, especially in CKD patients [9,21,22].",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.665and nighttime mSBP.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
Specific time for BP measurement in CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.665sion in patients with chronic kidney disease.,Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.665should blood pressure be measured at home for better  prediction of stroke risk?",Non-OADS,/arxiv_data1/oa_pdf/7a/db/kjim-30-5-665.PMC4578022.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:602-609 http://dx.doi.org/10.3904/kjim.2015.30.5.602INTRODUCTION Acute pancreatitis remains the most common adverse  event of endoscopic retrograde cholangiopancreatogra - phy (ERCP), with an incidence ranging from 2% to 4%  in low-risk patients to 8% to 20% in high-risk patients [1].",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"Prevention of post-ERCP pancreatitis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.602studies [3,4].",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.602patulous papilla, time to deep common bile duct (CBD)  cannulation, number of cannulations into the pancre - atic duct, extent of pancreatic opacification, and type of  therapy performed.",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"Prevention of post-ERCP pancreatitis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.602event or surgery (n = 81), need for emergency ERCP (n  = 193), refusal to participate (n = 5), or extrahepatic bile  duct diameter > 10 mm (n = 528).",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.602in 29 patients, moderate in four patients, and severe in  two patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"Prevention of post-ERCP pancreatitis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.602udenafil in combination with aceclofenac was based on  the ability of this combination to reduce the pressure of  the sphincter of Oddi, as well as inflammation present  in acute pancreatitis through modulation of the cyto - kine cascade.",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.602only 3.4.",Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
Prevention of post-ERCP pancreatitis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.602pholipase-A2 in acute pancreatitis by pharmacological  agents in vitro.,Non-OADS,/arxiv_data1/oa_pdf/ad/48/kjim-30-5-602.PMC4578023.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:742 http://dx.doi.org/10.3904/kjim.2015.30.5.742Department of Urology, Gulhane  Military Medical Academy, Ankara,  TurkeyPenicillin G-induced hemorrhagic cystitis Engin Kaya and Sercan Yilmaz Received : February 9, 2014 Revised : April 22, 2014 Accepted : July 10, 2014 Correspondence to Engin Kaya, M.D.",Non-OADS,/arxiv_data1/oa_pdf/09/70/kjim-30-5-742.PMC4578024.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:730-734 http://dx.doi.org/10.3904/kjim.2015.30.5.730Department of Internal Medicine,  College of Medicine, The Catholic  University of Korea, Seoul, Korea A novel  PRKAR1A  mutation resulting in a splicing  variant in a case of Carney complex Yi Sun Jang, Sung Dae Moon, Ju Hee Kim, Ihn Suk Lee, Jong Min Lee, and Hye Soo Kim Received : November 7, 2014 Revised : November 17, 2014 Accepted : November 27, 2014 Correspondence to  Hye Soo Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0a/61/kjim-30-5-730.PMC4578025.pdf
"731 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.730Jang YS, et al.",OADS,/arxiv_data1/oa_pdf/0a/61/kjim-30-5-730.PMC4578025.pdf
           732 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.730The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0a/61/kjim-30-5-730.PMC4578025.pdf
"733 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.730Jang YS, et al.",OADS,/arxiv_data1/oa_pdf/0a/61/kjim-30-5-730.PMC4578025.pdf
           734 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.730The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0a/61/kjim-30-5-730.PMC4578025.pdf
"EDITORIAL Korean J Intern Med 2015;30:590-592 http://dx.doi.org/10.3904/kjim.2015.30.5.590 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDetecting masked high blood pressure in    high-risk patients Hyungseop Kim Division of Cardiology,  Department of Internal Medicine,  Keimyung University Dongsan  Medical Center, Daegu, Korea Received : July 20, 2015 Accepted: July 24, 2015 Correspondence to Hyungseop Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/7e/15/kjim-30-5-590.PMC4578026.pdf
591 www.kjim.org Kim H. Ambulatory blood pressure monitoring   http://dx.doi.org/10.3904/kjim.2015.30.5.590and truly resistant hypertension [2].,Non-OADS,/arxiv_data1/oa_pdf/7e/15/kjim-30-5-590.PMC4578026.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.590blood pressure values.",OADS,/arxiv_data1/oa_pdf/7e/15/kjim-30-5-590.PMC4578026.pdf
"REVIEW Korean J Intern Med 2015;30:580-589 http://dx.doi.org/10.3904/kjim.2015.30.5.580 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgMesenchymal stem cell therapy for liver fibrosis Young Woo Eom1, Kwang Yong Shim2, and Soon Koo Baik1,2 1Cell Therapy and Tissue  Engineering Center, 2Department  of Internal Medicine, Yonsei  University Wonju College of  Medicine, Wonju, Korea  Received : November 26, 2014 Accepted : December 19, 2014 Correspondence to  Soon Koo Baik, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
MSCs as a treatment for liver fibrosis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580and (3) the clinical application of MSCs for the treatment  of liver fibrosis.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
        582  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
"MSCs as a treatment for liver fibrosis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580Moreover, after MSCs move to damaged sites for repair,  they are stimulated by local factors, such as inflammato - ry cytokines, ligands of Toll-like receptors and hypoxic  conditions.",Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
        584  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
MSCs as a treatment for liver fibrosis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580alcoholic cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
        586  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
MSCs as a treatment for liver fibrosis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.5802006;107:367-372.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
        588  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
MSCs as a treatment for liver fibrosis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.580chymal stem cell transplantation in patients with decom - pensated liver cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/9f/ac/kjim-30-5-580.PMC4578027.pdf
"REVIEW Korean J Intern Med 2015;30:571-579 http://dx.doi.org/10.3904/kjim.2015.30.5.571 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgEvidence for beneficial effects of vitamin E Etsuo Niki1,2 1Health Research Institute,  National Institute of Advanced  Industrial Science & Technology,  Ikeda; 2Department of Molecular  Gastroenterology and Hepatology,  Kyoto Prefectural University of  Medicine, Kyoto, Japan Received : January 22, 2015 Accepted : June 18, 2015 Correspondence to  Etsuo Niki, Ph.D. Health Research Institute,  National Institute of Advanced  Industrial Science & Technology,  1-8-31 Midorigaoka, Ikeda 563- 8577, Japan Tel: +81-3-5313-2555 Fax: +81-3-5313-2555 E-mail: etsuo-niki@aist.go.jpOxidative stress and lipid peroxidation have been implicated in the pathogenesis  of various diseases, including atherosclerosis and fatty liver diseases, and conse - quently the role of antioxidants in the prevention and treatment of such diseases  has received much attention.",Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
572  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
"573 Niki E. Vitamin E benefits www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571steatohepatitis (NASH), liver cirrhosis, liver failure, and  hepatocellular carcinoma [18].",Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
574  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
575 Niki E. Vitamin E benefits www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571diovascular disease [50].,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
576  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
577 Niki E. Vitamin E benefits www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571was reported.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
578  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
579 Niki E. Vitamin E benefits www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.571globin 2-2 genotype.,Non-OADS,/arxiv_data1/oa_pdf/57/4c/kjim-30-5-571.PMC4578028.pdf
"ORIGINAL ARTICLECopyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:657-664 http://dx.doi.org/10.3904/kjim.2015.30.5.657 INTRODUCTION Kidney transplantation (KT) is considered the best  treatment option for patients with end-stage renal dis - ease [1,2].",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.657fectiveness compared to patients who return to dialysis  after allograft failure [5,6,9-11].",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
Single-center experience with third kidney transplants www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.657for the first and second procedures are shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.657Of these patients, we performed nephrectomy of the  first and second grafts in three patients, the first graft  only in four patients, and the second graft only in the re - maining three patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"Single-center experience with third kidney transplants www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.65781.8%, 42.9%, and 42.9%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.657DISCUSSION Despite significant advances in transplantation tech - niques and immune suppressants, renal allograft sur - vival rates remain low.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
Single-center experience with third kidney transplants www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.657tal complications associated with the long-term use of  intense immune suppression.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.65715.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
Available from: http://www.kosis.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/kjim-30-5-657.PMC4578029.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:593-601 http://dx.doi.org/10.3904/kjim.2015.30.5.593INTRODUCTION The prevalence of gastric varices (GVs) in patients with  portal hypertension varies from 18% to 70% [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.593varix, which effectively controls active variceal bleeding.",Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
PPIs in GVH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.593on the size of the gastric varix.,OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.593Review Board of Chonnam National University Hospital  (CNUH-2013-191).",Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
PPIs in GVH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.593Patients were grouped according to the Child-Pugh  classification to assess the prognosis of chronic liver  disease.,Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.593Risk factors for rebleeding in the follow-up EGD  group Univariate analysis showed that use of PPIs (RR, 0.436;  95% CI, 0.222 to 0.857;  p = 0.016) and a previous history of variceal bleeding (RR, 3.257; 95% CI, 1.701 to 6.25; p <  0.001) were associated with rebleeding in the follow-up  EGD group.",Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
PPIs in GVH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.593bleeding-related deaths.,Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.593[7,10].",Non-OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
PPIs in GVH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.593Gastrointest Endosc 2000;52:160-167.,OADS,/arxiv_data1/oa_pdf/e1/d2/kjim-30-5-593.PMC4578030.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:629-637 http://dx.doi.org/10.3904/kjim.2015.30.5.629INTRODUCTION The updated guidelines of the Global Initiative for  Chronic Obstructive Lung Disease (GOLD) categorize patients with chronic obstructive pulmonary disease  (COPD) into subgroups (A to D) using symptoms based  on either their modified Medical Research Council  (mMRC) grade or COPD assessment test (CAT) score, Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, Seoul National  University College of Medicine,  Seoul, Korea Received : April  29, 201 4 Revised : June 10, 2014 Accepted : July 10, 2014 Correspondence to  Chul-Gyu Yoo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.629and risk is based on the forced expiratory volume in 1  second (FEV1) or exacerbation history [1].",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"CAT score and mMRC grade www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.629two subgroups based on the categories chosen and the  CART algorithm in the case of continuous variables (e.g.,  CAT score) that best reflected the probability of the out - come.",OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.629[CAT criterion]), 142 (44.2%) met only the CAT criterion,  16 (5.0%) met only the mMRC criterion, and 163 (50.8%)  met both.",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"CAT score and mMRC grade www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.629ria from 5.0% to 20.9% (Table 3), and an increase in the  percentage of patients classified into subgroups A and C  (22.0% to 37.4% in subgroup A, and 3.0% to 5.6% in sub - group C) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.629on alone, although the FEV1 criterion and exacerbation  criterion had comparable roles in determining the risk  group (among high-risk patients, 62.0% met the FEV1  criterion and 48.8% met the exacerbation criterion).",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
CAT score and mMRC grade www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.629of 2 is a more appropriate cut-off level than an mMRC  grade of 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.629Conflict of interest No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
Avail - able from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2013_Feb20.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
Available from: http://www.lungkorea.org.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
CAT score and mMRC grade www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.62918.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/kjim-30-5-629.PMC4578031.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:675-683 http://dx.doi.org/10.3904/kjim.2015.30.5.6751Department of Internal Medicine,  Kosin University College of Medicine,  Busan; 2Department of Internal  Medicine, College of Medicine,  Seoul St. Mary’s Hospital, The  Catholic University of Korea, Seoul;  3Department of Hematology- Oncology, Chonnam National  University Hwasun Hospital,  Hwasun; 4Department of Internal  Medicine, Samsung Medical Center,  Sungkyunkwan University School  of Medicine, Seoul; 5Department  of Oncology, Asan Medical Center,  University of Ulsan College of  Medicine, Seoul; 6Department of  Internal Medicine, National Cancer  Center , Goyang; 7Department of  Internal Medicine, Inje University  Busan Paik Hospital, Busan;  8Department of Internal Medicine,  Pusan National University Hospital,  Busan; 9Department of Internal  Medicine, Dong-A University College  of Medicine, Busan; 10Department of  Internal Medicine, Korea University  College of Medicine , Seoul;  11Department of Hematology and  Oncology, Ulsan University Hospital,  Ulsan; 12Department of Internal  Medicine, Keimyung University  School of Medicine, Daegu;  13Department of Internal Medicine,  Ewha Womans University School of  Medicine, Seoul, Korea Received : September 5, 2014 Revised : October 13, 2014 Accepted : October 15, 2014 Correspondence to Ho Sup Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.675INTRODUCTION  Many advances have been made in treatments for mul - tiple myeloma (MM), as novel agents, such as thalido - mide, bortezomib, and lenalidomide, have been devel - oped [1-3].",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"Prognostic impact of inflammatory factors www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.675deletion, t(14;16), tri 1q, and t(14;20) were also performed  in more than 100 patients.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.675date.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
Prognostic impact of inflammatory factors www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.675Table 2.,Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.675normal, 91.6% vs. 69.5%, p < 0.001), lower cytogenetic  risk (standard vs. intermediate vs. high, 92.1% vs. 90.3%  vs. 83.8%, p = 0.028), lower ISS (I, II, and III, 98.0%, 90.3%,  and 83.8%, respectively; p = 0.024), and having fewer than  two combined abnormal inflammatory factors (< 2 vs. ≥  2, 98.1% vs. 81.1%, p < 0.001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"Prognostic impact of inflammatory factors www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.675DISSCUSSION  In this study, various parameters were estimated to  identify prognostic factors for survival in patients who  were treated with thalidomide-containing chemother - apy and who underwent ASCT.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.675vival [28,29].",OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
Prognostic impact of inflammatory factors www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.67512.,Non-OADS,/arxiv_data1/oa_pdf/23/f7/kjim-30-5-675.PMC4578032.pdf
"Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTEREST Korean J Intern Med 2015;30:745-746 http://dx.doi.org/10.3904/kjim.2015.30.5.745An 80-year-old woman who had un - dergone aortic valve replacement for  aortic valve stenosis was hospitalized  for congestive heart failure and parox - ysmal atrial fibrillation 4 years prior to  the current presentation.",Non-OADS,/arxiv_data1/oa_pdf/bd/a7/kjim-30-5-745.PMC4578033.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.745scans may reveal an increased liver density due to iodine  deposition in this organ and phospholipidosis caused  by disordered metabolism.",Non-OADS,/arxiv_data1/oa_pdf/bd/a7/kjim-30-5-745.PMC4578033.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:735-738 http://dx.doi.org/10.3904/kjim.2015.30.5.7351Division of Nephrology,  Department of Internal Medicine,  2Department of Hematology,  Catholic Blood and Marrow  Transplantation Center, Depart­ ments of 3Laboratory Medicine and  4Surgery, College of Medicine, Seoul  St. Mary’s Hospital, The Catholic  University of Korea, Seoul, KoreaLimited immune tolerance induced by transient  mixed chimerism Ji Hyun Yu1, Byung Ha Chung1, Eun Ji Oh3, Ji-Il Kim4, Hee-Je Kim2, In Sung Moon4, and Chul Woo Yang1 Received : October 25, 2014 Revised : November 17, 2014 Accepted : November 27, 2014 Correspondence to  Chul Woo Yang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ab/33/kjim-30-5-735.PMC4578034.pdf
736 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.735The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ab/33/kjim-30-5-735.PMC4578034.pdf
"737 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.735Yu JH, et al.",OADS,/arxiv_data1/oa_pdf/ab/33/kjim-30-5-735.PMC4578034.pdf
738 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.735The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ab/33/kjim-30-5-735.PMC4578034.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:714-718 http://dx.doi.org/10.3904/kjim.2015.30.5.714INTRODUCTION Behcet’s disease (BD) is a chronic, multisystemic dis - order affecting the mucous membranes, skin, eyes,  blood vessels, nerves, and other bodily organs [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c2/1b/kjim-30-5-714.PMC4578035.pdf
"Validation of BDCAF in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.714METHODS Study subjects  Patients with BD who visited our rheumatology clin - ic were enrolled in this study, and the data from those  patients who agreed to participate were collected pro - spectively from November 2012 until March 2013.",Non-OADS,/arxiv_data1/oa_pdf/c2/1b/kjim-30-5-714.PMC4578035.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.714thema, skin pustule, arthralgia, nausea/vomiting/ab - dominal pain, and diarrhea with altered/frank blood per  rectum.",Non-OADS,/arxiv_data1/oa_pdf/c2/1b/kjim-30-5-714.PMC4578035.pdf
"Validation of BDCAF in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.714bloody diarrhea in the United Kingdom version was at - tributed to the difficulty in determining whether or not  this symptom relates to mucosal inflammation, when  based only on the information gained from the clinical  history.",Non-OADS,/arxiv_data1/oa_pdf/c2/1b/kjim-30-5-714.PMC4578035.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.714Conflict of interest No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/c2/1b/kjim-30-5-714.PMC4578035.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:684-693 http://dx.doi.org/10.3904/kjim.2015.30.5.684INTRODUCTION As the life span of human beings extends, the prevalence of elderly lymphoma patients is increasing.",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
Elderly DLBCL patients over 70 years old www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.684and elderly patients with diffuse large B cell lympho - ma (DLBCL) account for a significant portion of total  elderly lymphoma patients.,Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.684RESULTS  Patient characteristics  A total of 44 patients were investigated in this study.",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
Elderly DLBCL patients over 70 years old www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.684No significant differences were shown for adriamycin  aRDI and the cycle length between groups.,Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.684testinal bleeding in two), and underlying disease (five)  other than lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
Elderly DLBCL patients over 70 years old www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.684prognostic factors cannot be the criteria to determine  suitability for chemotherapy and whether to modify  chemotherapy even though treatment intolerance can  affect prognosis.,Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.684In the present study, a total of 23 patients (56%) ex - perienced infectious complications during treatment,  and many of these patients had treatment interruptions  and treatment-related death.",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"Elderly DLBCL patients over 70 years old www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.684imab in elderly DLBCL patients [13,14].",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.684with more defined criteria should be investigated to dis - tinguish patients who cannot tolerate reduced-intensity  R-CHOP [27,28].",Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
Elderly DLBCL patients over 70 years old www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.684in elderly lymphoma patients.,Non-OADS,/arxiv_data1/oa_pdf/0c/fd/kjim-30-5-684.PMC4578036.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:610-619 http://dx.doi.org/10.3904/kjim.2015.30.5.610INTRODUCTION Arterial blood pressure (BP) is regulated by neuronal, vas -cular, and renal mechanisms and can vary substantially  according to temperature, physical activity, emotional  stress, food intake, and the use of drugs including alcohol 1Department of Internal Medicine,  Hanyang University College of  Medicine, Seoul; 2Department  of Internal Medicine, Yonsei  University College of Medicine,  Seoul; 3Department of Internal  Medicine, Chonnam National  University Medical School, Gwangju;  4Department of Internal Medicine,  College of Medicine, Bucheon  St. Mary's Hospital, The Catholic  University of Korea, Bucheon;  5Department of Internal Medicine,  Seoul National University Bundang  Hospital, Seongnam; 6Department  of Internal Medicine, Kyung Hee  University School of Medicine, Seoul;  7Department of Internal Medicine,  Ewha Womans University School  of Medicine, Seoul; 8Department  of Preventive Medicine, Dong-A  University College of Medicine,  Busan, Korea Received : May  19, 201 4 Revised : July 22, 2014 Accepted : September 4, 2014 Correspondence to  Soon Kil Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
Blood pressure category and global risk www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.610and caffeine.,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.610CBP and ABPM data CBP was measured using an A&D UA-767 (A&D Co., Ltd.,  Tokyo, Japan), which passed European Society of Hyper - tension (ESH) International Protocols at all institutes.",OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"Blood pressure category and global risk www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.610(GE Medical Systems, Freiburg, Germany) and other GE  devices (38.5%), Del Mar (7.6%; Avionics, Irvine, CA, USA),  Spacelabs (3.5%; Spacelabs Medical, Issaquah, WA, USA),  and Mobil O graph (0.1%; I.E.M., Stolberg, Germany).",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.610risk category.",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
Blood pressure category and global risk www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.610BP was 88.5 ± 15.2 mmHg.,OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.610DISCUSSION  In this study, the discrepancy rate between CBP and  ABP was shown to be affected by patient GCR profiles.",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"Blood pressure category and global risk www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.610general population, not in the clinic.",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.610Conflict of interest No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
Blood pressure category and global risk www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.610als.,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/kjim-30-5-610.PMC4578037.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:719-726 http://dx.doi.org/10.3904/kjim.2015.30.5.719INTRODUCTION Telomeres are repetitive, non-coding DNA sequences  located at the ends of each chromosome.",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.719with a diverse range of human diseases, including can - cer [9-11].",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
SNPs associated with telomere length www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.719SNPs were within a region of approximately 15 kb on  chromosome 3q26.2 (169482335  to 169497585 bases) and  were in complete linkage disequilibrium (LD) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.719Table 2.",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
aData from NCBI ( http://www.ncbi.nlm.nih.gov/SNP).,OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"SNPs associated with telomere length www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.719length under the recessive model for the variant allele  of each SNP ( p = 0.01, p = 0.03, p = 0.01, and p = 0.02, re - spectively).",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.719that binds to the G-quadruplex DNA structures of sin - gle-stranded human telomeric sequences.",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
SNPs associated with telomere length www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.719REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.71928.",Non-OADS,/arxiv_data1/oa_pdf/76/50/kjim-30-5-719.PMC4578038.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:694-704 http://dx.doi.org/10.3904/kjim.2015.30.5.694INTRODUCTION Methicillin-resistant Staphylococcus aureus  (MRSA) and vancomycin-resistant enterococci (VRE) are significant  causes of nosocomial infections in transplant recipients  [1].",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"MRSA and VRE in liver transplant www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.694of MRSA or VRE infection among liver transplant recip - ients was approximately 8.8% and 3.4%, respectively [2].",OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.694for vancomycin was performed using a disk-diffusion  method.",OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
MRSA and VRE in liver transplant www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.694Table 2 shows the comparisons between patients ini - tially colonized with MRSA versus those who were not  colonized.,OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.694Table 2.",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"MRSA and VRE in liver transplant www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.694VRE colonization, infections, and clinical outcomes VRE colonization was detected in 37 patients (22.8%) on  initial the ASC (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.694Table 5.",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"MRSA and VRE in liver transplant www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.694who acquired VRE posttransplantation, five (23.8%) de - veloped a VRE infection (two cholangitis and three peri - tonitis cases).",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.694favorable outcome compared with those who were not  colonized.",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"MRSA and VRE in liver transplant www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.694acquisition during an ICU stay, reflecting a typical hos - pital experience in Korea.",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.694pared with a chromogenic agar-based culture method.",Non-OADS,/arxiv_data1/oa_pdf/0d/b4/kjim-30-5-694.PMC4578039.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:705-713 http://dx.doi.org/10.3904/kjim.2015.30.5.705INTRODUCTION Although the number of newly diagnosed human im - munodeficiency virus (HIV) infections each year is re - ducing, there were still 35.0 million people were living  with HIV and 1.5 million who died of HIV-related infec -tions in 2013 [1].",Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.705tent combination therapies in 1996 [3,4].",Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"CD4 slope as a predictor for immunologic recovery www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.705cording to the 1993 revised classification system of the  Centers for Disease Control and Prevention (CDC), and  OIs were defined as the clinical conditions listed in the  surveillance case definitions for HIV infection and ac - quired immunodeficiency syndrome (AIDS) in the CDC  [19].",OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.705Table 1.",Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
CD4 slope as a predictor for immunologic recovery www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.705Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.705The CD4 slope during 0 to 12 months of HAART was  also analyzed as a dichotomous categorical variable with  a cutoff of 20 cells/mm3/month.",OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"CD4 slope as a predictor for immunologic recovery www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.705ic recovery [9,13-15,19,20].",OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
"5, September 2015 http://dx.doi.org/10.3904/kjim.2015.30.5.705would therefore be related to immunologic recovery,  and the initial CD4 slope during the earlier phase of  HAART could possibly be a predictor for this recovery.",Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
Available  from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdo - lescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
CD4 slope as a predictor for immunologic recovery www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.5.705CD4 cell recovery in human immunodeficiency virus-in - fected patients receiving highly active antiretroviral  therapy: evidence from the EuroSIDA study.,OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
Available from:  http://aidsinfo.nih.gov / contentfiles/lvguidelines/adult_oi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/f4/kjim-30-5-705.PMC4578040.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Impaired Th1/Tc1 response in adenocarcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.255 913,Non-OADS,/arxiv_data1/oa_pdf/07/0b/bjc2015255a.PMC4578079.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BDNF/TrkB/p75NTRpro-survival axis in DLBCL 944 www.bjcancer.com | DOI:10.1038/bjc.2015.274,Non-OADS,/arxiv_data1/oa_pdf/f9/39/bjc2015274a.PMC4578080.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Stromal infiltration of CD8 T cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.277 893,Non-OADS,/arxiv_data1/oa_pdf/47/8b/bjc2015277a.PMC4578081.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BIRC3 predicts resistance in oesophageal adenocarcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.283 885,Non-OADS,/arxiv_data1/oa_pdf/eb/f6/bjc2015283a.PMC4578082.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Hypoxia in pancreatic cancer patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.284 871,Non-OADS,/arxiv_data1/oa_pdf/9a/35/bjc2015284a.PMC4578083.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Potential metastatic suppressor role of WISP-2 in GC cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.285 933,Non-OADS,/arxiv_data1/oa_pdf/34/22/bjc2015285a.PMC4578084.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Investigation of ADAM10 in breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.288 951,Non-OADS,/arxiv_data1/oa_pdf/2d/fe/bjc2015288a.PMC4578086.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER APC mutation prognostic value in colon cancer 988 www.bjcancer.com | DOI:10.1038/bjc.2015.296,Non-OADS,/arxiv_data1/oa_pdf/49/fe/bjc2015296a.PMC4578087.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER APM dysregulations in glioblastoma multiforme 962 www.bjcancer.com | DOI:10.1038/bjc.2015.297,Non-OADS,/arxiv_data1/oa_pdf/3f/3b/bjc2015297a.PMC4578088.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)FOLFOXIRI þbevacizumab in metastatic colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.299 877,Non-OADS,/arxiv_data1/oa_pdf/99/0b/bjc2015299a.PMC4578090.pdf
"dCt values were used to cluster cell lines according to EMT gene expression levels using the Cluster v.3.0 and Treeview v.1.60 softwares (Eisen Lab, University of California, Berkeley, CA, USA; http://rana.lbl.gov/EisenSoftware.htm).",OADS,/arxiv_data1/oa_pdf/c4/12/bjc2015302a.PMC4578092.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Endoglin in lung cancer 978 www.bjcancer.com | DOI:10.1038/bjc.2015.302,Non-OADS,/arxiv_data1/oa_pdf/c4/12/bjc2015302a.PMC4578092.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER RAS/BRAF mutation in paired endoscopy-surgical CRC 920 www.bjcancer.com | DOI:10.1038/bjc.2015.307,Non-OADS,/arxiv_data1/oa_pdf/63/4f/bjc2015307a.PMC4578093.pdf
REFERENCES [1] Health Statistics Quarterly 2003 Available from: http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/3b/2c/TOORTHJ-9-395.PMC4578128.pdf
Avail-able from: http://www.ics.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/3b/2c/TOORTHJ-9-395.PMC4578128.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/2c/TOORTHJ-9-395.PMC4578128.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/9d/TOORTHJ-9-422.PMC4578129.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/da/TOORTHJ-9-399.PMC4578130.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/87/TOORTHJ-9-427.PMC4578131.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/4a/TOORTHJ-9-418.PMC4578132.pdf
"[cited 2014 May 05]; Available from: http://guidance.nice.org.uk/   CG124/NICEGuidance/pdf/English   [3] Casaletto JA, Gatt R. Post -operative mortality related to waiting  time for hip fracture surgery.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/TOORTHJ-9-412.PMC4578133.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/TOORTHJ-9-412.PMC4578133.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/4e/TOORTHJ-9-432.PMC4578134.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/21/TONIJ-9-7.PMC4578136.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/46/TOORTHJ-9-379.PMC4578137.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/dc/TOOPHTJ-9-136.PMC4578138.pdf
Online head shape assessment [cited 2014 December 11]; Available from: http://www.cranialtech.com/index.,OADS,/arxiv_data1/oa_pdf/45/02/TONURSJ-9-33.PMC4578139.pdf
"Statistical methods for rater and diagnostic agreement [cited 2014 October 2]; Available from: http://www.john-uebersax.com/stat/ agree.htm [26] Bland JM, Altman DG.",OADS,/arxiv_data1/oa_pdf/45/02/TONURSJ-9-33.PMC4578139.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/02/TONURSJ-9-33.PMC4578139.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/50/TOORTHJ-9-405.PMC4578140.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/01/TOORTHJ-9-390.PMC4578141.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/1a/TORJ-9-65.PMC4578142.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/d7/TONIJ-9-13.PMC4578143.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/eb/TOOPHTJ-9-121.PMC4578144.pdf
DOI of original article: http://dx.doi.org/10.1016/j.neuroscience.2013.12.064 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/0b/04/nihms723007.PMC4578160.pdf
"131. http://www.hemcon.com/  132.Pangburn SH, Trescony PV, Heller J. Lysozyme  degradation of partially deacetylated chitin, its films and hydrogels.",Non-OADS,/arxiv_data1/oa_pdf/ce/60/RPS-10-1.PMC4578208.pdf
Comparison of                   the sequencing results with the caf1            sequences deposited in Gene bank              database was performed with BLAST  (http://blast.ncbi.nlm.nih.gov/Blast.cgi) which  confirmed the authenticity of the cloned  sequence.,OADS,/arxiv_data1/oa_pdf/a8/02/RPS-10-84.PMC4578216.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.This is a correction for another article previously published in this journal.",Non-OADS,/arxiv_data1/oa_pdf/0c/f3/atr-04-02-28954.PMC4578251.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3c/a4/atr-04-02-12039.PMC4578318.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/49/72/ijhrba-04-02-20021.PMC4578319.pdf
Website  http://nhm2.uio.no/paf/  [accessed 7 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/7d/02/apps.1500036.PMC4578374.pdf
"METHODS AND RESULTS   The 97,565 unigene sequences were downloaded from http://www.genome .clemson.edu/node/273 (presented by the transcriptome sequencing project) ( Zhao et al., 2013 ) and used for subsequent microsatellite mining.",OADS,/arxiv_data1/oa_pdf/c9/8d/apps.1500038.PMC4578375.pdf
a  Sequences were downloaded from the Clemson University Genomics  Institute Metasequioa RNA-Seq transcriptome sequencing project (available at  http://www.genome.clemson.edu/node/273   ).,OADS,/arxiv_data1/oa_pdf/c9/8d/apps.1500038.PMC4578375.pdf
"MATERIALS AND METHODS   Sequence database and reference miRNAs —   A total of 8316 known plant  miRNAs were downloaded from the miRBase database (http://www.mirbase.org/; release 20, November 2013) ( Kozomara and Grifﬁ  ths-Jones, 2011 ) and  used as a reference miRNA data set for identifying conserved miRNAs in  N. nucifera  .",OADS,/arxiv_data1/oa_pdf/47/e7/apps.1500046.PMC4578376.pdf
"Fragments containing microsatellite repeats were screened using MISA software ( Thiel et al., 2003 ;  http://pgrc.ipk-gatersleben.de/misa ).",OADS,/arxiv_data1/oa_pdf/e1/23/apps.1500064.PMC4578380.pdf
"The DROID Flat Sheets and Packets Working Group (https://www.idigbio.org/wiki/index.php/Developing_Robust_Object_to_Image_to_Data_%28DROID1%29) was charged with developing orderly task lists for digitizing specimens of that type, including (herein defined as having transcribed textual label data into a  retrievable electronic format), half (46%) of the herbaria had yet to begin databasing their specimens, and just 24% of the her - baria had begun imaging specimens.",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Applications in Plant Sciences 2015 3(9): 1500065 Nelson et al.—Herbarium digitization workflows doi:10.3732/apps.15000653 of 9  http://www.bioone.org/loi/appsPDF files at iDigBio (https://www.idigbio.org/content/workflow- modules-and-task-lists); the modules are also available as supple-mentary data with this article.,OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"Indeed, conveyor belt systems are being used to image herbarium specimens (e.g., Tegelberg et al., 2012, 2014; and with the New England Vascular Plants [NEVP] TCN [http://nevp.org/projsummary]), and ro-botic camera systems are being used to image trays of insects (Buffington et al., 2005; Blagoderov et al., 2010, 2012; Dietrich et al., 2012; Mantle et al., 2012; Schmidt et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"For example, whether building a conveyor sys-tem from scratch (e.g., NEVP approach) or contracting with an outside entity (e.g., Pignal and Michiels, 2011; Digitarium [http://digitarium.fi/en]) to implement a system, there is a significant monetary investment required to install such a system, to train the digitizing staff, and to maintain the system.",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"For institutions using an ORTech Photo e-Box Bio Photographic Lighting System (M. K. Digital Direct, Chula Vista, California, USA [http://www.or-tech   .com/photo-e-box-bio.html]), full-frame cameras should be fitted with a 50-mm lens for best results.",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"Results from a separate, previous  blitz are reported in an iDigBio blog (https://www.idigbio   .org/content/weekend-digitization-blitz-yields-4276-specimen-   images-archbold-biological-station).",OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"Greater outreach can lead to greater understanding and support in the local community for a herbarium, which can become an impor - tant strategy for sustainability of digitization beyond a typical grant funding cycle and make crowdfunding initiatives more successful (e.g., Florida State University’s Robert K. Godfrey Herbarium [http://spark.fsu.edu/Projects/121/Blazing-a-New-Trail-for-Sustainability-with-Citizen-Science]).",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"We address a variety of options, with a major focus on NSF-funded open access systems that can be freely downloaded or accessed online, such as Specify (http://specifyx.specifysoftware.org/) and Symbiota (Gries et al., 2014; http://symbiota.org/docs/).",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"Symbiota provides the back-bone for several existing herbarium digitization networks (http://swbiodiversity.org/portal/index.php, http://nansh.org/portal/, http://sernecportal.org/portal/, http://bryophyteportal.org/portal/, http://lichenportal.org/portal/, http://portal.neherbaria.org, http://macroalgae.org/portal/, http://mycoportal.org/portal/, http://greatlakesinvasives.org/portal/index.php) and has proven espe-cially relevant to small herbaria.",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
"Before embarking on an effort to georeference your collection, we highly recommend that you and your digitizing staff review the various training materials that are available on-line or participate in a georeferencing training workshop (See http://georeferencing.org/online-training-resources.html; http://georeferencing.org/index.html) .",Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website http://precedings.nature.com/documents/4486/version/1 [ac- cessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website https://www.idigbio.org/content/ypm-ip-workflow- voice-recognition-imaging [accessed 27 April 2015].,OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website  http://www.gbif.org/resource/80528 [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website  http://www.gbif.org/resource/80512 [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website http://www.gbif.org/resource/80536  [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website https://emu.kesoftware .com/news-and-events/conferences/2146-global-emu-user-conference- 15-17-october-2014 [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website  http://www.gbif.org/resource/80576 [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website https://www.idigbio.org/wiki/images/8/86/IDigBioImagingGeneralEquipmentRecommendations1_0.pdf [accessed  27 April 2015].,OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website https://www.idigbio.org/content/digitization-workflow-small-   herbarium [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website http://collections.mnhn.fr/wiki/attach/Visit_October2012/Paris-Herbarium- Digitization_2012-07-12.pdf [accessed 27 May 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website http://avh.chah.org.au/index.php/2014/   08/12/press-release/ [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
Website http://usvhproject.org/#/progress [accessed 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/01/65/apps.1500065.PMC4578381.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/22/mder-8-389.PMC4578482.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 389–393Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  389ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S9320 9acceptability of the reusable surePal™ self- injection device for Omnitrope® among pediatric  patients: results from a questionnaire-based,  cross-sectional, multicenter observational study carl-Joachim Partsch1 Dirk schnabel2 sarah Ehtisham3 helen c Johnstone4 Markus Zabransky5 Wieland Kiess6 1Endokrinologikum hamburg,   hamburg,  2Division of Endocrinology  and Diabetology, Otto-heubner- center for Pediatric and adolescent  Medicine, charité University, Berlin,   germany;  3central Manchester  University hospitals nhs  Foundation  Trust, Manchester,  4The newcastle  upon Tyne hospitals nhs Foundation  Trust, newcastle, UK;  5sandoz  international gmbh, holzkirchen,   6Department of Women and child  health, hospital for children and  adolescents, University hospitals,   University of leipzig, leipzig,   germany correspondence: Markus Zabransky   sandoz international gmbh, industriestr   25, D-83607, holzkirchen, germany   Tel +49 8024 476 2255  Fax +49 8024 476 2262  Email markus.zabransky@sandoz.co mBackground:  SurePal™ is a reusable self-injection system that has been developed to support  daily administration of Omnitrope® (Sandoz, Kundl, Austria).",Non-OADS,/arxiv_data1/oa_pdf/5d/22/mder-8-389.PMC4578482.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 393acceptability of the surePal™ self-injection device among pediatric patients cartridge is inserted (with no need for priming or adjusting of  the dose setting).,Non-OADS,/arxiv_data1/oa_pdf/5d/22/mder-8-389.PMC4578482.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/jdi0006-0491.PMC4578485.pdf
5 September 2015 493EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Editorial,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/jdi0006-0491.PMC4578485.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/jdi0006-0491.PMC4578485.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
†Allele frequencies reported in the International HapMap Pro ject site (http://hapmap.ncbi.nlm.nih.gov).,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 497REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 499REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 501REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 503REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 505REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Available from URL: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2011/021773s029s030lbl.pdf 75.,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
"U.S. Food and Durg Administration, 2010. https://www.accessdata.fda.gov/ drugsatfda_docs/label/2010/ 022341lbl.pdf 76.",Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Cho http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 507REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Incretin biology in Asians,Non-OADS,/arxiv_data1/oa_pdf/bb/be/jdi0006-0495.PMC4578486.pdf
5 September 2015 509MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome in Korea,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdMINI REVIEW Hong and Lim http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
5 September 2015 511MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome in Korea,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdMINI REVIEW Hong and Lim http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
5 September 2015 513MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome in Korea,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdMINI REVIEW Hong and Lim http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
5 September 2015 515MINI REVIEW http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome in Korea,Non-OADS,/arxiv_data1/oa_pdf/c4/2b/jdi0006-0508.PMC4578487.pdf
5 September 2015 517COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Metformin as an anticancer drug,Non-OADS,/arxiv_data1/oa_pdf/eb/82/jdi0006-0516.PMC4578488.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/eb/82/jdi0006-0516.PMC4578488.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Koya http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/f9/jdi0006-0519.PMC4578489.pdf
5 September 2015 521COMMENTARY http://onlinelibrary.wiley.com/journal/jdi EGFR inhibition and diabetic nephropathy,Non-OADS,/arxiv_data1/oa_pdf/78/f9/jdi0006-0519.PMC4578489.pdf
5 September 2015 523SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Fructose and hormone secretion,Non-OADS,/arxiv_data1/oa_pdf/ce/cd/jdi0006-0522.PMC4578490.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ce/cd/jdi0006-0522.PMC4578490.pdf
5 September 2015 525SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Fructose and hormone secretion,Non-OADS,/arxiv_data1/oa_pdf/ce/cd/jdi0006-0522.PMC4578490.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ce/cd/jdi0006-0522.PMC4578490.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/44/6e/jdi0006-0527.PMC4578491.pdf
5 September 2015 529ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi MetS is a risk factor for type 2 DM,Non-OADS,/arxiv_data1/oa_pdf/44/6e/jdi0006-0527.PMC4578491.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/44/6e/jdi0006-0527.PMC4578491.pdf
5 September 2015 531ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi MetS is a risk factor for type 2 DM,Non-OADS,/arxiv_data1/oa_pdf/44/6e/jdi0006-0527.PMC4578491.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/44/6e/jdi0006-0527.PMC4578491.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
5 September 2015 535ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Trends in diabetes prevalence in Japan,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
5 September 2015 537ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Trends in diabetes prevalence in Japan,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
5 September 2015 539ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Trends in diabetes prevalence in Japan,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
Proportion of the population aged 65 or over: international comparison 2013; http://www.ipss.go.jp/syoushika/tohkei/Popular/P_Detail2013.asp?fname=T02-17.htm.,OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2011; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h23-houkoku.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
5 September 2015 541ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Trends in diabetes prevalence in Japan,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
1997; http://www.mhlw.go.jp/toukei /kouhyo/indexkk_4_1.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2006; http://www.mhlw.go.jp/bunya/kenkou/eiyou08/01.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2007; http://www.mhlw.go.jp/bunya/kenkou/eiyou09/01.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2008; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h20-houkoku.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2009; http://www.mhlw.go.jp/bunya/ kenkou/eiyou/h21-houkoku.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2010; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h22-houkoku.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2013; http://www.e-stat.go.jp/SG1/estat/Xlsdl.do?,OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2013; http://www.e-stat.go.jp/SG1/estat/Xlsdl.do?sinfid=000012976595.,OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2013; http://www.ip ss.go.jp/syoushika/tohkei/ newest04/s-kekka/1-9.xls.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2012; http://esa.un.org/unpd/wpp/unpp/panel_indicators.htm.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
"R Foundation forStatistical Computing, Vienna, Austria, 2012; http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
2012; http://www.mhlw.go.jp/bunya/ kenkou/dl/kenkounippon21_02.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/21/jdi0006-0533.PMC4578492.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ff/a7/jdi0006-0543.PMC4578493.pdf
5 September 2015 545SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi MODY-iPS cells from Japanese patients,Non-OADS,/arxiv_data1/oa_pdf/ff/a7/jdi0006-0543.PMC4578493.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ff/a7/jdi0006-0543.PMC4578493.pdf
5 September 2015 547SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi MODY-iPS cells from Japanese patients,Non-OADS,/arxiv_data1/oa_pdf/ff/a7/jdi0006-0543.PMC4578493.pdf
5 September 2015 549ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Study of serum testosterone with ISI,Non-OADS,/arxiv_data1/oa_pdf/01/12/jdi0006-0548.PMC4578494.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/01/12/jdi0006-0548.PMC4578494.pdf
5 September 2015 551ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Study of serum testosterone with ISI,Non-OADS,/arxiv_data1/oa_pdf/01/12/jdi0006-0548.PMC4578494.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/01/12/jdi0006-0548.PMC4578494.pdf
"INTRODUCTION The estimated number of people with type 2 diabetes mellitus worldwide in 2011 was approximately 366 million people, and that number should reach more than 552 million in 20301.I n 2007, more than 22 million Japanese were estimated to havetype 2 diabetes mellitus based on analysis by The Ministry ofHealth, Labor and Welfare (http://www.mhlw.go.jp/houdou/2008/12/h1225-5a.html), with an increase of approximately 1.6- fold in the number of people with type 2 diabetes mellitus inthe past decade.",Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
5 September 2015 555CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Goal of weight reduction in obese men,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
5 September 2015 557CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Goal of weight reduction in obese men,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
5 September 2015 559CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Goal of weight reduction in obese men,Non-OADS,/arxiv_data1/oa_pdf/a0/da/jdi0006-0553.PMC4578495.pdf
5 September 2015 561CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Comparison of sitagliptin & nateglinide,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
5 September 2015 563CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Comparison of sitagliptin & nateglinide,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
5 September 2015 565CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Comparison of sitagliptin & nateglinide,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/07/2e/jdi0006-0560.PMC4578496.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e2/33/jdi0006-0567.PMC4578497.pdf
5 September 2015 569SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Fear of hypoglycemia and T2DM,Non-OADS,/arxiv_data1/oa_pdf/e2/33/jdi0006-0567.PMC4578497.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e2/33/jdi0006-0567.PMC4578497.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/88/41/jdi0006-0571.PMC4578498.pdf
5 September 2015 573ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Irisin associated with UII,Non-OADS,/arxiv_data1/oa_pdf/88/41/jdi0006-0571.PMC4578498.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/88/41/jdi0006-0571.PMC4578498.pdf
5 September 2015 575ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Irisin associated with UII,Non-OADS,/arxiv_data1/oa_pdf/88/41/jdi0006-0571.PMC4578498.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/88/41/jdi0006-0571.PMC4578498.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
5 September 2015 579ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Impacts of a disaster on diabetes,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
5 September 2015 581ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Impacts of a disaster on diabetes,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
5 September 2015 583ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Impacts of a disaster on diabetes,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
5 September 2015 585ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Impacts of a disaster on diabetes,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/10/16/jdi0006-0577.PMC4578499.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0f/61/jdi0006-0587.PMC4578500.pdf
5 September 2015 589CASE REPORT http://onlinelibrary.wiley.com/journal/jdi Ketoacidosis caused by a SGLT2 inhibitor,Non-OADS,/arxiv_data1/oa_pdf/0f/61/jdi0006-0587.PMC4578500.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0f/61/jdi0006-0587.PMC4578500.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/83/90/jdi0006-0591.PMC4578501.pdf
5 September 2015 593CASE REPORT http://onlinelibrary.wiley.com/journal/jdi Rare case of insulin allergy,Non-OADS,/arxiv_data1/oa_pdf/83/90/jdi0006-0591.PMC4578501.pdf
Some trans cription cofactors of PPAR cshown by GeneMANIA (http://www.genemania.org/) were alsodownregulated in the adipocytes of theinsulin-resistant population (Figure 1d).,Non-OADS,/arxiv_data1/oa_pdf/89/ee/jdi0006-0594.PMC4578502.pdf
"In agreement with this,several other articles published thesame results that HIPK2 expression waselevated after administration of insulin sensitizer, rosiglitazone and troglitazone(Table S1), suggested by The Compara-tive Toxicogenomics Database (http://ctd-base.org/).",Non-OADS,/arxiv_data1/oa_pdf/89/ee/jdi0006-0594.PMC4578502.pdf
5 September 2015 595LETTER TO THE EDITOR http://onlinelibrary.wiley.com/journal/jdi Letter to the Editor,Non-OADS,/arxiv_data1/oa_pdf/89/ee/jdi0006-0594.PMC4578502.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/89/ee/jdi0006-0594.PMC4578502.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1135-1143,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/83/38/epj-07-1135.PMC4578531.pdf
"http://www.ephysician.ir Page1136Some studies have confirmed that tricuspid E/Ea (E is the early tricuspid inflow velocity and Ea is the early tricuspid annular diastolic velocity) is useful for the noninvasive estimation of RV filling pressure and for detecting serial changes under a wide range of clinical conditions (6, 7).",Non-OADS,/arxiv_data1/oa_pdf/83/38/epj-07-1135.PMC4578531.pdf
http://www.ephysician.ir Page1138decreases in the average Ea/Aa and average Ea velocities in the patient group as compared to the control group (Table3).,Non-OADS,/arxiv_data1/oa_pdf/83/38/epj-07-1135.PMC4578531.pdf
http://www.ephysician.ir Page1140dysfunction and may progress to systolic dysfunction (4).,Non-OADS,/arxiv_data1/oa_pdf/83/38/epj-07-1135.PMC4578531.pdf
"http://www.ephysician.ir Page11424)Dadhich S,  Goswamia A , Jainb VK, Gahlotc A, Kulamarvaa G, Bhargavaa N. Cardiac dysfunction in cirrhotic portal hypertension with or without ascites.",Non-OADS,/arxiv_data1/oa_pdf/83/38/epj-07-1135.PMC4578531.pdf
"Electronic Physici an (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1144-1149,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/90/84/epj-07-1144.PMC4578532.pdf
"http://www.ephysician.ir Page11465)Multi-gestational pregnancy 6)Associated systemic disease (pre -eclampsia, diabetes, cardiovascular disease, renal disease, asthma, and hypothyroidism) 7)Congenital malformations 8)Evidence of urinary infection 9)Previous pre-term labor 2.4.",Non-OADS,/arxiv_data1/oa_pdf/90/84/epj-07-1144.PMC4578532.pdf
http://www.ephysician.ir Page1148acute pre-term labor was controlled.,Non-OADS,/arxiv_data1/oa_pdf/90/84/epj-07-1144.PMC4578532.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1150-1152,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/7e/e7/epj-07-1150.PMC4578533.pdf
http://www.ephysician.ir Page1152Authors' contributions: Allauthors contributed to this project and article equally.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/epj-07-1150.PMC4578533.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1153-1162,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
http://www.ephysician.ir Page1154The role of solitary nucleus (or solitary tract) in cerebral ischemia was recognized in clinical and experimental animal models (6).,OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
http://www.ephysician.ir Page11562.10.,Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
http://www.ephysician.ir Page11583.5.,Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
http://www.ephysician.ir Page1160Authors' contributions: Allauthors contributed to this project and article equally.,Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
2014 [updated 2014; cited]; Available from: http://www.who.int/mediacentre/factsheets/fs310/en/index.html.,OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
Available from: http://www.academicjournals.org/JMPR.,Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
"http://www.ephysician.ir Page116242)Woo M, Choi H, Seo M, Jeon H, Lee B. Ellagic acid suppresses lipid accumulation by suppressing early adipogenic events and cell cycle arrest.",Non-OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
2015; 349 (1 -2): 202-8. doi: http://dx.doi.org/10.1016/j.jns.2015.01.019.,OADS,/arxiv_data1/oa_pdf/26/1c/epj-07-1153.PMC4578534.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1163-1167,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/f9/69/epj-07-1163.PMC4578535.pdf
http://www.ephysician.ir Page1164consequences of performed actions (5).,Non-OADS,/arxiv_data1/oa_pdf/f9/69/epj-07-1163.PMC4578535.pdf
http://www.ephysician.ir Page1166that many factors determine the success or failure of any training program.,Non-OADS,/arxiv_data1/oa_pdf/f9/69/epj-07-1163.PMC4578535.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1168-1173,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
http://www.ephysician.ir Page1170occupation).,Non-OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
http://www.ephysician.ir Page1172may help to reduce pesticide exposure risks.,Non-OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
Available from: http://www.epa.gov/oppfead1/ annual/2002/2002annualreport.pdf [accessed 10 December 2014].,OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
Available from: http://progressreport.cancer.gov/ [accessed 15 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
"2002; 360 (9340): 1163 -7. doi: http://dx.doi.org/10.1016/S0140 -6736(02)11204 -9, PMID: 12387969.",OADS,/arxiv_data1/oa_pdf/39/da/epj-07-1168.PMC4578536.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, I ssue:4, Pages:1174-1182,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
http://www.ephysician.ir Page1176surface resting E CGwere additionally performed o n all subjects.,Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
"http://www.ephysician.ir Page1178Table4.Echocardiographic data of the patients (group1 , 2) and control (group3) Group 1 (n=30) (mean±SD)Group 2 (n=30) (mean±SD)Group 3 (n=20) (mean±SD)P1 P2 P3 LA (cm) 3.8±0.5 4.1±0.6 3.4±0.3 < 0.01 < 0.01 < 0.05 AO (cm) 3.1 ±0.3 3.4±0.8 2.8±0.2 < 0.05 < 0.01 < 0.05 IVST (cm) 1.0±0.3 1.0±0.4 0.9±0.1 < 0.01 < 0.01 NS PWT (cm) 1.0±0.1 1.0±0.2 0.9± 0.1 < 0.01 < 0.01 NS EDD (cm) 5.3±0.6 5.5±0.8 4.5±0.3 < 0.01 < 0.01 NS ESD (cm) 3.1±0.5 3.3±0.7 2.8±0.3 < 0.05 < 0.01 NS EF % 66.6±8.3 64.8±8.4 68.8±7.2 NS NS NS LV mass (gm) 182.8±53.1 184±54.1 136.8±28.8 < 0.01 < 0.01 NS E velocity (m/s) 0.58± 0.26 0.59± 0.26 0.62 ±0.15 NS NS NS A velocity (m/s) 0.65± 0.44 0.66±0.45 0.59 ±0.17 < 0.01 < 0.01 NS E/A E/A 0.9± 0.3 0.9± 0.4 1.1± 0.5 < 0.01 <0.01NS P1: value between groups 1&3; P2:value between group s 2&3;P3: valuebetween group s1&2;Ao: aortic diameter : EDD: end diastolic dimension ;EF: ejection fraction ;ESD: end systolic dimension ;IVST:interventricular septum thickness; LA: left atrium diameter; LVM: left ventricular mass; PWT: posterior wall thickness; NS: not significant Table5.Specific echocardiographic measurements of the patients (group1, 2) and control Variables Group 1 (n=30) (mean±SD)Group 2 (n=30) (mean±SD)Group 3 (n=2 0) (mean±SD)P1 P2 P3 SVR 0.13±.03 0.12±.06 0.21±.04 < 0.01 < 0.01 NS IVC (mm) 10.3±2.1 10.8±4.3 16.4±3.2 < 0.01 < 0.01 NS IVC coll.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
"http://www.ephysician.ir Page1180active α-adrenergic agonist, in patients with cirrhosis and ascites, improved circulatory functions.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
Available at http://en.wikipedia.org/wiki/Cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
"http://www.ephysician.ir Page118241)Moller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/epj-07-1174.PMC4578537.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1183-1189,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
http://www.ephysician.ir Page1184its percentage of the total expenditure required to obtain healthcare ser vices.,Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
http://www.ephysician.ir Page1186Insurance (33%) and National Health Service (NHS) (29%).,Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
policy and health reform Council 2007.Avaiable from: http://siasat.behdasht.gov.ir/uploads/291_1041_Primary%20Care.pdf,Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"http://www.ephysician.ir Page11883)Arab M, Kavosi Z, Ravangard D, Astovar R. Health insurance syst ems.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Avalable from: http://creativecommons.org/licenses/by -nc-nd/3.0/au/ 8)Keshavarz A, Kalhor R, Javadi A, Asefzadeh S. Estimating Out Of Pocket payments (oop) for medical cares in Qazvin province in 2009.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
Available from: http://jhosp.tums.ac.ir/browse.php?a_id=48&sid=1&slc_lang=fa.,OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Available on: http://www.who.int/health_financing/documents/dp_e_07_7/en/ 11)Asefzadeh S, Alijanzadeh M, Peyravian F. Out of pocket expenditures for outpatient clinics in teaching hospitals.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Available from: http://sph.qums.ac.ir/Portal/file/?237137/32 12)Delavande A, Hurd MD, Martorell P, Langa KM.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Available from: http://www.unicef.org/cambodi a/Cambodia_DHS_2010_Complete_Report_Part1.pdf 17)Minh MV, Phuong NTK, Saksena p, James CD, Xu K. Financial burden of household out -of pocket health expenditure in Viet Nam: Findings from the National Living Standard Survey 2002 -2010.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
Available from: http://medsab.ac.ir/uploads/hse_chapter_930207_1400.pdf 20)Mediterranean WHO.,Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Available from: http://www.emro.who.int/about -who/annual -reports/annual -report-2008.html 21)Xu K, Evans DB, Carrin G, Aguilar -Rivera  AM, Musgrove P, Evans T. Protecting households from catastrophic health spending.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Available from: http://www.who.int/healthsystems/topics/financing/healthreport/20public -private.pdf 24)Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malar ia, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome.",Non-OADS,/arxiv_data1/oa_pdf/14/69/epj-07-1183.PMC4578538.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue :4, Pages:1190-1195,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/a6/a6/epj-07-1190.PMC4578539.pdf
"http://www.ephysician.ir Page1192PCT (r=-0.55, p=0.001).",OADS,/arxiv_data1/oa_pdf/a6/a6/epj-07-1190.PMC4578539.pdf
http://www.ephysician.ir Page1194Acknowledgments: All members of the Neonatal Intensive Care Units (NICU) at El -Minia Children University Hospital and the Department of Biochemistry are acknowledged for their help in completing this work.,Non-OADS,/arxiv_data1/oa_pdf/a6/a6/epj-07-1190.PMC4578539.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue: 4, Pages:1196-1204,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"http://www.ephysician.ir Page1198wheel, automatic gear buttons, and virtual rear -view and side mirrors.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"http://www.ephysician.ir Page1200Table 2, by removing driver No.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
http://www.ephysician.ir Page12024.4.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"1980; 1: 127 -33.Available from: http://trid.trb.org/view.aspx?id=249687 6)Adkins S. Performance, heart rate, and respiration rate on the day -night continuum.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
1964; 18: 409 -12. http://dx.doi.org/10.2466/pms.1964.18.2.409.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"Big Sky, MT, USA, June 2009 Available from: http://trid.trb.org/view.aspx?id=918391 25)Craig A, Tran Y, Wijesuriya N, Boord P. A controlled investigation into the psychological determinants of fatigue.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"Available from: http://trid.trb.org/view.aspx?id=479029 32)Philip P, Sagaspe P, Moore N, Taillard J, Charles A, Guilleminault C, et al.",OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
http://www.ephysician.ir Page120434)Maycock G. Sleepiness and driving: the experience of heavy goods vehicle drivers in the UK.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/epj-07-1196.PMC4578540.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 4, Pages:1205-1213,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
http://www.ephysician.ir Page1206examination and discuss the best approach to diagnosing the disease and treating the patient (7).,Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
http://www.ephysician.ir Page12082.4.,Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
http://www.ephysician.ir Page121060% of the patients were satisfied in terms of having emotional connection with their physicians.,Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
"http://www.ephysician.ir Page121210)Green-Thompson L, Mcinerney P, Veller M. The evaluation of bedside teaching –an instrument for staff evaluation and student experience: A pilot study at a South African university.",Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
Available from: http://www.ucalgary.ca/ofd/resources new/resources.,Non-OADS,/arxiv_data1/oa_pdf/6e/cc/epj-07-1205.PMC4578541.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir August2015, Volume: 7, Issue :4, Pages:1214-1219,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/7b/2c/epj-07-1214.PMC4578542.pdf
"http://www.ephysician.ir Page1216Table 1.Demographic and clinical characteristics of patients with chronic liver disease Female, n1(%) 27 (49.1) Male, n (%) 28 (50.9) Age of onset (months), mean (SD2) 59.31 (59.36) Duration of treatment (m onths), mean (SD) 45.43 (25.8) Course of disease (months), mean (SD) 51.96 (29.67) CHILD3, mean (SD) 5.78 (1.15) MELD/PELD4, mean (SD) 9.67 (3.74) Metabolic disease, n 14 Cryptogenic cirrhosis, n 11 Autoimmune hepatitis, n 11 Wilson, n 10 Chronic h epatitis B, n 6 Cholestatic diseases, n 3 1n:Number;2SD:Standard deviation;3CHILD:Child-Pugh score;4MELD/PELD: Model for end -stage of Liver Disease/Pediatric end -stage liver disease Table 2.Child-self reports of the PedsQL 4.0 Generic Core Scale scores in case and control groups Scale Case Control Mean SD1Mean SD P-value Effect size Physical functioning 88.78 17.55 93.11 10.63 0.176 -0.14 Emotional functioning 85.25 12.62 92.87 12.24 0.001 -0.29 Social functioning 93.15 18.91 92.74 12.65 0.326 0.01 School functioning 92.59 15.51 93.72 12.98 0.993 -0.03 Total mean score 89.93 9.63 93.05 9.28 0.006 -0.16 1SD:Standard deviation Table 3.Parent-proxy reports of the PedsQL 4.0 Generic Core Scale scores in case and control groups Scale Case Control Mean SD Mean SD P-value Effect size Physical functioning 84.00 20.69 87.54 14.05 0.551 -0.09 Emotional functioning 78.40 17.50 85.99 16.34 0.002 -0.21 Social functioning 88.48 20.50 87.65 16.20 0.344 0.02 School functioning 87.72 22.04 89.75 16.22 0.898 -0.05 Total mean score 86.72 15.42 87.80 11.49 0.119 -0.39 1SD:Standard deviation Comparing each scale in both groups, there was only a significant difference in emotional functioning based on the child self -reports (p=0.001) and total HRQOL score (p=0.006), with the majority of effect s izes in the small range (>0.2).",Non-OADS,/arxiv_data1/oa_pdf/7b/2c/epj-07-1214.PMC4578542.pdf
http://www.ephysician.ir Page1218importance of parents being well acquainted with their child perception of quality of life and illness to help the children consciously adapt to the situation.,Non-OADS,/arxiv_data1/oa_pdf/7b/2c/epj-07-1214.PMC4578542.pdf
"2This malignancy has been associated with several clinical factors responsible for such mortality rates: (i) lack of diagnosticmarkers, (ii) high degree of inﬁltration and metastasis, and (iii) © Claudio Ricci, Carlos Mota, Stefania Moscato, Delfo D ’Alessandro, Stefano Ugel, Silvia Sartoris, Vincenzo Bronte, Ugo Boggi, Daniela Campani, Niccola Funel, Lorenzo Moroni, and Serena Danti*Correspondence to: Lorenzo Moroni; Email: l.moroni@utwente.nl; Serena Danti; Email: s.danti@med.unipi.itSubmitted: 01/11/2014; Revised: 07/03/2014; Accepted: 08/10/2014 http://dx.doi.org/10.4161/21592527.2014.955386 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Pri-mers for polymer-chain reaction (PCR) were designed using thePrimer3 program (available at http://bioinfo.ut.ee/primer3/).The annealing temperature used for PCR analysis was 57 /C14C.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Lancet 2011; 378:607-20; PMID:21620466; http://dx.doi.org/10.1016/S0140- 6736(10)62307-0 3.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Pathologe 2012; 33:189-93; PMID:23011021; http://dx.doi.org/10.1007/s00292-012-1673-x 4.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Clin Chim Acta 2013;418:22-9; PMID:23305796; http://dx.doi.org/10.1016/j.cca.2012.12.025 6.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Nat Med 2013;19:1423-37; PMID:24202395; http://dx.doi.org/ 10.1038/nm.3394 7.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Cell 2010; 141:39- 51; PMID:20371344; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Semin Cancer Biol 2005; 15:365- 77; PMID:15975824; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
J Cell Mol Med 2009; 13(8A):1417-27; PMID:19627398; http://dx.doi.org/10.1111/j.1582-4934.2009.00853.x 15.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Tissue Eng Part A 2010; 16:2153-6; PMID:20214448; http://dx.doi.org/10.1089/ ten.tea.2010.0135 16.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Tissue Eng Part B Rev2010;6:351-9; PMID:20092396; http://dx.doi.org/ 10.1089/ten.teb.2009.0676 17.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
OA Tissue Eng 2013; 1:4; http://dx.doi.org/10.13172/2052-9643-1-1-607 18.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Biomed Microdevices2013; 15:583-93; PMID:23559404; http://dx.doi.org/ 10.1007/s10544-013-9763-y 19.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
J Biomed Mater Res A 2013; 102:2636-43; PMID:23983015; http://dx.doi.org/ 10.1002/jbm.a.34937 21.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Food Chem Toxicol 2003; 41:319-26; PMID:12504164; http://dx.doi.org/10.1016/S0278-6915(02)00258-2 22.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Int J Cancer 2000; 85:14-20; PMID:10585576; http://dx.doi.org/10.1002/(SICI)1097- 0215(20000101)85:1 <14::AID-IJC3>3.0.CO;2-O 25.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Tis- sue Eng 2006; 12:3265-83; PMID:17518669; http://dx.doi.org/10.1089/ten.2006.12.3265 26.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Pancreatology 2010; 10:545-52; PMID:20975318; http://dx.doi.org/ 10.1159/000266127 27.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
PLoS One 2013; 8:e82282; PMID:24340014; http://dx.doi.org/10.1371/journal.pone.0082282 28.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Tis-sue Eng Part B Rev 2013; 19:485-502; PMID:23672709; http://dx.doi.org/10.1089/ten.teb.2012.0437 29.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
"J Biomater Sci Polym Ed 2001;12:107-24; PMID:11334185; http://dx.doi.org/ 10.1163/156856201744489 3 2 .L o n g a t iP ,J i aX ,E i m e rJ ,W a g m a nA ,W i t tM R , Rehnmark S, Verbeke C, Toftg ǻrd R, Lohr M, Heuchel RL.",OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Int J Nanome- dicine 2013; 8:1167-76; PMID:23658483; http://dx.doi.org/10.2147/IJN.S42464 35.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Micron 2008; 39:569-79; PMID:17702585; http://dx.doi.org/10.1016/j.micron.2007.06.016 37.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
J Biomed Mater Res 2002; 59:535-46; PMID:11774312; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Biomaterials 2006; 27:4911-22; PMID:16762409; http://dx.doi.org/ 10.1016/j.biomaterials.2006.05.027 39.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Science 2002; 295:2387-92; PMID:11923519; http://dx.doi.org/10.1126/science.1067100 40.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
"Breast Can- cer Res Treat 2011; 128:657-66; PMID:20821046; http://dx.doi.org/10.1007/s10549-010-1147-x 4 1 .F u n e lN ,G i o v a n n e t t iE ,D e lC h i a r oM ,M e yV , Pollina LE, Nannizzi S, Boggi U, Ricciardi S, Del T a c c aM ,B e v i l a c q u aG ,e ta l .L a s e rm i c r o d i s s e c t i o n and primary cell cultures improve pharmacogeneticanalysis in pancreatic adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Lab Invest 2008; 88:773-84; PMID:18490900; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
PLoS One 2012; 7:e49145; PMID:23155457; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
Pancreatology 2011;11:30-42; PMID:21412023; http://dx.doi.org/ 10.1159/000322990 44.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/kbim-04-01-955386.PMC4578550.pdf
"Cell lines are © Anna Burmester, B /C19ereng /C18ere Luthringer, Regine Willumeit, and Frank Feyerabend *Correspondence to: Regine Willumeit; Email: regine.willumeit@hzg.deSubmitted: 05/08/2014; Revised: 07/07/2014; Accepted: 09/17/2014 http://dx.doi.org/10.4161/21592527.2014.967616 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Acta Biomater 2010; 6:1680-92; PMID:20172057; http://dx.doi.org/10.1016/j.actbio.2010.02.028 2.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Biomed Mater Res Part B-App Biomater 2011; 99B:276-81; http://dx.doi.org/10.1002/jbm.b.31896 3.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Biomater 2005; 26:3557-63; PMID: 15621246; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Front Biosci 1999; 4:607-17; http://dx.doi.org/10.2741/Wolf 6.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Bioessays 2005;27:311-20; PMID:15714553; http://dx.doi.org/ 10.1002/bies.20183 8.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Science 1998;279:349-52; PMID:9454332; http://dx.doi.org/ 10.1126/science.279.5349.349 10.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Antimicrob Agents Chemother 1977; 12:11-5; PMID:883813; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Connect Tissue Res 1989; 20:49- 61; PMID:2533054; http://dx.doi.org/10.3109/03008208909023874 12.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Bioenerg Biomembr 2011; 43:311-22; PMID:21523406; http://dx.doi.org/ 10.1007/s10863-011-9354-7Table 4.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Acta Biomater 2011; 7:3196-208; PMID: 21571105; http://dx.doi.org/10.1016/j.actbio.2011.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Acta Biomater 2013; 9:8660-70; PMID:23454214; http://dx.doi.org/10.1016/j.actbio.2013.02.036 16.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Mech Behav Biomed Mater 2013; 20:36-44; PMID:23455162; http://dx.doi.org/10.1016/j.jmbbm.2012.12.012 17.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Mol Carcinogen 1995; 14:170- 8; http://dx.doi.org/10.1002/mc.2940140306 19.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Mol Genet Metab 2008; 94:375-81; PMID:18455459; http://dx.doi.org/10.1016/j.ymgme.2008.03.015 20.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Biomed Mater Res 2013; 102:2636-43; http://dx.doi.org/10.1002/jbm.a.3493724.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Biomed Mater Res 2004; 70A:122-8; http://dx.doi.org/10.1002/jbm.a.30072 25.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Mat Sci Eng B-Solid 2011; 176:830-4; http://dx.doi.org/10.1016/j.mseb.2011.04.008 26.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Mater Sci Mater Med 2007; 18:699-703; PMID:17136605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Cell Physiol 1996; 168:521-31;PMID:8816906; http://dx.doi.org/10.1002/(SICI) 1097-4652(199609)168:3%3c521::AID-JCP4%3e3.0.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Calcif Tissue Int 1991; 49:421-6; PMID: 1818768; http://dx.doi.org/10.1007/BF02555854 32.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
"Ann N Y Acad Sci 1995; 760:223-41; PMID:7785896; http://dx.doi.org/10.1111/j.1749- 6632.1995.tb44633.x 34. van der Rest M, Garrone R. Collagen family of pro- teins.",OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Faseb J 2003; 17:1015-25; PMID:12773484; http://dx.doi.org/10.1096/fj.02- 0773com 36.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Cell 1998; 93:165-76; PMID:9568710; http://dx.doi.org/ 10.1016/S0092-8674(00)81569-X 37.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Calcif Tissue Int 2010;87:365-72; PMID:20811796; http://dx.doi.org/ 10.1007/s00223-010-9410-z 39.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Oral Pathol Med 2004; 33:417-23; PMID: 15250834; http://dx.doi.org/10.1111/j.1600-0714.2004.00228.x 41.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
J Orthop Res 2010; 28:1315-22; PMID: 20309870; http://dx.doi.org/10.1002/jor.21138 42.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Bone 2006; 39:283-8; PMID: 16567138; http://dx.doi.org/10.1016/j.bone.2006.,OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Tissue Eng 2004; 10:81-92; PMID:15009933; http://dx.doi.org/10.1089/107632704322791727 44.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Osteoarthr Cartilage 2003; 11:653-64; http://dx.doi.org/10.1016/S1063-4584(03)00120-1 46.,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
Clin Oral Investig 2012; 16:79-86; PMID:20938793; http://dx.doi.org/10.1007/s00784-010-0477-8 www.landesbioscience.com e967616-11 Biomatter,Non-OADS,/arxiv_data1/oa_pdf/96/f2/kbim-04-01-967616.PMC4578555.pdf
"E-mail: bypark@yonsei.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.060Received 31 March 2015Keywords: TDP-43, Cytokine, IL-6, Nuclear body, RNA processing Abbreviations:  NF-κB, nuclear factor kappa B; MEFs: mouse em- bryonic fibroblast cells; Cy3, Cyanine dye 3; RNA-FISH, RNA-fluo-rescence in situ hybridization Perspective to:  Sungwook Lee et al (2015), Identification of a sub- nuclear body involved in sequence-specific cytokine RNA process-ing, Nature Communications, 6:5791, doi: 10.1038/ncomms6791.",Non-OADS,/arxiv_data1/oa_pdf/66/a1/BMB-48-239.PMC4578560.pdf
A functional role of TDP-43 in IL-6 and IL-10 RNA processing Sungwook Lee and Boyoun Park 240 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/66/a1/BMB-48-239.PMC4578560.pdf
"E-mail: kimyj@gist.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.067Received 8 April 2015Keywords: Sperm ejection, Post copulatory sexual selection, Cryptic  female choice, Diuretic hormone 44, Female reproductive behavior,  Drosophila melanogaster Abbreviations:  CFC, cryptic female choice; CRF , corticotrophin re- leasing factor; diruretic hormone 44 (Dh44); PCSS, post-copulatory sexual selection; SFP , seminal fluid protein  Perspective to:  Kang Min Lee et al (2015), A Neuronal Pathway that  Controls Sperm Ejection and Storage in Female Drosophila.",Non-OADS,/arxiv_data1/oa_pdf/06/a6/BMB-48-241.PMC4578561.pdf
242 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/06/a6/BMB-48-241.PMC4578561.pdf
"Tel: +82-2-961-9381; Fax: +82-2-969-4570; E-mail: bdaelee@khu.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.032Received 22 February 2015Keywords: Leucine rich repeat kinase 2 (LRRK2), Parkinson's dis- ease (PD), Alzheimer's disease (AD), Crohn's disease(CD) ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Function and dysfunction of leucine-rich repeat kinase 2  (LRRK2): Parkinson’s disease and beyond Jae Ryul Bae1 & Byoung Dae Lee1,2,3,* 1Department of Neuroscience, 2Neurodegeneration Control Research Center, 3Department of Physiology, School of Medicine, Kyung Hee  University, Seoul 130-701, Korea Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most  common cause of familial Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
Parkinson’s disease and beyond Jae Ryul Bae and Byoung Dae Lee 244 BMB Reports http://bmbreports.orgrecognized by leucine-rich repeat domains of nucleotide-bind- ing oligomerization domain-containing proteins (NODs).,OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
Parkinson’s disease and beyond Jae Ryul Bae and Byoung Dae Lee 245 http://bmbreports.org BMB ReportsLRRK2 has also been shown to phosphorylate eukaryotic ini- tiation factor 4E (eIF4E)-binding protein (4E-BP) and ribosomal protein S15 (RPS15).,Non-OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
Parkinson’s disease and beyond Jae Ryul Bae and Byoung Dae Lee 246 BMB Reports http://bmbreports.orgflammatory bowel disease (48).,Non-OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
"Parkinson’s disease and beyond Jae Ryul Bae and Byoung Dae Lee 247 http://bmbreports.org BMB Reportsase activity of LRRK2, and the pathology is not linked to its  kinase activity.",Non-OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
Parkinson’s disease and beyond Jae Ryul Bae and Byoung Dae Lee 248 BMB Reports http://bmbreports.organd Abeliovich A (2006) The familial Parkinsonism gene  LRRK2 regulates neurite process morphology.,Non-OADS,/arxiv_data1/oa_pdf/b8/8a/BMB-48-243.PMC4578562.pdf
"Tel: +82-42-879-8437; Fax: +82-42-879-8596; E-mail: leejr@kribb.re.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.037Received 25 February 2015Keywords: PTPRT , Receptor-type protein tyrosine phosphatase,  Neuronal synapse formation, Dendritic arborization, Neuronal de-velopment ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Protein tyrosine phosphatase PTPRT as a regulator of synaptic  formation and neuronal development Jae-Ran Lee * Biomedical Translational Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 305-806, Korea PTPRT/RPTP  is the most recently isolated member of the type  IIB receptor-type protein tyrosine phosphatase family and its expression is restricted to the nervous system.",Non-OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 250 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 251 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 252 BMB Reports http://bmbreports.orgpartner of PTPRT from rat synaptosomes using a novel method  of sequential immunoprecipitation with an anti-PTPRT mono-clonal antibody and then identification with tandem mass  spectrometry.,OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 253 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 254 BMB Reports http://bmbreports.orgicit of PTPRT activity appears to elicit delayed brain develop- ment and neuronal diseases.,OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
"Neuronal function of protein tyrosine phosphatase recptor T Jae-Ran Lee 255 http://bmbreports.org BMB Reports20, 5329-5338 31.",Non-OADS,/arxiv_data1/oa_pdf/82/ca/BMB-48-249.PMC4578563.pdf
"Tel: +82-2-3408-4485; Fax: +82-2-3408-  4334; E-mail: changkim@sejong.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.100Received 9 May 2014, Revised 15 June 2014,  Accepted 4 August 2014 Keywords:  Disease modeling, Drug screen, IPSC, Patient specific  therapy, Stem cell  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.iPSC technology-Powerful hand for disease modeling and  therapeutic screen Changsung Kim * Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea Cardiovascular and neurodegenerative diseases are major  health threats in many developed countries.",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 257 http://bmbreports.org BMB ReportsDisease MutationsDisease pathology  foundDisease mechanism  foundPatient specific  therapy suggested Reference Leopard syndrome LQT1 LQT2 LQT8LQT3- ARVD/C Brugada Schizophrenia AD ADAD ALS SMAHD PD RTTPWS Hepatic disorderPTPN11 KCNQ1 (R190Q) KCNH2 (A614V) CACNA1CSCN5A (F1473C), KCNH2 (K897T) PKP2 PKP2Not identified Sporadic & familial (APP) PS1 (A246E) & PS2 (N141I) Sporadic & APP (duplication) SOD1 (+/A4V), SOD1 (+/D90A) SMN1HTT PINK, Parkin, LRRK2 MECP2Chromosome 15q11-q13 deletion AATYES YES YES YESYES YES YESYES YES YESYES YES YESYES YES YES YESNA NA NA NAYES YES YESYES YES YESYES YES YESYES YES YESNA YESNA NA NA NAYES* NA NAYES YES YESYES YES YESYES** YES YESNA YES**(22) (16) (17) (18)(20) (55) (78)(32) (28) (29)(31) (48, 49) (44, 46)(52, 53) (54, 56) (37)(43) (62) *Living patient therapy has been made, **Novel drug screen has been made, NA: Not applicable, PS1: Presenilin-1, PS2: Prsenlili n-2, APP:  Amyloid Precursor Protein, PKP2: Plakophilin-2.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 258 BMB Reports http://bmbreports.orgmens before the study had begun (20); however, by increasing  the beating frequency, it was observed that inactivation of the Na + current increased and the proarrhythmic activity decreased.",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 259 http://bmbreports.org BMB ReportsAmyotrophic lateral sclerosis (ALS) Multiple groups reported ALS iPSC disease modeling (48, 49).",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 260 BMB Reports http://bmbreports.orgto manifest robust PD pathology in vitro  (54).",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 261 http://bmbreports.org BMB Reports Fig.",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 262 BMB Reports http://bmbreports.org Fig.",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 263 http://bmbreports.org BMB Reportsbroblast to neurons have been reported recently (75).",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 264 BMB Reports http://bmbreports.orgQT syndrome family with complex genetics.",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"iPSCs, New drug candidates search platform  Changsung Kim 265 http://bmbreports.org BMB Reportsical compound that promotes expression of neuronal  genes.",OADS,/arxiv_data1/oa_pdf/5d/dc/BMB-48-256.PMC4578564.pdf
"Young-Sam Keum, Tel: +82-31-961-5215; Fax: +82-31-961-5206; E-mail: keum03@dongguk.edu, Bu Young Choi, Tel: +82-43-299-8411; Fax: +82-43-299-8460; E-mail: bychoi@seowon.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.021Received 1 February 2015, Revised 23 February 2015,  Accepted 16 March 2015 Keywords: Cancer Metabolism, Isocitrate dehydrogenases (IDHs),  Isocitrate (ICT), -ketoglutarate ( -KG), ( R)-2-hydroxyglutarate (R-2HG) ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Isocitrate dehydrogenase mutations: new opportunities for  translational research Young-Sam Keum1,* & Bu Young Choi2,* 1College of Pharmacy, Dongguk University, Goyang 410-820, 2Department of Pharmaceutical Science and Engineering, Seowon University,  Cheongju 361-742, Korea Over the last decade, comprehensive genome-wide sequencing  studies have enabled us to find out unexpected genetic alter-ations of metabolism in cancer.",Non-OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
Molecular mechanisms of IDH1/2 mutations  Young-Sam Keum and Bu Young Choi 267 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
"Molecular mechanisms of IDH1/2 mutations  Young-Sam Keum and Bu Young Choi 268 BMB Reports http://bmbreports.orgular residue in the enzyme’s active site, both of which are un- usual features for tumor suppressor genes, the alternative spec-ulation that IDH1/2 mutations might be oncogenic arose.",Non-OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
Molecular mechanisms of IDH1/2 mutations  Young-Sam Keum and Bu Young Choi 269 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
"Currently, phase I/II clinical trials for targeted therapy against cancer patients, who harbor IDH1/2 mutations  are currently undergoing with selective mutant IDH1 (AG-120)  and IDH2 (AG-221) chemical inhibitors (please refer to the fol-lowing website for more information, http://www.agios.com/  pipeline-idh.php) and the final outcomes of these clinical trials  will reveal the feasibility of targeting metabolic alterations for mechanism-based cancer therapies.",Non-OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
Molecular mechanisms of IDH1/2 mutations  Young-Sam Keum and Bu Young Choi 270 BMB Reports http://bmbreports.orgREFERENCES 1.,OADS,/arxiv_data1/oa_pdf/6c/52/BMB-48-266.PMC4578565.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.5.131Received 17 June 2014, Revised 11 July 2014, Accepted 16 August 2014Keywords: Angiogenesis, Angiotensin II, Baicalin, Oxygen-induced retinopathy, VEGF ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The effect of baicalin in a mouse model of retinopathy of  prematurity  Hyoung Jo1,#, Sang Hoon Jung1,#, Hye Bin Yim2, Sung Jin Lee3 & Kui Dong Kang2,* 1Functional Food Center, Korea Institute of Science and Technology (KIST) Gangneung Institute, Gangneung 210-340, 2Department of  Ophthalmology, Incheon St. Mary’s Hospital, College of Me dicine, The Catholic University of Korea, Incheon 403-720, 3Department of  Ophthalmology, College of Medicine, Soonchunhyang University, Seoul 140-743, Korea Baicalin is a flavonoid derived from the dried root of Scutellaria  baicalensis .",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
272 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
273 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
274 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
"275 http://bmbreports.org BMB Reportsgroup, an oxygen-exposed group (OIR group), and 2 groups  that received different doses of baicalin.",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
"276 BMB Reports http://bmbreports.orgpriate secondary antibody (horseradish peroxidase-conjugated  goat anti-rabbit or horse anti-mouse secondary antibody at 1:3,000; Santa Cruz Biotechnology, Santa Cruz, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/BMB-48-271.PMC4578566.pdf
"Tel: +82-2-2123-2700; Fax: +82-2-312-  6027; E-mail: dskim@yonsei.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.5.161Received 5 August 2014, Revised 24 August 2014,  Accepted 4 September 2014 Keywords: ADAM15, Ectodomain shedding, Exosomes, MEK/ERK  signaling, Tumor suppression ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The ADAM15 ectodomain is shed from secretory exosomes Hee Doo Lee1, Yeon Hyang Kim2, Bon-Hun Koo1 & Doo-Sik Kim1,* 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, 2Department of Bioinformatics,  Korea Polytechnics, Nonsan 320-905, Korea We demonstrated previously that a disintegrin and metal- loproteinase 15 (ADAM15) is released into the extracellular space as an exosomal component, and that ADAM15-rich exo- somes have tumor suppressive functions.",Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
278 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
279 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
280 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
281 http://bmbreports.org BMB Reportsmediated tumor suppression.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
"282 BMB Reports http://bmbreports.org279, 47929-47938 6.",Non-OADS,/arxiv_data1/oa_pdf/bd/32/BMB-48-277.PMC4578567.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.5.190Received 1 September 2014, Revised 5 September 2014,  Accepted 22 September 2014 Keywords: Bone marrow-derived dendritic cells, CD8 + T cell,  Glycogen synthase kinase 3, Resveratrol, Tryptophanyl-tRNA syn-thetase ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Resveratrol regulates naïve CD 8+ T-cell proliferation by  upregulating IFN- -induced tryptophanyl-tRNA synthetase  expression Kyung Tae Noh1,#,*, Joon Cho2,#, Sung Hak Chun3,#, Jong-Hwa Jang4,#, Gil Sun Cha3, In Duk Jung3, Dong Deuk Jang1 &  Yeong-Min Park3,* 1Department of Infectious Diseases, Armed Forces Medical Research Institute, Daejeon 305-878, Korea, 2Department of Neurosurgery,  College of Medicine, Konkuk University, Seoul 143-701, Korea, 3Department of Immunology, Lab of Dendritic Cell Differentiation &  Regulation, KU Open Innovation Center and School of  Medicine, Konkuk University, Chungju 380-701, Korea, 4Department of Dental  Hygiene, Hanseo University, Seosan 356-706, Korea We found that resveratrol enhances interferon (IFN)- -induced  tryptophanyl-tRNA-synthetase (TTS) expression in bone mar-row-derived dendritic cells (BMDCs).",Non-OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
284 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
285 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
286 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
"287 http://bmbreports.org BMB ReportsInterestingly, the resveratrol-mediated increase in the pop- ulation of TTS-positive cells was more pronounced in CD8+  T-cells than that in CD4+ T-cells in the in vivo  tumor environ- ment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
"288 BMB Reports http://bmbreports.orgwith a Cy5-labeled anti-CD8 monoclonal Ab (to gate OT-1  T-cells), and assessed by flow cytometry.",OADS,/arxiv_data1/oa_pdf/3e/b2/BMB-48-283.PMC4578568.pdf
"Tel: +82-33-650-3653; Fax: +82-33-650-  3679; E-mail: shjung507@gmail.com http://dx.doi.org/10.5483/BMBRep.2015.48.5.189Received 3 September 2014, Revised 19 September 2014,  Accepted 19 September 2014 Keywords: Antioxidant, Caesalpinia sappan , Centrifugal partition  chromatography, Homoisoflavonoids, N-retinylidene- N-retinyl-etha- nolamine (A2E) photooxidation ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.One-step isolation of sappanol and brazilin from  Caesalpinia sappan  and their effects on oxidative  stress-induced retinal death Golam Mezbah Uddin1,3, Chul Young Kim2, Donghwa Chung3, Kyung-A Kim1 & Sang Hoon Jung1,* 1Natural Products Research Center, Korea Institute of Science and Technology (KIST) Gangneung Institute, Gangneung 201-340,  2College of Pharmacy, Hanyang University, Ansan 426-791, 3Department of Marine Food Science and Technology, Gangneung-Wonju  National University, Gangneung 210-702, Korea Caesalpinia sappan  is a well-distributed plant that is cultivated  in Southeast Asia, Africa, and the Americas.",Non-OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
290 BMB Reports http://bmbreports.org                       A B CD Fig.,OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
291 http://bmbreports.org BMB ReportsSamplePhotochem* SampleLipid Peroxidation** Concentration (M)Inhibition (%)IC50 (M)Concentration (g/ml)Inhibition (%)IC50 (M) Sappanol Brazilin Lutein400 200 100   50400 200 100  50 20058.78 38.11 21.62 10.9268.01 50.49 32.6820.07 86.49316.14 ± 3.38 197.93 ± 1.59 -EGCG Sappanol  1   0.5   0.25   0.125  0.0625   0.03125 10  5   2.5   1.25  0.625   0.312582.91 ± 2.50 62.22 ± 4.35 39.14 ± 8.62 24.86 ± 3.0318.99 ± 2.41 12.74 ± 3.73 56.49 ± 1.9133.09 ± 4.86 22.85 ± 4.19 15.44 ± 3.5412.09 ± 1.05   9.95 ± 3.850.50 8.59 *Sappanol and brazilin reduce A2E photooxidation.,Non-OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
292 BMB Reports http://bmbreports.org A   B  C   D Fig.,Non-OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
293 http://bmbreports.org BMB ReportsFig.,Non-OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
"MATERIALS AND METHODS Materials and Methods are described in the online data supple-ment, available at http://www.bmbreports.org/.",OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
294 BMB Reports http://bmbreports.org16.,Non-OADS,/arxiv_data1/oa_pdf/40/a4/BMB-48-289.PMC4578569.pdf
"Wang Yue, Tel: +86-22-23508677; Fax:  +86-22-23502554; E-mail: wangyue@nankai.edu.cn, Hong Ni, Tel: +86-22-23509842; Fax: +86-22-23502554; E-mail: hongni@ nan-kai.edu.cn http://dx.doi.org/10.5483/BMBRep.2015.48.5.008Received 14 January 2015, Revised 12 February 2015,  Accepted 6 March 2015 Keywords: Adrenergic receptor, Breast cancer, Epinephrine, Macro- phage polarization, Stress ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Adrenergic receptor 2 activation by stress promotes breast  cancer progression through macrophages M2 polarization in tumor microenvironment Jun-fang Qin1,2, Feng-jiao Jin1, Ning Li1, Hai-tao Guan1,2, Lan Lan3, Hong Ni1,2,* & Yue Wang1,* 1School of Medicine, Nankai University, 2State Key Laboratory of Medical Chemical Biology, Nankai University, 3Tianjin Cancer Hospital,  Tianjin Medical University, Tianjin 300071, PR China Stress and its related hormones epinephrine (E) and nor- epinephrine (NE) play a crucial role in tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
296 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
297 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
"298 BMB Reports http://bmbreports.orggroup vs.E+ADR 2 siRNA group, P ＜ 0.05, Fig.",Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
"299 http://bmbreports.org BMB ReportsVital River Lab Animal Technology Co., Ltd. All experimental  procedures were approved by the Medical Ethics Committee, Nankai University.",Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
300 BMB Reports http://bmbreports.orgREFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/84/75/BMB-48-295.PMC4578570.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.6.080Received 27 April 2015Keywords: Hypoxia, Lactate signaling, NDRG3, HIF-independent  hypoxia responses, PHD2/VHL pathway Abbreviations:  HIF , hypoxia-inducible factor; NDRG3, NDRG fam- ily member 3; PHD2, prolyl hydroxylase domain protein 2; VHL, von-Hippel Lindau; LDHA, lactate dehydrogenase A Perspective to:  Lee et al (2015), A Lactate-Induced Response to  Hypoxia, Cell, 161(3):595-609, doi: 10.1016/j.cell.2015.03.011.",Non-OADS,/arxiv_data1/oa_pdf/d2/d5/BMB-48-301.PMC4578614.pdf
302 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/d5/BMB-48-301.PMC4578614.pdf
"Michael J. Morgan, Tel: +1-303-724-5923;  E-mail: michael.morgan@ucdenver.edu, You-Sun Kim, Tel: +82-31- 219-4509; Fax: +82-31-219-4530; E-mail: yousunkim@ajou.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.6.068Received 10 April 2015Keywords: Hypomethylating agents, Programmed Necrosis, RIP3  (RIPK3) ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The serine threonine kinase RIP3: lost and found Michael J. Morgan1,* & You-Sun Kim2,3,* 1Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA, 2Department of Biochemistry, Ajou  University School of Medicine, 3Department of Biomedical Sciences, Graduate School, Ajou University, Suwon 443-749, Korea Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is an es- sential protein in the “programmed”, or “regulated” necrosis cell death pathway that is activated in response to death re- ceptor ligands and other types of cellular stress.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 304 BMB Reports http://bmbreports.orgology associated with Multiple Sclerosis (9).,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 305 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 306 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 307 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
"The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 308 BMB Reports http://bmbreports.orgwe examined possible reasons for loss of RIP3 expression in  cancer cells, including DNA methylation or histone deacety-lation.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
"The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 309 http://bmbreports.org BMB Reportsdeath has been largely unexplored, with a couple of notable  exceptions.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
"The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 310 BMB Reports http://bmbreports.orgcells and likely during tumor development and/or growth, al- though evidence in non-tumorigenic cells may suggest effects on the latter, rather than the former.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 311 http://bmbreports.org BMB Reportsstream of RIP3 kinase.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
The serine threonine kinase RIP3: lost and found Michael J. Morgan and You-Sun Kim 312 BMB Reports http://bmbreports.orgThe Next Generation.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/BMB-48-303.PMC4578615.pdf
"Tel: +82-2-2220-2560; Fax: +82-2-6280-  6725; E-mail: ypilkim@hanyang.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.6.054Received 27 March 2015Keywords: ECM, Enzyme activity, Imaging, Matrix metallopro- teinase, Nanoprobe ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Fluorescent and biolumin escent nanoprobes for in vitro  and  in vivo  detection of matrix metalloproteinase activity Hawon Lee1,2 & Young-Pil Kim1,2,* 1Department of Life Science, 2Research Institute for Natural Sciences and Research Institute for Convergence of Basic Sciences, Hanyang  University, Seoul 133-791, Korea Matrix metalloproteinases (MMPs) are zinc-dependent endo- peptidases that degrade the extracellular matrix (ECM) and reg-ulate the extracellular microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
Nanoprobes for MMP activity Hawon Lee and Young-Pil Kim 314 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
"Nanoprobes for MMP activity Hawon Lee and Young-Pil Kim 315 http://bmbreports.org BMB Reportssion and high photostability (12, 19-21).",OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
"Nanoprobes for MMP activity Hawon Lee and Young-Pil Kim 316 BMB Reports http://bmbreports.orgminus and TAMRA dye at the C-terminus, was mixed with the  carboxyl AuNP, the addition of Ni(II) caused a strong coordi-nation between the histidine group of the peptide and the car- boxyl group of the AuNPs, leading to a strong reduction of  TAMRA as a result of the quenching effect.",OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
"Nanoprobes for MMP activity Hawon Lee and Young-Pil Kim 317 http://bmbreports.org BMB Reportsand not suitable for in vivo  animal models, due to QD-related  toxicity and the instability of QD-luciferase conjugate.",Non-OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
Nanoprobes for MMP activity Hawon Lee and Young-Pil Kim 318 BMB Reports http://bmbreports.orgbiodiagnostics.,OADS,/arxiv_data1/oa_pdf/59/62/BMB-48-313.PMC4578616.pdf
"Tel: +82-32-835-8238; Fax: +82-32-835-0763; E-mail: harakang@incheon.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.6.206Received 24 September 2014Keywords:  Adipogenesis, Mesenchymal stem cells, MicroRNAs, Osteogenesis  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The role of microRNAs in cell fate determination of mesenchymal  stem cells : balancing adipogenesis and osteogenesis Hara Kang1,* & Akiko Hata2 1Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 406-772, Korea, 2Cardiovascular  Research Institute, University of California, San Francisco, CA 94158, USA Mesenchymal stem cells (MSCs) are multipotent stem cells ca- pable of differentiating into adipocytes, osteoblasts, or chon-drocytes.",Non-OADS,/arxiv_data1/oa_pdf/79/25/BMB-48-319.PMC4578617.pdf
"microRNAs for balancing adipogenesis and osteogenesis Hara Kang and Akiko Hata 320 BMB Reports http://bmbreports.orgmiRNA Target mRNA Osteogenic switch  (Increased expression   during osteogenesis) Adipogenic switch (Increased expression   during adipogenesis)miR-21 miR-22 miR-204 miR-211 miR-17-5p miR-106amiR-30e miR-637Sox2, Spry2 HDAC6 Runx2 Rnux2 BMP2 BMP2LPR6 OsxTable 1.  miRNAs that reciprocally regulate the differentiation of adipo- cytes  and osteoblasts Fig.",Non-OADS,/arxiv_data1/oa_pdf/79/25/BMB-48-319.PMC4578617.pdf
 microRNAs for balancing adipogenesis and osteogenesis Hara Kang and Akiko Hata 321 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/79/25/BMB-48-319.PMC4578617.pdf
"microRNAs for balancing adipogenesis and osteogenesis Hara Kang and Akiko Hata 322 BMB Reports http://bmbreports.orgCONCLUSIONS AND PERSPECTIVES The differentiation of mesenchymal stem cells into a particular  lineage is tightly regulated, and a malfunction in this regu- lation could lead to pathological consequences.",Non-OADS,/arxiv_data1/oa_pdf/79/25/BMB-48-319.PMC4578617.pdf
 microRNAs for balancing adipogenesis and osteogenesis Hara Kang and Akiko Hata 323 http://bmbreports.org BMB Reportsregulates the differentiation of adipocytes and osteoblasts  by directly targeting low-density lipoprotein receptor-re-lated protein 6.,Non-OADS,/arxiv_data1/oa_pdf/79/25/BMB-48-319.PMC4578617.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.6.073Received 1 April 2014, Revised 19 May 2014, Accepted 19 July 2014Keywords: Antimicrobial peptide, Anticancer activity, CopA3,  Necrosis, Phosphatidylserine ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Anticancer activity of CopA3 dimer peptide in human gastric  cancer cells Joon Ha Lee1,#, In-Woo Kim1,#, Sang-Hee Kim1, Eun-Young Yun1, Sung-Hee Nam1, Mi-Young Ahn1, Dong-Chul Kang2 &  Jae Sam Hwang1,* 1Department of Agricultural Biology, National Academy of Agricultural Science, RDA, Wanju 565-851, 2Ilsong Institute of Life Science,  Hallym University, Anyang 431-060, Korea CopA3 is a homodimeric -helical peptide derived from copri- sin which is a defensin-like antimicrobial peptide that was identified from the dung beetle, Copris tripartitus .",Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
325 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
326 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
327 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
328 BMB Reports http://bmbreports.orgshort incubation time (1 h) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
"329 http://bmbreports.org BMB ReportsAnnexin V/Propidium Iodide (PI) staining SNU-668 cells were plated into 6-well tissue culture plates (1  × 106 cells per well) and treated with various concentrations  of CopA3 (25, 50, and 100 M) or without CopA3.",Non-OADS,/arxiv_data1/oa_pdf/58/ac/BMB-48-324.PMC4578618.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.6.139Received 1 July 2014, Revised 4 August 2014,  Accepted 21 September 2014 Keywords: Apoptosis inhibitor 5, Cervical cancer, Metastasis,  Matrix metaloproteinase  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Apoptosis inhibitor 5 increases metastasis via Erk-mediated  MMP expression Kwon-Ho Song1,3,#, Seok-Ho Kim2,#, Kyung Hee Noh1,3,#, Hyun Cheol Bae1, Jin Hee Kim1, Hyo-Jung Lee1,3, Jinhoi Song2,  Tae Heung Kang4, Dong-Wan Kim5, Se-Jin Oh1,3, Ju-Hong Jeon6,* & Tae Woo Kim1,3,* 1Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University, Ansan 425-707, 2Immunotherapy Research  Center, Korea Research Institute of Bioscience & Biothechnology (KRIBB), Daejeon 305-806, 3Department of Biochemistry, Korea  University College of Medicine, Seoul 136-705, 4Department of Immunology, School of Me dicine, Konkuk University, Seoul 143-701,  5Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-779, 6Department of Physiology, Seoul  National University, College of Medicine, Seoul 110-779, Korea Apoptosis inhibitor 5 (API5) has recently been identified as a  tumor metastasis-regulating gene in cervical cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
331 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
332 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
333 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
334 BMB Reports http://bmbreports.orgAP-1 in API5 transfected cells was higher than in control cells.,OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
"MATERIALS AND METHODS DNA construct, Cells, siRNA transfection, Promoter assay, and  Zymographic assay are described in the online data supple- ment, available at http://www.bmbreports.org/.",OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
335 http://bmbreports.org BMB Reportswere taken.,Non-OADS,/arxiv_data1/oa_pdf/01/bf/BMB-48-330.PMC4578619.pdf
"Young Whan Choi, Tel: +82-55-350-  5522; Fax: +82-55-350-5529; E-mail: ywchoi@pusan.ac.kr, Yoe-Sik Bae, Tel: +82-31-290-5914; Fax: +82-31-290-7015; E-mail:  yoesik  @skku.edu http://dx.doi.org/10.5483/BMBRep.2015.48.6.202Received 18 September 2014, Revised 30 September 2014,  Accepted 2 October 2014 Keywords:  -Cubebenoate, Apoptosis, Bactericidal activity, Inflamm- ation, Sepsis ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Anti-septic activity of -cubebenoate isolated from  Schisandra chinensis Minsoo Kook1, Sung Kyun Lee1, Sang Doo Kim1, Ha Young Lee1,2, Jae Sam Hwang3, Young Whan Choi4,* &  Yoe-Sik Bae1,2,5,* 1Department of Biological Sciences, Sungkyunkwan University, Suwon 440-746, 2Mitochondria Hub Regulation Center, Dong-A  University, Busan 602-714, 3Department of Agricultural Biology, National Academy of Agricultural Science, RDA, Wanju 565-851,  4Department of Horticultural Bioscience, College of Natural Reso urces and Life Science, Pusan National University, Miryang 627-7 06,   5Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul 135-710, Korea Sepsis is a life-threatening, infectious, systemic inflammatory  disease.",Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
337 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
338 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
339 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
340 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
"MATERIALS AND METHODS Materials and Methods are described in the online data supple-ment, available at http://www.bmbreports.org/.ACKNOWLEDGEMENTS This work was supported by grants from the National Research Foundation of Korea (No.",OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
"341 http://bmbreports.org BMB ReportsVirulence 5, 36-44 6.",Non-OADS,/arxiv_data1/oa_pdf/18/4b/BMB-48-336.PMC4578620.pdf
"Hyun Kyu Song, Tel: +82-2-3290-3457;  Fax: +82-2-3290-3628; E-mail: hksong@korea.ac.kr, Hyesung Jeon,  Tel: +1-617-632-4398, Fax: +1-617-632-4393, E-mail: hjeon@  red.dfci.harvard.edu http://dx.doi.org/10.5483/BMBRep.2015.48.6.157Received 31 July 2014, Revised 22 August 2014,  Accepted 21 October 2014 Keywords:  EGFR activation, IGF-1R interaction, Insulin, MDA-MB-  436, Triple-negative breast cancer cellsInsulin activates EGFR by stimulating its interaction with  IGF-1R in low-EGFR-expressing TNBC cells Miyoung Shin1,2, Eun Gyeong Yang2, Hyun Kyu Song1,* & Hyesung Jeon2,3,* 1Division of Life Sciences, Korea University, Seoul 136-701, 2Center for Theragnosis, Biomedical Research Institute, Korea Institute of  Science and Technology, Seoul 136-791, Korea, 3Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA  The expression of epidermal growth factor receptor (EGFR) is  an important diagnostic marker for triple-negative breast cancer (TNBC) cells, which lack three hormonal receptors:  estrogen and progesterone receptors as well as epidermal  growth factor receptor 2.",Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
343 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
344 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
345 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
"346 BMB Reports http://bmbreports.orgmega), containing 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme- thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) solution.",Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
347 http://bmbreports.org BMB Reports5367-5374 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/7d/BMB-48-342.PMC4578621.pdf
"Tel: +82-33-248-2524; Fax: +82-33-256-1614; E-mail: tckang@hallym.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.6.237Received 4 November 2014, Revised 7 November 2014,  Accepted 7 November 2014 Keywords:  Breast cancer resistance protein, Multidrug resistance  protein, P-glycoprotein, Pharmacoresistent epilepsy, Vasogenic edema ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Cellular and regional specific changes in multidrug efflux  transporter expression during recovery of vasogenic edema in the rat hippocampus and piriform cortex Yeon-Joo Kim1,2, Ji-Eun Kim1,2, Hui-Chul Choi2,3, Hong-Ki Song2,3 & Tae-Cheon Kang1,2,* 1Department of Anatomy and Neurobiology, College of Medicine, Hallym University, 2Institute of Epilepsy Research, College of Medicine,  Hallym University, 3Department of Neurology, College of Medici ne, Hallym University, Chunchon 200-702, Korea In the present study, we investigated the characteristics of drug  efflux transporter expressions following status epilepticus (SE).",Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
349 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
350 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
351 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
"352 BMB Reports http://bmbreports.orgmals were provided with a commercial diet and water ad libi- tum under controlled temperature, humidity, and lighting con- ditions (22 ± 2oC, 55 ± 5% and a 12:12 light/dark cycle with  lights).",Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
353 http://bmbreports.org BMB Reports2.,Non-OADS,/arxiv_data1/oa_pdf/bf/29/BMB-48-348.PMC4578622.pdf
"Xiaochun Yu, Tel: +734-615-4932; Fax:  +734-936-6684; E-mail: xiayu@umich.edu, Zhonggao Wang, Tel: +86-10-83198868; Fax:+86-10-83198213; E-mail: wangzg35@126.com http://dx.doi.org/10.5483/BMBRep.2015.48.6.012Received 22 January 2015, Revised 12 February 2015,  Accepted 6 March 2015 Keywords: DNA damage, Oxidative stress, Poly(ADP-ribosyl)ation, Poly(ADP-ribose) glycohydrolase, Vascular smooth muscle cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Poly(ADP-ribose) protects vascular smooth muscle cells from  oxidative DNA damage Chao Zhang1, Tao Luo1, Shijun Cui1, Yongquan Gu1, Chunjing Bian2, Yibin Chen2, Xiaochun Yu2,* & Zhonggao Wang1,* 1Vascular Surgery Department of Xuanwu Hospital, Institute of Vascular Surgery, Capital Medical University, Beijing 100053, Chin a, 2Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor,  MI  48109, USA Vascular smooth muscle cells (VSMCs) undergo death during  atherosclerosis, a widespread cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
355 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
356 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
357 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
358 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
"MATERIALS AND METHODS Materials and Methods are described in the online data supple- ment, available at http://www.bmbreports.org/.",OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
359 http://bmbreports.org BMB Reportsto accelerate smooth muscle cell senescence and is a novel  biomarker of human vascular aging.,Non-OADS,/arxiv_data1/oa_pdf/57/13/BMB-48-354.PMC4578623.pdf
"Tel: +82-2-2258-7476; Fax: +82-2-593-  2522; E-mail: sjkyoon@catholic.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.6.031Received 17 February 2015, Revised 12 March 2015,  Accepted 14 March 2015 Keywords: Fzd6, MiR-199a-5p, CRC, Wnt4 , miRNA ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.FZD6 expression is negatively regulated by miR-199a-5p in  human colorectal cancer Bong-Kyu Kim, Hye-In Yoo, Injung Ki m, Jongkeun Park & Sungjoo Kim Yoon * Department of Medical Lifesciences, The Catholic University of Korea, Seoul 137-701, Korea Colorectal cancer (CRC), the third most common cancer  worldwide, also has the highest rate of cancer-related morbid-ity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
361 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
362 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
363 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
364 BMB Reports http://bmbreports.orgrelationship between these target genes and miR-199a-5p in pa- tients with CRC.,OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
"mirbase.org/), TargetScan version 5.2 (http://www.targetscan.org/),  and microRNA.org (http://www.microrna.org/microrna/home.",OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
"365 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS This study was supported by a grant from the National R&D  Program for Cancer Control, Ministry for Health, Welfare and  Family Affairs, Republic of Korea (1220180), and the author(s) also wish to acknowledge the financial support of the Catholic  Medical Center Research Foundation made in the program year  of 2012.",Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
366 BMB Reports http://bmbreports.orgof Frizzled-7 (FZD7) in human gastric cancer.,Non-OADS,/arxiv_data1/oa_pdf/15/df/BMB-48-360.PMC4578624.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/0b/main.PMC4578658.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.01.001,OADS,/arxiv_data1/oa_pdf/eb/0b/main.PMC4578658.pdf
"Pub-lished online, http://dx.doi.org/10.1002/hep.27489 .",Non-OADS,/arxiv_data1/oa_pdf/eb/0b/main.PMC4578658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/26/nihms723168.PMC4578660.pdf
"*Correspondence: kime@kaist.ac.kr.7Co-first author SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, five figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.08.002 .",OADS,/arxiv_data1/oa_pdf/f0/26/nihms723168.PMC4578660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f6/8a/main.PMC4578701.pdf
E-mail address: eoh9@jhmi.edu http://dx.doi.org/10.1016/j.dadm.2015.06.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/8a/main.PMC4578701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/8a/main.PMC4578701.pdf
Alzheimers Dement 2014; http://dx.doi.org/10.1016/j.jalz.2014.07.156 .,OADS,/arxiv_data1/oa_pdf/f6/8a/main.PMC4578701.pdf
"WHO, http://www.who.int/media centre/factsheets/fs275/en/ (accessed 13 March 2015).",OADS,/arxiv_data1/oa_pdf/9e/f0/10.1177_1741134315588986.PMC4579056.pdf
"Herald Scotland, http://www.heraldscotland.com/comment/herald-view/new-drink- driving-limit-has-a-positive- impact.114827531 (accessed 28 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/9e/f0/10.1177_1741134315588986.PMC4579056.pdf
"PharmaTimes Digital (Internet), http://www.pharmatimes.com/Article/13-03-25/French_drugs_regulator_facing_manslaughter _charge.aspx (25 March 2013, accessed 28 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/9e/f0/10.1177_1741134315588986.PMC4579056.pdf
"PHARMACEUTICAL COMMITTEE: Implementation of the ‘‘Falsified Medicines Directive’’ 2011/62/EU (Internet), http://ec.europa.eu/health/files/committee/74meeting/pharm682.pdf (2015, accessed 29 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/9e/f0/10.1177_1741134315588986.PMC4579056.pdf
"Advice on the implementation of EU-Directive 2011/62/EU: Report commissioned by the European Generic MedicinesAssociation (EGA) conducted by KPMG (Internet), http://www.kpmg.com/NL/nl/IssuesAndInsights/ArticlesPublications/ Documents/PDF/Advisory/Advice-on-the-implementation-of- EU-Directive-2011-62-EU.pdf (2013, accessed 29 April 2015).172 Journal of Generic Medicines 11(3–4)",Non-OADS,/arxiv_data1/oa_pdf/9e/f0/10.1177_1741134315588986.PMC4579056.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.563 www.annlabmed.org  563Ann Lab Med 2015;35:563-569 http://dx.doi.org/10.3343/alm.2015.35.6.563Original Article Diagnostic Hematology Adverse Prognostic Impact of Bone Marrow Microvessel  Density in Multiple Myeloma Nuri Lee, M.D.1,3,*, Hyewon Lee, M.D.2,*, Soo Young Moon, M.D.3, Ji Yeon Sohn, M.D.1, Sang Mee Hwang, M.D.4,   Ok Jin Yoon, M.T.1, Hye Sun Youn, M.T.1, Hyeon-Seok Eom, M.D.2, and Sun-Young Kong, M.D.1,5 Department of Laboratory Medicine1, Center for Diagnostic Oncology, Hospital and Research Institute, National Cancer Center, Goyang; Hematologic  Oncology Clinic2, Center for Specific Organs Cancer, Hospital and Research Institute, National Cancer Center, Goyang; Department of Laboratory Medicine3,  Seoul National University Hospital, Seoul; Department of Laboratory Medicine4, Seoul National University Bundang Hospital, Seongnam; Research Institute5,  Translational Epidemiology Branch, National Cancer Center, Goyang, Korea Background:  Angiogenesis is important for the proliferation and survival of multiple my - eloma (MM) cells.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"Prognostic impact of BM microvessel density 564  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.563clinical symptoms, plasmacytosis, β2-microglobulin concentra - tion, and plasma cell labeling index [6, 7].",OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"Prognostic impact of BM microvessel density http://dx.doi.org/10.3343/alm.2015.35.6.563 www.annlabmed.org  565tralian Biostain, Pty.",OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"Prognostic impact of BM microvessel density 566  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.56339.2 (26.7) and 32.5 (18.2), respectively, with the two means  differing significantly according to paired t-test ( P=0.004).",Non-OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
Prognostic impact of BM microvessel density http://dx.doi.org/10.3343/alm.2015.35.6.563 www.annlabmed.org  567PFS and OS was determined by using optimal points as cutoff  values on ROC curves.,OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"Prognostic impact of BM microvessel density 568  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.563and 10.2 months, respectively (Fig.",OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"Prognostic impact of BM microvessel density http://dx.doi.org/10.3343/alm.2015.35.6.563 www.annlabmed.org  569ture [11, 14, 22-24].",OADS,/arxiv_data1/oa_pdf/b0/86/alm-35-563.PMC4579099.pdf
"ISSN 2234-3806 • eISSN 2234-3814  570  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.570Ann Lab Med 2015;35:570-577 http://dx.doi.org/10.3343/alm.2015.35.6.570Original Article Clinical Chemistry Soluble ST2 Has a Prognostic Role in Patients With  Suspected Sepsis Mina Hur, M.D.1, Hanah Kim, M.D.1, Hyun Jeong Kim, M.D.1, Hyun Suk Yang, M.D.2, Laura Magrini, M.D.3,   Rossella Marino, M.D.3, Patrizia Cardelli, M.D.4, and Salvatore Di Somma, M.D.3; on behalf of GREAT Network Departments of Laboratory Medicine1 and Internal Medicine2, Konkuk University School of Medicine, Seoul, Korea; Departments of Medical-Surgery  Sciences and Translational Medicine3 and Clinical and Molecular Medicine4, School of Medicine and Psychology, ‘Sapienza’ University, Sant’ Andrea  Hospital, Rome, Italy Background:  Soluble suppression of tumorigenicity 2 (sST2) has emerged as a novel bio - marker for heart failure, and serum sST2 concentrations could be increased in inflamma - tory diseases.",Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"sST2 in patients with suspected sepsis http://dx.doi.org/10.3343/alm.2015.35.6.570 www.annlabmed.org  571creased in sepsis [11-14], and in one study, sST2 concentra - tions were found to be correlated with disease severity and mor - tality in patients with severe sepsis [14].",OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
sST2 in patients with suspected sepsis 572  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.570munosorbent assay comprising a ready-to-use 96-well microtiter  plate coated with mouse monoclonal anti-human sST2 antibod - ies.,Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"sST2 in patients with suspected sepsis http://dx.doi.org/10.3343/alm.2015.35.6.570 www.annlabmed.org  573of 0.5 ng/mL of PCT in serum, its distribution was found to differ  significantly between the groups with and without sepsis (184.4  [104.1-273.9] ng/mL vs. 51.3 [32.4-95.0] ng/mL, respectively,  P<0.0001).",OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"sST2 in patients with suspected sepsis 574  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.570 Regarding sepsis, sST2 has been explored in one experimen - tal study and four clinical studies [11-14, 19].",Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"sST2 in patients with suspected sepsis http://dx.doi.org/10.3343/alm.2015.35.6.570 www.annlabmed.org  575 failure in sepsis, using variables independent of the therapeutic  interventions [7].",Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
sST2 in patients with suspected sepsis 576  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.570centration seems to be attributable to both cardiac and inflam - matory comorbidities and may reflect the prognosis in sepsis.,Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"sST2 in patients with suspected sepsis http://dx.doi.org/10.3343/alm.2015.35.6.570 www.annlabmed.org  577Martins M, et al.",OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"16. http://www.accessdata.fda.gov/cdrh_docs/reviews/k111452.pdf (Ac - cessed in July 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/a2/23/alm-35-570.PMC4579100.pdf
"ISSN 2234-3806 • eISSN 2234-3814  578  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.578Ann Lab Med 2015;35:578-585 http://dx.doi.org/10.3343/alm.2015.35.6.578Original Article Clinical Chemistry Dried Blood Spot Testing for Seven Steroids Using  Liquid Chromatography-Tandem Mass Spectrometry  With Reference Interval Determination in the Korean  Population Borahm Kim, M.D.1, Mi-Na Lee, M.D.1, Hyung-Doo Park, M.D.1, Jong Won Kim, M.D.1, Yun Sil Chang, M.D.2,   Won Soon Park, M.D.2, and Soo-Youn Lee, M.D.1 Departments of Laboratory Medicine and Genetics1, Pediatrics2, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Conventional screening for congenital adrenal hyperplasia (CAH) using im - munoassays generates a large number of false-positive results.",Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS http://dx.doi.org/10.3343/alm.2015.35.6.578 www.annlabmed.org  579surement of 17-hydroxyprogesterone in CAH screening.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS 580  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.578mL and stored at -70°C.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
"Dried blood spot testing for steroids with LC-MS/MS http://dx.doi.org/10.3343/alm.2015.35.6.578 www.annlabmed.org  581alyte spiked after extraction, multiplied by 100.",OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS 582  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.5782014.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS http://dx.doi.org/10.3343/alm.2015.35.6.578 www.annlabmed.org  583Table 3.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS 584  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.57869.4-97.5% for the other steroids.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Dried blood spot testing for steroids with LC-MS/MS http://dx.doi.org/10.3343/alm.2015.35.6.578 www.annlabmed.org  585genital adrenal hyperplasia due to 21-hydroxylase deficiency.,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
Available from http://www.mayomedicallaboratories.com/ test-catalog/Clinical+and+Interpretive/91196 (Accessed on Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/48/8f/alm-35-578.PMC4579101.pdf
"ISSN 2234-3806 • eISSN 2234-3814  586  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.586Ann Lab Med 2015;35:586-594 http://dx.doi.org/10.3343/alm.2015.35.6.586Original Article Clinical Chemistry Hypertriglyceridemia is a Major Factor Associated With  Elevated Levels of Small Dense LDL Cholesterol in  Patients With Metabolic Syndrome Yonggeun Cho, M.D.1,4,*, Sang-Guk Lee, M.D.2,*, Sun Ha Jee, Ph.D.3, and Jeong-Ho Kim, M.D.2 Departments of Microbiology and Immunology1, Laboratory Medicine2; Epidemiology and Health Promotion3, Graduate School of Public Health; and Brain  Korea 21 PLUS Project for Medical Science4, Yonsei University College of Medicine, Seoul, Korea Background:  We aimed to determine the major contributing component of metabolic syn - drome (MetS) that results in an elevated small dense LDL cholesterol (sdLDL-C) concen - tration and sdLDL-C/LDL-C ratio.",Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
"Triglyceride and sdLDL-C in MetS patients http://dx.doi.org/10.3343/alm.2015.35.6.586 www.annlabmed.org  587lin resistance) and non-lipid factors (hypertension and abdomi - nal obesity), has been proposed as a criterion that would be help - ful in identifying those patients who are at high risk of CVD re - gardless of LDL-C level [5].",Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
Triglyceride and sdLDL-C in MetS patients 588  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.586meet the criteria for each MetS component.,OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
Triglyceride and sdLDL-C in MetS patients http://dx.doi.org/10.3343/alm.2015.35.6.586 www.annlabmed.org  589with high LDL-C (>4.14 mmol/L) as defined by the NCEP [3]  than healthy men and women.,Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
Triglyceride and sdLDL-C in MetS patients 590  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.586Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
"Triglyceride and sdLDL-C in MetS patients http://dx.doi.org/10.3343/alm.2015.35.6.586 www.annlabmed.org  591C concentration and the sdLDL-C/LDL-C ratio, multiple linear  regression analysis using anthropometric and metabolic param - eters was conducted for the whole study population (Table 3).",OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
"Triglyceride and sdLDL-C in MetS patients 592  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.586DISCUSSION In this study, we evaluated sdLDL-C concentration in both healthy  subjects and patients with MetS.",Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
Triglyceride and sdLDL-C in MetS patients http://dx.doi.org/10.3343/alm.2015.35.6.586 www.annlabmed.org  593and the insulin resistance correlates well with sdLDL-C concen - tration [33].,Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
Triglyceride and sdLDL-C in MetS patients 594  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.5866.,Non-OADS,/arxiv_data1/oa_pdf/2b/82/alm-35-586.PMC4579102.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.595 www.annlabmed.org  595Ann Lab Med 2015;35:595-601 http://dx.doi.org/10.3343/alm.2015.35.6.595Original Article Clinical Microbiology Distribution of β-Lactamase Genes Among  Carbapenem-Resistant Klebsiella pneumoniae  Strains  Isolated From Patients in Turkey Meryem Iraz, M.D.1, Azer Özad Düzgün, M.S.2, Cemal Sandallı, Ph.D.3, Mehmet Ziya Doymaz, Ph.D.1,   Yasemin Akkoyunlu, M.D.4, Ayşegül Saral, M.S.5, Anton Y. Peleg, Ph.D.6,7, Osman Birol Özgümü ş, Ph.D.8,   Fatih Şaban Beri ş, Ph.D.3, Hakan Karao ğlu, Ph.D.9, and Ayşegül Çopur Çiçek, M.D.8 Department of Medical Microbiology1, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey; Department of Genetic and Bioengineering2,  Faculty of Engineering and Natural Sciences, Gumushane University, Gumushane, Turkey; Department of Biology3, Faculty of Arts & Sciences, Recep Tayyip  Erdoğan University, Rize, Turkey; Department of Infectious Diseases and Clinical Microbiology4, Faculty of Medicine, Bezmialem Vakif University, Istanbul,  Turkey; Department of Biology5, Faculty of Arts & Sciences, ArtvinCoruh University, Artvin, Turkey; Department of Microbiology6, Monash University,  Melbourne, Australia; Department of Infectious Diseases7, The Alfred Hospital, Melbourne, Australia; Department of Microbiology8, Faculty of Medicine,  Recep Tayyip Erdo ğan University, Rize, Turkey; Department of Aquaculture9, Faculty of Fisheries, Recep Tayyip Erdo ğan University, Rize, Turkey Background:  The emergence of carbapenem-resistant Klebsiella pneumoniae  poses a se - rious problem to antibiotic management.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
β-Lactamase genes in carbapenem-resistant K. pneumoniae 596  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.595emases [1].,Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
β-Lactamase genes in carbapenem-resistant K. pneumoniae http://dx.doi.org/10.3343/alm.2015.35.6.595 www.annlabmed.org  597agarose containing 0.5 μg/mL ethidium bromide and subse - quently visualized under UV light.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
"Sequencing results were analyzed  by using the alignment search tool, BLAST (http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
"nlm.nih.gov/BLAST) [14], and the multiple sequence aligment  program CLUSTALW2 (http://www.ebi.ac.uk/Tools/msa/clust - alw2/).",OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
β-Lactamase genes in carbapenem-resistant K. pneumoniae 598  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.595Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
"β-Lactamase genes in carbapenem-resistant K. pneumoniae http://dx.doi.org/10.3343/alm.2015.35.6.595 www.annlabmed.org  599and reanimation intensive care unit (ICU), and three were iso - lated from the thoracic surgery unit.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
β-Lactamase genes in carbapenem-resistant K. pneumoniae 600  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.595velopment of control strategies for hospital infections.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
β-Lactamase genes in carbapenem-resistant K. pneumoniae http://dx.doi.org/10.3343/alm.2015.35.6.595 www.annlabmed.org  6012014;63:86-9.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/alm-35-595.PMC4579103.pdf
"ISSN 2234-3806 • eISSN 2234-3814  602  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.602Ann Lab Med 2015;35:602-610 http://dx.doi.org/10.3343/alm.2015.35.6.602Original Article Clinical Microbiology Molecular Identification and Amphotericin B  Susceptibility Testing of Clinical Isolates of Aspergillus   From 11 Hospitals in Korea Min Seok Heo, M.D.1, Jong Hee Shin, M.D.1, Min Ji Choi, M.T.1, Yeon-Joon Park, M.D.2, Hye Soo Lee, M.D.3,   Sun Hoe Koo, M.D.4, Won Gil Lee, M.D.5, Soo Hyun Kim, M.D.1, Myung-Geun Shin, M.D.1, Soon-Pal Suh, M.D.1,   and Dong-Wook Ryang, M.D.1 Department of Laboratory Medicine1, Chonnam National University Medical School, Gwangju; Department of Laboratory Medicine2, The Catholic University  of Korea College of Medicine, Seoul; Department of Laboratory Medicine3, Chonbuk National University Medical School and Chonbuk National University  Hospital Branch of National Culture Collection for Pathogens, Jeonju; Department of Laboratory Medicine4, College of Medicine, Chungnam National  University, Gwangju; Department of Laboratory Medicine5, Kyungpook National University School of Medicine, Daegu, Korea Background:  We investigated the species distribution and amphotericin B (AMB) suscep - tibility of Korean clinical Aspergillus  isolates by using two Etests and the CLSI broth micro - dilution method.",Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"Amphotericin B susceptibility of Aspergillus http://dx.doi.org/10.3343/alm.2015.35.6.602 www.annlabmed.org  603species identification is particularly important for determining the  implications of resistance for patient management strategies, as  some species show specific patterns of antifungal susceptibility  [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
Gene sequences  derived from the ITS and β-tubulin regions of all the Aspergillus   isolates were compared with sequences available in GenBank  by means of the BLAST program (http://blast.ncbi.nlm.nih.gov/ Blast.cgi) to identify isolates to the species complex level (by us - ing the ITS region) and to the species level within the complex  (by using the β-tubulin region) [3-5].,OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"Amphotericin B susceptibility of Aspergillus 604  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.602parisons, and the frequency of discrepancies among MIC end - points of more than two dilutions (two wells) was used to calcu - late essential agreement.",OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
Amphotericin B susceptibility of Aspergillus http://dx.doi.org/10.3343/alm.2015.35.6.602 www.annlabmed.org  605Table 2.,Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"Amphotericin B susceptibility of Aspergillus 606  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.602Two isolates of the A. fumigatus  complex and one of the A. ustus   complex, with an AMB MIC of 4 μg/mL, were identified as A.  lentulus  and A. calidoustus , respectively, by partial sequencing  of β-tubulin.",Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
Amphotericin B susceptibility of Aspergillus http://dx.doi.org/10.3343/alm.2015.35.6.602 www.annlabmed.org  607Table 3.,Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"Amphotericin B susceptibility of Aspergillus 608  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.602Species     (N of isolates tested)Test methodMIC (µg/mL)Essential  agreement  (%)*N (%) of  isolates with  MIC > ECV†Categorical  agreement  (%)†% of categorical  discrepancies‡  Range MIC 50 MIC 90 Very major Major Total, A. versicolor  complex (6) CLSI 1-2 2 2  0 (0.0)     Etest-MH 0.5-3 2 3 100.0 2 (33.3) 66.7 0.0 33.3  Etest-RPG 0.25-0.75 1 1 83.3 0 (0.0) 100.0 0.0 0.0  A. calidoustus  (1) CLSI 4 NA NA       Etest-MH 4 NA NA 100.0 NA NA NA NA Etest-RPG 3 NA NA 100.0 NA NA NA NA Total (136) CLSI 0.06-4 1 2  4 (3.0)     Etest-MH 0.032-32 1 8 81.6 34 (25.2) 77.8 0.0 22.2  Etest-RPG 0.012-32 1 4 83.8 23 (17.0) 85.9 0.0 14.1  *Essential agreement (±2 log 2 dilutions) between the CLSI method and each of the Etests; †The recently published ECVs (2 μg/mL for the A. fumigatus , A.  niger , A. flavus , and A. versicolor  complexes and 4 μg/mL for the A. terreus  complex) were used for analysis of categorical agreement [8, 13]; ‡Discrepancies  were considered to be very major when an isolate classified as non-WT (above the ECV) by the CLSI method was categorized as WT by one of the Etests and  major when an isolate classified as WT by the CLSI method was classified as non-WT by one of the Etests.",OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"Amphotericin B susceptibility of Aspergillus http://dx.doi.org/10.3343/alm.2015.35.6.602 www.annlabmed.org  609ods, and it showed >98% of categorical agreement with the  CLSI method for all Aspergillus  complexes, with the exception of  the A. terreus  (86.7%) and A. flavus  (37.5%) complexes.",OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
Amphotericin B susceptibility of Aspergillus 610  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.60224.,Non-OADS,/arxiv_data1/oa_pdf/42/37/alm-35-602.PMC4579104.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.611 www.annlabmed.org  611Ann Lab Med 2015;35:611-617 http://dx.doi.org/10.3343/alm.2015.35.6.611Original Article Diagnostic Immunology Increase in Anti-Gal IgM Level is Associated With Early  Graft Failure in Intraportal Porcine Islet  Xenotransplantation Hee Jung Kang, M.D.1, Haneulnari Lee, M.S.1, Eun Mi Park, M.S.1, Jong Min Kim, Ph.D.2, Jun-Seop Shin, Ph.D.2,   Jung-Sik Kim, Ph.D.2, Chung-Gyu Park, M.D.2,3, and Sang Joon Kim, M.D.2 Department of Laboratory Medicine1, Hallym University College of Medicine, Anyang; Xenotransplantation Research Center2, Seoul National University  College of Medicine, Seoul; Department of Microbiology and Immunology3, Cancer Research Institute, Seoul National University College of Medicine, Seoul  National University Hospital Biomedical Research Institute, Seoul, Korea Background:  Anti-Gal is a major antibody induced in non-human primates (NHPs) after  xenotransplantation.",Non-OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
"Anti-Gal IgM in porcine islet xenotransplantation 612  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.611antibody in humans, which is found as IgM, and to a lesser ex - tent as IgG and IgA; it is continuously produced in response to  antigenic stimulation by common gut bacteria [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
Anti-Gal IgM in porcine islet xenotransplantation http://dx.doi.org/10.3343/alm.2015.35.6.611 www.annlabmed.org  613requirement.,Non-OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
"Anti-Gal IgM in porcine islet xenotransplantation 614  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.611each other but were significantly lower than that in Group I  (3.33, P=0.0013 and 0.0229).",OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
Anti-Gal IgM in porcine islet xenotransplantation http://dx.doi.org/10.3343/alm.2015.35.6.611 www.annlabmed.org  615PITx have not been a primary concern.,Non-OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
Anti-Gal IgM in porcine islet xenotransplantation 616  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.611signals: forward signaling for the activation of antigen presenting  cells and reverse signaling for the stimulation of T cells and in - nate NK cells [37].,Non-OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
"Anti-Gal IgM in porcine islet xenotransplantation http://dx.doi.org/10.3343/alm.2015.35.6.611 www.annlabmed.org  61726. van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimula - tion of T cells in the development of helper function.",OADS,/arxiv_data1/oa_pdf/20/b5/alm-35-611.PMC4579105.pdf
"ISSN 2234-3806 • eISSN 2234-3814  618  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.618Ann Lab Med 2015;35:618-623 http://dx.doi.org/10.3343/alm.2015.35.6.618Original Article Transfusion Medicine Duffy Blood Group Genotyping in Thai Blood Donors Oytip Nathalang, Ph.D.1, Kamphon Intharanut, M.S.1, Kanokpol Siriphanthong, B.S.1, Siriporn Nathalang, B.S.2,   and Pawinee Kupatawintu, M.S.2 Graduate Program1, Faculty of Allied Health Sciences, Thammasat University, Pathumtani; National Blood Centre2, Thai Red Cross Society, Bangkok, Thailand Background:  Duffy (FY) blood group genotyping is important in transfusion medicine be - cause Duffy alloantibodies are associated with delayed hemolytic transfusion reactions  and hemolytic disease of the fetus and newborn.",Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
"Duffy genotyping in Thais http://dx.doi.org/10.3343/alm.2015.35.6.618 www.annlabmed.org  619phenotyping in clinical situations, e.g., for finding matched blood  for alloimmunized patients, assessing the risk of HDFN, and  studying anthropology and disease associations [9, 10].",Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
"Duffy genotyping in Thais 620  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.618FY*BES, FY*A , and FY*B  alleles were each 711 bp, whereas that  of the internal control (i.e., the HGH  gene) was 434 bp.",Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
Duffy genotyping in Thais http://dx.doi.org/10.3343/alm.2015.35.6.618 www.annlabmed.org  621quencing results for the Guinea family also confirmed a point  mutation in the GATA promoter region of FY*BES.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
"Duffy genotyping in Thais 622  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.618FY*A /FY*A  was Fy(a+b-) (92.8%), FY*A /FY*B  was Fy(a+b+)  (6.8%), and FY*B /FY*B  was Fy(a-b+) (0.4%).",OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
Duffy genotyping in Thais http://dx.doi.org/10.3343/alm.2015.35.6.618 www.annlabmed.org  623Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
(in Thai) J Hematol Transfus Med 2010;20:  255-62. http://www.tci-thaijo.org/index.php/JHematolTransfusMed/arti - cle/viewFile/4371/3812.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
(in Thai) Thai J Hematol Transfus  Med 2002;12:277-86. http://www.tsh.or.th/journal_detail2.php?id=63.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/alm-35-618.PMC4579106.pdf
"ISSN 2234-3806 • eISSN 2234-3814  624  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.624Ann Lab Med 2015;35:624-629 http://dx.doi.org/10.3343/alm.2015.35.6.624Original Article Diagnostic Genetics Evaluation of the Anyplex BRAF  V600E Real-Time  Detection Assay Using Dual-Priming Oligonucleotide  Technology in Fine-Needle Aspirates of Thyroid  Nodules  Rihwa Choi, M.D.",OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
"BRAF  V600E detection using real-time PCR http://dx.doi.org/10.3343/alm.2015.35.6.624 www.annlabmed.org  625needle aspirates (FNAs), in clinical pathology and clinical oncol - ogy practices.",OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
BRAF  V600E detection using real-time PCR 626  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.6243.,OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
BRAF  V600E detection using real-time PCR http://dx.doi.org/10.3343/alm.2015.35.6.624 www.annlabmed.org  627malignant by FNA cytology.,OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
"BRAF  V600E detection using real-time PCR 628  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.624nosed with PTC contained the BRAF  V600E mutation as deter - mined by the Anyplex assay and MEMO sequencing, including  conflicting results.",OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
BRAF  V600E detection using real-time PCR http://dx.doi.org/10.3343/alm.2015.35.6.624 www.annlabmed.org  6299.,OADS,/arxiv_data1/oa_pdf/ca/bc/alm-35-624.PMC4579107.pdf
"ISSN 2234-3806 • eISSN 2234-3814  630  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.630Ann Lab Med 2015;35:630-634 http://dx.doi.org/10.3343/alm.2015.35.6.630Original Article General Laboratory Medicine Association Between High Platelet Indices and  Proteinuria in Patients With Hypertension Ihsan Ates, M.D., Mesudiye Bulut, M.D., Nihal Ozkayar, M.D., and Fatih Dede, M.D.",Non-OADS,/arxiv_data1/oa_pdf/55/69/alm-35-630.PMC4579108.pdf
"Platelet indices and proteinuria  http://dx.doi.org/10.3343/alm.2015.35.6.630 www.annlabmed.org  631crit (PCT), and platelet distribution width (PDW) are easily cal - culated via routine blood counts.",OADS,/arxiv_data1/oa_pdf/55/69/alm-35-630.PMC4579108.pdf
"Platelet indices and proteinuria  632  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.630ing beta-blockers, 39.9% were using calcium channel blockers,  and 30.9% were using diuretics.",OADS,/arxiv_data1/oa_pdf/55/69/alm-35-630.PMC4579108.pdf
"Platelet indices and proteinuria  http://dx.doi.org/10.3343/alm.2015.35.6.630 www.annlabmed.org  6330.552-0.682; P=0.011), and a PDW level >13.1% predicted  proteinuria with a sensitivity of 62.1% and a specificity of 52.8%  (AUC±SE, 0.612±0.042; 95% CI, 0.544-0.677; P=0.007).",OADS,/arxiv_data1/oa_pdf/55/69/alm-35-630.PMC4579108.pdf
"Platelet indices and proteinuria  634  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.630patient population with proteinuria, lack of other thrombogenic  factors, and no follow-up evaluations to determine the correla - tion between PCT, MPV, and PDW levels and disease prognosis.",Non-OADS,/arxiv_data1/oa_pdf/55/69/alm-35-630.PMC4579108.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.635 www.annlabmed.org  635Ann Lab Med 2015;35:635-638 http://dx.doi.org/10.3343/alm.2015.35.6.635Brief Communication Clinical Microbiology Establishing Quality Control Ranges for Antimicrobial  Susceptibility Testing of Escherichia coli , Pseudomonas  aeruginosa , and Staphylococcus aureus : A Cornerstone  to Develop Reference Strains for Korean Clinical  Microbiology Laboratories  Sung Kuk Hong, M.D.1, Seung Jun Choi, M.D.1, Saeam Shin, M.D.1, Wonmok Lee, M.D.2, Naina Pinto, M.S.1,   Nari Shin, Vet.D.3, Kwangjun Lee, Ph.D.3, Seong Geun Hong, M.D.4, Young Ah Kim, M.D.5, Hyukmin Lee, M.D.6,   Heejung Kim, M.D.1, Wonkeun Song, M.D.7, Sun Hwa Lee, M.D.8, Dongeun Yong, M.D.1, Kyungwon Lee, M.D.1,   and Yunsop Chong, Ph.D.1 Department of Laboratory Medicine and Research Institute of Bacterial Resistance1, Yonsei University College of Medicine, Seoul; Department of Laboratory  Medicine2, Keimyung University School of Medicine, Daegu; Division of High-risk Pathogen Research3, Korea Center for Disease Control and Prevention,  Osong; Department of Laboratory Medicine4, CHA Bundang Medical Center, CHA University, Seongnam; Department of Laboratory Medicine5, National  Health Insurance Corporation Ilsan Hospital, Goyang; Department of Laboratory Medicine6, Catholic Kwandong University International St. Mary’s Hospital,  Incheon; Department of Laboratory Medicine7, Hallym University College of Medicine, Seoul; Seegene Medical Foundation8, Seoul, Korea Quality control (QC) processes are being performed in the majority of clinical microbiology  laboratories to ensure the performance of microbial identification and antimicrobial sus - ceptibility testing by using ATCC strains.",Non-OADS,/arxiv_data1/oa_pdf/4a/a8/alm-35-635.PMC4579109.pdf
Establishing AST QC ranges using Korean strains 636  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.635and time required for delivery of the ordered strains pose incon - veniences to these laboratories.,Non-OADS,/arxiv_data1/oa_pdf/4a/a8/alm-35-635.PMC4579109.pdf
"Establishing AST QC ranges using Korean strains http://dx.doi.org/10.3343/alm.2015.35.6.635 www.annlabmed.org  637using the CLSI and Range Finder methods were 6-11 mm and  9-15 mm, respectively [piperacillin (9; 11), ceftazidime (8; 14),  cefepime (10; 13), aztreonam (9; 14), imipenem (8; 13), me - ropenem (9; 12), amikacin (6; 9), and gentamicin (9; 13)], and  95.2-96.4% and 96.6-98.6% of ZD results were within the QC  ranges.",Non-OADS,/arxiv_data1/oa_pdf/4a/a8/alm-35-635.PMC4579109.pdf
"Establishing AST QC ranges using Korean strains 638  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.635range of MIC and ZD for ASTs, excessively broad ranges of ZD  and MIC are not recommended: a ZD range of >12 and twofold  dilution rage of ≥5 for MIC [1].",Non-OADS,/arxiv_data1/oa_pdf/4a/a8/alm-35-635.PMC4579109.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.639 www.annlabmed.org  639Ann Lab Med 2015;35:639-642 http://dx.doi.org/10.3343/alm.2015.35.6.639Brief Communication Diagnostic Genetics Novel Pathogenic Variant (c.3178G>A) in the SMC1A   Gene in a Family With Cornelia de Lange Syndrome  Identified by Exome Sequencing Mi-Ae Jang, M.D.1, Chang-Woo Lee, Ph.D.2, Jin-Kyung Kim, M.D.3, and Chang-Seok Ki, M.D.4 Department of Laboratory Medicine1, Korea University College of Medicine, Seoul; Department of Molecular Cell Biology2, Samsung Biomedical Research  Institute, Sungkyunkwan University School of Medicine, Suwon; Department of Pediatrics3, Catholic University of Daegu School of Medicine, Daegu;  Department of Laboratory Medicine and Genetics4, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Cornelia de Lange syndrome (CdLS) is a clinically and genetically heterogeneous congeni - tal anomaly.",Non-OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
Novel pathogenic variant (c.3178G>A) in SMC1A   640  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.639the other four genes [6].,Non-OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
Novel pathogenic variant (c.3178G>A) in SMC1A   http://dx.doi.org/10.3343/alm.2015.35.6.639 www.annlabmed.org  641in the SMC1A  gene (Fig.,Non-OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
The p.Glu1060Lys variant was  absent from dbSNP (build 135) and the Exome Sequencing  Project database (http://evs.gs.washington.edu/EVS/) and was  not detected in our in-house variant database consisting of 96  Korean exomes of various inherited disorders other than CdLS.,OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
"Bioinformatic analysis revealed that the affected residue,  Glu1060, is strictly conserved from zebrafish to humans, and  both SIFT (http://sift.bii.a-star.edu.sg/index.html) and Poly - Phen-2 (http://genetics.bwh.harvard.edu/pph2/) predicted  p.Glu1060Lys to be deleterious.",Non-OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
"Novel pathogenic variant (c.3178G>A) in SMC1A   642  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.639with CdLS, we compared the clinical features of the family with  the SMC1A  pathogenic variant from this study and those of the  three previously reported patients with NIPBL  mutations (Table  1).",Non-OADS,/arxiv_data1/oa_pdf/51/b9/alm-35-639.PMC4579110.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.643 www.annlabmed.org  643Ann Lab Med 2015;35:643-646 http://dx.doi.org/10.3343/alm.2015.35.6.643Letter to the Editor  Diagnostic Hematology Cryptic e1a2 BCR-ABL1  Fusion With Complex  Chromosomal Abnormality in de novo  Myelodysplastic  Syndrome Bo-Young Seo, M.D.1, Jun-Hyoung Lee, M.D.1, Min-Gu Kang, M.D.2, Seok-Yong Choi, M.D.3, Soo-Hyun Kim, M.D.1,   Jong-Hee Shin, M.D.1, Soon-Pal Suh, M.D.1, Dong-Wook Ryang, M.D.1, and Myung-Geun Shin, M.D.1,2,3 Department of Laboratory Medicine1, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun;  Environmental Health Center for Childhood Leukemia and Cancer2, Chonnam National University Medical School and Chonnam National University Hwasun  Hospital, Hwasun; Brain Korea 21 Plus Project3, Chonnam National University Medical School, Gwangju, Korea Dear Editor MDS is a clonal disorder marked by ineffective hematopoiesis,  cytopenias, clonal chromosomal abnormalities, and a variable  predilection to undergo clonal evolution to AML.",Non-OADS,/arxiv_data1/oa_pdf/e7/6b/alm-35-643.PMC4579111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/6b/alm-35-643.PMC4579111.pdf
"BCR-ABL1 -positive MDS 644  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.64314,-16,+mar [cp20].",OADS,/arxiv_data1/oa_pdf/e7/6b/alm-35-643.PMC4579111.pdf
BCR-ABL1 -positive MDS http://dx.doi.org/10.3343/alm.2015.35.6.643 www.annlabmed.org  645 C  M1 M2 M3 M4 M5 M6 M7 M8  8A 8B 8C 8D 8E 8F B A Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/6b/alm-35-643.PMC4579111.pdf
BCR-ABL1 -positive MDS 646  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.643REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/e7/6b/alm-35-643.PMC4579111.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.647 www.annlabmed.org  647Ann Lab Med 2015;35:647-650 http://dx.doi.org/10.3343/alm.2015.35.6.647Letter to the Editor  Diagnostic Hematology Use of Delta Neutrophil Index for Differentiating Low- Grade Community-Acquired Pneumonia From Upper  Respiratory Infection Hyunjung Kim, M.D.1, Yonggoo Kim, M.D.1, Kwan Hyoung Kim, M.D.2, Chang Dong Yeo, M.D.2, Jin Woo Kim, M.D.2,   and Hae Kyung Lee, M.D.1 Departments of Laboratory Medicine1 and Internal Medicine2, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor Pneumonia is a major cause of death worldwide, especially in  aging and immunodeficient patients [1].",Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
Delta neutrophil index and pneumonia 648  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.647tients recovered.,Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
Delta neutrophil index and pneumonia http://dx.doi.org/10.3343/alm.2015.35.6.647 www.annlabmed.org  649Fig.,Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
Delta neutrophil index and pneumonia 650  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.647power than individual biomarkers.,Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
http://www.who.int/mediacentre/ factsheets/fs310/en/ (Updated on May 2014).,Non-OADS,/arxiv_data1/oa_pdf/cd/b4/alm-35-647.PMC4579112.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.651 www.annlabmed.org  651Ann Lab Med 2015;35:651-653 http://dx.doi.org/10.3343/alm.2015.35.6.651Letter to the Editor  Diagnostic Hematology Straightforward Identification of Masked Polycythemia  Vera Based on Proposed Revision of World Health  Organization Diagnostic Criteria for BCR-ABL1 - Negative Myeloproliferative Neoplasms Daehyun Chu, M.D., Young-Uk Cho, M.D., Seongsoo Jang, M.D., Eul-Ju Seo, M.D., and Chan-Jeoung Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/e4/alm-35-651.PMC4579113.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/e4/alm-35-651.PMC4579113.pdf
"Masked polycythemia vera from revision criteria 652  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.651years and one and a half years, respectively.",OADS,/arxiv_data1/oa_pdf/e6/e4/alm-35-651.PMC4579113.pdf
Masked polycythemia vera from revision criteria http://dx.doi.org/10.3343/alm.2015.35.6.651 www.annlabmed.org  653Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,Non-OADS,/arxiv_data1/oa_pdf/e6/e4/alm-35-651.PMC4579113.pdf
"ISSN 2234-3806 • eISSN 2234-3814  654  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.654Ann Lab Med 2015;35:654-656 http://dx.doi.org/10.3343/alm.2015.35.6.654Letter to the Editor  Clinical Microbiology The First Case of Concurrent Infective Endocarditis  and Spondylitis Caused by Streptococcus tigurinus Borahm Kim, M.D.1, Hee Jae Huh, M.D.1, Doo Ryeon Chung, M.D.2, Wook Sung Kim, M.D.3, Chang-Seok Ki, M.D.1,   and Nam Yong Lee, M.D.1 Department of Laboratory Medicine and Genetics1, Division of Infectious Disease, Department of Internal Medicine2, and Department of Thoracic and  Cardiovascular Surgery3, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Dear Editor Streptococcus tigurinus , a novel bacterial species, was first dis - covered by Zbinden et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/alm-35-654.PMC4579114.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/alm-35-654.PMC4579114.pdf
"The first case of endocarditis due to S. tigurinus http://dx.doi.org/10.3343/alm.2015.35.6.654 www.annlabmed.org  655white to grayish, and alpha-hemolytic with a diameter of 0.5-1  mm after incubation at 37°C under aerobic conditions for 24 hr  [1].",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/alm-35-654.PMC4579114.pdf
The first case of endocarditis due to S. tigurinus 656  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.654senshogaku Zasshi 2014;88:304-6.,Non-OADS,/arxiv_data1/oa_pdf/2e/1b/alm-35-654.PMC4579114.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.657 www.annlabmed.org  657Ann Lab Med 2015;35:657-659 http://dx.doi.org/10.3343/alm.2015.35.6.657Letter to the Editor  Clinical Microbiology Campylobacter hyointestinalis  Isolated From a Human  Stool Specimen Do-kyun Kim, M.D.1, Sung Kuk Hong, M.D.1, Myungsook Kim, M.T.1, Jin Young Ahn, M.D.2, Dongeun Yong, M.D.1,   and Kyungwon Lee, M.D.1 Department of Laboratory Medicine and Research Institute of Bacterial Resistance1; Department of Internal Medicine2, Yonsei University College of Medicine,  Seoul, Korea Dear Editor Campylobacter  are curved, gram-negative, non-spore-forming  rods that usually grow in a microaerophilic environment.",Non-OADS,/arxiv_data1/oa_pdf/9f/e7/alm-35-657.PMC4579115.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/e7/alm-35-657.PMC4579115.pdf
C. hyointestinalis  isolated from human stool 658  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.657ezbiocloud.net/eztaxon) showed 99.5% identity with GenBank  sequence JHQP01000019 ( C. hyointestinalis ) and 99.3% iden - tity with GenBank sequence AY621303 ( C. fetus ).,OADS,/arxiv_data1/oa_pdf/9f/e7/alm-35-657.PMC4579115.pdf
C. hyointestinalis  isolated from human stool http://dx.doi.org/10.3343/alm.2015.35.6.657 www.annlabmed.org  659et al.,Non-OADS,/arxiv_data1/oa_pdf/9f/e7/alm-35-657.PMC4579115.pdf
"ISSN 2234-3806 • eISSN 2234-3814  660  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.660Ann Lab Med 2015;35:660-662 http://dx.doi.org/10.3343/alm.2015.35.6.660Letter to the Editor  Diagnostic Immunology Anti-Rods and Rings Autoantibodies in a Patient With  Hepatitis C Virus Infection Kyung Ho Choi, M.D.1, Young Ae Lim, M.D.1, Think-You Kim, M.D.2, La-He Jearn, M.D.2, Sae Yun Baik, M.D.3,   Sung Won Cho, M.D.4, and Eunju Jeong, M.D.4 Departments of Laboratory Medicine1 and Internal Medicine4, Ajou University School of Medicine, Suwon; Department of Laboratory Medicine2, Hanyang  University School of Medicine, Seoul; Green Cross Laboratories3, Yongin, Korea Dear Editor The fluorescent antinuclear antibody (FANA) test is widely used  for the detection of systemic autoantibodies.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/alm-35-660.PMC4579116.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/alm-35-660.PMC4579116.pdf
Anti-rods and rings autoantibodies http://dx.doi.org/10.3343/alm.2015.35.6.660 www.annlabmed.org  661 There have been several reports about the incidence of the  anti-RR pattern with hepatitis C and other illnesses.,Non-OADS,/arxiv_data1/oa_pdf/fb/68/alm-35-660.PMC4579116.pdf
Anti-rods and rings autoantibodies 662  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.660Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and  unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US  and Italian HCV patients.,Non-OADS,/arxiv_data1/oa_pdf/fb/68/alm-35-660.PMC4579116.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.6.663 www.annlabmed.org  663Ann Lab Med 2015;35:663-665 http://dx.doi.org/10.3343/alm.2015.35.6.663Letter to the Editor  Diagnostic Genetics Isochromosome 1q in Childhood Burkitt Lymphoma: The First Reported Case in Korea John Hoon Rim, M.D.1, Hyo Sun Kim, M.D.2, Saeam Shin, M.D.1, Seo-Jin Park, M.D.1, and Jong Rak Choi, M.D.1 Departments of Laboratory Medicine1 and Pediatrics2, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Dear Editor Aberrations of the human chromosome 1 are common in he - matologic malignancies such as multiple myeloma, myeloprolif - erative disorders, and myelodysplastic syndrome, highlighting  their significance in carcinogenesis [1].",Non-OADS,/arxiv_data1/oa_pdf/1b/bc/alm-35-663.PMC4579117.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/bc/alm-35-663.PMC4579117.pdf
"The first Korean case of i(1q) in Burkitt lymphoma 664  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.663hood BL with i(1)(q10) previously classified as ALL FAB L3 type  (before the 2008 WHO classification) [6, 7].",Non-OADS,/arxiv_data1/oa_pdf/1b/bc/alm-35-663.PMC4579117.pdf
"The first Korean case of i(1q) in Burkitt lymphoma http://dx.doi.org/10.3343/alm.2015.35.6.663 www.annlabmed.org  665(q10) patients was recognized, which is consistent with our  case.",Non-OADS,/arxiv_data1/oa_pdf/1b/bc/alm-35-663.PMC4579117.pdf
"ISSN 2234-3806 • eISSN 2234-3814  666  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.6.666This erratum is being published to correct the printing error on page 96 of the article entitled ‘Antimicrobial  Susceptibility of Clinical Isolates of Bacteroides fragilis  Group Organisms Recovered from 2009 to 2012 in a  Korean Hospital ’ by Jisook Yim, Yangsoon Lee, Myungsook Kim, Young Hee Seo, Wan Hee Kim, Dongeun  Yong, Seok Hoon Jeong, Kyungwon Lee, and Yunsop Chong in Ann Lab Med 2015;35:94-98, DOI 10.3343/ alm.2015.35.1.94 as follows.",Non-OADS,/arxiv_data1/oa_pdf/4c/aa/alm-35-666.PMC4579118.pdf
Before correction Susceptibility After correction BreakpointsAnn Lab Med 2015;35:666 http://dx.doi.org/10.3343/alm.2015.35.6.666Erratum,Non-OADS,/arxiv_data1/oa_pdf/4c/aa/alm-35-666.PMC4579118.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/12/aps-42-515.PMC4579160.pdf
Available from: http://www.washingtonpost.com/news/  wonkblog/wp/2015/05/16/stunning ­photos ­show ­why ­ south­korea ­is­the­plastic ­surgery ­capital ­of­the­world/.,Non-OADS,/arxiv_data1/oa_pdf/fc/12/aps-42-515.PMC4579160.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/f1/aps-42-517.PMC4579161.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/54/aps-42-521.PMC4579162.pdf
"532Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/c3/aps-42-532.PMC4579163.pdf
http://dx.doi.org/10.1111/iwj.12228.,Non-OADS,/arxiv_data1/oa_pdf/98/c3/aps-42-532.PMC4579163.pdf
"544Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/f9/aps-42-544.PMC4579164.pdf
"552Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/35/aps-42-552.PMC4579165.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/c6/aps-42-559.PMC4579166.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/c4/aps-42-567.PMC4579167.pdf
"572Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/2e/aps-42-572.PMC4579168.pdf
"580Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/b1/aps-42-580.PMC4579169.pdf
"588Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/22/aps-42-588.PMC4579170.pdf
"596Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/a7/aps-42-596.PMC4579171.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/91/aps-42-601.PMC4579172.pdf
"608Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/02/aps-42-608.PMC4579173.pdf
"614Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/aa/aps-42-614.PMC4579174.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/81/aps-42-619.PMC4579175.pdf
"626Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/11/aps-42-626.PMC4579176.pdf
"630Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/95/aps-42-630.PMC4579177.pdf
"For those that are interested, I have gathered the paintings studied by  the authors and they can be seen online in a Pinterest board I created:  https://www.pinterest.com/fixer1254/ anthropology ­plastic/.",Non-OADS,/arxiv_data1/oa_pdf/41/3a/aps-42-635A.PMC4579178.pdf
"Received: 29 May 2015 • Revised: 6 Aug 2015 • Accepted: 7 Aug 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2015.42.5.635A • Arch Plast Surg 2015;42:635 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/3a/aps-42-635A.PMC4579178.pdf
"Received: 18 May 2015 • Revised: 6 Aug 2015 • Accepted: 7 Aug 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2015.42.5.635B • Arch Plast Surg 2015;42:635-636 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/3a/aps-42-635A.PMC4579178.pdf
"For those that are interested, I have gathered the paintings studied by  the authors and they can be seen online in a Pinterest board I created:  https://www.pinterest.com/fixer1254/ anthropology ­plastic/.",Non-OADS,/arxiv_data1/oa_pdf/5e/96/aps-42-635B.PMC4579179.pdf
"Received: 29 May 2015 • Revised: 6 Aug 2015 • Accepted: 7 Aug 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2015.42.5.635A • Arch Plast Surg 2015;42:635 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/96/aps-42-635B.PMC4579179.pdf
"Received: 18 May 2015 • Revised: 6 Aug 2015 • Accepted: 7 Aug 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2015.42.5.635B • Arch Plast Surg 2015;42:635-636 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/96/aps-42-635B.PMC4579179.pdf
Available from: http://www.bbc.com/news/  magazine­18409752.,Non-OADS,/arxiv_data1/oa_pdf/5e/96/aps-42-635B.PMC4579179.pdf
"Received: 22 Feb 2015 • Revised: 24 Apr 2015 • Accepted: 24 Apr 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.637 • Arch Plast Surg 2015;42:637-639 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.IMAGESImages Frontonasal dysplasia (FND) is an unusual  congenital condition that presents with a broad range  of phenotypes [1].",Non-OADS,/arxiv_data1/oa_pdf/4e/4f/aps-42-637.PMC4579180.pdf
"Received: 3 Apr 2015 • Revised: 30 Jun 2015 • Accepted: 14 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.640 • Arch Plast Surg 2015;42:640-642 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/c0/aps-42-640.PMC4579181.pdf
"Received: 11 Mar 2015 • Revised: 27 May 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.642 • Arch Plast Surg 2015;42:642-645 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/c0/aps-42-640.PMC4579181.pdf
"Received: 11 Mar 2015 • Revised: 27 May 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.642 • Arch Plast Surg 2015;42:642-645 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/0d/aps-42-642.PMC4579182.pdf
"Received: 17 Dec 2014 • Revised: 12 Jun 2015 • Accepted: 15 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.645 • Arch Plast Surg 2015;42:645-647 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/0d/aps-42-642.PMC4579182.pdf
"Received: 17 Dec 2014 • Revised: 12 Jun 2015 • Accepted: 15 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.645 • Arch Plast Surg 2015;42:645-647 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/8b/aps-42-645.PMC4579183.pdf
"Received: 20 Apr 2015 • Revised: 2 Jul 2015 • Accepted: 14 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.647 • Arch Plast Surg 2015;42:647-650 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.when posterior pinna lesions are excised as the skin  of the pinna is extremely thin.",Non-OADS,/arxiv_data1/oa_pdf/4d/8b/aps-42-645.PMC4579183.pdf
"Received: 20 Apr 2015 • Revised: 2 Jul 2015 • Accepted: 14 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.647 • Arch Plast Surg 2015;42:647-650 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.when posterior pinna lesions are excised as the skin  of the pinna is extremely thin.",Non-OADS,/arxiv_data1/oa_pdf/d8/86/aps-42-647.PMC4579184.pdf
"Received: 28 May 2015 • Revised: 14 Jun 2015 • Accepted: 15 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.650 • Arch Plast Surg 2015;42:650-652 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/86/aps-42-647.PMC4579184.pdf
"Received: 28 May 2015 • Revised: 14 Jun 2015 • Accepted: 15 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.650 • Arch Plast Surg 2015;42:650-652 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/1d/aps-42-650.PMC4579185.pdf
"Received: 28 Feb 2015 • Revised: 30 Mar 2015 • Accepted: 30 Mar 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.652 • Arch Plast Surg 2015;42:652-655 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/1d/aps-42-650.PMC4579185.pdf
"Received: 28 Feb 2015 • Revised: 30 Mar 2015 • Accepted: 30 Mar 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.652 • Arch Plast Surg 2015;42:652-655 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/2d/aps-42-652.PMC4579186.pdf
"Received: 17 Feb 2015 • Revised: 13 May 2015 • Accepted: 1 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.655 • Arch Plast Surg 2015;42:655-658 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/2d/aps-42-652.PMC4579186.pdf
"Received: 17 Feb 2015 • Revised: 13 May 2015 • Accepted: 1 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.655 • Arch Plast Surg 2015;42:655-658 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/aps-42-655.PMC4579187.pdf
"Received: 16 Jun 2015 • Revised: 29 Jun 2015 • Accepted: 6 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.658 • Arch Plast Surg 2015;42:658-660 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/aps-42-655.PMC4579187.pdf
"Received: 16 Jun 2015 • Revised: 29 Jun 2015 • Accepted: 6 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.658 • Arch Plast Surg 2015;42:658-660 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/d1/aps-42-658.PMC4579188.pdf
"Received: 30 Apr 2015 • Revised: 16 Jun 2015 • Accepted: 2 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.661 • Arch Plast Surg 2015;42:661-663 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/b4/aps-42-661.PMC4579189.pdf
"Received: 12 Mar 2015 • Revised: 15 Apr 2015 • Accepted: 12 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.663 • Arch Plast Surg 2015;42:663-665 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/b4/aps-42-661.PMC4579189.pdf
"Received: 12 Mar 2015 • Revised: 15 Apr 2015 • Accepted: 12 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.663 • Arch Plast Surg 2015;42:663-665 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/36/aps-42-663.PMC4579190.pdf
"Received: 1 Apr 2015 • Revised: 20 May 2015 • Accepted: 26 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.665 • Arch Plast Surg 2015;42:665-668 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/36/aps-42-663.PMC4579190.pdf
"Received: 1 Apr 2015 • Revised: 20 May 2015 • Accepted: 26 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.665 • Arch Plast Surg 2015;42:665-668 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/d4/aps-42-665.PMC4579191.pdf
"Received: 22 Apr 2015 • Revised: 23 Jun 2015 • Accepted: 24 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.668 • Arch Plast Surg 2015;42:668-671 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/d4/aps-42-665.PMC4579191.pdf
"Received: 22 Apr 2015 • Revised: 23 Jun 2015 • Accepted: 24 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.5.668 • Arch Plast Surg 2015;42:668-671 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/13/aps-42-668.PMC4579192.pdf
"Received: 13 Aug 2015 • Revised: 13 Aug 2015 • Accepted: 14 Aug 2015   pISSN: 2234-6163 • eISSN: 2234-6171  http://dx.doi.org/ 10.5999/aps.2015.42.5.672 • Arch Plast Surg 2015;42:672-674 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.Communication",Non-OADS,/arxiv_data1/oa_pdf/94/ef/aps-42-672.PMC4579193.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/fa/5c/40266_2015_Article_292.PMC4579247.pdf
Available from: http://amr-review.org/ sites/default/ﬁles/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth% 20of%20nations_1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fa/5c/40266_2015_Article_292.PMC4579247.pdf
Available from: http://ec.europa.e u/health/mental_ health/docs/services_older.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fa/5c/40266_2015_Article_292.PMC4579247.pdf
Avail- able from: http://www.euro.who.int/__data/assets/pdf_ﬁle/0004/ 135148/e94836.pdf .,OADS,/arxiv_data1/oa_pdf/fa/5c/40266_2015_Article_292.PMC4579247.pdf
Available from: http://blogs.cdc.gov/ safehealthcare/2010/11/16/let’s-take-an-antibiotic-time-out/ .,Non-OADS,/arxiv_data1/oa_pdf/fa/5c/40266_2015_Article_292.PMC4579247.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Table 3 Adverse events occurring in C5 % of subjects in any treatment group: safety analysis set Adverse event, n(%) Hydrocodone ER 15 mg Water ( n=32) 4 % alcohol ( n=36) 20 % alcohol ( n=35) 40 % alcohol ( n=33) Patients with C1 adverse event 11 (34) 9 (25) 20 (57) 20 (61) Nausea 4 (13) 1 (3) 5 (14) 13 (39)Headache 3 (9) 3 (8) 10 (29) 12 (36)Vomiting 1 (3) 1 (3) 4 (11) 9 (27)Feeling drunk 0 1 (3) 5 (14) 10 (30)Dizziness 0 0 3 (9) 5 (15)Paresthesia 0 0 5 (14) 6 (18) Abdominal pain 1 (3) 3 (8) 3 (9) 0 Fatigue 1 (3) 1 (3) 2 (6) 2 (6)Somnolence 2 (6) 1 (3) 1 (3) 1 (3)Pain in extremity 1 (3) 0 2 (6) 0Diarrhea 0 2 (6) 1 (3) 1 (3)Diplopia 0 0 0 2 (6)Tremor 2 (6) 0 0 0 ERextended releaseEffect of Alcohol on the PK of Hydrocodone ER 651",Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
http://www.fda.gov/ohrms/ dockets/ac/05/brieﬁng/2005-4187B1_01_08-Alcohol-Induced.,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
http://www.nlm.nih.gov/med lineplus/druginfo/meds/ a601006.html .,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
2012. http://www.cimalabs.,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/Efﬁcacy/E6/E6_R1_Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
"US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070244.pdf .",OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/2005/ucm108460.htm .,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
http://www.fda.gov/Drugs/Drug Safety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm129288.htm .,Non-OADS,/arxiv_data1/oa_pdf/00/4d/40261_2015_Article_324.PMC4579248.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
1997. http://www.fda.gov/ohrms/ dockets/ac/03/brieﬁng/pubs/cpmp.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
Woosley R. Drugs that prolong the QTc interval and/or induce torsade de pointes; Available from: http://www.crediblemeds.,Non-OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
HapMap Project; Available from: http://www.hapmap.org .,Non-OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
A deep catalogue of human genetic variation; Available from: http://www.1000genomes.org .,Non-OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
National Center for Biotechnology Information (NCBI) Gene; Available from: http://www.ncbi.nlm.nih.gov/gene/ .,OADS,/arxiv_data1/oa_pdf/85/71/40264_2015_Article_316.PMC4579250.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/91/ca/40261_2015_Article_322.PMC4579251.pdf
"In order to supplement the Twitter data obtained via its search API, an additional search engine, Topsy ( http://topsy.com/ ) was used.",Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
"Our ﬁndings corroborate what other researchers have shown regarding the geographic distribution of users ofsocial media networks: a small number of countries, led by the US, account for a large share of the total user popu- lation and likewise make up the active and inﬂuential user population [ 19,20] (see also http://www.beevolve.com/ twitter-statistics/ ).",Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
"Interestingly, two posts identi- ﬁed in the current study referenced a health informationand community website that claims to have studied (as of the time of writing this article) ‘‘65,460 people who have side effects while taking Avandia from FDA and socialmedia’’, and among them, 21,015 had a ‘heart attack’ (http://www.ehealthme.com/ds/avandia/heart ?attack ).",Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
http://www.fda.gov/ AboutFDA/CentersOfﬁces/OfﬁceofMedicalProductsandTobacco/ CDER/ucm397791.htm .,Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
2014.http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm401087.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
2012. https://www.aaai.org/ocs/ index.php/ICWSM/ICWSM12/paper/view/4685 .,Non-OADS,/arxiv_data1/oa_pdf/e4/09/40264_2015_Article_333.PMC4579253.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.622 K. Holl et al.",Non-OADS,/arxiv_data1/oa_pdf/58/1c/40261_2015_Article_319.PMC4579255.pdf
"31st Annual Meeting, Milan, Italy, May 28 to June 1, 2013. http://w3.kenes-group.com/apps/espid2013/ abstracts/pdf/594.pdf .",Non-OADS,/arxiv_data1/oa_pdf/58/1c/40261_2015_Article_319.PMC4579255.pdf
"Considerable systematic studies of the potential value of these databases in post-marketing pharmacovigi-lance have been undertaken by the Observational Medical Outcomes Partnership (OMOP, http://omop.org )[16,19, 20] and the European Union project Exploring and Understanding Adverse Drug Reactions (EU-ADR, http:// euadr-project.org )[21].",Non-OADS,/arxiv_data1/oa_pdf/b7/64/40264_2015_Article_314.PMC4579260.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b7/64/40264_2015_Article_314.PMC4579260.pdf
[cited]; Available from: http://www.fda.gov/cder/aers/default.htm .,Non-OADS,/arxiv_data1/oa_pdf/b7/64/40264_2015_Article_314.PMC4579260.pdf
[cited]; Available from: http://www.meddramsso.com .,OADS,/arxiv_data1/oa_pdf/b7/64/40264_2015_Article_314.PMC4579260.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f1/40/40261_2015_Article_320.PMC4579261.pdf
2010. http://c.ymcdn.com/sites/www.,Non-OADS,/arxiv_data1/oa_pdf/f1/40/40261_2015_Article_320.PMC4579261.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original724 M. A. E.-M. Oomens, T. Forouzanfar",Non-OADS,/arxiv_data1/oa_pdf/c6/a7/40266_2015_Article_293.PMC4579266.pdf
2012. https://www.nice.org.uk/guidance/ cg137/resources/guidance-the-epilepsies-the-diagnosis-and- management-of-the-epilepsies-in-adults-and-children-in-primary- and-secondary-care-pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/a7/40266_2015_Article_293.PMC4579266.pdf
"355© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Current Issues and Clinical Evidence in Tumor-Infiltrating   Lymphocytes in Breast Cancer Sung Gwe Ahn · Joon Jeong   SoonWon Hong1 · Woo Hee Jung1 Departments of Surgery and 1Pathology,  Gangnam Severance Hospital, Yonsei University  College of Medicine, Seoul, KoreaWith the advance in personalized therapeutic strategies in patients with breast cancer, there is an  increasing need for biomarker-guided therapy.",Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"Key Words:  Breast neopalsms; Immune system; Lymphocytes, tumor-infiltrating; Triple negative  breast neoplasmsReceived:  July 19, 2015 Revised:  July 22, 2015 Accepted:  July 28, 2015 Corresponding Author Joon Jeong, MD Department of Surgery, Gangnam Severance  Hospital, Yonsei University College of Medicine,   211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea  Tel: +82-2-2019-3379 Fax: +82-2-3462-5994 E-mail: gsjjoon@yuhs.acJournal of Pathology and Translational Medicine 2015; 49: 355-363 http://dx.doi.org/10.4132/jptm.2015.07.29▒ REVIEW ▒ Molecular medicine has shown that all cancers are caused by  mutations accumulated in various genes.",Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29356     •  Ahn SG, et al.",OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29Tumor-Infiltrating Lymphocytes   •     357 cells.,Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29358     •  Ahn SG, et al.",OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29Tumor-Infiltrating Lymphocytes   •     359Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29360     •  Ahn SG, et al.Table 3.",OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29Tumor-Infiltrating Lymphocytes   •     361 immune signatures associated with TILs or treatment outcome.,Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29362     •  Ahn SG, et al.",OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.29Tumor-Infiltrating Lymphocytes   •     363 42.,Non-OADS,/arxiv_data1/oa_pdf/e1/3d/jptm-49-5-355.PMC4579275.pdf
"364pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cytology Specimen Management, Triage and Standardized Reporting   of Fine Needle Aspiration Biopsies of the Pancreas  Won Jae Yoon   Martha Bishop Pitman1,2 Department of Internal Medicine,   Inje University Seoul Paik Hospital, Inje University  College of Medicine, Seoul, Korea; 1Department  of Pathology, Massachusetts General Hospital,  Boston, MA; 2Harvard Medical School, Boston,  MA, USAThe recent advances in pancreas cytology specimen sampling methods have enabled a specific  cytologic diagnosis in most cases.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"Key Words:  Pancreas; Cytology; Biopsy, fine-needle; Triage; TerminologyReceived:  July 16, 2015 Accepted:  July 19, 2015 Corresponding Author Martha Bishop Pitman, MD Department of Pathology, Massachusetts General  Hospital, 55 Fruit Street, Boston, MA 02114, USA  Tel: +1-617-726-3185 Fax: +1-617-724-6564 E-mail: mpitman@mgh.harvard.eduJournal of Pathology and Translational Medicine 2015; 49: 364-372 http://dx.doi.org/10.4132/jptm.2015.07.19▒ REVIEW ▒ The advances in techniques of pancreas cytology specimen  sampling have improved the yield of specimen for diagnosis in  various pancreatic diseases.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19Pancreas FNA Triage and Reporting   •     365 duodenal approach; lesions in the body or the tail of the pancre - as are accessed via a transgastric route.4 Selection of appropriate  EUS needles is based on the vascularity of the target lesion, dif - ficulty in accessing the lesion, and the type of specimen needed  for the diagnosis.4 For cytology, simple aspiration needles of 22-  or 25-gauge are used.9 A recent meta-analysis concluded that  the EUS-FNA using 25-gauge needles are more sensitive than  that using 22-gauge needles for diagnosis of pancreatic malig - nancy.10 Histologic samples may be obtained by standard 19-  gauge and 22-gauge FNA needles.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19366     •  Yoon WJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19Pancreas FNA Triage and Reporting   •     367 pendent on cytology, and in many cases on the immunohisto - chemical staining that supports the neuroendocrine nature of  the cells, for a specific diagnosis since biochemical analysis and  molecular analysis are noncontributory.23,24 So in addition to the  simple hematoxylin and eosin stained sections from the cell - block, additional sections of the tissue can be used for ancillary  testing including immunohistochemical stains and molecular  analysis (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19368     •  Yoon WJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19Pancreas FNA Triage and Reporting   •     369 tation.,OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19370     •  Yoon WJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19Pancreas FNA Triage and Reporting   •     371 multidisciplinary and multimodal approach where the cytologi - cal features are interpreted in the context of the clinical, imaging  and ancillary testing information available.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.19372     •  Yoon WJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
http://dx.doi.org/10.1016/j.gie.2015.06.047.,OADS,/arxiv_data1/oa_pdf/7d/d5/jptm-49-5-364.PMC4579276.pdf
"373© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 SALL4 Expression in Hepatocellular Carcinomas Is Associated   with EpCAM-Positivity and a Poor Prognosis Hyunjin Park · Hyejung Lee   An Na Seo1 · Jai Young Cho2  Young Rok Choi2 · Yoo-Seok Yoon2  Ho-Seong Han2 · Young Nyun Park3  Haeryoung Kim Department of Pathology, Seoul National   University Bundang Hospital, Seoul National   University College of Medicine, Seoul;   1Department of Pathology, Kyungpook National  University Medical Center, Kyungpook National  University School of Medicine, Daegu;   2Department of Surgery, Seoul National   University Bundang Hospital, Seoul National  University College of Medicine, Seoul;   3Department of Pathology, Yonsei University  College of Medicine, Seoul, KoreaBackground:  There is increasing interest in hepatocellular carcinomas (HCC) expressing  “stemness”-related markers, as they have been associated with aggressive behavior and poor  prognosis.",Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"Key Words:  Carcinoma, hepatocellular; SALL4; Immunohistochemistry; PrognosisReceived:  May 28, 2015 Revised:  July 1, 2015 Accepted:  July 8, 2015 Corresponding Author Haeryoung Kim, MD, PhD Department of Pathology, Seoul National University  Bundang Hospital, Seoul National University College  of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea  Tel: +82-31-787-7715 Fax: +82-31-787-4012 E-mail: haeryoung.kim@snu.ac.kr Young Nyun Park, MD, PhD Department of Pathology, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul  03722, Korea  Tel: +82-2-2228-1678 Fax: +82-2-362-0860 E-mail: young0608@yuhs.acJournal of Pathology and Translational Medicine 2015; 49: 373-381 http://dx.doi.org/10.4132/jptm.2015.07.09▒ ORIGINAL ARTICLE ▒ Hepatocellular carcinoma (HCC) is one of the leading causes  of cancer mortality in the world, with a limited number of cur - rently available therapeutic options.",Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09374     •  Park H, et al.",OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09SALL4 Expression in Hepatocellular Carcinoma   •     375 (1:100, mouse monoclonal antibody, clone EE-30, Santa Cruz  Technologies Inc., Santa Cruz, CA, USA), K19 (1:150, mouse  monoclonal antibody, clone BA17, Dako, Glostrup, Denmark)  and EpCAM (1:3,000, mouse monoclonal antibody, clone VU- 1D9, Calbiochem, Darmstadt, Germany).",Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09376     •  Park H, et al.",OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
protein in more than 10% of the tumor cells after calculating  the SALL4-labeling index (a ratio of positive nuclei/total nuclei  under the 400 × field magnification) with the help of the Image  J software (downloaded from http://imagej.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09SALL4 Expression in Hepatocellular Carcinoma   •     377 overall survival (p = .053); however, it was not associated with  disease-free survival.",Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09378     •  Park H, et al.",OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09SALL4 Expression in Hepatocellular Carcinoma   •     379 EpCAM, suggesting that SALL4 may be a marker of stem cells.",Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09380     •  Park H, et al.",OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.09SALL4 Expression in Hepatocellular Carcinoma   •     381 caused by SALL4  mutations.,Non-OADS,/arxiv_data1/oa_pdf/59/4b/jptm-49-5-373.PMC4579277.pdf
"382pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Membranous Insulin-like Growth Factor-1 Receptor (IGF1R)   Expression Is Predictive of Poor Prognosis in Patients with Epidermal  Growth Factor Receptor ( EGFR )-Mutant Lung Adenocarcinoma Eunhyang Park1* · Soo Young Park2*  Hyojin Kim1 · Ping-Li Sun2  Yan Jin2 · Suk Ki Cho3  Kwhanmien Kim3 · Choon-Taek Lee4  Jin-Haeng Chung1,2 1Department of Pathology, Seoul National   University College of Medicine, Seoul;   Departments of 2Pathology, 3Thoracic and  Cardiovascular Surgery, and 4Internal Medicine,  Seoul National University Bundang Hospital,  Seoul National University College of Medicine,  Seongnam, KoreaBackground:  Insulin-like growth factor-1 receptor (IGF1R) is a membrane receptor-type tyrosine ki - nase that has attracted considerable attention as a potential therapeutic target, although its clinical  significance in non-small cell lung cancer (NSCLC) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"Key Words:  Carcinoma, non-small-cell lung; Insulin-like growth factor-1 receptor; Receptor, epidermal  growth factor; Immunohistochemistry; Membranous expressionReceived:  July 7, 2015 Revised:  July 7, 2015 Accepted:  July 9, 2015 Corresponding Author Jin-Haeng Chung, MD, PhD Department of Pathology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea  Tel: +82-31-787-7713 Fax: +82-31-787-4012 E-mail: chungjh@snu.ac.kr  *Eunhyang Park and Soo Young Park contributed  equally to this work.Journal of Pathology and Translational Medicine 2015; 49: 382-388 http://dx.doi.org/10.4132/jptm.2015.07.10▒ ORIGINAL ARTICLE ▒ Epidermal growth factor receptor (EGFR)-tyrosine kinase in - hibitors (TKIs) have been used to treat non-small cell lung cancer  (NSCLC), and a better response and prolonged survival have  been observed in patients who harbor EGFR  mutations.1,2 How - ever, despite a dramatic response, most NSCLC patients experi - ence drug resistance and tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10Prognostic Significance of IGF1R in NSCLC   •     383 that low IGF1R expression was associated with poor prognosis  in lung adenocarcinomas (ADCs).,Non-OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10384     •  Park E, et al.",OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10Prognostic Significance of IGF1R in NSCLC   •     385 plasmic expression-positive (M –/C+), and group IV that was  negative for both membranous and cytoplasmic expression (M –/ C–).",OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10386     •  Park E, et al.",OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10Prognostic Significance of IGF1R in NSCLC   •     387 ceptor expression would reflect the level of its ligands, is that, if  the level of the ligand is higher, more receptors would be occu - pied and internalized for signaling, while low circulating ligand  level would result in receptor overexpression as a compensatory  mechanism.",Non-OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.10388     •  Park E, et al.",OADS,/arxiv_data1/oa_pdf/23/96/jptm-49-5-382.PMC4579278.pdf
"389© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Parafibromin Staining Characteristics in Urothelial Carcinomas and   Relationship with Prognostic Parameters Serap Karaarslan · Banu Yaman1  Hakan Ozturk2  Banu Sarsik Kumbaraci1 Department of Pathology, Sifa University   Faculty of Medicine, Izmir;   1Department of Pathology, Ege University   Faculty of Medicine, Izmir;   2Department of Urology, Sifa University   Faculty of Medicine, Izmir, TurkeyBackground:  Parafibromin is a recently defined tumor suppressor gene.",Non-OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"7, Bornova, Izmir 35100, Turkey  Tel: +90-232-343-4445 Fax: +90-232-343-5656 E-mail: serapkaraarslan@gmail.comJournal of Pathology and Translational Medicine 2015; 49: 389-395 http://dx.doi.org/10.4132/jptm.2015.08.10▒ ORIGINAL ARTICLE ▒ Urothelial neoplasms are the most common urinary tract  cancers and can be located in the lower (bladder and urethra) or  upper (pelvocalyceal cavities and ureter) urinary tract.",Non-OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10390     •  Karaarslan S, et al.",OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10Parafibromin in Urothelial Carcinomas   •     391 was almost no staining (<  1%) of tumor nuclei, and partially  positive in all other cases.17 A negative result was reported only if  there was an internal positive control.",Non-OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10392     •  Karaarslan S, et al.",OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10Parafibromin in Urothelial Carcinomas   •     393 weaker in UCs with muscularis propria invasion than in those  without invasion of the muscle.,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10394     •  Karaarslan S, et al.",OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.10Parafibromin in Urothelial Carcinomas   •     395 family with hyperparathyroidism-jaw tumor syndrome and a novel  HRPT2  gene mutation.,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/jptm-49-5-389.PMC4579279.pdf
"396pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Comparison of Cytologic Characteristics between Adenoid Cystic   Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix Juhyeon Jeong · Seung Yeon Ha   Hyun Yee Cho · Dong Hae Chung   Jungsuk An Department of Pathology, Gachon University   Gil Medical Center, Incheon, KoreaBackground:  Adenoid cystic carcinoma (ACC) and adenoid basal carcinoma (ABC) are rare in the  uterine cervix.",Non-OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"Key Words:  Adenoid cystic carcinoma; Adenoid basal carcinoma; Vaginal smears; Papanicolaou  testReceived:  May 20, 2015 Revised:  June 26, 2015 Accepted:  July 8, 2015 Corresponding Author Seung Yeon Ha, MD, PhD Department of Pathology, Gachon University   Gil Medical Center, 21 Namdong-daero   774beon-gil, Namdong-gu, Incheon 21565, Korea  Tel: +82-32-460-3073 Fax: +82-32-460-2394 E-mail: syha@gilhospital.comJournal of Pathology and Translational Medicine 2015; 49: 396-402 http://dx.doi.org/10.4132/jptm.2015.07.08▒ ORIGINAL ARTICLE ▒ The World Health Organization (WHO) classifies malignant  tumors of the uterine cervix into three categories: squamous tu - mors, glandular tumors, and “other epithelial tumors.”1 The cat - egory of “other epithelial tumors” is composed of five different  tumor types: adenosquamous carcinoma, adenoid cystic carci - noma (ACC), adenoid basal carcinoma (ABC), neuroendocrine  tumors, and undifferentiated carcinoma.1 Both ACC and ABC  are rare tumors, accounting for less than 1% of all cervical ade - nocarcinomas and are usually found in postmenopausal women  over the age of 60.2 In spite of the fact that the cytologic features  of these two malignant tumors of the uterine cervix can be very  confusing, an accurate diagnosis of ACCs and ABCs is impor - tant because their clinical and biological behaviors are quite dif - ferent; ACCs have worse prognosis than ABCs.1 The Papanicolaou test, the most useful screening method for  detecting precursor lesions of the uterine cervix, has been used  universally with very high diagnostic accuracy.",Non-OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08Adenoid Cystic and Adenoid Basal Carcinoma   •     397 specimens were obtained by the routine Papanicolaou cervico - vaginal smear and the cases were confirmed by surgical specimens  obtained from punch biopsy, conization or hysterectomy.",Non-OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08398     •  Jeong J, et al.",OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08Adenoid Cystic and Adenoid Basal Carcinoma   •     399 mensional clusters.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08400     •  Jeong J, et al.",OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08Adenoid Cystic and Adenoid Basal Carcinoma   •     401 ings of ACC.3,6,7,9,10 While these features are meaningful find - ings in the two different tumor groups, because ACC and ABC  may show similar findings in the histology of surgical speci - mens, these are not significantly distinguishing points.",Non-OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.08402     •  Jeong J, et al.",OADS,/arxiv_data1/oa_pdf/1b/c3/jptm-49-5-396.PMC4579280.pdf
"403© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Paediatric Primary Pachymeningeal Xanthogranuloma with Scattered  Foci Displaying Reticulohistiocytoma-like Features Miguel Fdo.",Non-OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
3302) E-mail: k7nigricans@hotmail.comJournal of Pathology and Translational Medicine 2015; 49: 403-408 http://dx.doi.org/10.4132/jptm.2015.05.28▒ CASE STUDY ▒ Fibrohistiocytic tumours are well-recognized histopathologi - cal entities that usually occur in subcutaneous and soft tissues.,Non-OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.28404     •  Salazar MF, et al.",OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.28Pediatric Primary Pachymeningeal Xanthogranuloma: Cholesterol Granuloma with Reticulohistiocytoma-like Features   •     405 macrophages in the neural axis can arise from known metabolic/ storage disorders or serum lipid disturbances (secondary CNS  involvement) but can also occur without an exact cause or trig - gering factor (primary CNS involvement).4-7 At present, the  pathogenesis of the latter remains poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.28406     •  Salazar MF, et al.",OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.28Pediatric Primary Pachymeningeal Xanthogranuloma: Cholesterol Granuloma with Reticulohistiocytoma-like Features   •     407 ic activity.1 In spite of the nuclear pleomorphism focally detected  in our case, mitotic activity was not present; thus, the bizarre  nuclei observed were considered a degenerative phenomenon  such as that seen in ancient neurilemmoma or giant cell ependy - moma.",Non-OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.28408     •  Salazar MF, et al.",OADS,/arxiv_data1/oa_pdf/a8/5d/jptm-49-5-403.PMC4579281.pdf
"409© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Human Herpesvirus 8-Negative and Epstein-Barr Virus-Positive Effusion- Based Lymphoma in a Patient with Human Immunodeficiency Virus Jung-Woo Choi · Younghye Kim   Ju-Han Lee · Young-Sik Kim Department of Pathology, Korea University Ansan  Hospital, Korea University College of Medicine,  Ansan, KoreaA 39-year-old man infected with human immunodeficiency virus (HIV) was admitted to our hospi - tal because of sudden onset of chest pain.",Non-OADS,/arxiv_data1/oa_pdf/48/54/jptm-49-5-409.PMC4579282.pdf
"Key Words:  Effusion-based lymphoma; Human herpesvirus 8; Epstein-Barr virus; HIVReceived:  May 12, 2015 Revised:  June 2, 2015 Accepted:  June 3, 2015 Corresponding Author Young-Sik Kim, MD, PhD Department of Pathology, Korea University Ansan  Hospital, Korea University College of Medicine, 123  Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea  Tel: +82-31-412-5321 Fax: +82-31-412-5324 E-mail: apysk@korea.ac.krJournal of Pathology and Translational Medicine 2015; 49: 409-412 http://dx.doi.org/10.4132/jptm.2015.06.03▒ CASE STUDY ▒ Primary effusion lymphoma (PEL) is the only subtype of effu - sion-based lymphoma (EBL) listed on the 2008 World Health  Organization (WHO) classification, and it is specified as a large  B-cell lymphoma that presents as serous effusions without a de - tectable tumor mass.1 PEL represents one of the specific lympho - mas that occur in human immunodeficiency virus (HIV)-posi - tive patients, accounting for less than 3% of all HIV-related lym- phomas.2 PEL cells are usually negative for pan-B-cell markers  and often reveal a consistent dual herpesvirus infection with  both human herpesvirus 8 (HHV8) and Epstein-Barr virus (EBV).",Non-OADS,/arxiv_data1/oa_pdf/48/54/jptm-49-5-409.PMC4579282.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.03410     •  Choi J-W, et al.",OADS,/arxiv_data1/oa_pdf/48/54/jptm-49-5-409.PMC4579282.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.03HIV-Positive Effusion-Based Lymphoma   •     411 EBV nuclear antigen-2 (EBNA-2), but negative for HHV8.",Non-OADS,/arxiv_data1/oa_pdf/48/54/jptm-49-5-409.PMC4579282.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.03412     •  Choi J-W, et al.",OADS,/arxiv_data1/oa_pdf/48/54/jptm-49-5-409.PMC4579282.pdf
"413© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Oncocytic Renal Cell Carcinoma with Tubulopapillary   Growth Having a Fat Component Na Rae Kim · Hyun Yee Cho Department of Pathology, Gachon University Gil  Medical Center, Incheon, KoreaWe report a rare case of oncocytic renal cell carcinoma (RCC) with tubulopapillary growth in the  background of tuberculous end-stage kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
"Key Words:  Oxyphil cells; Carcinoma, renal cell; Adipocytes; Mycobacterium tuberculosisReceived:  April 24, 2015 Revised:  June 3, 2015 Accepted:  July 1, 2015 Corresponding Author Hyun Yee Cho, MD Department of Pathology, Gachon University Gil  Medical Center, 21 Namdong-daero 774 beon-gil,  Namdong-gu, Incheon 21565, Korea  Tel: +82-32-460-3865 Fax: +82-32-460-2394 E-mail: hicho@gilhospital.comJournal of Pathology and Translational Medicine 2015; 49: 413-417 http://dx.doi.org/10.4132/jptm.2015.07.01▒ CASE STUDY ▒ Recent advances in cytogenetics have altered the traditional  classification of renal cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.01414     •  Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.01Oncocytic Papillary Renal Cell Carcinoma   •     415 A C EB D F Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.01416     •  Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.07.01Oncocytic Papillary Renal Cell Carcinoma   •     417 from biologic complexity.,Non-OADS,/arxiv_data1/oa_pdf/e6/b0/jptm-49-5-413.PMC4579283.pdf
"418pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Multifocal Polypoid Endometriosis Mimicking Malignancy in a Young  Woman with a History of Hormonal Treatment Ji-Young Kim · Tae-Jong Song1 · Hye-Kyung Choi2 · Jeong Yun Shim Department of Pathology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul;   1Department of Obstetrics and Gynecology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;   2Department of Radiology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2015; 49: 418-420 http://dx.doi.org/10.4132/jptm.2015.05.12▒ BRIEF CASE REPORT ▒ Polypoid endometriosis is a rare type of endometriosis that  sometimes mimics the clinical presentation of malignancy.",Non-OADS,/arxiv_data1/oa_pdf/fd/5b/jptm-49-5-418.PMC4579284.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.12Polypoid Endometriosis Mimicking Malignancy   •     419 na, cervix, adnexa, and colorectum.2-4 It usually causes non-spe - cific symptoms, such as dysmenorrhea, menorrhagia, or vaginal  spotting.1,3,5 The etiology of polypoid endometriosis is uncertain.",Non-OADS,/arxiv_data1/oa_pdf/fd/5b/jptm-49-5-418.PMC4579284.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.12420     •  Kim J-Y, et al.",OADS,/arxiv_data1/oa_pdf/fd/5b/jptm-49-5-418.PMC4579284.pdf
"421© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Gastric Langerhans Cell Histiocytosis: Case Report and   Review of the Literature So Jung Lee1,2 · Chung Su Hwang1,2 · Gi Young Huh1,2 · Chang Hun Lee1,2 · Do Youn Park1,2 1Department of Pathology, Pusan National University Hospital, Pusan National University School of Medicine, Busan;   2Biomedical Research Institute, Pusan National University Hospital, Busan, KoreaJournal of Pathology and Translational Medicine 2015; 49: 421-423 http://dx.doi.org/10.4132/jptm.2015.05.19▒ BRIEF CASE REPORT ▒ Corresponding Author Do Youn Park, MD, PhD Department of Pathology, Pusan National University Hospital, Pusan National University  School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-51-240-7422, Fax: +82-51-242-7422, E-mail: pdy220@pusan.ac.kr Received:  February 3, 2015  Revised:  May 4, 2015 Accepted:  May 19, 2015Langerhans cell histiocytosis (LCH) is a rare disease of un - known etiology and is characterized by a clonal proliferation of  Langerhans cells.1 The clinical presentation of LCH is variable,  ranging from single organ to multisystem involvement; patients  may experience benign to life-threatening outcomes.1 Localiza - tion of LCH to the stomach is extremely rare and is most often  found in pediatric patients with systemic disease.2 Here we pres - ent a case of localized LCH to the stomach in a 64-year-old man  who underwent a complete resection of the lesion by endoscopic  submucosal dissection (ESD).",Non-OADS,/arxiv_data1/oa_pdf/6e/16/jptm-49-5-421.PMC4579285.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.19422     •  Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/6e/16/jptm-49-5-421.PMC4579285.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.19Gastric Langerhans Cell Histiocytosis   •     423 port,4 our case showed aggregates of histiocytic cells with Lang - erhans cell nuclear features, which were mixed with inflamma - tory cells, mainly eosinophils.",OADS,/arxiv_data1/oa_pdf/6e/16/jptm-49-5-421.PMC4579285.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
: +1 415 476 6383; fax: +1 415 514 1028. http://dx.doi.org/10.1016/j.nicl.2015.08.017 2213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
The NODDI MATLAB toolbox ( http://www.nitrc.org/projects/noddi_ toolbox/ ) was employed for NODDI.,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00336-714568458 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1097/01.rmr.0000136558.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.1015311979585 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"Imaging 36 (1), 55 –72.http://dx.doi.org/10.1002/jmri.2363922696125 .",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"Imaging 26 (2), 375 –385.http://dx.doi.org/ 10.1002/jmri.2096917622966 .",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.03.05724680870 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.02.05617532649 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.1059714587013 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"4), iv1 –i63.http://dx.doi.org/10.1093/neuonc/nou22325304271 .Panagiotaki, E., Walker-Samuel, S., Siow, B., Johnson, S.P., Rajkumar, V., Pedley, R.B., Lythgoe, M.F., Alexander, D.C., 2014.",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1148/ radiology.201.3.89392098939209 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/ 10.1212/01.wnl.0000184471.83948.e016301477 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.2309721858868 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"74 (3), 747 –755.http://dx.doi.org/10.1002/mrm.25455 .",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2004.07.05115501092 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"Neuroimage80, 125– 143.http://dx.doi.org/10.1016/j.neuroimage.2013.05.05723702418 .",OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"Focus 22 (5), E8.http://dx.doi.org/10.3171/foc.2007.22.5.917613239 .",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
Neuroimage 80. http://dx.doi.org/10.1016/j.neuroimage.2013.05.01223702417 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1161/01.STR.29.9.17839731595 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/ (SICI)1522-2594(200005)43:5 b682::AID-MRM10 N3.0.CO;2-G10800033 .,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1200/JCO.2009.26.354120231676 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/ mrm.2018315282821 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.20281 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.2482823801410 .,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
"23 (7), 661 –681.http://dx.doi.org/10.1002/nbm.152020886562 .",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1002/mrm.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.03.,OADS,/arxiv_data1/oa_pdf/a4/7f/main.PMC4579286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
: +31 24 3668254. http://dx.doi.org/10.1016/j.nicl.2015.08.018 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1002/ mds.2098716758482 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4570-14.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2679-13.201424623769 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"8, 494. http://dx.doi.org/ 10.3389/fnhum.2014.0049425071522.",Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"Neuroimage 85 (2), 637– 647. http://dx.doi.org/10.1016/j.neuroimage.2013.",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.tics.2014.02.00524630166 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1097/00001756-200112040- 0005111726809 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"1169, 15 –34.http://dx.doi.org/ 10.1111/j.1749-6632.2009.04556.x19673752 .",Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"Neuropsychologia 52, 73 –81.http://dx.doi.org/10.1016/j.neuropsychologia.",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4675- 12.201323447609 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/brain/118.4.9357655889 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/ 10.1016/S1388-2457(01)00467-911275532 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00148- 412880805 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.conb.2010.02.01520359884 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5153-11.201222553024 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"Cortex 45 (1), 54 –61.http://dx.doi.org/10.1016/j.cortex.2008.",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2018-08.200919515922 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.tins.2007.05.00417532060 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/cercor/bht12123645717 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1002/hbm.2239724123553 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/cercor/bht14023733911 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"Neuroimage 90, 15 –23.http://dx.doi.org/ 10.1016/j.neuroimage.2013.11.02324269570 .",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1097/00004728-199803000-000329530404 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1002/hbm.2097920162604 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1126/science.115473518388295 .308 E.S.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0010-13.201323843536 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1037/ 0033-295X.106.1.119 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"8, 96.http://dx.doi.org/10.3389/fnhum.2014.0009624605099 .",Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.jneumeth.2007.,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
370 (1664) 20140093 http://dx.doi.org/10.1098/rstb.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/brain/awu38125567321 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1371/journal.pone.008964224586929 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1088/0031-9155/48/22/ 00214680264 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.neubiorev.2013.08.00324012774 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"2011, 156869, 156869. http://dx.doi.org/10.1155/2011/15686921253357 .",Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/0013-4694(95)00258-88641150 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1152/jn.00224.200717728390 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/brain/120.6.9639217681 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5821-12.201323678108 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"32 (1), 9 –18.http://dx.doi.org/10.1016/j.tins.",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
"Neuroscience 166 (2), 712– 719. http://dx.doi.org/10.1016/j.neuroscience.2009.12.",OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.apmr.2012.10.,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4739-13.201424741058 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.06.03924969569 .,OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1093/brain/123.2.39410648446 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1109/10.6230569282479 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
http://dx.doi.org/10.1177/154596831143196422291041 .,Non-OADS,/arxiv_data1/oa_pdf/a1/43/main.PMC4579287.pdf
Corresponding author: yaniv@cs.columbia.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191692.115.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Erlich This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 25:1411 –1416 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1411 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
http://www.smithsonianmag.com/science-nature/creepy-or-cool-portraits-derived-from-the-dna-in-hair- and-gum-found-in-public-places-50266864/?no-ist.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
http://i.imgur.com/Up4mGEE.png; https://github.com/biocore/Platypus-Conquistador.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
http://microbe.net/2015/02/17/the-long-road-from-data-to-wisdom-and-from-dna-to-pathogen/.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
http://bioethics.gov/cms/ sites/default/files/PrivacyProgress508.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/1411.PMC4579324.pdf
We end with a look into what technological and societal challenges Corresponding author: mschatz@cshl.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191684.115.,Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Schatz This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 25:1417 –1422 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1417 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"Already this trend is beginning, and the NCBI Sequence Read Archive (SRA) currently only storesapproximately one-tenth of the worldwide sequence production,∼3.8 Pbp of the >35 Pbp sequenced so far (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"2014)or ICGC (The International Cancer Genome 2010) for consolida- ting cancer genomic data, or the recently launched BGI-Cloud to provide access to the great resources available there (http://bgiamericas.com/data-analysis/bgi-cloud/).",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"Illumina BaseSpace(https://basespace.illumina.com), DNAnexus (https://www.dnanexus.com/), Google Genomics (https://cloud.google.com/ genomics/), and other commercial vendors are also emerging to help manage the deluge of data using commercial cloud plat-forms and are likely to play an increasingly important role in ge-nomics in the future.",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"Although even the most basic of federated tasks, so-called“Beacons ”that identify if a resource has any individual with a par- ticular mutation, are proving to be difficult to execute mostly fornontechnical reasons (http://ga4gh.org/#/beacon).",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/1417.PMC4579325.pdf
"Genome-driven vari- ant descriptions also bypass the constrictions and complications imposed by protein-, transcript-, or locus-specific frameworks(http://www.hgvs.org/mutnomen/).",Non-OADS,/arxiv_data1/oa_pdf/32/cd/1423.PMC4579326.pdf
"Further, even when confined to a single, rel- atively well-defined property, any given level or flavor of signifi-cance can have distinct implications when viewed by different Corresponding author: gcooper@hudsonalpha.org Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190116.115.",Non-OADS,/arxiv_data1/oa_pdf/32/cd/1423.PMC4579326.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Cooper This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 25:1423 –1426 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1423 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/32/cd/1423.PMC4579326.pdf
This has allowed us Corresponding author: tlappalainen@nygenome.org Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190983.115.,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/1427.PMC4579327.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Lappalainen This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.Perspective 25:1427 –1431 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1427 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/0f/e0/1427.PMC4579327.pdf
Integrating results from studies of Corresponding author: tim.reddy@duke.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190603.115.,OADS,/arxiv_data1/oa_pdf/53/9d/1432.PMC4579328.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Lowe and Reddy This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.Perspective 1432 Genome Research 25:1432 –1441 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/53/9d/1432.PMC4579328.pdf
"Queries wereperformed via the NCBI PubMed website (http://www.ncbi.nlm.nih.gov/pubmed/) on July 14, 2015.",OADS,/arxiv_data1/oa_pdf/53/9d/1432.PMC4579328.pdf
Other genome Corresponding author: charles.gersbach@duke.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190124.115.,Non-OADS,/arxiv_data1/oa_pdf/9b/a5/1442.PMC4579329.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Hilton and Gersbach This article, published in Genome Research ,i s available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Perspective 1442 Genome Research 25:1442 –1455 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/9b/a5/1442.PMC4579329.pdf
"In contrast, efforts should be directed towardthe identification and dissection of the RNA domains, sequences, Corresponding authors: loyalgoff@jhmi.edu, john_rinn@harvard.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191122.115.",Non-OADS,/arxiv_data1/oa_pdf/24/98/1456.PMC4579330.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Goff and Rinn This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 1456 Genome Research 25:1456 –1465 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/24/98/1456.PMC4579330.pdf
functional lncRNA genes are directed to http://lncRNAdb.org for an up-to-date catalog (Amaral et al.,OADS,/arxiv_data1/oa_pdf/24/98/1456.PMC4579330.pdf
2014; Padovan-Merhar Corresponding author: arjunraj@seas.upenn.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190579.115.,Non-OADS,/arxiv_data1/oa_pdf/94/ac/1466.PMC4579331.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Mellis and Raj This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.Perspective 1466 Genome Research 25:1466 –1472 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/94/ac/1466.PMC4579331.pdf
Finding such pairs of genes is often a major goal of Corresponding author: coletrap@uw.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.190595.115.,Non-OADS,/arxiv_data1/oa_pdf/bf/14/1491.PMC4579334.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Trapnell This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 25:1491 –1498 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1491 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/bf/14/1491.PMC4579334.pdf
Corresponding author: nnavin@mdanderson.org Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191098.115.,OADS,/arxiv_data1/oa_pdf/38/c3/1499.PMC4579335.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Navin This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 25:1499 –1507 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1499 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/38/c3/1499.PMC4579335.pdf
"Third, commercialization of Corresponding author: Paul.Boutros@oicr.on.ca Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191114.115.",Non-OADS,/arxiv_data1/oa_pdf/61/3c/1508.PMC4579336.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Boutros This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 1508 Genome Research 25:1508 –1513 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/61/3c/1508.PMC4579336.pdf
Corresponding author: egrice@upenn.edu Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.191320.115.,OADS,/arxiv_data1/oa_pdf/ea/38/1514.PMC4579337.pdf
"Freely available online through the Genome Research Open Access option.© 2015 Grice This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Perspective 1514 Genome Research 25:1514 –1520 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/ea/38/1514.PMC4579337.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.196238.115.© 2015 Ewing et al.",OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 1536 Genome Research 25:1536 –1545 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
This gene is a known tumor suppressor that is alsosomatically mutated in various epithelial cancers and is represent- ed in the COSMIC Cancer Gene Census (http://cancer.sanger.ac.,Non-OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
Python scripts used for the mapping and primary analysis are available in the Supplemental Material and at https://github.com/adamewing/ l1seq.,OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
Data access The L1-seq data from this study have been submitted to the NCBI database of Genotypes and Phenotypes (dbGaP; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
The SNP array data have been submitted to the NCBI GeneExpression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE63601.,OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
The proteomics data have been submitted to the PRoteomics IDEntifications database (PRIDE; http://www.ebi.ac.uk/pride/archive/) under accession number PXD001626.,OADS,/arxiv_data1/oa_pdf/45/6f/1536.PMC4579339.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.261867.115.,Non-OADS,/arxiv_data1/oa_pdf/75/44/1891.PMC4579346.pdf
"This article, published in Genes & Development , is available under a Creative Commons License (Attribution-NonCom- mercial 4.0 International), as described at http://creativecommons.org/ licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/75/44/1891.PMC4579346.pdf
TIG fibroblasts were from the Japanese Collection of Research Bioresources (JCRB) and were cultured according to the JCRB Cell Bank (http://cellbank.nibio.go.jp).,OADS,/arxiv_data1/oa_pdf/75/44/1891.PMC4579346.pdf
B cells and fibroblasts were from Coriell Cell Repositories and were cul-tured according to the Coriell Cell Repositories site (http://ccr.coriell.org).,OADS,/arxiv_data1/oa_pdf/75/44/1891.PMC4579346.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.268482.115.© 2015 Boynton and Shimkets This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months afterthe full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/cb/8b/1903.PMC4579348.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/cb/8b/1903.PMC4579348.pdf
"For the CsgA K155R mu- tant expression plasmid, pTOB57 was constructed via Quick- Change PCR (Agilent Technologies) using primers designed by PrimerX (http://www.bioinformatics.org/primerx) to change co- don AAA to AGA.",OADS,/arxiv_data1/oa_pdf/cb/8b/1903.PMC4579348.pdf
Corresponding author: bo.porse@finsenlab.dkArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.268409.115.© 2015 Knudsen et al.,OADS,/arxiv_data1/oa_pdf/35/bd/1915.PMC4579349.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/35/bd/1915.PMC4579349.pdf
Gene sets originated from theMSigDB (http://www.broadinstitute.org/gsea/msigdb)and a list of curated signatures extracted from Veneziaet al.,OADS,/arxiv_data1/oa_pdf/35/bd/1915.PMC4579349.pdf
ETPs sequentially develop through double-negative(DN) stages (DN2 –DN4) —during which cells do not ex- press either the CD4 or CD8 coreceptor (CD4 −CD8−)— into a double-positive stage (DP; CD4+CD8+) and finally resolve into either CD4 single-positive (SP) helper T cells Corresponding author: engel@umich.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.265025.115.© 2015 Ku et al.,Non-OADS,/arxiv_data1/oa_pdf/f8/be/1930.PMC4579350.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f8/be/1930.PMC4579350.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.264192.115.© 2015 Jiang et al.,OADS,/arxiv_data1/oa_pdf/59/a2/1955.PMC4579352.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue pub-lication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/59/a2/1955.PMC4579352.pdf
"Af-ter six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/59/a2/1955.PMC4579352.pdf
(2015) and on the Texas A&M Institute for Geno-mic Medicine Web site (http://www.tigm.org).,Non-OADS,/arxiv_data1/oa_pdf/59/a2/1955.PMC4579352.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7d/45/ijhrba-04-02-7310.PMC4579361.pdf
Available at: http://www.networks.nhs.uk/nhs-networks/ahp-networks/ahp-qipp-toolkits (accessed 2 April 12).,Non-OADS,/arxiv_data1/oa_pdf/02/21/10.1177_0308022614562396.PMC4579409.pdf
Available at: http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri ¼CELEX:32006L0126:en:NOT (accessed 2 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/02/21/10.1177_0308022614562396.PMC4579409.pdf
of the Russian Academy of Sciences [ http://bioinf.spbau.ru/spades ]) and a reference G. sulfurreducens genome as a trusted contig.,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
MUMmer (ver- sion 3.23 [ http://mummer.sourceforge.net ]) was used to isolate the plas- mid sequences remaining in the unmatched SPAdes scaffolds.,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
Sequences were reconﬁrmed by mapping reads to the assembled contigs using breseq (version 0.24rc6; Barrick Lab/Uni-versity of Texas at Austin [ http://barricklab.org/twiki/bin/view/Lab /ToolsBacterialGenomeResequencing ]) (20).,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1038/nmeth.2926 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
FEMS Microbiol Rev 35:577– 608. http://dx.doi.org/10 .1111/j.1574-6976.2011.00265.x .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1073/pnas.0305939101 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi .org/10.1128/AEM.00044-12 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
J Bacteriol 193:1023– 1033. http://dx.doi.org/10.1128/JB.01092-10 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
J Biol Chem 287:10958 – 10966. http://dx.doi.org/10.1074/jbc.M112.345041 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1128/mBio.02034-14 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1128/AEM.67.7.3180-3187.2001 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1128/AEM.02250-09 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1128/JB.185.7.2096-2103 .2003 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1038/ismej.2011.166 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
Appl Environ Microbiol 74:7329 – 7337. http://dx.doi.org/10.1128/AEM.00177-08 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
BMC Genomics 15:1039. http://dx.doi.org/10.1186 /1471-2164-15-1039 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1038/nmeth.2474 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1371/journal.pone.0112963 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1128/AEM.01098-08 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1093/nar /gkm818 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10 .1016/j.bbapap.2006.04.017 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
Nat Commun 4:1755. http://dx.doi.org/10.1038/ncomms2743 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1128/JB .01110-12 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi .org/10.1016/j.bios.2013.03.010 .,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1038 /nbt1183-784 .,Non-OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
http://dx.doi.org/10.1128/AEM.69.5 .2800-2809.2003 .Chan et al.,OADS,/arxiv_data1/oa_pdf/40/0b/zam7178.PMC4579418.pdf
"Editor: J. Björkroth Address correspondence to Lothar H. Wieler, WielerLH@rki.de.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01921-15 .",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
"Most of the bovine E. coli strains of O serogroups O26, O103, O111, and O145 were chosen from strain collections of the Institute of Microbiologyand Epizootics (IMT), Freie Universität, Berlin, Berlin, Germany, as wellas the E. coli MLST database ( http://mlst.warwick.ac.uk/mlst/dbs/Ecoli ) (25).",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
"The alleles and sequence types (STs) were assigned in accordance with the E. coli MLST website ( http://mlst.warwick.ac.uk /mlst/dbs/Ecoli ) using Ridom SeqSphere software (Ridom GmbH, Mün- ster, Germany) in order to generate a database.",OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
"Furthermore, in the Escherichia coli O-antigen Database (EcoDAB; http://nevyn.organ.su.se/ECODAB/ ), only a high similarity with a signiﬁcant E value of 2e /H1100266 between glycosyltransferases WdbH of O111 and WbtG of O103 is indi- FIG 1 Minimum spanning tree (MST) calculated with Bionumerics, version 7.1 (Applied Maths), displaying the population structure of 250 Shiga toxin- harboring Escherichia coli isolates based on allele sequence combinations of the adk,fumC ,gyrB ,icd,mdh ,purA , and recA genes.",OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1093/infdis/155.3.377 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Appl Environ Microbiol 75:5074 – 5081. http://dx.doi.org/10.1128/AEM.00391-09 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10 .1016/j.ijfoodmicro.2004.01.015 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1111/j.1439-0450.2006.00968.x .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1017/S0950268813000915 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Emerg Infect Dis 7:812– 819. http://dx.doi.org/10.3201/eid0705.017507 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Epidemiol Infect 139:688 – 699. http://dx.doi.org/10.1017/S0950268810001858 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10 .1371/journal.pone.0036144 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.3201 /eid1408.071082 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Front Mi- crobiol 2:90.http://dx.doi.org/10.3389/fmicb.2011.00090 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1073 /pnas.0903585106 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1089/fpd.2013.1696 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
BMC Genomics 15:17. http://dx.doi.org/10.1186/1471-2164-15-17 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1086 /516470 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Clin Microbiol Infect 12:634 – 641. http://dx.doi.org/10.1111/j.1469-0691.2006.01478.x .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1371/journal.pone.0001024 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1128/AEM .02937-06 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1128/AEM.01906-07 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Int J Med Microbiol 292:477– 486. http://dx.doi.org/10 .1078/1438-4221-00226 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Appl Environ Microbiol 73:3380 – 3390. http://dx.doi.org/10.1128/AEM.02855-06 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1128/JCM.41.6.2448-2453 .2003 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1128 /JCM.00860-12 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1023/A:1008972605514 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1086/466536 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10 .4315/0362-028X.JFP-12-503 .35.Bettelheim KA.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Foodborne Pathog Dis 10:453– 460. http://dx.doi.org /10.1089/fpd.2012.1401 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1086/517438 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
J Clin Microbiol 50:4123– 4127. http://dx.doi.org/10.1128/JCM.02262-12 .,OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Nature 406: 64 – 67. http://dx.doi.org/10.1038/35017546 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1046/j.1365-2672.2003.01964.x .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Gastroenterology 136:1925– 1938. http://dx.doi.org/10.1053/j.gastro.2008.12.072 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
Infect Immun 71:4674 – 4683. http://dx.doi.org/10.1128 /IAI.71.8.4674-4683.2003 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
http://dx.doi.org/10.1128/AEM.01728-13 .Phylogenetic Analysis of Non-O157 EHEC October 2015 Volume 81 Number 20 aem.asm.org 7047 Applied and Environmental Microbiology,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/zam7041.PMC4579429.pdf
"Editor: D. Cullen Address correspondence to Kerry Burton, kerry.burton@emr.ac.uk.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01093-15 .",Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
These meanvalues were then analyzed using a MicroArray analysis of variance(MAANOVA) approach in R ( http://cran.rproject.org/web/packages /maanova/index.html ).,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org/10.1146/annurev-phyto -080508-081932 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org/10.1017 /S0953756203007202 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
Phytopathol-ogy82:285 290. http://dx.doi.org/10.1094/Phyto-82-285 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
J Sci Food Agr 26:835– 842. http://dx.doi.org/10.1002/jsfa .2740260615 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
Fungal Genet Biol 55:54 – 66. http://dx.doi.org/10.1016/j.fgb.2013.01.001 .,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi .org/10.1016/j.virusres.2004.08.017 .,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
Trans R Soc B 365:1899 – 1905. http://dx.doi.org/10.1098/rstb.2010.0057 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
Virology272:1– 6. http://dx.doi.org/10.1006/viro.2000.0381 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org/10.1016/j.ceb.2009.01.008 .,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org /10.1016/j.mycres.2007.05.012 .,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org/10.1016/j.fgb.2012.10.004 .,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://dx.doi.org/10.1021 /jf9813539 .,Non-OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
http://www.hdc.org.uk/sites/default/ﬁles/research_papers/M5 1%20Final%20Report.pdf .Eastwood et al.,OADS,/arxiv_data1/oa_pdf/07/21/zam7125.PMC4579443.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on The I SME Journal website (http:/ /www.nature.",Non-OADS,/arxiv_data1/oa_pdf/b8/7c/ismej2015111a.PMC4579463.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The IS ME Journal website (http:// www.nature.com/ismej)Carbon conversion by riverbed methanotrophy M Trimmer et al 2314 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/88/d4/ismej201598a.PMC4579481.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f4/d3/ijhrba-04-02-24388.PMC4579483.pdf
Available from: http://www.who.int/medcentre/factsheets/2003/ fs134/en/.,OADS,/arxiv_data1/oa_pdf/55/15/JIE-4-228.PMC4579485.pdf
Available from http://priory.com/ medicine/nocebo.htm (2007).,Non-OADS,/arxiv_data1/oa_pdf/38/1b/JIE-4-221.PMC4579488.pdf
Available from: http://www.care.diabetesjournals.org/content/27/suppl_1/s58.full.,Non-OADS,/arxiv_data1/oa_pdf/6e/89/JIE-4-202.PMC4579489.pdf
http://www.planalto.gov.br /ccivil03/ato2004-2006/2004/lei/l10.973.htm>.,Non-OADS,/arxiv_data1/oa_pdf/23/28/JIE-4-256.PMC4579491.pdf
Available from: http://www.imshealth.com/deployedfiles/ims//Insights/IMS%20Institute20for%20Healthcare%20Informatics/Global_Use_of_Medicines_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/28/JIE-4-256.PMC4579491.pdf
Available from: http://www.flowersofindia.net/ catalog/slides/Garlic%20Pear%20Tree.html.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/JIE-4-224.PMC4579496.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0a/e6/ijhrba-04-02-22702.PMC4579556.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Hunger promotes fear extinction D Verma et al 439 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/d6/1f/npp2015163a.PMC4579557.pdf
"Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrug-SafetyInformationforPatie ntsandProviders/DrugSafetyInformationfor- HeathcareProfessionals/ucm085249.htm, accessed 8 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/b3/35/ja201518a.PMC4579589.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ Supplementary Information accompanies the paper on The Journal of Antibiotics website (http://www.nature.com/ja)Immunomodulation by last-resort antibiotics CB o d e et al 490 The Journal of Antibiotics",Non-OADS,/arxiv_data1/oa_pdf/b3/35/ja201518a.PMC4579589.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website (http://www.nature.com/pcan)Age-speci ﬁc prostate cancer biomarkers SG Zhao et al 236 Prostate Cancer and Prostatic Disease (2015), 229 –236 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/36/03/pcan201522a.PMC4579590.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on The Journal of Antibiotics website (http://www.nature.com/ja)Novel autophagy inducers SW a d a et al 529 The Journal of Antibiotics",Non-OADS,/arxiv_data1/oa_pdf/4f/2d/ja201523a.PMC4579591.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/d5/ncomms9193.PMC4579603.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhou, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/58/d5/ncomms9193.PMC4579603.pdf
Available from: http://www.icmr.nic.in/final/RDA‑2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/c7/IJNM-30-303.PMC4579613.pdf
"30: Issue 4   |  October-December, 2015 313https://www.inkling.com/read/.of./diffuse‑and‑multinodular‑goiters.",Non-OADS,/arxiv_data1/oa_pdf/2d/d7/IJNM-30-309.PMC4579614.pdf
Available from: https://www.ispub.com/IJEN/3/1/12/12738.,Non-OADS,/arxiv_data1/oa_pdf/08/82/IJNM-30-341.PMC4579622.pdf
Supplementary information of this article can be found on Cellular & Molecular Immunology website: http://www.nature.com/cmi.,Non-OADS,/arxiv_data1/oa_pdf/8d/63/cmi201557a.PMC4579658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Increased CD81Treg cells in ovarian cancer S Zhang et al 591 Cellular & Molecular Immunology",Non-OADS,/arxiv_data1/oa_pdf/8d/63/cmi201557a.PMC4579658.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/04/73/ijhrba-04-02-22350.PMC4579756.pdf
Available from: http://www.healthyeating.sfgate.,Non-OADS,/arxiv_data1/oa_pdf/20/55/JEHP-4-53.PMC4579763.pdf
Available from: http://www.uptodate.com/online/ content/topic.do?topic key=diabetes/13843andview.print.,Non-OADS,/arxiv_data1/oa_pdf/d2/c2/JEHP-4-68.PMC4579764.pdf
Available  from: http://www.qualitymeasures.ahrq.gov/content.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.who.int/patientsafety/en/ brochure_final.pdf[Last accessed on 2013 Feb 13].,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available  from: http://www.archive.ahrq.gov/downloads/pub/evidence/pdf/ psi/psi.pdf.,OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available  from: http://www.qualityindicators.ahrq.gov.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available  from: http://www.ahrq.gov/qual/pscongrpt.,OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.qualityindicators.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.behdasht.gov.ir/index.aspx?sitei d=1andpageid=127andnewsview=15217.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.alzahra.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.qualityindicators.ahrq.gov March  2003Version 3.1 [Last accessed on 2007 Mar 12].,OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available  from: http://www.hhnmag.com/hhnmag_app/jsp/articledisplay.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/JEHP-4-54.PMC4579765.pdf
Available from: http://www.rayasamin.ir/ ejournal?IssueId = 336.,Non-OADS,/arxiv_data1/oa_pdf/f8/6a/JEHP-4-49.PMC4579771.pdf
Available from: http://treeves.coe.uga.edu/Bertlesmann_Impact_ Report.pdf.,OADS,/arxiv_data1/oa_pdf/9a/5e/JEHP-4-60.PMC4579775.pdf
Available from: http://www.fdo.behdasht.gov.ir/ index.aspx?siteid=1 and pageid=13391 and newsview=33463.,Non-OADS,/arxiv_data1/oa_pdf/43/cf/JEHP-4-59.PMC4579777.pdf
"http://onlinelibrary.wiley.com/doi/10.1002/xrs.2442/abstract [27] S. Smolek, B. Pemmer, M. Folser, C. Streli, P. Wobrauschek, Rev.",Non-OADS,/arxiv_data1/oa_pdf/68/96/xrs0043-0093.PMC4579790.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/12/22/ijhrba-04-02-23751.PMC4579801.pdf
[Available at http://www.ic1004.org/.],Non-OADS,/arxiv_data1/oa_pdf/c1/97/rds0049-0371.PMC4579845.pdf
Global Ecology and Biogeography published by John Wiley & Sons LtdDOI: 10.1111/geb.12122 http://wileyonlinelibrary.com/journal/geb 259,Non-OADS,/arxiv_data1/oa_pdf/76/df/geb0023-0259.PMC4579867.pdf
"The more recent VCF products (Version 5; availablethrough the USGS EROS data centre at https://lpdaac.usgs.gov/)are based on a larger calibration set and several methodological Figure 2 Potential woody canopy cover percentage ( τ′) in Africa estimated from the empirical relationship of Sankaran et al., 2005 and mean annual rainfall (Mitchell & Jones, 2005) at c. 10 km spatial resolution (a).",OADS,/arxiv_data1/oa_pdf/76/df/geb0023-0259.PMC4579867.pdf
"R package version 0.11. http://www.r-project.org ,http://www.komsta.net/ Käse H (1969) Ein Vorschlag für eine Methode zur Bestimmung und V orhersage der Waldbrandgefährdung mit Hilfe komplexerKennziffern.",Non-OADS,/arxiv_data1/oa_pdf/25/e7/704_2013_Article_839.PMC4579912.pdf
http://wiki.fire.wsl.ch ZAMG (2012a) Phänologie und ZAMG.,Non-OADS,/arxiv_data1/oa_pdf/25/e7/704_2013_Article_839.PMC4579912.pdf
http://zacost.zamg.ac.at/ phaeno_portal/informationen/zamg-und-phaenologie.html .,Non-OADS,/arxiv_data1/oa_pdf/25/e7/704_2013_Article_839.PMC4579912.pdf
http://www.zamg.ac.,Non-OADS,/arxiv_data1/oa_pdf/25/e7/704_2013_Article_839.PMC4579912.pdf
http://www.zamg.ac.at/ cms/de/forschung/wetter/inca .,Non-OADS,/arxiv_data1/oa_pdf/25/e7/704_2013_Article_839.PMC4579912.pdf
"Accompanying Tables S1 through S5 are available at http://jaha.ahajournals.org/content/4/3/e001424/suppl/DC1Correspondence to: Kim G. Smolderen, PhD, Implementation Science, UMKC School of Medicine –Biomedical & Health Informatics, 1000 E 24th Street, 5th Floor, Kansas City, MO 64108.",Non-OADS,/arxiv_data1/oa_pdf/47/3e/jah3-4-e001424.PMC4579927.pdf
http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6051a7.htm.,OADS,/arxiv_data1/oa_pdf/47/3e/jah3-4-e001424.PMC4579927.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/4/4/e001561/suppl/DC1 Correspondence to: Victoria Vaughan Dickson, PhD, RN, FAHA, FAAN, New York University College of Nursing, 726 Broadway, #1022, New York, NY10003.",Non-OADS,/arxiv_data1/oa_pdf/08/f4/jah3-4-e001561.PMC4579928.pdf
"Sample collection and handling was performed in accordance with the guidelines of the Medical and Ethical Committee in Leiden, Netherlands and the code of conduct ofthe Dutch Federation of Biomedical Scienti ﬁc Societies (http://www.federa.org/?s=1&m=82&p=0&v=4#827).",Non-OADS,/arxiv_data1/oa_pdf/f0/e3/jah3-4-e001403.PMC4579929.pdf
A list of OECD member countries can be found at http://www.oecd.org/general/ listofoecdmembercountries-rati ﬁcationoftheconventiononthe oecd.htm.,Non-OADS,/arxiv_data1/oa_pdf/37/e2/jah3-4-e001606.PMC4579930.pdf
Deaths and disability-adjusted life years (DALYs) from HIV and CVD were matched by country from the Global Burden of Disease (GBD) database (http://ghdx.health- metricsandevaluation.org/global-burden-disease-study-2010- gbd-2010-data-downloads) and the World Health Organization (WHO) Health Statistics and Information Systems Programme (http://www.who.int/healthinfo/en/).,OADS,/arxiv_data1/oa_pdf/37/e2/jah3-4-e001606.PMC4579930.pdf
Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm.,Non-OADS,/arxiv_data1/oa_pdf/7b/d2/jah3-4-e001793.PMC4579931.pdf
"Statistical Methods In accordance with the current ACC/AHA guidelines,3we classi ﬁed participants as eligible for statin therapy if they met the following criteria: They had blood LDL-C concentration ≥70 mg/dL plus either 10-year ASCVD risk of ≥7.5% or diabetes or they had LDL-C levels ≥190 mg/dL regardless of other risk factors.7To compare the numbers of people eligible for statins under old versus new cholesterol guidelines, we also used the ATP III risk estimator to calculate the 10-yearrisk of myocardial infarction or coronary heart disease death (ie, coronary heart disease risk; http://cvdrisk.nhlbi.nih.gov/ DOI: 10.1161/JAHA.115.001888 Journal of the American Heart Association 2ACC/AHA Risk Calculator, Statin Eligibility Andersson et alORIGINAL RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/9e/72/jah3-4-e001888.PMC4579932.pdf
Available at: http://jaccjacc.cardiosource.com/acc_docu- ments/2013_FPR_S5_Risk_Assesment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/72/jah3-4-e001888.PMC4579932.pdf
"Costs per episode were adjusted to 2013 Canadian dollarsusing the Consumer Price Index, (http://www.bankofcana- da.ca/en/cpi.html) and then summed over the entire DOI: 10.1161/JAHA.114.001684 Journal of the American Heart Association 2Healthcare Costing in Atrial Fibrillation Bennell et alORIGINAL RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/a6/a1/jah3-4-e001684.PMC4579933.pdf
Available at: http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.5052135/ k.2C86/Heart_disease__Atrial_ ﬁbrillation.htm.,Non-OADS,/arxiv_data1/oa_pdf/a6/a1/jah3-4-e001684.PMC4579933.pdf
Available at: http://www.cadth.ca/media/pdf/H0483_Canadian_Admin_Databases_mg_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/a1/jah3-4-e001684.PMC4579933.pdf
Potential confounders were identi ﬁed using an a priori direct acyclic graph 23via a web-based tool (http://www.dagitty.net).,OADS,/arxiv_data1/oa_pdf/e0/1e/jah3-4-e001611.PMC4579937.pdf
Sources of Funding This study has been funded by research grants from the Swedish Foundation of Strategic Research (http://www.stratresearch.com/en/).,Non-OADS,/arxiv_data1/oa_pdf/e0/1e/jah3-4-e001611.PMC4579937.pdf
Available at: http://www.socialstyrelsen.se/register/halsodatareg- ister/patientregistret/inenglish.,Non-OADS,/arxiv_data1/oa_pdf/e0/1e/jah3-4-e001611.PMC4579937.pdf
The authors regret this error.The online version of the article has been updated and is available at http://jaha.ahajourn als.org/content/4/2/e001510.,Non-OADS,/arxiv_data1/oa_pdf/34/ab/jah3-4-e000649.PMC4579938.pdf
"Accompanying Data S1 and Tables S1, S2 are available at http://jaha.ahajournals.org/content/4/4/e001599/suppl/DC1 *CRIC Study Investigators are listed in the Appendix.",OADS,/arxiv_data1/oa_pdf/99/47/jah3-4-e001599.PMC4579944.pdf
"Accompanying Videos S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/4/e001844/suppl/DC1 Correspondence to: Hiroshi Ashikaga, MD, PhD, Cardiac Arrhythmia Service, Division of Cardiology, Johns Hopkins University School of Medicine, 600 N.Wolfe St, Carnegie 568, Baltimore, MD 21287.",Non-OADS,/arxiv_data1/oa_pdf/44/8b/jah3-4-e001844.PMC4579945.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov/ Unique identi ﬁer: NCT01873950.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
"Accompanying Figures S1 through S8 and Tables S1 and S2 are available at http://jaha.ahajournals.org/content/4/4/e001615/suppl/DC1 Corresponding to: David G. Strauss, MD, PhD, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, WO62-1126 Silver Spring,MD 20993.",Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
Available at: http://www.fda.gov/down-loads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm0731 53.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
Available at: http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
Available at: http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
Available at: http://dailymed.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/jah3-4-e001615.PMC4579946.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.org/content/4/3/e001626/suppl/DC1Correspondence to: Warren K. Laskey, MD, MPH, Division of Cardiology, Department of Internal Medicine, University of New Mexico School of Medicine, MSC10- 5550, 1 University of New Mexico, Albuquerque, NM 87131.",Non-OADS,/arxiv_data1/oa_pdf/a8/d4/jah3-4-e001626.PMC4579947.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/4/4/e001524/suppl/DC1Parts of this study were presented at the American Heart Association Epidemiology and Prevention/Nutrition, Physical Activity, and Metabolism International Conference, March 13 to 16, 2012, in San Diego, CA, and at theAmerican Diabetes Association 73rd Scienti ﬁc Sessions June 21 to 25, 2013, in Chicago, IL.",Non-OADS,/arxiv_data1/oa_pdf/dd/72/jah3-4-e001524.PMC4579948.pdf
Available at: http://www.cdc.gov/nchs/data/hus/hus12.pdf.,OADS,/arxiv_data1/oa_pdf/dd/72/jah3-4-e001524.PMC4579948.pdf
Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr61/ nvsr61_06.pdf.,OADS,/arxiv_data1/oa_pdf/dd/72/jah3-4-e001524.PMC4579948.pdf
Available at: http://well.blogs.nytimes.com/ 2012/12/25/heart-disease-in-military-shows-dramatic-drop-since-korean- war/?_php=true&_type=blogs&_r=0.,Non-OADS,/arxiv_data1/oa_pdf/dd/72/jah3-4-e001524.PMC4579948.pdf
The online version of the article has been updated and is available at http://jaha.ahajourn als.org/content/3/5/e001033.,Non-OADS,/arxiv_data1/oa_pdf/60/80/jah3-4-e000653.PMC4579949.pdf
"Accompanying Data S1 and Tables S1 through S5 are available at http://jaha.ahajournals.org/content/4/4/e001745/suppl/DC1 This article was handled independently by Holli A. DeVon, PhD, RN, as a guest editor.",Non-OADS,/arxiv_data1/oa_pdf/f6/b9/jah3-4-e001745.PMC4579951.pdf
"Available at: http://www.fda.gov/ Drugs/DrugSafety/ucm396470.htm Accessed May 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c2/1e/jah3-4-e001798.PMC4579955.pdf
The online version of the article has been updated and is available at http://jaha.ahajourn als.org/content/4/3/e001505.,Non-OADS,/arxiv_data1/oa_pdf/64/89/jah3-4-e000633.PMC4579956.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajour- nals.org/content/4/4/e001709/suppl/DC1 Correspondence to: Nilay S. Shah, MD, MPH, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, 680 N Lake Shore D, Suite1400, Chicago, IL 60611.",Non-OADS,/arxiv_data1/oa_pdf/81/54/jah3-4-e001709.PMC4579957.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm263729.htm.,Non-OADS,/arxiv_data1/oa_pdf/7c/e5/jah3-4-e001891.PMC4579959.pdf
"Arcadia, CA: Children ’s Oncology Group; October 2008; Available at http://www.survivo rshipguidelines.org.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/jah3-4-e001891.PMC4579959.pdf
"Washington, DC: National Academies Press.Avalable at http://iom.edu/Reports/2003/Childhood-Cancer-Survivorship- Improving-Care-and-Quality-of-Life.aspx.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/jah3-4-e001891.PMC4579959.pdf
"Accompanying Data S1, Figures S1, S2 and Tables S1, S2 are available at http://jaha.ahajournals.org/content/4/4/e001813/suppl/DC1 Correspondence to: G. Andr /C19e Ng, MBChB, PhD, Department of Cardiovas- cular Sciences, Cardiology Group, Glen ﬁeld Hospital, University of Leicester, LE3 9QP United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/jah3-4-e001813.PMC4579960.pdf
"8Additionally, in April 2014, ivabradine was added to the list of “drugs with a conditional risk ”of TdP in the “CredibleMeds ”database of QT interval –prolonging drugs, with the update stating “There is substantial evidence that ivabradine is associated with TdP when taken with other medicines that prolong the QT interval, diuretics or drugs that block the metabolic break- down of ivabradine, or electrolyte abnormalities (low potas- sium or low magnesium), which may be induced by co- administration of diuretics ”(https://www.crediblemeds.org/ blog/nel ﬁnavir-and-ivabradine-added-list-drugs-avoid/Credi- bleMeds/C226).",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/jah3-4-e001813.PMC4579960.pdf
Accompanying Figures S1 through S4 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/b9/0f/jah3-4-e001868.PMC4579961.pdf
Retrieved from http://www.impactjournals.com/oncotarget/index.php?journal= oncotarget&page=article&op=view&path%5B%5D=3303.,OADS,/arxiv_data1/oa_pdf/1f/38/jah3-4-e001464.PMC4579962.pdf
The authors regret this error.The online version of the article has been updated and is available at http://jaha.ahajo urnals.org/content/3/5/e001356.,Non-OADS,/arxiv_data1/oa_pdf/74/f9/jah3-4-e000634.PMC4579964.pdf
"18,19 In this study, we investigated the effect of a vitamin D3 analog, maxacalcitol (22-oxacalcitriol [OCT]), on Th2 cytokine-induced © Mika Terao, Lingli Yang, Sayaka Matsumura, Mizuki Yutani, Hiroyuki Murota, and Ichiro Katayama *Correspondence to: Mika Terao; Email: mterao@derma.med.osaka-u.ac.jpSubmitted: 12/16/2014; Revised: 01/09/2015; Accepted: 01/19/2015 http://dx.doi.org/10.1080/19381980.2015.1010983 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Clin Dermatol 2013; 31:432-7; PMID:23806160; http://dx.doi.org/10.1016/j.clindermatol.2013.01.010 2.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Int Arch Allergy Immunol 2006; 140:345-56; PMID:16804319; http://dx.doi.org/10.1159/000094242 3.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Serum 25- OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a ret- rospective cohort study and review of the literature.Autoimmun Rev 2011; 10:490-4; PMID:21320645; http://dx.doi.org/10.1016/j.autrev.2011.02.002 4.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Rheu- matol 2011; 38:2492-3; author reply 4; PMID:22045936; http://dx.doi.org/10.3899/jrheum.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Clin Rheumatol 2010; 29:1419-25; PMID:20454816; http://dx.doi.org/10.1007/s10067- 010-1478-3 7.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Autoimmun Rev 2012; 12:127-36; PMID:22776787; http://dx.doi.org/10.1016/j.autrev.,OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
PMID:11100017; http://dx.doi.org/10.1067/mjd.,OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Adv Exp Med Biol 1999; 455:299-304; PMID:10599359; http://dx.doi.org/10.1007/978-1- 4615-4857-7_44 10.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Dermatolog Treat 2003; 14:219-21;PMID:14660267; http://dx.doi.org/10.1080/ 09546630310015449 12.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Am Acad Dermatol 1998; 39:211-5;PMID:9704831; http://dx.doi.org/10.1016/S0190- 9622(98)70077-5 13.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
PloS one 2012; 7:e41994; PMID:22911870; http://dx.doi.org/10.1371/journal.pone.0041994 16.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
The British journal ofdermatology 2013; 168:717-25; PMID:23110679; http://dx.doi.org/10.1111/bjd.12117 17.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Clin Invest 2012; 122:2590-600; PMID:22684102; http://dx.doi.org/ 10.1172/JCI58978 19.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Allergy Clin Immunol 2006; 118:98- 104; PMID:16815144; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Br J Dermatol 1999; 141:274-8; PMID:10468799; http://dx.doi.org/10.1046/j.1365-2133.1999.02975.x 21.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Exp Dermatol 2010; 19:38-43; PMID:19758314; http://dx.doi.org/10.1111/j.1600- 0625.2009.00973.x 22.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Clin Endocrinol Metab 2013; 98:E298-303; PMID:23295467; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Rheumatology (Oxford) 2012;51:1540-9; PMID:22577083; http://dx.doi.org/ 10.1093/rheumatology/kes090 25.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Am J Pathol 2012; 180:165-76; PMID:22062222; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Rheumatology (Oxford) 2010; 49:2408-12; PMID:20819796; http://dx.doi.org/ 10.1093/rheumatology/keq275 27.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Eur J Immunol2006; 36:361-70; PMID:16402404; http://dx.doi.org/ 10.1002/eji.200425995 28.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Clin Exp Immunol 2011; 164:72-9; PMID:21323660; http://dx.doi.org/10.1111/j.1365- 2249.2010.04315.x 29.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
J Dermatol Sci 1997; 15:207-13; PMID:9302649; http://dx.doi.org/ 10.1016/S0923-1811(97)00609-9 30.,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
Arch Dermatol Res 1999; 291:500-6; PMID:10541880; http://dx.doi.org/ 10.1007/s004030050444 www.tandfonline.com e1010983-7 Dermato-Endocrinology,Non-OADS,/arxiv_data1/oa_pdf/82/7c/kder-07-01-1010983.PMC4579972.pdf
"Sunscreens with primarily UVB(290–315 nm) protection were available from the early 1950s until1988, and sunscreens with both UVB and UVA (316–400 nm) protection were available since 1988 with increasing SPF numbers over the years (http://en.wikipedia.org/wiki/Sunscreen).",Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
"Some © Stephen J Merrill, Samira Ashra ﬁ, Madhan Subramanian, and Dianne E Godar *Correspondence to: Dianne E Godar; E-mail: Dianne.Godar@FDA.HHS.GOVSubmitted: 09/26/2014; Revised: 12/12/2014; Accepted: 12/19/2014 http://dx.doi.org/10.1080/19381980.2014.1004018 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Med Hypotheses 2009; 72:434-43; PMID:19155143; http://dx.doi.org/10.1016/j.mehy.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Recent Results Cancer Res 1986; 102:18-37; PMID:3738185; http://dx.doi.org/ 10.1007/978-3-642-82641-2_3 12.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photo- biol 2005; 81:736-49; PMID:15819599; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Invest Dermatol 2003; 120:1087-93; PMID:12787139; http://dx.doi.org/10.1046/j.1523-1747.2003.12246.x 14.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Eur J Cancer 2005; 41:45-60; PMID:15617990; http://dx.doi.org/ 10.1016/j.ejca.2004.10.016 15.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Int J Epidemiol 2009;38:814-30; PMID:19359257; http://dx.doi.org/ 10.1093/ije/dyp166 16.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Int Arch Occup Env Health 2009; 82:357-63;PMID:18649084; http://dx.doi.org/10.1007/s00420- 008-0342-0 17.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photobiol 2005; 81:3-8; PMID:15335275; http://dx.doi.org/10.1562/2004-07-27-IR-247.1 19.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photodermatol Photoimmunol Photomed 2003; 19:175-81; PMID:12925188; http://dx.doi.org/ 10.1034/j.1600-0781.2003.00031.x 20.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Biochemistry 2007; 46:5515-22; PMID:17439242; http://dx.doi.org/10.1021/bi062238r 22.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
JInvest Dermatol 1984; 82:219-22; PMID:6699425; http://dx.doi.org/10.1111/1523-1747.ep12260043 24.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Med Hypotheses 2008; 70:855-9; PMID:17881138; http://dx.doi.org/ 10.1016/j.mehy.2007.07.029 25.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Sci- ence 1982; 216:1001-3; PMID:6281884; http://dx.doi.org/10.1126/science.6281884 27.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Arch Dermatol 1988; 124:1802-4; PMID:3190255;http://dx.doi.org/10.1001/ archderm.1988.01670120018003 28.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Preventive Med 2001; 33:155-61;PMID:11522155; http://dx.doi.org/10.1006/pmed.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photobiol 2003; 78:342-8; PMID:14626661; http://dx.doi.org/10.1562/0031-8655(2003)078%3c0342: MSUREO%3e2.0.CO;2 30.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photobiol 2013; 89:1226-33; PMID:23809057; http://dx.doi.org/10.1111/php.12123 32.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Environ Health 2007; 6:22; PMID:17686155; http://dx.doi.org/10.1186/ 1476-069X-6-22 33.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Cancer 1988; 61:2586-95;PMID:3365679; http://dx.doi.org/10.1002/1097- 0142(19880615)61:12%3c2586::AID- CNCR2820611233%3e3.0.CO;2-2 34.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Intl J Cancer 2014; PMID:24890612; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Ann Surg 2000; 231:664-71; PMID:10767787; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Dermatol 2007; 156:38-44; PMID:17199564; http://dx.doi.org/10.1111/j.1365- 2133.2006.07541.x 37.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Br J Dermatol 2005; 152:909-14; PMID:15888145; http://dx.doi.org/10.1111/j.1365-2133.2005.06344.x 38.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Exp Dermatol 2009; 18:857-62; PMID:19469900; http://dx.doi.org/10.1111/j.1600-0625.2009.00866.x 39.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
124:869-71; PMID:3377516; http://dx.doi.org/ 10.1001/archderm.1988.01670060015008 40.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photobiol 2001; 73:621-9; PMID:11421067; http://dx.doi.org/10.1562/0031- 8655(2001)073%3c0621:UDOA%3e2.0.CO;2 43.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Photochem Photobiol 2001; 74:787-93; PMID:11783934; http://dx.doi.org/10.1562/0031-8655(2001)074%3c0787:UDOACA%3e2.0.CO;2 44.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Radiation Res 1987; 110:224-54; PMID:3575654; http://dx.doi.org/10.2307/3576902 45.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
"Luxembourg 2004. http://ec.europa.eu/eurostat/web/ population-demography-migration-projections/popula- tion-data/main-tables, accessed February 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Annal Epidemiol 2003; 13:395-404; PMID:12875796; http://dx.doi.org/10.1016/S1047-2797(02)00461-1 47.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Arch Dermatol2003; 139:60-2; PMID:12533166; http://dx.doi.org/ 10.1001/archderm.139.1.60 49.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Int J Cancer 2000; 88:838-42; PMID:11072258; http://dx.doi.org/10.1002/1097-0215(20001201)88:5%3c838::AID- IJC25%3e3.0.CO;2-X 50.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Clin Endocrinol Metab 1989; 68:882-7; PMID:2541158; http://dx.doi.org/10.1210/ jcem-68-5-882 52.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
JAMA Dermatol 2014;PMID:25517516; http://dx.doi.org/10.1001/ jamadermatol.2014.4643 53.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Cancer Biol Ther 2007; 6:48-55; PMID:17172823; http://dx.doi.org/10.4161/cbt.6.1.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Cell Death Different 1998; 5:946-51; PMID:9846181; http://dx.doi.org/10.1038/sj.cdd.4400437 55.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Nat Rev Cancer 2007; 7:684-700;PMID:17721433; http://dx.doi.org/10.1038/nrc219656.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Dermatoendocrinol 2011; 3:205-10; PMID:22110781; http://dx.doi.org/10.4161/derm.16519 57.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Nat Cancer Inst 2005;97:195-9; PMID:15687362; http://dx.doi.org/ 10.1093/jnci/dji019 59.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Endo- crinol 1981; 108:1083-6; PMID:6257495; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
"Circulation Res 2000; 87:214-20; PMID:10926872; http://dx.doi.org/10.1161/01.RES.87.3.214 65. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells.",OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Nat Immunol 2010; 11:344-9; PMID:20208539; http://dx.doi.org/10.1038/ni.1851 66.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Biochem Biophys Acta 1993; 1158:279-86; PMID:8251528; http://dx.doi.org/10.1016/0304-4165(93)90026-5 67.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Arch Biochem Biophys Acta 1993; 303:98-106; PMID:8489269; http://dx.doi.org/10.1006/abbi.1993.1260 68.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Adv Exp Med Biol 2008; 624:179-86; PMID:18348456; http://dx.doi.org/10.1007/978-0-387-77574-6_14 70.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Melanoma Res 1994; 4:235-41; PMID:7950359; http://dx.doi.org/10.1097/00008390-199408000-0000572.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
British J Dermatol 1997; 136:968-9;PMID:9217839; http://dx.doi.org/10.1111/j.1365- 2133.1997.tb03947.x 73.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Cancer Res 2010; 70:9777-86; PMID:21098702; http://dx.doi.org/10.1158/0008-5472.CAN-10-0352 74.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
PLoS Pathog 2011; 7; PMID:21779166; http://dx.doi.org/10.1371/journal.ppat.1002125 75.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Future Virol 2011; 6:45-57; PMID:21318095; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Cell 1993; 75:495-505; PMID:8221889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Genes Dev 2000; 14:3065-73; PMID:11114894; http://dx.doi.org/ 10.1101/gad.182100 78.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Investig Dermatol Symp Proc 1999; 4:17-23; PMID:10537002; http://dx.doi.org/10.1038/sj.jidsp.5640175 79.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Vitro Cell Dev Biol Anim 1997; 33:42-9; PMID:9028834; http://dx.doi.org/10.1007/s11626- 997-0021-6 81.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Mol Med Rep 2011; 4:369-75; PMID:21468579; http://dx.doi.org/10.3892/mmr.2011.429 82.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Curr OpinVirol 2012; 2:459-66; PMID:22658985; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Vet Pathol 1991; 28:55-65;PMID:2017828; http://dx.doi.org/10.1177/ 030098589102800108 84.,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
Curr Opin Virol 2013; 3:416-21; PMID:23816390; http://dx.doi.org/10.1016/j.coviro.,OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
J Invest Dermatol Symp Proc 2005; 10:153-63; PMID:16358819; http://dx.doi.org/10.1111/j.1087- 0024.2005.200407.x e1004018-8 Volume 7 Issue 1 Dermato-Endocrinology,Non-OADS,/arxiv_data1/oa_pdf/05/61/kder-07-01-1004018.PMC4579973.pdf
"control group and treatment group and in order to restrict drop out then a fol-low up was performed using schedule of assessment visit © Puguh Riyanto, Prasetyowati Subchan, and Rosa Lelyana *Correspondence to: Puguh Riyanto; Email: Puguhungaran@gmail.comSubmitted: 01/12/2015; Revised: 05/31/2015; Accepted: 06/15/2015 http://dx.doi.org/10.1080/19381980.2015.1063751 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
J Am Acad Dermatol 2008; 58:56–9;PMID:17945383; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
J Am Acad Dermatol 2010; 62:486–8; PMID:20159314; http://dx.doi.org/10.1016/j.jaad.2009.12.002 6.,OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
J Endocrinol Invest 2009; 32(2):150–5; PMID:19411814; http://dx.doi.org/10.1007/ BF03345705 10.,Non-OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
Reprod Biol Endocriol 2011; 6:57; http://dx.doi.org/10.1186/ 1477-7827-6-5712.,OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
J Nutrition 2010; 140(70):1363s-62s;http://dx.doi.org/10.3945/jn.109.119784 14.,Non-OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
Am J Clin Nutr 2011; 93:356–67; PMID:21177797;http://dx.doi.org/10.3945/ajcn.110.008359 15.,Non-OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
Eur J Clin Nutr 2003:57:100–6; PMID:12548304; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/0c/71/kder-07-01-1063751.PMC4579974.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/99/44/ircmj-17-07-13454.PMC4580069.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/e7/3d/10.1177_2058460115599423.PMC4580118.pdf
Hill M. Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE).Available at: http://clinicaltrials.gov/show/NCT017783356.,Non-OADS,/arxiv_data1/oa_pdf/e7/3d/10.1177_2058460115599423.PMC4580118.pdf
Available at: http://www.cdc.gov/stroke/facts.htm 14.,Non-OADS,/arxiv_data1/oa_pdf/e7/3d/10.1177_2058460115599423.PMC4580118.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/b3/f3/10.1177_2047981615574354.PMC4580119.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/92/7f/10.1177_2058460115604340.PMC4580120.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/7b/bd/10.1177_2058460115592164.PMC4580121.pdf
http://dx.doi.org/10 .1146/annurev.pathmechdis.3.121806.151534 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
"http://dx.doi.org/10 .1093/eurheartj/ehq467 .4.Chow LH, Beisel KW, McManus BM.",Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1038/sj.cr.7290165 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1056/nejm199508033330501 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1056/nejm199007263230405 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.molimm .2010.11.018 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10 .1371/journal.pone.0018186 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.clim.2011.03.017 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1371/journal.pone.0046515 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1152/ajpheart.00441.2014 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.it.2011.04.001 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
J Immunol 191: 464 – 471. http://dx.doi.org/10.4049/jimmunol.1203533 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
Br J Pharmacol 150:862– 872. http://dx.doi .org/10.1038/sj.bjp.0707165 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1038/nm1652 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1172/jci16153 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.jss.2010.04 .024.,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
Gene Ther 10:630 – 636. http://dx.doi .org/10.1038/sj.gt.3301936 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
Trends Mol Med 18:426 – 437. http://dx.doi.org/10 .1016/j.molmed.2012.05.005 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.3892/ijmm.2011.831 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
CancerGene Ther 11:477– 486. http://dx.doi.org/10.1038/sj.cgt.7700726 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1128/jvi.00641-08 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10 .4161/auto.20160 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
J Biol Chem 284:6782– 6789. http://dx.doi.org /10.1074/jbc.M807898200 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.tim.2013.02.005 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1371/journal .pone.0092919 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi .org/10.3748/wjg.v19.i31.5159 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1002/jcb.24541 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
Acta Virol 57:462– 466. http://dx.doi.org/10.4149/av_2013_04_462 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1038/35106079 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org /10.1172/jci73938 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism.Semin Cell Dev Biol 21:683– 690. http://dx.doi.org/10.1016/j.semcdb .2010.03.002 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1126/scisignal.2003187 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1128/jvi.01417-10 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10 .1016/j.chom.2012.01.014 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10 .1146/annurev-biochem-052709-094552 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1016/j.amjcard.2004.05 .056.,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org /10.1016/S0042-6822(03)00242-3 .,OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1161/circresaha.109.209338 .,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1161/01.CIR.103.5.743 .HDAC Inhibition Aggravates Viral Myocarditis October 2015 Volume 89 Number 20 jvi.asm.org 10523 Journal of Virology,Non-OADS,/arxiv_data1/oa_pdf/64/cc/zjv10512.PMC4580191.pdf
http://dx.doi.org/10.1371/journal.ppat.1000012 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Host restriction of avian inﬂuenza viruses at the level of the ribonucleoproteins.Annu Rev Microbiol 62:403– 424. http://dx.doi.org/10.1146/annurev .micro.62.081307.162746 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Nat Rev Microbiol 13:28 – 41. http://dx.doi.org /10.1038/nrmicro3367 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1371/journal.ppat .1002998 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
J Virol 83:8021– 8031. http://dx.doi.org/10.1128/JVI.00826-09 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1126 /science.1222213 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1038/nm1201-1306 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1093/nar/gkr487 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10 .1128/JVI.01677-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128 /JVI.02284-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Cell 142:902– 913. http://dx.doi.org/10.1016/j.cell.2010.08.029 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
J Virol 86:4883– 4891. http://dx.doi.org/10 .1128/JVI.06586-11 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org /10.1099/0022-1317-72-6-1301 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1016/j.celrep.2012.12 .010.,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Proc Natl Acad Sc iUSA 92:6324 – 6328. http://dx.doi.org /10.1073/pnas.92.14.6324 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1099/vir.0.035485-0 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.01725-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi .org/10.1099/vir.0.2008/004606-0 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi .org/10.1006/viro.1998.9508 .Zheng et al.,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.00647-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10 .4049/jimmunol.1302813 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Nat Commun 5:5509. http://dx.doi.org/10.1038/ncomms6509 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Proc Natl Acad Sc iUSA 97:6108 – 6113. http://dx.doi.org/10 .1073/pnas.100133697 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Methods 25:402– 408. http://dx.doi.org/10.1006/meth.2001.1262 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10 .1016/S0264-410X(97)00301-0 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Vaccine 29:6976 – 6985. http://dx.doi.org/10.1016/j.vaccine.2011.07.037 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.00506-08 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.74.12.5556-5561.2000 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Nat Immunol 11:404 – 410. http://dx.doi.org/10.1038/ni.1861 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Cell Host Microbe 6:367– 380. http://dx.doi.org/10.1016/j.chom.2009.09.005 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org /10.1371/journal.ppat.1003019 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Nat Commun 3:802. http://dx.doi.org/10.1038 /ncomms1804 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1016/S1097-2765(00)80099-4 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
Nucleic Acids Res35:4573– 4582. http://dx.doi.org/10.1093/nar/gkm230 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.76.3.1206-1212.2002 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
J Virol 80: 6295– 6304. http://dx.doi.org/10.1128/JVI.02381-05 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10 .1128/JVI.01131-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1128/JVI.01317-09 .,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1086/649428 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10 .1016/j.vaccine.2009.02.087 .,OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
http://dx.doi.org/10.1099/vir.0.015727-0 .A14U in M Segment Supports NS1 Deletion Virus Growth October 2015 Volume 89 Number 20 jvi.asm.org 10285 Journal of Virology,Non-OADS,/arxiv_data1/oa_pdf/75/fe/zjv10273.PMC4580205.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69079 .2.,OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
Motor activity was quanti ﬁed by custom-made video-based motion detection algorithms with a time resolution of 1 s. The program detects animal motion every second within a previously set monitored area corresponding toGenomics Data 6 (2015) 114 –117 http://dx.doi.org/10.1016/j.gdata.2015.08.031 2213-5960/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"14 (2011) 1418 –1420, http://dx.doi.org/10.1038/nn.2934 .",Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"PLoS ONE 7 (2012), e34139, http://dx.doi.org/10.1371/journal.pone.0034139 .",Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"Cell 135 (2008) 749 –762, http://dx.doi.org/10.1016/j.cell.2008.10.029 .",OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"Cell 135 (2008) 738 –748, http://dx.doi.org/10.1016/j.cell.2008.10.028 .",OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"33 (2013) 14288 –14300, http://dx.doi.org/10.1523/JNEUROSCI.5102-12.2013 .",Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"5 (2004) R80, http://dx.doi.org/10.1186/gb-2004-5-10-r80 .",Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"Biostatistics 4 (2003) 249 –264, http://dx.doi.org/10.1093/biostatistics/4.2.",Non-OADS,/arxiv_data1/oa_pdf/1c/fe/main.PMC4580259.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provide d the original author(s) and the source are credited.JOURNAL OF MEDICINAL FOOD J Med Food 18 (9) 2015, 1042–1048 DOI: 10.1089/jmf.2015.0041 1042",Non-OADS,/arxiv_data1/oa_pdf/bd/58/jmf.2015.0041.PMC4580304.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 23, Number 9, 2015 DOI: 10.1089/ars.2015.6247 734",Non-OADS,/arxiv_data1/oa_pdf/d7/28/ars.2015.6247.PMC4580308.pdf
A complete list of proteins and standard deviations are given as an online supplement (http://dx.doi.org/ 10.1016/j.molcel.2012.06.016) to the original publication (58).,OADS,/arxiv_data1/oa_pdf/d7/28/ars.2015.6247.PMC4580308.pdf
Concentrations were interpolated from a standard curve using the five-parameter logistic model with Readerfit (http://readerfit.com).,OADS,/arxiv_data1/oa_pdf/4a/91/bjc2015163a.PMC4580380.pdf
"Proteins were visualised by chemiluminescence with luminol (Santa Cruz Biotechnologies, Heidelberg, Germany) and semi-quantified using ImageJ software (US National Institute of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/) with normalisation against b-actin (Sigma-Aldrich).",OADS,/arxiv_data1/oa_pdf/4a/91/bjc2015163a.PMC4580380.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Targeting ADAM-17 in triple-negative breast cancer cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.163 1903,Non-OADS,/arxiv_data1/oa_pdf/4a/91/bjc2015163a.PMC4580380.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BRAF V600E and anti-EGFR mAb benefit in mCRC 1894 www.bjcancer.com | DOI:10.1038/bjc.2015.173,Non-OADS,/arxiv_data1/oa_pdf/5d/5a/bjc2015173a.PMC4580381.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1977,Non-OADS,/arxiv_data1/oa_pdf/86/3e/bjc2014656a.PMC4580382.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1979,Non-OADS,/arxiv_data1/oa_pdf/f1/53/bjc2015118a.PMC4580383.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1980 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/f1/53/bjc2015118a.PMC4580383.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Characterizing tumour-budding cells in PDAC 1950 www.bjcancer.com | DOI:10.1038/bjc.2015.177,Non-OADS,/arxiv_data1/oa_pdf/90/bd/bjc2015177a.PMC4580384.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1979,Non-OADS,/arxiv_data1/oa_pdf/af/5f/bjc2015117a.PMC4580385.pdf
"Protein signals were determined with background subtraction and normalisation to the internal housekeeping targets using RPPanalyzer, a module within the R statistical language on the CRAN (http://cran.r-project.org/).",OADS,/arxiv_data1/oa_pdf/c9/7a/bjc2015165a.PMC4580386.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1977,Non-OADS,/arxiv_data1/oa_pdf/dc/28/bjc2015156a.PMC4580388.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr EL Korn; E-mail: korne@ctep.nci.nih.gov Published online 12 May 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/dc/28/bjc2015156a.PMC4580388.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1978 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/dc/28/bjc2015156a.PMC4580388.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)EBV in gastric inflammatory lesions BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.175 1873,Non-OADS,/arxiv_data1/oa_pdf/bd/e9/bjc2015175a.PMC4580389.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER NLR and ipilimumab in melanoma patients 1910 www.bjcancer.com | DOI:10.1038/bjc.2015.180,Non-OADS,/arxiv_data1/oa_pdf/b7/ae/bjc2015180a.PMC4580390.pdf
http://www.nccn.org/ professionals/physician_gls/pdf/colon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/e5/bjc2015142a.PMC4580391.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BRAF andRAS in liver-resected CRC patients 1928 www.bjcancer.com | DOI:10.1038/bjc.2015.142,Non-OADS,/arxiv_data1/oa_pdf/95/e5/bjc2015142a.PMC4580391.pdf
"Three plans specifically targeted women and youth in health development (Ministe `re de la Sante ´Publique Re ´publique du Madagascar, 2010; Re´publique Gabonaise Ministe `re de la Sante ´des Affaires Sociales de la Solidarite ´et de la Famille, 2010; Ministe `re de la Sante ´ LMIC LMIC LMIC LMIC = lower-middle-income (4)Very high human development High human development Medium development Low human development World Bank Index Base map: http://hdr.undp.org/en/countries accessed 14/10/2014LMICLICLIC LIC LIC LIC LIC = low-income (9)LIC LICLIC LICUMIC UMIC UMIC = upper-middle-income (5)UMIC UMICUMIC Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
"Countries with plans reviewed in context of Human Development Index-utilised base map unaltered as available from Human Development Reports, United Nations Development Programme, available from http://hdr.undp.org/en/countries (last accessed 14 October 2014); for illustrative purposes only.",Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Inclusion of paediatric cancer in control plans Inclusion of paediatric cancer in plan CountryaGeneral Facilities Technology DrugsHuman resourcesBudget Evaluation Low-income economies Madagascar Burkina Faso Zimbabwe Lower-middle-income economies Ghana Morocco Upper-middle-income economies Algeria Mauritius Continental aCountries listed in order of increasing Gross National Income per capita per World Bank Atlas Method: http://data.worldbank.org/data-catalog/wo rld-development-indicators (last accessed 22 November 2014).BRITISH JOURNAL OF CANCER Paediatrics and palliative care: African cancer plans 1850 www.bjcancer.com | DOI:10.1038/bjc.2015.158,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Inclusion of palliative care domains in control plans Inclusion of palliative care in plan CountryaGeneral need Guideline/framework Upstream approach Access to analgesia Budget Evaluation Low-income economies Malawi Madagascar Burkina Faso Zimbabweb Kenyab Lower-middle-income economies Coˆ te d’Ivoire Ghana Moroccob Upper-middle-income economies Algeria South Africab Mauritius Continental aCountries listed in order of increasing Gross National Income per capita per World Bank Atlas Method: http://data.worldbank.org/data-catalog/wo rld-development-indicators (last accessed 22 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
REFERENCES African Organisation for Research and Training in Cancer (AORTIC) (2013– 2017) Cancer Plan for the African Continent 2013–2017.Available at http://www.iccp-portal.org/sites/default/files/plans/ AORTIC_CANCER_PLAN%20AFRICA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.thewhpca.org/resources/item/national-cancer- prevention-and-control-plan-2010-2019.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/Burkina%20Faso_Plan%20strat%C3%A9gique%20de%20lutte% 20contre%20le%20cancer%202013-2017.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://globocan.iarc.fr (accessed 1 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/Cancer%20Plan%20Ghana%202012-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://iom.edu/Reports/2013/Identifying-and-Addressing-the-Needs-of-Adolescents-and-Young-Adults-with-Cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://malawipublichealth.org/wp-content/ uploads/2014/03/Malawi-HSSP-Summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/ MNT%20COTE%20IVOIRE%202011%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/Madasgascar%20- %20Politique%20Nationale%20cancer%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/Mali-Politique% 20nationale%20de%20lutte%20contre%20les%20maladies %20non%20transmissibles%202013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.moh.gov.bw/Publications/policies/ Botswana%20IHSP%20Final%20HLSP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/ PNPCC_-_Axes_strategique s_et_mesures_2010-2019.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/ plans/Kenya-National-Cancer-Control-strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/cancer-ap.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/ plan_strategique_integre_lutte_contre_maladies_non_transmissibles_ VF_Imprimerie.pdf.Paediatrics and palliative care: African cancer plans BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.158 1855,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.nationalplanningcycles.org/ sites/default/files/country_docs/Gabon/pnds_2011_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/ plans/Version_Finale_PSI_MNT_2012_-2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/sites/default/files/plans/NCDs-STRAT-PLAN- CONTENT-8-april-proof.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.uicc.org/sites/main/files/private/eNCCPTOOLK_FA_0_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.iccp-portal.org/cancer-plans (accessed1 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available athttp://www.icpcn.org/wp-content/uploads/2013/11/Assessment-of-the- Need-for-Palliative-Care-for-Children.-Three-Country-Report-South- Africa-Kenya-and-Zimbabawe.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
"World Health Organization: Geneva, Switzerland, Available at http://www.who.int/cancer/publications/nccp2002/en/.",Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.who.int/cancer/modules/en/.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Available at http://www.who.int/tb/challenges/mdr/ethics_closingthegap/en/.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
"Worldwide Palliative Care Alliance and World Health Organization: London, UK.Available at http://www.who.int/cancer/pub lications/palliative-care-atlas/en/.",Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
Zimbabwe Ministry of Health and Child Welfare (2013–2017) The National Cancer Prevention and Control Strategy for Zimbabwe 2013–2017.Available at http://www.iccp-portal.org/sites/default/files/plans/Zimbabwe%20Cancer%20Control%20Strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Paediatrics and palliative care: African cancer plans 1856 www.bjcancer.com | DOI:10.1038/bjc.2015.158,Non-OADS,/arxiv_data1/oa_pdf/b5/22/bjc2015158a.PMC4580392.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr EL Korn; E-mail: korne@ctep.nci.nih.gov Published online 12 May 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/6c/fc/bjc2015157a.PMC4580398.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1978 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/6c/fc/bjc2015157a.PMC4580398.pdf
dhttp://www.dako.com/nl/ar38/p102130/prod_products.htm Accessed 8-9-14. ehttp://www.ptglab.com/PView/SPA17-Antibody-13367-1-AP-PVIEW.htm Accessed 8-9-14.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/bjc201592a.PMC4580401.pdf
"IARC (2011) Available at http://www-dep.iarc.fr/ (accessed 08.10.14).Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics.",OADS,/arxiv_data1/oa_pdf/4d/3b/bjc201592a.PMC4580401.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tumour antigen expression in HCC 1920 www.bjcancer.com | DOI:10.1038/bjc.2015.92",Non-OADS,/arxiv_data1/oa_pdf/4d/3b/bjc201592a.PMC4580401.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d8/53/13555_2015_Article_81.PMC4580654.pdf
http://www.nccn.org/professionals/physician_gls/ pdf/nmsc.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/53/13555_2015_Article_81.PMC4580654.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4f/85/13555_2015_Article_82.PMC4580657.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/c8/13555_2015_Article_80.PMC4580658.pdf
25. https://www.gsk.com/en-gb/media/press-releases/ 2015/gsk-announces-positive-overall-survival- results-from-phase-iii-combi-d-study-of-dabrafenib- taﬁnlar-and-trametinib-mekinist-combination/ .,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/13555_2015_Article_80.PMC4580658.pdf
"Interestingly, there  is very poor correlation between the presence and size of  angiographic collaterals and actual perfusion within the  collateralized zone.9)10)Review Article http://dx.doi.org/10.4070/kcj.2015.45.5.351 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Assessment of Myocardial Collateral Blood Flow with Contrast  Echocardiography Sanjiv Kaul, MD Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA Humans have pre-formed collateral vessels that enlarge with ischemia.",Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
352  Collateral Blood Flow http://dx.doi.org/10.4070/kcj.2015.45.5.351 www.e-kcj.org Myocardial Contrast Echocardiography   (Intracoronary Injection) MCE facilitates easy visualization of collateralized zones within  regions supplied by occluded vessels and subsequent quantification  of myocardial collateral blood flow and prediction of myocardial  viability during acute myocardial infarction.,Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
353 Sanjiv Kaul http://dx.doi.org/10.4070/kcj.2015.45.5.351 www.e-kcj.org entire myocardium after left main injection of microbubbles  despite an occluded right coronary artery is indicative of collateral  blood flow within the right coronary arterial bed.,Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
"354  Collateral Blood Flow http://dx.doi.org/10.4070/kcj.2015.45.5.351 www.e-kcj.org acute left circumflex artery coronary occlusion with continuous  infusion of microbubbles.21) Images are acquired at specific time  points after microbubble destruction, once steady-state is achieved.",Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
"355 Sanjiv Kaul http://dx.doi.org/10.4070/kcj.2015.45.5.351 www.e-kcj.org disease, the sensitivity of wall thickening assessment (stress echo) is  reportedly less than that of perfusion assessment (MCE or single- photon emission computed tomography).",Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
356  Collateral Blood Flow http://dx.doi.org/10.4070/kcj.2015.45.5.351 www.e-kcj.org angiography is a poor tool for collateral flow assessment.,Non-OADS,/arxiv_data1/oa_pdf/ec/a7/kcj-45-351.PMC4580691.pdf
"The remaining 5% of patients Review Article http://dx.doi.org/10.4070/kcj.2015.45.5.357 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Genetic Syndromes associated with Congenital Heart Disease Jung Min Ko, MD Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Recent research has demonstrated that genetic alterations or variations contribute considerably to the development of congenital heart  disease.",Non-OADS,/arxiv_data1/oa_pdf/4e/43/kcj-45-357.PMC4580692.pdf
"358  Syndromes with Congenital Heart Diseases http://dx.doi.org/10.4070/kcj.2015.45.5.357 www.e-kcj.org have Down syndrome resulting from Robertsonian translocations,  which can be familial.",Non-OADS,/arxiv_data1/oa_pdf/4e/43/kcj-45-357.PMC4580692.pdf
359 Jung Min Ko http://dx.doi.org/10.4070/kcj.2015.45.5.357 www.e-kcj.org Genetic Syndromes Diagnosed by Fluorescence in  situ Hybridization 22q11.2 deletion syndrome 22q1 1.2 deletion syndrome (OMIM#188400) is the most common  microdeletion found in humans.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/kcj-45-357.PMC4580692.pdf
"360  Syndromes with Congenital Heart Diseases http://dx.doi.org/10.4070/kcj.2015.45.5.357 www.e-kcj.org studies, electrocardiograms, and blood pressure measurements on  an annual basis during childhood, and every 3-5 years in  adulthood.23) Genetic Syndromes Diagnosed by DNA Sequencing  Analyses Noonan syndrome Noonan syndrome (OMIM#163950) is an autosomal dominant  disorder showing variable phenotypes including short stature,  congenital heart disease, and typical facial features.",Non-OADS,/arxiv_data1/oa_pdf/4e/43/kcj-45-357.PMC4580692.pdf
361 Jung Min Ko http://dx.doi.org/10.4070/kcj.2015.45.5.357 www.e-kcj.org 12.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/kcj-45-357.PMC4580692.pdf
"Editorial http://dx.doi.org/10.4070/kcj.2015.45.5.362 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Right Ventricular Longitudinal Strain: A Target Indicator in the   Treatment of Pulmonary Arterial Hypertension Kyoung Im Cho, MD Division of Cardiology, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea Received:  August 18, 2015 Accepted:  September 1, 2015 Correspondence: Kyoung Im Cho, MD, Division of Cardiology, Department  of Internal  Medicine, Kosin University College of Medicine, 262, Gamcheon-ro, Seo-gu, Busan,  49267, Korea Tel: 82-51-990-6105, Fax: 82-51-990-3047 E-mail: kyoungim74@gmail.com • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/03/55/kcj-45-362.PMC4580693.pdf
"This is an Open Access article distributed under the terms of the Creative          Commons Attribution Non-Commercial License (http://creativecommons.org/      licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/55/kcj-45-362.PMC4580693.pdf
363 Kyoung Im Cho http://dx.doi.org/10.4070/kcj.2015.45.5.362 www.e-kcj.org References   1.,Non-OADS,/arxiv_data1/oa_pdf/03/55/kcj-45-362.PMC4580693.pdf
"APE1 is involved in the base excision repair pathway, Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.364 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Elevation of the Serum Apurinic/Apyrimidinic Endonuclease 1/Redox  Factor-1 in Coronary Artery Disease Seon-Ah Jin, MD1, Hee Jung Seo, MS1, Sun Kyeong Kim, BS1, Yu Ran Lee, MS2, Sunga Choi, PhD2, Kye-Taek Ahn, MD1,  Jun-Hyung Kim, MD1, Jae-Hyeong Park, MD1, Jae-Hwan Lee, MD1, Si Wan Choi, MD1, In-Whan Seong, MD1,   Byeong Hwa Jeon, MD2, and Jin-Ok Jeong, MD1 1Divison of Cardiology, Department of Internal Medicine, 2Department of Physiology, Chungnam National University Hospital, Chungnam National University School of  Medicine, Daejeon, Korea  Background and Objectives:  Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein in - volved in the DNA base excision repair pathway, inflammation, angiogenesis, and survival pathways.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org and Ref-1 acts as a reductive activator of many transcription  factors in controlling different cellular process such as apoptosis,  inflammation, proliferation, angiogenesis, and is involved in survival  pathways.3)4) There are many reports that alterations in the  expression, subcellular localization, and activities of APE1/Ref-1 are  associated with various human diseases, including cancer,  neurodegenerative disease, and hypertension.4-6) Because DNA  damage plays an important role in the pathogenesis of CAD,7-9)  alterations in APE1/Ref-1 can occur in CAD.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
366  Serum APE1/Ref-1 and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org Service in Korea.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org APE1/Ref-1 (ng/100 μL) Control10 8 6 4 2 0 Sensitivity 1-SpecificityAUC = 0.66  0.0              0.2               0.4              0.6               0.8              1.01.0 0.8 0.6 0.4 0.2 0.0 CAD Fig.,OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
"368  Serum APE1/Ref-1 and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org Serum apurinic/apyrimidinic endonuclease 1/redox effector  factor 1 is higher in patients with myocardial infarction than angina  The levels of APE1/Ref-1 were higher in patients with MI than  angina in the CAD group (0.81 ±0.101.30 for MI vs. 0.38±0.1 1 ng/100  μL for angina, p<0.01) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org positively correlated with serum APE1/Ref-1 (r=0.217, p<0.01 for NT  pro-BNP, and r=0.222, p<0.01 for troponin I) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
370  Serum APE1/Ref-1 and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org hypertension or diabetes showed relatively higher levels of APE1/ Ref-1.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.364 www.e-kcj.org trol study on human apurinic/apyrimidinic endonuclease 1/redox ef - fector factor-1 gene and essential hypertension.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
http://dx.doi.org/10.4143/crt.2014.074.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/kcj-45-364.PMC4580694.pdf
"The severity of coronary artery calcification (CAC) has been found  to be a useful marker of atherosclero sis,8) and is an independent Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.372 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Association between Red Blood Cell Distribution Width and Coronary  Artery Calcification in Patients Undergoing 64-Multidetector  Computed Tomography Ozgul Malcok Gürel, MD1, Muhammed Bora Demircelik, MD1, Mukadder Ayse Bilgic, MD2, Hakki Yilmaz, MD2,   Omer Caglar Yilmaz, MD3, Muzaffer Cakmak, MD4, and Beyhan Eryonucu, MD1 1Department of Cardiology,  2Department of Internal Medicine, Section of Nephrology, School of Medicine, Turgut Ozal University, Ankara, 3Department of Cardiology, Ankara Occupational Diseases Hospital, Ankara, 4Department of Internal Medicine, School of Medicine, Turgut Ozal University, Ankara, Turkey Background and Objectives:  The red blood cell distribution width (RDW) has been found to be associated with cardiovascular morbidity  and mortality.",Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.372 www.e-kcj.org predictor of CV eve nts.9) Although the relationship between the  RDW and CV disease (CVD) is well-documented in the literature,  there are limited data concerning the relationship between  haematological parameters and the C ACS.10) The goal of this study  was to determine whether serum RDW measures are associated  with the CACS in patients with a low to intermediate risk for  coronary heart disease (CHD) but without known CHD.",Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
374  Red Blood Cell Distribution Width and Coronary Artery Calcification http://dx.doi.org/10.4070/kcj.2015.45.5.372 www.e-kcj.org shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.372 www.e-kcj.org associated with higher patient age, DM, HT, FRS, Hb, RDW,  neutrophil count, and NLR.",Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
376  Red Blood Cell Distribution Width and Coronary Artery Calcification http://dx.doi.org/10.4070/kcj.2015.45.5.372 www.e-kcj.org associated with a poorer prognosis and increased mortality rate  during a median follow-up period of 1 2 months.6) Afonso et al.7) emphasized that the RDW is found to be elevated  in patients with microalbuminuria.,Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
http://dx.doi.org/10.1136/heartjnl-2013-303910.,Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.372 www.e-kcj.org coronary artery calcium and cardiac events: a 37-month follow-up  of 5635 initially asymptomatic low- to intermediate-risk adults.,Non-OADS,/arxiv_data1/oa_pdf/c4/4e/kcj-45-372.PMC4580695.pdf
"However, individual response to oral clopidogrel to  inhibit P2Y12 receptor is variable,4)5) and, despite taking clopidogrel,  high residual platelet reactivity in patients with PCI has been  associated with death, myocardial infarction, or stent thrombosis.6) Platelet function tests such as light transmission aggregometry  (LTA), VerifyNow P2Y12 assay, platelet function analyser, or flow  cytometric analysis of vasodilator-stimulated phosphoprotein  (VASP) phosphorylation or P-selectin are used to measure on- treatment high residual platelet reactivity;4-9) however, no single test  can evaluate the complex mechanisms of platelet activation and  aggregation.4) In patients undergoing coronary stent implantation, Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.378 Print ISSN 1738-5520  • On-line ISSN 1738-5555 An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody  against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel  Seung-Jae Joo, MD1, Joon-Hyouk Choi, MD1, Song-Yi Kim, MD1, Ki-Seok Kim, MD1, Young Ree Kim, MD2,   and Sung Ha Kang, MD2 1Department of Cardiology, and 2Laboratory Medicine, Jeju National University Hospital, Jeju, Korea Background and Objectives:  Residual platelet reactivity in patients who are taking clopidogrel is commonly measured with VerifyNow  assay, which is based on the principle of light transmission aggregometry.",Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org the diagnostic accuracy of each test to predict cardiovascular  events was not high.10)  Activation and prothrombin binding of platelet glycoprotein (GP)  IIb/IIIa is a final common pathway of platelet aggregation.11 )12 ) If the  reactivity of platelet GP IIb/IIIa is directly measured, it would be a  more accurate assay to evaluate the residual platelet reactivity.",Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"380  Measuring Platelet Glycoprotein IIb/IIIa Reactivity  http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org from DAKO Co. (Glostrup, Denmark).",Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org appropriate, mean ±standard error of mean .",OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"382  Measuring Platelet Glycoprotein IIb/IIIa Reactivity  http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org index at 20 µM of ADP (2235, 88%, and 1959, respectively) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org from whole blood, lengthy processing time, and a trained technician,  all of which result in variable reproducibility, making it difficult for a  point-of-care method in daily clinical situations.4)7) Presently,  VerifyNow P2Y12 assay has been the most commonly used point- of-care system to measure the residual platelet reactivity in clinical  studies.",Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
384  Measuring Platelet Glycoprotein IIb/IIIa Reactivity  http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org staining process of fluorescent PAC1 with platelets.,Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.378 www.e-kcj.org in whole blood using activation-dependent monoclonal antibodies  and flow cytometry.,Non-OADS,/arxiv_data1/oa_pdf/76/21/kcj-45-378.PMC4580696.pdf
"In this study, Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.386 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Apelin Levels In Isolated Coronary Artery Ectasia Mehmet Zihni Bilik, MD1, İbrahim Kaplan, MD2, Abdulkadir Yıldız, MD1, Mehmet Ata Akıl, MD1, Halit Acet, MD1,   Murat  Yüksel, MD1, Nihat Polat, MD¹, Mesut Aydın, MD1, Mustafa Oylumlu, MD1, Faruk Erta ș, MD1, Hasan Kaya, MD1,  and Sait Alan,MD1  1Department of Cardiology, 2Department of Biochemistry, Medicine Faculty, Dicle University, Diyarbakır, Turkey Background and Objectives:  The etiopathogenesis  of  coronary artery ectasia (CAE)  is not known completely.",Non-OADS,/arxiv_data1/oa_pdf/f6/54/kcj-45-386.PMC4580697.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.386 www.e-kcj.org we aimed to examine the relation between serum apelin level and  isolated CAE.,Non-OADS,/arxiv_data1/oa_pdf/f6/54/kcj-45-386.PMC4580697.pdf
388  Apelin In Isolated Coronary Artery Ectasia http://dx.doi.org/10.4070/kcj.2015.45.5.386 www.e-kcj.org Results The study included a total of 54 patients.,Non-OADS,/arxiv_data1/oa_pdf/f6/54/kcj-45-386.PMC4580697.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.386 www.e-kcj.org vasodilator that increases myocardial contractility in humans via  nitric oxide–dependent mechanisms and causes a reduction in left  ventricular end-diastolic pressures.,Non-OADS,/arxiv_data1/oa_pdf/f6/54/kcj-45-386.PMC4580697.pdf
390  Apelin In Isolated Coronary Artery Ectasia http://dx.doi.org/10.4070/kcj.2015.45.5.386 www.e-kcj.org prevalence and clinical significance in 4993 patients.,Non-OADS,/arxiv_data1/oa_pdf/f6/54/kcj-45-386.PMC4580697.pdf
"1): 1) frequent VPCs (>1% or >1000  beats/day) on 24-hr Holter ECG (SEER Light Extend Compact Holter  Recorders, GE Medical Systems, Fairfield, Conn., USA) monitoring at Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.391 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Characteristics and Features of Frequent Idiopathic  Ventricular Premature Complexes in the Korean Population Jin Kyung Hwang, MD, Seung-Jung Park, MD, Young Keun On, MD, June Soo Kim, MD, and Kyoung-Min Park, MD Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives:  Frequent ventricular premature complexes (VPCs) increase the risk of cardiomyopathy (CMP).",Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
"392  Characteristics of VPCs in the Korean Population http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org enrollment, 2) symptoms fully described in medical records, and       3) underwent baseline and follow-up echocardiography within 6  months from enrollment.",Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org and again if palpitations recurred.,Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
394  Characteristics of VPCs in the Korean Population http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org (14 patients; 2.1%).,OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org axis.,Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
"396  Characteristics of VPCs in the Korean Population http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org Conclusion The incidence of frequent VPCs was slightly higher in females  than that in males, and the most common complaints were  palpitations and dropped beats.",Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2015.45.5.391.,Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.391 www.e-kcj.org ventricular outflow tract tachycardia origin.,Non-OADS,/arxiv_data1/oa_pdf/18/46/kcj-45-391.PMC4580698.pdf
"398 Copyright © 2015 The Korean Society of CardiologyKorean Circulation JournalIntroduction Pulmonary arterial hypertension (PAH) is a progressive disease that can cause right ventricular (RV) dilatation and dysfunction as a  result of increased pulmonary vascular resistance (PVR) and  pulmonary arterial (PA) pressure.1)2) Echocardiographic evidence of Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.398 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Relationship between Right Ventricular Longitudinal Strain,   Invasive Hemodynamics, and Functional Assessment in Pulmonary  Arterial Hypertension Jae-Hyeong Park, MD1,2*, Kenya Kusunose, MD1,3*, Deborah H. Kwon, MD1, Margaret M. Park, BS1,4, Serpil C. Erzurum, MD4,5,  James D. Thomas, MD1, Richard A. Grimm, MD1, Brian P. Griffin, MD1, Thomas H. Marwick, MD1,6, and Zoran B. Popovi ć, MD1 1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA, 2Cardiology Division of Internal Medicine, Chungnam National  University, Chungnam National University Hospital, Daejeon, Korea, 3Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan, 4Department of Pathobiology, Lerner Research Institute, 5Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA, 6Menzies Research Institute, Tasmania, Australia Background and Objectives:  Right ventricular longitudinal strain (RVLS) is a new parameter of RV function.",Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org RV systolic dysfunction and clinical features of right-sided heart  failure have been regarded as the main determinants of morbidity  and mortality in patients with PAH.3-5)     Despite the obvious clinical importance of assessing RV systolic  function, the estimation of RV function can be challenging.6,)7)  Because of their invasiveness and/or high-cost, right heart  catheterization (RHC) and cardiac magnetic resonance imaging  (CMR) are impractical for frequent serial assessment.",Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
400  RV Longitudinal Strain and Hemodynamics in PAH http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org Cardiac output was determined by the Fick method.,OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org study.,Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
402  RV Longitudinal Strain and Hemodynamics in PAH http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org Right ventricular strain findings Baseline RVLS are listed in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org prostaglandin therapy, 3 with PDE5I, 1 with ERA, and 2 with  combination of ERA and PDE5I).",Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
404  RV Longitudinal Strain and Hemodynamics in PAH http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org Discussion Baseline RVLS correlated with functional capacity and  hemodynamic parameters in PAH patients.,Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org and some parameters; TAPSE or presence of pericardial effusion, are  known as prognostic factors in PAH patients.20) However, the  assessment of RV function parameters by standard 2DE often  remains insufficient because of measurement variability intrinsic to  the parameters measured.19) Two-dimensional strain echocardiography is a new method  providing relatively easy and angle-independent quantification of  myocardial deformation on 2DE images.12) Because the predominant  orientation of muscle fiber in the RV is in the longitudinal plane,  longitudinal motion of RV is a major determinant of RV systolic  function, especially in patients with PAH.7) Strain echocardiography  can measure RVLS, and RVLS can give direct information about  regional and global RV mechanics.",Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
406  RV Longitudinal Strain and Hemodynamics in PAH http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org grounds.,Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.398 www.e-kcj.org pulmonary hypertension.,Non-OADS,/arxiv_data1/oa_pdf/28/13/kcj-45-398.PMC4580699.pdf
"We retrospectively analyzed our experience of the stepwise  management using targeted medical therapy and surgical/Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.408 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Stepwise Approach Using Combined Management in Patients with  Congenital Heart Disease and Borderline Pulmonary Vascular Disease Sang-Yun Lee, MD1, Soo-Jin Kim, MD2, Jae Sung Son, MD2, Seong-Ho Kim, MD1, and Chang-Ha Lee, MD1 1Department of Pediatrics, Department of Thoracic and Cardiovascular Surgery, Sejong Cardiovascular Institute, Bucheon, 2Department of Pediatrics, Konkuk University  School of Medicine, Seoul, Korea  Background and Objectives:  Despite remarkable advances in pediatric cardiology, pulmonary arterial hypertension associated with   congenital heart disease remains a major problem.",Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org interventional closure in patients with congenital heart disease and  severe PAH.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
410  Congenital Heart Disease with Borderline Pulmonary Vascular Disease http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org Group 3 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org pressure {p(RV/Ao)} or ratio of peak pulmonary arterial pressure/ aortic pressure {p(PA/Ao)} was <0.3 (range, 0.32–0.35).",Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
412  Congenital Heart Disease with Borderline Pulmonary Vascular Disease http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org residual fenestration.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org were given pulmonary vasodilators as a preoperative conditioning  therapy and/or as postoperative long-term therapy for residual  pulmonary hypertension.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
414  Congenital Heart Disease with Borderline Pulmonary Vascular Disease http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org closure.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.408 www.e-kcj.org test (INOP Test I): the INOP Test Study Group .,Non-OADS,/arxiv_data1/oa_pdf/5e/60/kcj-45-408.PMC4580700.pdf
"Capitalizing on the Original Article http://dx.doi.org/10.4070/kcj.2015.45.5.416 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Analysis of Cardiovascular Risk Factors in Adults with Congenital  Heart Disease Ju Ryoung Moon, RN1, Jinyoung Song, MD2, June Huh, MD2, I-Seok Kang, MD2, Seung Woo Park, MD3,   Sung-A Chang, MD3, Ji-Hyuk Yang, MD4, and Tae-Gook Jun, MD4 1Grown-Up Congenital Heart Clinic, Heart Vascular Stroke Institute, 2Department of Pediatrics, Grown-Up Congenital Heart Clinic, Heart Vascular Stroke Institute,  3Division of Cardiology, Grown-Up Congenital Heart Clinic, Heart Vascular Stroke Institute, 4Department of Thoracic & Cardiovascular Surgery, Grown-Up Congenital  Heart Clinic, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  Background and Objectives:  The objective of this study was to analyze cardiovascular risk factors in adults with congenital heart  disease (ACHD).",Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org improved diagnosis and cardiac surgery, 5250 cases of cardiac  surgery are performed annually in Korea and a low mortality rate of  less than two percent after these surgeries has been recorded.4) As a  result, more than 85% of domestic congenital heart disease (CHD)  patients, including cyanotic and complex CHD patients, reach adult  age,5) and it is estimated that there are already about 150000 to  200000 adults with congenital heart disease (ACHD) patients  nationwide.6) However, prevention and management strategies for  IHD are still required in these ACHD patients.",Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
"418  Cardiovascular Risk Factors in Adults with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org ACHD group comprised 90 ACHD patients who did not have  cyanosis after undergoing total correction via cardiac surgery,  regardless of the original CHD.",Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org (p=0.002).,OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
420  Cardiovascular Risk Factors in Adults with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org (p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org has been undertaken in Korea.,Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
"422  Cardiovascular Risk Factors in Adults with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org surgically corrected ACHD group demonstrated lower exercise levels,  higher lipid levels, and increased obesity compared with the controls  and they showed higher risk of hypertension, diabetes, and  hyperlipidemia.",Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
Available from: http://kostat.go.kr/portal/ korea/kor_nw/2/6/2/index.board?bmode=read&aSeq=308559.,OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
Available  from: http://www.heart.or.kr/korean/board/board.php?sa=list&bid=2.,Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
Available from: http://www.nhlbi.,Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.416 www.e-kcj.org 2005;96:283-90.,Non-OADS,/arxiv_data1/oa_pdf/df/f2/kcj-45-416.PMC4580701.pdf
"The  activation patterns obtained from three AF beats of unipolar  recordings at each CFAE site were classified into four categories: 1) Case Report http://dx.doi.org/10.4070/kcj.2015.45.5.424 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Ethanol Infusion in the Vein of Marshall in a Patient   with Persistent Atrial Fibrillation Jah Yeon Choi, MD, Eun Jin Park, MD, Hee Dong Kim, MD, Sung Hun Park, MD,   Ji Young Song, MD, Dae In Lee, MD, Jaemin Shim, MD, and Young-Hoon Kim, MD Department of Cardiology, Korea University College of Medicine, Anam Hospital, Seoul, Korea We report the case of a 64-year-old male with persistent atrial fibrillation (AF) terminated by ethanol infusion into vein of Marshall as  add-on therapy.",OADS,/arxiv_data1/oa_pdf/52/dd/kcj-45-424.PMC4580702.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.424 www.e-kcj.org complete reentry, 2) incomplete reentry, 3) wave collision, and 4)  wave breakup with conduction block.",OADS,/arxiv_data1/oa_pdf/52/dd/kcj-45-424.PMC4580702.pdf
426  Ethanol Infusion into the Vein of Marshall http://dx.doi.org/10.4070/kcj.2015.45.5.424 www.e-kcj.org Discussion This case report demonstrates that ethanol infusion into the VOM  can effectively eliminate CFAEs at PMI.,Non-OADS,/arxiv_data1/oa_pdf/52/dd/kcj-45-424.PMC4580702.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.424 www.e-kcj.org different wavelets at the same area is contentious.,OADS,/arxiv_data1/oa_pdf/52/dd/kcj-45-424.PMC4580702.pdf
"During  physical examination, typical pain in the left axillary area was Case Report http://dx.doi.org/10.4070/kcj.2015.45.5.428 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Brachial Plexus Injury Caused by Indwelling   Axillary Venous Pacing Leads So Yeon Kim, MD1, Jong Sung Park, MD1, Jung Hee Bang, MD2, and Eun Ju Kang, MD3 1Departments of Cardiology, 2Cardiovascular Surgery, and 3Radiology, Dong-A University Medical Center, Busan, Korea A 64-year-old male patient underwent cardiac resynchronization therapy (CRT) device implantation via the axillary venous approach.",Non-OADS,/arxiv_data1/oa_pdf/d4/80/kcj-45-428.PMC4580703.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.428 www.e-kcj.org reproduced whenever his left shoulder was passively abducted more  than 60 degrees.,Non-OADS,/arxiv_data1/oa_pdf/d4/80/kcj-45-428.PMC4580703.pdf
430  Brachial Plexus Injury by CRT-D Leads http://dx.doi.org/10.4070/kcj.2015.45.5.428 www.e-kcj.org vessel wall were then dissected carefully.,Non-OADS,/arxiv_data1/oa_pdf/d4/80/kcj-45-428.PMC4580703.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.428 www.e-kcj.org for minimizing the risk of pacing lead-induced nerve injury.,Non-OADS,/arxiv_data1/oa_pdf/d4/80/kcj-45-428.PMC4580703.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2015.45.5.428.,Non-OADS,/arxiv_data1/oa_pdf/d4/80/kcj-45-428.PMC4580703.pdf
"The initial ECG obtained after transfer showed  bradycardia (55 beats/min), PR prolongation followed by AV block Case Report http://dx.doi.org/10.4070/kcj.2015.45.5.432 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Stroke in a Young Individual with Left Ventricular Noncompaction  and Left Atrium Standstill Ga-Hee Lee, MD, Dae-Kyeong Kim, MD, Yeo-Jeong Song, MD, Ju-Il Yang, MD, Ho-Cheol Shin, MD,  Sungmoon Ong, MD, and Ho Young Lee, MD Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hostpital, Busan, Korea Isolated left ventricular noncompaction (LVNC) is a rare cardiomyopathy with morphologic characteristics of two distinct myocardial  layers i.e., thin compacted epicardial and thick noncompacted endocardial layers.",Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org characteristic of second degree AV block, Mobitz type 1 with left  axis deviation and poor R wave progression (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
434  Left Ventricular Noncompaction and Left Atrial Standstill http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org A (b) A (a) B (a) B (b) Fig.,Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org fraction was 67% with E/E’ of 5.24 implying normal LV systolic  function and filling pressure.,OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
436  Left Ventricular Noncompaction and Left Atrial Standstill http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org of septum portion of RA and LA.,Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org image quality, CMR shows better signal to noise ratio, contrast to  noise ratio, unlimited imaging planes and ability to use tissue  characterization.",Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
438  Left Ventricular Noncompaction and Left Atrial Standstill http://dx.doi.org/10.4070/kcj.2015.45.5.432 www.e-kcj.org tricular noncompaction.,Non-OADS,/arxiv_data1/oa_pdf/c1/6f/kcj-45-432.PMC4580704.pdf
"Noncompacted thickness (NC) of the RV in diastole was 22.2 mm at Case Report http://dx.doi.org/10.4070/kcj.2015.45.5.439 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Noncompaction of Ventricular Myocardium Involving   the Right Ventricle Muzaffer Saglam, MD, Hasan Saygin, MD, Huseyin Kozan, MD*, Ersin Ozturk, MD, and Hakan Mutlu, MD Department of Radiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey Noncompaction ventricular myocardium is an unusual cause of cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/kcj-45-439.PMC4580705.pdf
440  Noncompaction of the Right Ventricle http://dx.doi.org/10.4070/kcj.2015.45.5.439 www.e-kcj.org the apical level with compacted thickness (C) of 2.6 mm (NC/C ratio  8.5) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fc/d2/kcj-45-439.PMC4580705.pdf
http://dx.doi.org/10.4070/kcj.2015.45.5.439 www.e-kcj.org Developmental Pathology of the Embryo and Fetus .,Non-OADS,/arxiv_data1/oa_pdf/fc/d2/kcj-45-439.PMC4580705.pdf
"442 Copyright © 2015 The Korean Society of CardiologyKorean Circulation JournalKorean Circ J 2015;45:202-209  http://dx.doi.org/10.4070/kcj.2015.45.3.202 In this article, on page 205, Fig.",Non-OADS,/arxiv_data1/oa_pdf/46/d1/kcj-45-442.PMC4580706.pdf
"Before correction             After correctionErratum: Figure Corrections http://dx.doi.org/10.4070/kcj.2015.45.5.442 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Erratum to: Thirty-Year Trends in Mortality from Cardiovascular   Diseases in Korea Seung Won Lee, MPH1,2, Hyeon Chang Kim, MD2,3, Hye Sun Lee, MS4, and Il Suh, MD3 1Department of Public Health, Yonsei University Graduate School, Seoul,   2Cardiovascular and Metabolic Diseases Etiology Research Center, 3Department of Preventive Medicine, 4Department of Biostatistics, Yonsei University College   of Medicine, Seoul, Korea 140 120 100 80 60 40 20 0140 120 100 80 60 40 20 0 1983   1985  1987   1989  1991  1993   1995   1997  1999  2001   2003  2005   2007   2009   2011 1983   1985  1987  1989  1991  1993   1995   1997  1999  2001   2003  2005   2007  2009   2011 Age-adjusted death rate per 100000 population Age-adjusted death rate per 100000 populationPenalized B-spline fit for men Year YearPenalized B-spline fit for women C  D    Fit         95% confidence limits                       95% prediction limits  Fit         95% confidence limits                       95% prediction limits 30 25 20 15 10 5 030 25 20 15 10 5 0Age-adjusted death rate per 100000 population Age-adjusted death rate per 100000 populationPenalized B-spline fit for men Year YearPenalized B-spline fit for women C  D    Fit         95% confidence limits                       95% prediction limits  Fit         95% confidence limits                       95% prediction limits 1983   1985  1987  1989  1991  1993  1995  1997 1999  2001   2003 2005  2007   2009  2011  2013 1983  1985  1987  1989  1991  1993  1995  1997  1999  2001  2003  2005  2007  2009  2011  2013",Non-OADS,/arxiv_data1/oa_pdf/46/d1/kcj-45-442.PMC4580706.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"Adenocarcinomas are characterized by invasive capsular penetration (d) and a highly disorganized cellular conﬁguration with extensive mitotic activity (e).Mitochondrial catalase suppresses lung cancer in mice Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
doi: http://dx.doi.org/ 10.1146/annurev-pathol-121808-102144 2.,Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"Mice were euthanized 3 weeks later and tumors assessed for volume to determine the tumor burden.Mitochondrial catalase suppresses lung cancer in mice Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
doi: http://dx.doi.org/ 10.1371/journal.pone.0080123 9.,Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
doi: http://dx.doi.org/ 10.1093/jnci/djv040 10.,OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"6 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28776 - http://dx.doi.org/10.3402/pba.v5.28776",Non-OADS,/arxiv_data1/oa_pdf/45/24/PBA-5-28776.PMC4580711.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
"Burlington, Ontario: Boehringer-In- gelheim Canada Ltd. 2014. http://boehringer-ingelheim.ca/ content/dam/internet/opu/ca_EN/documents/humanhealth/product_monograph/PradaxaPMEN.pdf .",Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
March 2010. http://www.fda.gov/downloads/Drugs/Guidances/ UCM204959.pdf .,Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
"Meetingdate October 30, 2014. http://www.fda.gov/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDr ugsAdvisoryCommittee/ucm420703.htm .",Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
March 2010. http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm064981.htm .,Non-OADS,/arxiv_data1/oa_pdf/35/a6/40265_2015_Article_452.PMC4580720.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/5a/40262_2015_Article_271.PMC4580721.pdf
Available at: http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM07 0246 .,Non-OADS,/arxiv_data1/oa_pdf/89/5a/40262_2015_Article_271.PMC4580721.pdf
Available at: http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107 .,Non-OADS,/arxiv_data1/oa_pdf/89/5a/40262_2015_Article_271.PMC4580721.pdf
Available at: http://www.fda.gov/RegulatoryInformation/Guidances/ UCM126833 .,Non-OADS,/arxiv_data1/oa_pdf/89/5a/40262_2015_Article_271.PMC4580721.pdf
Availableat: http://www.fda.gov/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM072123 .,Non-OADS,/arxiv_data1/oa_pdf/89/5a/40262_2015_Article_271.PMC4580721.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ea/fd/40262_2015_Article_283.PMC4580724.pdf
"Guidance for industry: bioanalytical method validation, 2001. http://www.fda.",Non-OADS,/arxiv_data1/oa_pdf/ea/fd/40262_2015_Article_283.PMC4580724.pdf
2012.http://www.fda.gov/downloads/drugs/guidancecomplianceregul- atoryinformation/guidances/ucm292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/fd/40262_2015_Article_283.PMC4580724.pdf
http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/ea/fd/40262_2015_Article_283.PMC4580724.pdf
"A total of 3,115 keratinocyte-speci ﬁc DHSs were extracted from the Regulatory Elements Database (available from: http://dnase.genome.duke.edu), and we found that onlyeight MVPs position in keratinocyte-speci ﬁc DHSs.",OADS,/arxiv_data1/oa_pdf/c5/92/jid2015128a.PMC4580729.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/XG u et al.",Non-OADS,/arxiv_data1/oa_pdf/c5/92/jid2015128a.PMC4580729.pdf
"Approval Date: 02 August 2006 http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/050808s000_StatR.pdf Strauss JS, Stranieri AM, Farrell LN et al.",Non-OADS,/arxiv_data1/oa_pdf/16/de/jid201589a.PMC4580730.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/DY Paithankar et al.",Non-OADS,/arxiv_data1/oa_pdf/16/de/jid201589a.PMC4580730.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/SF a n g et al.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jid2015138a.PMC4580731.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/A Blauvelt et al.",Non-OADS,/arxiv_data1/oa_pdf/64/02/jid2015144a.PMC4580732.pdf
"In this article, we  review the insight into the mTOR activity in neural stem cell (NSC)  functions thereby illustrating the close relationship between Roles of mTOR Signaling in Brain Development Da Y ong Lee * Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.177 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
"TEL: 82-42-860-4475, FAX: 82-42-879-8495 e-mail: daylee@kribb.re.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
178 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177Da Y ong Lee mTOR and the pathological events which are mainly occurred in  brain developmental disorders and pediatric brain tumors.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
"179 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177mTOR Signaling in Brain Development STAT3 signaling pathways [24, 25].",Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
180 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177Da Y ong Lee cell populations rather than differentiated brain cells could have  an implication in disease phenotypes.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
181 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177mTOR Signaling in Brain Development defects of mTOR in NSCs are closely implicated to the pediatric  gliomagenesis.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
182 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177Da Y ong Lee REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
183 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177mTOR Signaling in Brain Development 25.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
184 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177Da Y ong Lee 49.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
185 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.177mTOR Signaling in Brain Development a model for understanding the role of cerebellar pathology in  autism.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/en-24-177.PMC4580744.pdf
"Other behavioral disturbances such as deviant behavior, Peripheral Biomarker Candidates of   Posttraumatic Stress Disorder Hee Jin Kang1, Sujung Y oon1* and In Kyoon Lyoo1,2,3 1Ewha Brain Institute, 2Department of Brain and Cognitive Sciences, 3College of Pharmacy,   Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.186 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"TEL: 82-2-3277-2478, FAX: 82-2-3277-6562 e-mail: sujungjyoon@ewha.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"187 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Biomarker Candidates of PTSD suicide, violence, and decreased quality of life may also be  frequently observed in trauma-exposed individuals.",Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"188 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Hee Jin Kang, et al.",OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"189 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Biomarker Candidates of PTSD childhood maltreatment history than those without, implying  the potential effects of increased early life stress on lowering  adiponetin, the anti-inflammatory marker [38].",Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"190 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Hee Jin Kang, et al.",OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"191 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Biomarker Candidates of PTSD having heterozygous genotype for the COMT polymorphism  rs4680, valine/methionine genotype, were less likely to develop  chronic PTSD symptoms than those with homozygous genotype  [86].",Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"192 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Hee Jin Kang, et al.",OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
193 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Biomarker Candidates of PTSD 27.,Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"194 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Hee Jin Kang, et al.",OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
195 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Biomarker Candidates of PTSD derived neurotrophic factor and inflammatory markers in  school-aged children with early trauma.,Non-OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"196 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.186Hee Jin Kang, et al.",OADS,/arxiv_data1/oa_pdf/d9/25/en-24-186.PMC4580745.pdf
"Indeed, we previously demonstrated that  prototypic DA neurotoxins recruit a distinct cell death pathway  in primary cultures of cortical or DA neurons as well as MN9D Glucose Levels in Culture Medium Determine  Cell Death Mode in MPP+-treated Dopaminergic  Neuronal Cells So-Y oung Y oon and Y oung J. Oh * Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul 03722, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.197 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
"TEL: 82-2-2123-2662, FAX: 82-2-312-5657 e-mail: yjoh@yonsei.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
"198 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197So-Y oung Y oon and Y oung J. Oh DA neuronal cell line [11, 12].",OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
"199 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197Apoptotic and non-apoptotic Death Induced by MPP+ Primary cultures of DA neurons T o prepare primary cultures of DA neurons, the ventral  mesencephalon was isolated from the 14d gestation Sprague  Dawley rat embryo (Daehan; Daejon, Korea) as described  previously [12].",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
200 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197So-Y oung Y oon and Y oung J. Oh under an Axiocam Digital Camera (Carl Zeiss).,Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
"201 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197Apoptotic and non-apoptotic Death Induced by MPP+ mode after MPP+ treatment, MN9D cells were incubated in N2  culture medium containing varying concentrations of D-glucose  (5~35 mM) plus 200 µM MPP+.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
202 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197So-Y oung Y oon and Y oung J. Oh HET-positive cells appeared in a time-dependent manner when  cells were cultivated at 5 mM glucose but not at 17.5 mM ( Fig.,OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
203 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197Apoptotic and non-apoptotic Death Induced by MPP+ neurons were healthy when they are cultivated in medium  containing 5~33.3 mM glucose for up to 10 days (data not shown).,OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
204 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197So-Y oung Y oon and Y oung J. Oh cell death [20-22].,Non-OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
205 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.197Apoptotic and non-apoptotic Death Induced by MPP+ p38 MAPK induced by oxidative stress is linked to activation  of both caspase-8- and -9-mediated apoptotic pathways in  dopaminergic neurons.,OADS,/arxiv_data1/oa_pdf/1f/9b/en-24-197.PMC4580746.pdf
"Polegaev1 1Kirov Medical Academy, St. Petersburg 194 044, 2Ioffe Physical–Technical Institute, St. Petersburg 194 026, Russiahttp://dx.doi.org/10.5607/en.2015.24.3.206 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
"TEL: 812 297-2245, FAX: 812 297-1017 e-mail: a.elizarov@mail.ioffe.ru Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
"207 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.206Membrane Separator Interface spectrometer, dependence of membrane characteristics on the  temperature, and selectivity (transmission coefficient) for various  compounds [4, 5].",OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
208 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.206Vyacheslav Yu.,Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
209 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.206Membrane Separator Interface hypnotic of choice for inhalational or intravenous anaesthesia.,Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
210 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.206Vyacheslav Yu.,Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
Available from: https://www.osha.,Non-OADS,/arxiv_data1/oa_pdf/27/22/en-24-206.PMC4580747.pdf
"However, physiological relevance of Disinhibitory Action of Astrocytic GABA at the  Perforant Path to Dentate Gyrus Granule Neuron  Synapse Reverses to Inhibitory in Alzheimer's  Disease Model Oleg Y arishkin1, Jaekwang Lee1, Seonmi Jo1,2, Eun Mi Hwang1,3 and C. Justin Lee1,3,4* 1Center for Neuroscience and Functional Connectomics, Korea Institute of Science and Technology (KIST), Seoul 02792,   2Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141,   3Neuroscience Program, University of Science and Technology (UST), Daejeon 34113,   4KU-KIST Graduate School of Converging Science and Technology, Seoul 02841, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.211 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"TEL: 82-2-958-6940, FAX: 82-2-958-6937 e-mail: cjl@kist.re.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"212 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Oleg Y arishkin, et al.",OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"213 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Astrocytic GABA in the Dentate Gyrus block the production of GABA in astrocytes [7, 8].",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"214 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Oleg Y arishkin, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
215 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Astrocytic GABA in the Dentate Gyrus The excitatory role of GABAB receptor in WT mice and  inhibitory role of GABAA in APP/PS1 mice were confirmed in  PPR experiment using bicuculline and CGP55845.,OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"216 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Oleg Y arishkin, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
217 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Astrocytic GABA in the Dentate Gyrus granule neurons in favor of excitatory drive from PP ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"218 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.211Oleg Y arishkin, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/b4/en-24-211.PMC4580748.pdf
"Procaspase-8 translocates  to the Fas-FADD complex, and it triggers activation of initiator Control of Mitochondrial Dynamics by Fas-induced  Caspase-8 Activation in Hippocampal Neurons Hyo Min Cho and Woong Sun * Department of Anatomy, Korea University College of Medicine, Brain Korea 21, Seoul 02841, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.219 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
"TEL: 82-2-920-6404, FAX: 82-2-929-5696 e-mail: woongsun@korea.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
"220 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Hyo Min Cho and Woong Sun caspase-8, which in turn directly activates caspase-3 without  formation of mitochondria-dependent apoptosomes [10].",OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
221 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Caspase-8 Dependent Mitochondrial Fission in Hippocampal Neurons test.,Non-OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
"222 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Hyo Min Cho and Woong Sun morphology, but a small subset of neurons exhibited rather  fragmented mitochondria.",OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
"223 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Caspase-8 Dependent Mitochondrial Fission in Hippocampal Neurons Z-IETD completely prevented Fas-induced mitochondrial  fragmentation, suggesting that mitochondrial fragmentation is  dependent on caspase-8 activation.",OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
224 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Hyo Min Cho and Woong Sun REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
225 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.219Caspase-8 Dependent Mitochondrial Fission in Hippocampal Neurons 27.,Non-OADS,/arxiv_data1/oa_pdf/bc/d4/en-24-219.PMC4580749.pdf
"Many studies have shown  that ALS is at least partially a non-cell-autonomous disease and Modulation of SOD1 Subcellular Localization by  Transfection with Wild- or Mutant-type SOD1 in  Primary Neuron and Astrocyte Cultures from   ALS Mice Do-Y eon Lee1#, Gye Sun Jeon1,2#, Yu-mi Shim1, Seung-Y ong Seong3,   Kwang-Woo Lee1 and Jung-Joon Sung1* 1Department of Neurology, 2Biomedical Research Institute, Seoul National University Hospital College of Medicine,   3Wide River Institute of Immunology, Department of Microbiology and Immunology, Department of Biomedical Sciences,  Seoul National University College of Medicine, Seoul 03080, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.226 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
227 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Modulation of SOD1 Subcellular Localization in ALS that cells such as astrocytes expressing mutant hSOD1 contribute  to the pathogenesis of ALS [3].,OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"228 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Do-Y eon Lee, et al.",OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
229 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Modulation of SOD1 Subcellular Localization in ALS Fig.,OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"230 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Do-Y eon Lee, et al.",OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
231 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Modulation of SOD1 Subcellular Localization in ALS whether or not cytoplasmic accumulation of mtSOD1 aggregates  promotes apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"232 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Do-Y eon Lee, et al.",OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
233 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Modulation of SOD1 Subcellular Localization in ALS aggregates of non-native SOD1 delineate a common feature.,OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"234 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.226Do-Y eon Lee, et al.",OADS,/arxiv_data1/oa_pdf/2b/79/en-24-226.PMC4580750.pdf
"Several studies have recently  shown that reduction of tetrazolium salts is related not only The Unreliability of MTT Assay in the Cytotoxic  Test of Primary Cultured Glioblastoma Cells Hwa Y eon Jo1,2,3, Y ona Kim1,2,3, Hyung Woo Park1,2,3, Hyo Eun Moon1,2,3,   Seongtae Bae1,2,3, JinWook Kim1,2,3, Dong Gyu Kim1,2,3 and Sun Ha Paek1,2,3* 1Department of Neurosurgery, 2Cancer Research Institute, and 3Ischemic/Hypoxic Disease Institute,   Seoul National University College of Medicine, Seoul 03082, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.235 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"TEL: 82-2-2072-3993, FAX: 82-2-744-8459 e-mail: paeksh@snu.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"236 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235Hwa Y eon Jo, et al.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"237 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235The Unreliability of MTT Assay Morphological Changes of Glioblastoma Cells by Light  Microscopy  After the treatment of 5% ethanol for 24 h, morphological  changes of the cells were observed by phase contrast microscopy  (Nikon, TS100, Japan).",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"238 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235Hwa Y eon Jo, et al.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
239 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235The Unreliability of MTT Assay Fig.,OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"240 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235Hwa Y eon Jo, et al.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"241 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235The Unreliability of MTT Assay concentration-dependent manner, and that a very similar pattern  was also observed for the primary glioblastoma cells.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"242 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235Hwa Y eon Jo, et al.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
243 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235The Unreliability of MTT Assay at a 5% ethanol concentration.,Non-OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"244 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235Hwa Y eon Jo, et al.",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"245 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.235The Unreliability of MTT Assay funded by Ministry of Health & W elfare, Republic of Korea, by  the T echnology Innovation Program (10050154, Business Model  Development for Personalized Medicine Based on Integrated  Genome and Clinical Information) funded by the Ministry of  T rade, Industry & Energy (MI, Korea), and by the Bio & Medical  T echnology Development Program of the NRF funded by the  Korean government, MSIP (2015M3C7A1028926).",OADS,/arxiv_data1/oa_pdf/99/98/en-24-235.PMC4580751.pdf
"The targeting mediated by the 20 N-terminal amino acids  may be due to direct association with the membrane as evidenced  by the ability of the first 16 N-terminal amino acids of ApPDE4 Specific Expression of Aplysia  Phosphodiesterase 4 in  Bag Cells Revealed by in situ  Hybridization Analysis Deok-Jin Jang1,#, Hyoung F. Kim2,#, Jae-Hoon Sim2,   Chae-Seok Lim2 and Bong-Kiun Kaang2,* 1Department of Ecological Science, College of Ecology and Environment, Kyungpook National University, Sangju 37224, Korea   2Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 08826, Korea http://dx.doi.org/10.5607/en.2015.24.3.246 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
"Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
247 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.246 In situ  Hybridization Analysis of ApPDE4 long-form to associate with the membrane through hydrophobic  interactions [7].,Non-OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
"248 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.246Deok-Jin Jang, et al.",OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
249 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.246 In situ  Hybridization Analysis of ApPDE4 ganglia.,OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
"250 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.246Deok-Jin Jang, et al.",OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
251 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.246 In situ  Hybridization Analysis of ApPDE4 modulation by an activator of adenylate cyclase.,OADS,/arxiv_data1/oa_pdf/1e/d1/en-24-246.PMC4580752.pdf
"Neither further focal neurological deficits Neuro-Behçet’s Disease Presenting as Hypertrophic  Pachymeningitis Byung-Nam Y oon1, Soo-Jung Kim1, Mi-Jin Lim2, Jee-Y oung Han3, Kwang-Woo Lee3,  Jung-Joon Sung3, Choong Kun Ha1 and Seong Hye Choi1* 1Department of Neurology, 2Division of Rheumatology, Department of Internal Medicine, Inha University Hospital,   Incheon 22332, 3Department of Neurology, Seoul National University Hospital, College of Medicine, Seoul 03080, Koreahttp://dx.doi.org/10.5607/en.2015.24.3.252 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/3f/ae/en-24-252.PMC4580753.pdf
"TEL: 82-32-890-3668, FAX: 82-32-890-3097 e-mail: nrybn1230@gmail.com Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/ae/en-24-252.PMC4580753.pdf
253 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.252Hypertrophic Pachymeningitis Associated with Behçet’s Disease nor meningeal irritation signs including neck stiffness were  detected.,Non-OADS,/arxiv_data1/oa_pdf/3f/ae/en-24-252.PMC4580753.pdf
"254 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.252Byung-Nam Y oon, et al.",OADS,/arxiv_data1/oa_pdf/3f/ae/en-24-252.PMC4580753.pdf
255 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.3.252Hypertrophic Pachymeningitis Associated with Behçet’s Disease IgG4-related disease is a recently described inflammatory  condition and is suggested to be a common cause in IHP [15].,Non-OADS,/arxiv_data1/oa_pdf/3f/ae/en-24-252.PMC4580753.pdf
"© Rex A Hess *Corresponding author: Rex A Hess; Email: rexhess@illinois.edu Submitted: 05/22/2014; Accepted: 10/16/2014http://dx.doi.org/10.4161/21565562.2014.979103 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/kspe-04-02-979103.PMC4581051.pdf
"Biochemical changes that arecontrolled by genes which are active only in spermatids and in theprocess of spermiogenesis, 56including the elaboration of new and© Thomas A Aire *Correspondence to: Tom A Aire; Email: taire@sgu.edu Submitted: 07/22/2014; Accepted: 08/05/2014http://dx.doi.org/10.4161/21565554.2014.959392 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Ann N Y Acad Sci 1952; 55:548-73;PMID:13139144; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1952; 90:167-215; PMID:14923625; http://dx.doi.org/10.1002/aja.1000900202 6.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1955; 96:229-50; PMID:14376352; http://dx.doi.org/ 10.1002/aja.1000960203 7.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Rec 1969; 165:153-84; PMID:5387815;http://dx.doi.org/10.1002/ar.1091650204 8.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Dev Biol 1971; 26:220-51;PMID:5168310; http://dx.doi.org/10.1016/0012- 1606(71)90124-210.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Z Zellforsch Mikrosck Anat 1972; 125:497- 505; PMID:4551791; http://dx.doi.org/10.1007/ BF00306656 11.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Andrologia 1976; 8:157-65; PMID:962174; http://dx.doi.org/10.1111/j.1439-0272.1976.tb02126.x 13.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Histol Embryol 1986;15:23-48; PMID:2939773; http://dx.doi.org/ 10.1111/j.1439-0264.1986.tb00529.x 15.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Anat 1997; 190:377-95; PMID:9147224; http://dx.doi.org/10.1046/j.1469- 7580.1997.19030377.x 18.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Anat 2000; 196:217-32; PMID:10739018; http://dx.doi.org/10.1046/j.1469-7580.2000.19620217.x 19.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Anat 2008; 212:257-74; PMID:18304206; http://dx.doi.org/10.1111/j.1469-7580.2008.00861.x 20.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Cell Biol 1962; 14:193-205; PMID:14477885;http://dx.doi.org/10.1083/jcb.14.2.193 24.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Cell Biol 1967; 35:153-73; PMID:6061713; http://dx.doi.org/ 10.1083/jcb.35.1.153 25.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Reprod Fertil 1973;34:255-65; PMID:4741694; http://dx.doi.org/ 10.1530/jrf.0.0340255 28.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell Tiss Res 1975; 156:411-16; http://dx.doi.org/10.1007/BF00225369 29.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell Tiss Res 1976; 169:345-59; http://dx.doi.org/10.1007/BF00219607 30.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell Tiss Res 1980; 205:319-25; PMID:7357577;http://dx.doi.org/10.1007/BF00234690 34.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastr Res1980; 71:272-87; PMID:6893210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastr Res 1988; 98:158-68; PMID:3373069; http://dx.doi.org/10.1016/S0889- 1605(88)80908-X 36.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Morphol 1988; 198:95-118; PMID:3199450; http://dx.doi.org/10.1002/jmor.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Mor- phol 1996; 227:101-11; http://dx.doi.org/10.1002/ (SICI)1097-4687(199601)227 40.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Anat 1997; 190:563-76; PMID:9183679; http://dx.doi.org/10.1046/j.1469- 7580.1997.19040563.x 41.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Tiss Cell 2002; 34:273-82; PMID: 12176310; http://dx.doi.org/10.1016/S0040-8166 (02)00017-4 42.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Brit Poult Sci 2003; 44:674-82; PMID:14965087; http://dx.doi.org/10.1080/00071660310001643651 43.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Acta Zool 2005; 86:239-44; http://dx.doi.org/10.1111/j.1463-6395.2005.00204.x 44.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Tiss Cell 2012; 44:63-67; PMID:22129754; http://dx.doi.org/10.1016/j.tice.2011.10.004 45.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"J Morphol 2012; 273:1291-1305; PMID:22821829; http://dx.doi.org/10.1002/jmor.20060 46. du Plessis L. The morphology and development of normal and abnormal spermatozoa in emu, Dro- maius novaehollandiae.",OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1986; 177:301-12; PMID:3799487; http://dx.doi.org/ 10.1002/aja.1001770303 48.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Rec 1989; 223:276-82; PMID: 2923278; http://dx.doi.org/10.1002/ar.1092230306 49.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Acta VetBrno 1995; 64:23-29; http://dx.doi.org/10.2754/ avb199564010023 51.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Histol Embryol 2005; 34:307-11; PMID:16159372; http://dx.doi.org/10.1111/j.1439-0264.2005.00620.x52.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Reprod Fertil 1972; 29:327-36;PMID:4113685; http://dx.doi.org/10.1530/jrf.0.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1950; 87:1-30; PMID:14771006; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
ActaZool (Copenhagen) 1995; 76:45-50; http://dx.doi.org/ 10.1111/j.1463-6395.1995.tb00981.x 62.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Exptl Cell Res 1967; 48:622-24; http://dx.doi.org/10.1016/0014-4827(67)90329-1 63.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastr Mol Struct Res 1986; 94:170-5; http://dx.doi.org/ 10.1016/0889-1605(86)90063-7 67.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
PMID:4113685; http://dx.doi.org/10.1530/jrf.0.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"Oscine sper- matozoa: a light and electron-microscopy study.Condor 1978; 80, 41-48; http://dx.doi.org/ 10.2307/1367789 72.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Acta Zool 2006; 87:297-304; http://dx.doi.org/10.1111/j.1463-6395.2006.00242.x 73.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"(Stockholm) 2007; 88, 119-128; http://dx.doi.org/10.1111/j.1463-6395.2007.00259.x 74.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Auk 2006; 383-92; http://dx.doi.org/10.1642/0004-8038(2006)123 75.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Andrologia 1982; 14:200-7;PMID:7103139; http://dx.doi.org/10.1111/j.1439- 0272.1982.tb03124.x 81.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell Tiss Res 1986; 244:1-8; http://dx.doi.org/10.1007/BF00218375 82.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
2011; 1:95-98; PMID:22319656; http://dx.doi.org/10.4161/spmg.1.2.16820 84.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Biophys Biochem Cytol 1955; 2:223-40; PMID:13331956; http://dx.doi.org/10.1083/jcb.2.3.223 85.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Ann Biol AnimBiochim Biophys 1971; 11:531-46; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"J Morph 2006; 267, 1157-64; PMID:16804921; http://dx.doi.org/10.1002/jmor.",OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"Nuclear shaping in the absence of a microtubular manchette in the sper- matids of the bird Crotophaga ani, (Cuculiformes).Boll Zool 1982; 49:115-23; http://dx.doi.org/ 10.1080/11250008209439379 90.",OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Acta Zool 86:239-44; http://dx.doi.org/10.1111/j.1463-6395.2005.00204.x 95.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1982; 165:121-30; PMID:6890760; http://dx.doi.org/ 10.1002/aja.1001650204 98.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Rec 1990; 227:447-57; PMID:2393097; http://dx.doi.org/10.1002/ar.1092270408 99.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastr Res 1972; 39:364-88;PMID:4112748; http://dx.doi.org/10.1016/S0022- 5320(72)90029-9 100.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Poult Sci 1982; 61:1738-43; PMID:7134129; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Asymmetry of spermia- tion and sperm surface charge patterns over the giant acrosome in the musk shrew Suncus murinus.J Cell Biol 1976; 69:415-28; PMID:1262397; http://dx.doi.org/10.1083/jcb.69.2.415 104.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1970; 129:177-92; PMID:4097414; http://dx.doi.org/10.1002/aja.1001290205 107.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Rec 1988; 221:591-98; PMID:2843065; http://dx.doi.org/10.1002/ar.1092210205 111.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Biol Reprod1970; 2:114-20; PMID:4106273; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
BMC Evol Biol 2013; 13:104; PMID:23705947; http://dx.doi.org/10.1186/1471-2148-13-104 116.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Caryology 1977; 30:151-62; http://dx.doi.org/10.1080/00087114.1977.10796688 118.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cytologia1978; 43:61-68; http://dx.doi.org/10.1508/ cytologia.43.61 119.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastr Res 1984; 88:261-74; http://dx.doi.org/10.1016/S0022-5320(84)90124-2 120.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Amphibia-Reptilia 2001; 22:217-23; http://dx.doi.org/10.1163/ 15685380152030445 121.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Nature 1972; 237:257-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Nature 1979; 279:234-35; PMID:440432; http://dx.doi.org/10.1038/279234a0 125.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Mol Phylogenet Evol 2003; 29:289- 97; PMID:13678684; http://dx.doi.org/10.1016/ S1055-7903(03)00108-8 126.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Struct Biol 2011; 173:391- 405; PMID:20869443; http://dx.doi.org/10.1016/ j.jsb.2010.09.020 127.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Biol Reprod1975; 12:632-40; PMID:1220830; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Biol Cell (Paris) 1991; 71:209-16; PMID:1912945; http://dx.doi.org/10.1016/0248-4900(91)90067-W 132.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Anat Rec 1995; 241:461-68; PMID:7604961; http://dx.doi.org/10.1002/ar.1092410404 136.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastruct Res 1989; 33:369-80; PMID:5494322; http://dx.doi.org/10.1016/S0022-5320(70)90029-8 138.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
J Ultrastruct Res 1976; 54:397-405; PMID:943568; http://dx.doi.org/ 10.1016/S0022-5320(76)80025-1 139.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Dev Biol 1982; 90:238-52; PMID:7200435; http://dx.doi.org/ 10.1016/0012-1606(82)90373-6 140.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Res Tech 2010; 73:320-63; PMID:19941287; http://dx.doi.org/10.1002/jemt.20783 142.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell 1985; 42:39-50;PMID:3926325; http://dx.doi.org/10.1016/S0092- 8674(85)80099-4 143.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Mol Reprod Dev 2002; 63:1-4; PMID:12211054; http://dx.doi.org/10.1002/mrd.10179 145.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Mol Reprod Dev 2002; 63:131-40; PMID:12211070; http://dx.doi.org/ 10.1002/mrd.10164 146.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Arch Histol Cytol 2004; 67:271-84; PMID:15700535; http://dx.doi.org/10.1679/aohc.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
The surface features of the epithelial lining of the epididymis of the ostrich.Anat Histol Embryol 2000; 29:119-26; PMID:10932389; http://dx.doi.org/10.1046/j.1439-0264.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Annals New York Acad Sci 1952; 55:574-84; PMID:13139145; http://dx.doi.org/ 10.1111/j.1749-6632.1952.tb26577.x 149.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Am J Anat 1963; 112:35-51;PMID:14021715; http://dx.doi.org/10.1002/aja.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
Cell Tiss Res 1992; 270:451-57; PMID: 1486599; http://dx.doi.org/10.1007/BF00645046 151.,OADS,/arxiv_data1/oa_pdf/13/e1/kspe-04-03-959392.PMC4581053.pdf
"34,36-40 Because the disruption of cell junctions in the testis2,4,6,33and other organs13,41by environmental toxicants has been the subject of several reviews, we will use this short review to describe the main features ofthe different types of junctions in the testis as summarized in Table 1 ,© C Yan Cheng *Correspondence to: C Yan Cheng; Email: y-cheng@popcbr.rockefeller.edu; ccheng@mail.rockefeller.edu Submitted: 10/22/2014; Accepted: 10/23/2014http://dx.doi.org/10.4161/21565562.2014.981485 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Trends Pharmacol Sci 2011; 32:290-9; PMID:21324536; http://dx.doi.org/10.1016/j.tips.2011.01.001 2.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Neurotoxicol Teratol 1988; 10:393-416; PMID:2854607; http://dx.doi.org/10.1016/0892- 0362(88)90001-3 4.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Pharmacol 2009; 238:240-9; PMID:19236889; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1:283-90; PMID:22332111; http://dx.doi.org/ 10.4161/spmg.1.4.18328 6.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1:2-13;PMID:21866273; http://dx.doi.org/10.4161/ spmg.1.1.13971 7.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Pharmacol Ther2007; 114:74-93; PMID:17316817; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Pharmacol 2002; 182:255-65; PMID:12183105; http://dx.doi.org/ 10.1006/taap.2002.9422 10.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Pharmacol 2003; 189:180-95;PMID:12791303; http://dx.doi.org/10.1016/S0041- 008X(03)00130-3 11.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Hum Reprod 2014; 29:1279-91; PMID:24532171; http://dx.doi.org/10.1093/humrep/deu011 12.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Lett 1998; 102- 103:71-8; PMID:10022235; http://dx.doi.org/ 10.1016/S0378-4274(98)00288-4 14.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Endocrinol- ogy 2014; 155:249-62; PMID:24169556; http://dx.doi.org/10.1210/en.2013-1657 15.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1:303-17; PMID:22332114;http://dx.doi.org/10.4161/spmg.1.4.18392 16.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Reprod Toxicol 2004; 18:413-21; PMID:15082077; http://dx.doi.org/10.1016/j.reprotox.2004.01.002 17.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int J Biochem Cell Biol 2009; 41:2302-14; PMID:19497385; http://dx.doi.org/10.1016/j.biocel.2009.05.016 18.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
ReprodToxicol 1993; 7 (Suppl 1):23-37; PMID:8400637; http://dx.doi.org/10.1016/0890-6238(93)90066-G 21.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Sci 2013; 135:229-40; PMID:23761298; http://dx.doi.org/ 10.1093/toxsci/kft129 23.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Endocrinology 2003; 144:1139-42; PMID:12639893; http://dx.doi.org/10.1210/en.2002-0211 24.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Regula- tion of blood-testis barrier dynamics: an in vivo study.J Cell Sci 2004; 117:783-98; PMID:14734653; http://dx.doi.org/10.1242/jcs.00900 25.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 1993;49:840-9; PMID:8218650; http://dx.doi.org/ 10.1095/biolreprod49.4.840 26.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Endo- crinology 2005; 146:1893-908; PMID:15618353; http://dx.doi.org/10.1210/en.2004-1464 29.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2013; 88:59; PMID:23325809; http://dx.doi.org/10.1095/biolreprod.112.104414 30.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2003; 68:1597-612; PMID:12606350; http://dx.doi.org/10.1095/ biolreprod.102.011387 31.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int J Biochem Cell Biol 2011;43:651-65; PMID:21256972; http://dx.doi.org/ 10.1016/j.biocel.2011.01.008 32.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Trends Mol Med 2013; 19:396-405; PMID:23643465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
PMID:24598768; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Philos Trans R Soc Lond B Biol Sci2010; 365:1557-69; PMID:20403869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Trends Mol Med 2009; 15:159-68; PMID:19303360; http://dx.doi.org/10.1016/j.molmed.2009.02.002 39.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Coordinating cellular events during spermatogenesis: a biochemical model.Trends Biochem Sci 2009; 34:366-73; PMID:19535250; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Cytokine Growth Factor Rev 2007; 18:299-311; PMID:17521954; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Sci 2006; 94:240-55; PMID:16880199;http://dx.doi.org/10.1093/toxsci/kﬂ066 42.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Contraception 2005; 72:251-61; PMID:16181968; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Contraception 2010 82:476-82; PMID:20933122; http://dx.doi.org/ 10.1016/j.contraception.2010.03.017 44.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Trends Endo- crinol Metab 2004; 15:439-47; PMID:15519891; http://dx.doi.org/10.1016/j.tem.2004.09.009 45.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Reproduction 2011; 141:571-80; PMID:21307270; http://dx.doi.org/10.1530/REP-10-0464 46.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Pharmacol Rev 2008; 60:146-80; PMID:18483144; http://dx.doi.org/10.1124/pr.107.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Pharmacol Rev 2012; 64:16-64; PMID:22039149; http://dx.doi.org/ 10.1124/pr.110.002790 48.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
J Androl 2005; 26:354-9; PMID:15867003; http://dx.doi.org/10.2164/jandrol.04142 49.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
J Androl 2006; 27:790-4; PMID:16809272; http://dx.doi.org/10.2164/jandrol.106.000422 50.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Tissue Barriers 2013; 1: e24252; PMID:24665388; http://dx.doi.org/ 10.4161/tisb.24252 51.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2003; 69:656-72; PMID:12700184; http://dx.doi.org/10.1095/biolreprod.103.016881 52.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int J Androl 2012; 35:86- 101; PMID:21696392; http://dx.doi.org/10.1111/ j.1365-2605.2011.01183.x 53.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Com- mun Integr Biol 2009; 2:359-61; PMID:19721891; http://dx.doi.org/10.4161/cib.2.4.8289 57.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
CommunIntegr Biol 2012; 5:399-403; PMID:23060969; http://dx.doi.org/10.4161/cib.20569 58.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Nature Rev Endocrinol 2010; 6:380-95; PMID:20571538; http://dx.doi.org/10.1038/nrendo.2010.71 59.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Tissue Cell 1977; 9:475- 98; PMID:929577; http://dx.doi.org/10.1016/0040- 8166(77)90007-6 60.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Adv Exp Med Biol 2008; 636:186-211; PMID:19856169; http://dx.doi.org/10.1007/978-0- 387-09597-4_11 61.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Am J Anat 1979; 155:259-79; PMID:474448; http://dx.doi.org/10.1002/aja.1001550208 64.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int Rev Cytol 1985; 94:177-211; PMID:3894273; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Proc Natl Acad Sci USA 2008; 105:9657-62; PMID:18621709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1:137-46; PMID:22319662; http://dx.doi.org/10.4161/ spmg.1.2.16449 67.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Endocrinol- ogy 2013; 154:1907-20; PMID:23546604; http://dx.doi.org/10.1210/en.2012-2269 69.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
FASEB J 2009; 23:2555-67; PMID:19293393; http://dx.doi.org/10.1096/fj.06-070573 70.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Proc Natl Acad Sci USA 2010; 107:11411-6; PMID:20534520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1;291-7; PMID:22332112; http://dx.doi.org/ 10.4161/spmg.1.4.18393 72.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Crit Rev Biochem Mol Biol 2009; 44:245- 63; PMID:19622063; http://dx.doi.org/10.1080/ 10409230903061207 74.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2011; 1:14-35; PMID: 21866274; http://dx.doi.org/10.4161/spmg.1.1.14525 75.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Anat Rec 1979; 194:233-46; PMID:464324; http://dx.doi.org/10.1002/ar.1091940205 76.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int Rev Cell Mol Biol 2013; 303:319-55; PMID:23445814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Anat Rec 1979; 194:213-32; PMID:464323; http://dx.doi.org/10.1002/ ar.1091940204 78.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2009; 80:153-61; PMID:18799755; http://dx.doi.org/10.1095/ biolreprod.108.070615 79.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2009; 80:162-74; PMID:18799754;http://dx.doi.org/10.1095/biolreprod.108.070623 80.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Reproduction 2012;143:347-57; PMID:22157319; http://dx.doi.org/ 10.1530/REP-11-0317 81.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2013; 88:60; PMID:23303684;http://dx.doi.org/10.1095/biolreprod.112.104851 83.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Am J Physiol Endocrinol Metab 2014; 307:E553-62; PMID:25117412; http://dx.doi.org/10.1152/ ajpendo.00176.2014; (in press) 84.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Endocr Rev 2004; 25:747-806;PMID:15466940; http://dx.doi.org/10.1210/ er.2003-0022 86.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
BioEssays 2007; 29:36-48; PMID:17187371;http://dx.doi.org/10.1002/bies.20513 87.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
J Endocrinol 2013; 217:R13-23; PMID:23449618; http://dx.doi.org/10.1530/JOE- 12-0586 88.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogenesis 2013; 3:e23473; PMID:23687615; http://dx.doi.org/10.4161/spmg.23473 89.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Sem Cell Dev Biol 2014; 30:65-74;PMID:24727349; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Human Reprod Update 2004; 10:349- 69; PMID:15192055; http://dx.doi.org/10.1093/ humupd/dmh026 92.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Semin Cell Dev Biol 2014; 30:45-54; PMID:24440897; http://dx.doi.org/10.1016/j.semcdb.2014.01.003; (in press) 93.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Pharmacol 1989; 101:373-89; PMID:2690397; http://dx.doi.org/10.1016/0041- 008X(89)90188-9 94.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 1993; 48:143-53; PMID:8418902; http://dx.doi.org/ 10.1095/biolreprod48.1.143 95.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Tissue Cell 1994; 26:917-27; PMID:7886678; http://dx.doi.org/10.1016/0040-8166(94)90041-8 96.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Pharmacol 1997; 142:401-10; PMID:9070363; http://dx.doi.org/10.1006/taap.1996.8042 97.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Sci 2001; 59:138-46; PMID:11134553; http://dx.doi.org/10.1093/toxsci/59.1.13899.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Tissue Cell 200; 34:73- 80; PMID:12165241; http://dx.doi.org/10.1016/S0040-8166(02)00006-X 100.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Contraception 1984; 29:291-302; PMID:6428807; http://dx.doi.org/10.1016/S0010- 7824(84)80009-8 101.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Annu Rev Pharmacol Toxciol 2003; 43:125-47; PMID:12471174; http://dx.doi.org/ 10.1146/annurev.pharmtox.43.100901.135930 103.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermato- genesis 2012; 2:117-26; PMID:22670221; http://dx.doi.org/10.4161/spmg.20724 105.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biochem J 2010; 429:419-33; PMID:20626351; http://dx.doi.org/10.1042/BJ20100567 106.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Nat Rev Cell Biol2000; 1:208-16; PMID:11252896; http://dx.doi.org/ 10.1038/35043032 107.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
J Invest Dermatol 2007; 127:2499-515; PMID:17934502; http://dx.doi.org/10.1038/sj.jid.5701015 108.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Spermatogene- sis 2011; 1:47-51; PMID:21866275; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Int Rev Cell Mol Biol 2011; 286:223-69; PMID:21199783 [http://dx.doi.org/10.1016/B978-0-12-385859-7.00005-7 111.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Am J Anat 1977; 148:301-12; PMID:857631; http://dx.doi.org/ 10.1002/aja.1001480302 112.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Cold Spring Harb Perspect Biol 2010; 2: a000125; PMID:20182611; http://dx.doi.org/ 10.1101/cshperspect.a000125 114.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Cell1994; 79:679-94; PMID:7954832; http://dx.doi.org/ 10.1016/0092-8674(94)90553-3115.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Philos Trans R Soc Lond B Biol Sci 2010; 365:1607- 20; PMID:20403873; http://dx.doi.org/10.1098/ rstb.2009.0114 117.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Toxicol Appl Phar- macol 1991; 111:443-53; PMID:1746025; http://dx.doi.org/10.1016/0041-008X(91)90249-E 119.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Exp Mol Pathol 1983; 38:149-69; PMID:6832342; http://dx.doi.org/ 10.1016/0014-4800(83)90082-5 120.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Contraception 2002; 65:265-8; PMID:12020774; http://dx.doi.org/10.1016/S0010- 7824(01)00318-3 123.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2001; 64:1500-8; PMID:11319158; http://dx.doi.org/10.1095/biolreprod64.5.1500 124.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Mol Cell Endocrinol 2010; 315:49-56; PMID:19682538 [http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
The consequences of actin disruption at Sertoli ectoplas- mic specialization sites facing spermatids after in vivo exposure of rat testis to cytochalasin D. Biol Reprod1988; 39:105-18; PMID:3207792; http://dx.doi.org/ 10.1095/biolreprod39.1.105 129.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 1992; 47:1173-82; PMID:1283530; http://dx.doi.org/10.1095/ biolreprod47.6.1173 130.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 1998; 58:371-8; PMID:9475391; http://dx.doi.org/10.1095/ biolreprod58.2.371 131.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 2004; 70:945-64; PMID:14645107; http://dx.doi.org/ 10.1095/biolreprod.103.023606 132.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
J Biol Chem 2006; 281:17286-303; PMID:16608848; http://dx.doi.org/ 10.1074/jbc.M513218200 133.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Nature Med 2006; 12:1323-8; PMID:17072312; http://dx.doi.org/10.1038/nm1420 135.,OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Biol Reprod 1978; 18:579-91; PMID:207367; http://dx.doi.org/10.1095/ biolreprod18.4.579 136.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Arthritis Rheum 2012;64:2518-28; PMID:22488218; http://dx.doi.org/ 10.1002/art.34480 137.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
Immunol Cell Biol 2013;91:416-26; PMID:23689306; http://dx.doi.org/ 10.1038/icb.2013.22 139.,Non-OADS,/arxiv_data1/oa_pdf/48/51/kspe-04-02-981485.PMC4581065.pdf
"17,85Each IC is composed of 64 actin cones, which form around the 64 germ nuclei of the cyst.9,11 Once the actin cones have formed, the IC moves away from thenuclei, which are located basally in the testis, and travels along *Correspondence to: Josefa Steinhauer; Email: jsteinha@yu.edu Submitted: 06/23/2014; Revised: 12/15/2014; Accepted: 01/06/2015 http://dx.doi.org/10.1080/21565562.2015.1006089 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Int Rev Cytol 2000; 195:1-65; PMID:10603574; http://dx.doi.org/10.1016/S0074-7696(08)62703-5 2.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Adv Exp Med Biol 2013; 757:321-50;PMID:22872482; http://dx.doi.org/10.1007/978-1- 4614-4015-4_11 3.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Curr Topic Dev Biol 1998; 38:1-34; PMID:9399075; http://dx.doi.org/ 10.1016/S0070-2153(08)60243-4 4.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Spermatogenesis 2011; 1:14-35; PMID:21866274; http://dx.doi.org/10.4161/spmg.1.1.14525 5.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Cold Spring Harbor Perspect Biol 2011; 3:a005850; PMID:21669984; http://dx.doi.org/10.1101/cshperspect.a005850 7.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Am J Anatomy 1991; 192:121-8;PMID:1759679; http://dx.doi.org/10.1002/ aja.1001920203 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Am J Anatomy 1987; 180:1-24; PMID:3661461; http://dx.doi.org/ 10.1002/aja.1001800102 9.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Z Zellforsch Mikrosk Anat 1972; 124:479-506; PMID:4622067; http://dx.doi.org/ 10.1007/BF00335253 10.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Zhejiang Univ Sci B 2007; 8:498-506; PMID:17610330; http://dx.doi.org/10.1631/jzus.2007.B0498 11.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Rep Biol Endocrinol 2012; 10:92; PMID:23159014; http://dx.doi.org/10.1186/1477-7827-10-92 14.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Cold Spring Harbor Perspectives Biol 2011; 3:a002642; PMID:21791699; http://dx.doi.org/10.1101/cshperspect.a002642 16.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Spermatogenesis 2012;2:145-57; PMID:23087834; http://dx.doi.org/ 10.4161/spmg.21380 e1006089-12 Volume 5 Issue 1 Spermatogenesis,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Development 2003; 130:1805-16; PMID:12642486; http://dx.doi.org/10.1242/dev.00406 18.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Spermatogenesis 2012; 2:197-212; PMID:23087837; http://dx.doi.org/ 10.4161/spmg.21798 19.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Genetics 2004; 167:207-16;PMID:15166148; http://dx.doi.org/10.1534/genetics.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2008; 19:2363-72;PMID:18353976; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2009; 20:5224-35; PMID:19864461; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Annu Rev Biochem 1965; 34:313-46; PMID:14321173; http://dx.doi.org/ 10.1146/annurev.bi.34.070165.001525 23.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Annu Rev Pharmacol Toxicol 1999; 39:175-89; PMID:10331081; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Prog-ress Lipid Res 2011; 50:152-92; PMID:21185866; http://dx.doi.org/10.1016/j.plipres.2010.12.001 25.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Lipid Res 2009; 50:S46-51;PMID:18931347; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Science 2001; 294:1871-5; PMID:11729303; http://dx.doi.org/10.1126/ science.294.5548.1871 28.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Science 2001;294:1875-8; PMID:11729304; http://dx.doi.org/ 10.1126/science.1065323 29.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Cell 1995; 83:803-12; PMID:8521497; http://dx.doi.org/10.1016/0092- 8674(95)90193-0 30.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Cell 1995; 83:813-9; PMID:8521498; http://dx.doi.org/ 10.1016/0092-8674(95)90194-9 31.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Biochim Biophys Acta 2007; 1768:923-40; PMID:17078925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
FASEB J 2011; 25:813-8; PMID:21357250;http://dx.doi.org/10.1096/fj.11-0302ufm33.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Science 1987; 237:1171-6; PMID:2820055; http://dx.doi.org/10.1126/science.2820055 34.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
BioEs- says 2004; 26:870-81; PMID:15273989; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Exp Ani- malJapanese Association Lab Animal Sci 2011; 60:7- 20; PMID:21325748; http://dx.doi.org/10.1538/expanim.60.7 36.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
FASEB J 2004; 18:790-804; PMID:15117884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Rep Dev 2013; 80:244-59; PMID:23440886; http://dx.doi.org/10.1002/ mrd.22167 38.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Ann Rev Entomol 2006; 51:25-44; PMID:16332202; http://dx.doi.org/ 10.1146/annurev.ento.51.110104.151021 39.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Biochem 1997; 122:1-16;PMID:9276665; http://dx.doi.org/10.1093/ oxfordjournals.jbchem.a021715 40.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
BiochimBiophysic Acta 1984; 779:89-137; PMID:6229284; http://dx.doi.org/10.1016/0304-4157(84)90005-4 41.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
PloS One 2012; 7:e50858; PMID:23251394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2006; 17:2559-71; PMID:16571671; http://dx.doi.org/10.1091/mbc.E06-01-0031 43.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Nature 2008; 456:599-604; PMID:18923395; http://dx.doi.org/ 10.1038/nature07386 44.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Curr Biol 1999; 9:R787-90;PMID:10531020; http://dx.doi.org/10.1016/S0960- 9822(00)80014-7 45.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Biochem 2011; 150:233-55; PMID:21746768; http://dx.doi.org/ 10.1093/jb/mvr088 47.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Chemical Rev 2011; 111:6130-85; PMID:21910409; http://dx.doi.org/ 10.1021/cr200085w49.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mech Dev 2002; 119 1:S293-301;PMID:14516700; http://dx.doi.org/10.1016/S0925- 4773(03)00131-X 50.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Neuroscience 2005; 25:2865-73; PMID:15772346;http://dx.doi.org/10.1523/JNEUROSCI.5097- 04.2005 51.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Bio- chem Genet 2001; 39:339-49; PMID:11758729; http://dx.doi.org/10.1023/A:1012209030803 52.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Dev Cell 2010; 19:858-71; PMID:21145501; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Dev 2008;135:839-47; PMID:18216169; http://dx.doi.org/ 10.1242/dev.017590 54.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
IUBMB Life 2010; 62:414-28; PMID:20503434; http://dx.doi.org/10.1002/iub.354 55.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2014; 25:397-411; PMID:24284900; http://dx.doi.org/10.1091/mbc.E13-07-0366 56.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2012; 23:4567-78; PMID:23051736; http://dx.doi.org/10.1091/mbc.E12-05-0417 57.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Syst Biol 2012;8:600; PMID:22864382; http://dx.doi.org/10.1038/ msb.2012.29 60.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice.Prog Lipid Res 2010; 49:186-99; PMID:20018209; http://dx.doi.org/10.1016/j.plipres.2009.12.002 61.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Prog Lipid Res 2003; 42:289-317; PMID:12689621; http://dx.doi.org/10.1016/S0163-7827(02)00067-X 62.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Biol Chem 2004; 279:24024-33; PMID:15044461; http://dx.doi.org/10.1074/jbc.M400830200 63.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2010; 21:1546-55; PMID:20237161; http://dx.doi.org/ 10.1091/mbc.E09-07-0582 64.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Cell Sci 2008; 121:1076- 84; PMID:18334551; http://dx.doi.org/10.1242/jcs.024927 65.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Curr Biol 2005; 15:1401-6; PMID:16085493; http://dx.doi.org/10.1016/j.cub.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Curr Biol 2006;16:195-201; PMID:16431372; http://dx.doi.org/ 10.1016/j.cub.2005.12.011 68.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Cell Biol 2009; 187:847-58; PMID:19995935; http://dx.doi.org/ 10.1083/jcb.200908107 70.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Curr Biol 2008; 18:1426-31; PMID:18804373; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Bio- chim Biophysic Acta 2012; 1821:1078-88; PMID:22562055; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Proc Nat Acad Sci U S A 2013;110:4628-33; PMID:23487760; http://dx.doi.org/ 10.1073/pnas.1217611110 73.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Biol Chem 2010;285:22027-35; PMID:20489212; http://dx.doi.org/ 10.1074/jbc.M110.126870 74.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Mol Biol Cell 2003;14:190-200; PMID:12529436; http://dx.doi.org/ 10.1091/mbc.E02-06-0343 75.,Non-OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Dev Biol 2002;251:294-306; PMID:12435359; http://dx.doi.org/ 10.1006/dbio.2002.0830 76.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Exp Biol 2004; 207:2735-43; PMID:15235002; http://dx.doi.org/ 10.1242/jeb.01087 77.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Meth Cell Biol 1994; 44:635-54; PMID:7707973; http://dx.doi.org/10.1016/ S0091-679X(08)60936-X 78.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Biol Chem 2009; 284:1-5;PMID:18718904; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
J Cell Sci 2002; 115:4855-65; PMID:12432073; http://dx.doi.org/10.1242/jcs.00149 81.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Nat Protocol 2009; 4:1807- 19; PMID:20010932; http://dx.doi.org/10.1038/ nprot.2009.192 82.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Nucl Acid Res 2011; 39:W475-8; PMID:21470960;http://dx.doi.org/10.1093/nar/gkr201 83.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Int J Biochem Cell Biol 2004; 36:1187-205; PMID:15109566; http://dx.doi.org/10.1016/j.biocel.2003.08.006 84.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
Dev Biol 2005; 280:177-86; PMID:15766757; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/d5/94/kspe-05-01-1006089.PMC4581069.pdf
"Although Myosins V and VI are important for thisprocess, motor activity does not seem to power migration of the © Josefa Steinhauer *Correspondence to: Josefa Steinhauer; Email: jsteinha@yu.eduSubmitted: 02/27/2015; Revised: 03/26/2015; Accepted: 03/26/2015 http://dx.doi.org/10.1080/21565562.2015.1041345 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/14/kspe-05-02-1041345.PMC4581072.pdf
"14Keywords: brain, electrospun ﬁbers, hydrogel, neuroengineering *Correspondence to: Christopher J Rivet; Email: chrisjrivet@gmail.com; John S Forsythe; Email: John.Forsythe@Monash.edu Submitted: 05/12/2014Revised: 08/02/2014 Accepted: 01/05/2015 http://dx.doi.org/10.1080/21592535.2015.1005527 Government non-exclusive license to publish This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Nat Rev Neurosci 2004; 5:146-56; PMID:14735117; http://dx.doi.org/10.1038/nrn1326 2.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Brain Res Bull 1999; 49:377-391; PMID:10483914; http://dx.doi.org/10.1016/S0361- 9230(99)00072-6 3.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Neurosci 2011; 31:5605-5616; PMID:21490201; http://dx.doi.org/ 10.1523/JNEUROSCI.6663-10.2011 4.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Curr Stem Cell Res Ther 2011; 6:171-89; PMID:21476979; http://dx.doi.org/10.2174/157488811796575350 5.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Nat Rev Neurosci 2009; 10:682-92; PMID:19654582; http://dx.doi.org/10.1038/nrn2685 6.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Crit Rev Biomed Eng 2011; 39:125-80; PMID:21488818; http://dx.doi.org/10.1615/ CritRevBiomedEng.v39.i2.30 7.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Neurotraum 2006;23:496-507; PMID:16629632; http://dx.doi.org/ 10.1089/neu.2006.23.496 8.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2009; 30:354-62; PMID:18930315; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Neural Eng 2009; 6:016001; PMID:19104139; http://dx.doi.org/10.1088/1741-2560/6/1/016001 11.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2009; 30:4573-80; PMID:19500836; http://dx.doi.org/10.1016/j.biomaterials.2009.05.011 13.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2008; 29:1989-2006; PMID:18281090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Promot- ing engraftment of transplanted neural stem cells/pro- genitors using biofunctionalised electrospun scaffolds.Biomaterials 2012; 33:9188-97; PMID:23022345; http://dx.doi.org/10.1016/j.biomaterials.2012.09.013 15.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Biomed Mater Res B 2008; 87:251-63; PMID:18161806; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Funct Biomater 2012; 3:487-513; PMID:24955629; http://dx.doi.org/ 10.3390/jfb3030497 18.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2008; 29:2348-58; PMID:18313138; http://dx.doi.org/10.1016/j.biomaterials.2008.01.032 19.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Biomed Mater Res A 2009; 91:231-40; PMID:18814222; http://dx.doi.org/10.1002/jbm.a.32208 20.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Tissue Eng 2007; 13:2249-57; PMID:17536926; http://dx.doi.org/10.1089/ten.2006.0306 21.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Prog Polym Sci 2014; 39:862-890; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Prog Polym Sci 2014; 39:862-890; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Smart Struct Syst 2011; 7:213-22; PMID:22287978; http://dx.doi.org/10.12989/sss.2011.7.3.213 24.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2011; 32:3387-94; PMID:21303718; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Soft Matter 2010; 6:2227-37; http://dx.doi.org/10.1039/b924349f 26.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Nanomed Nanotech Biol Med 2013; 9:322-335; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2014; 35:1439-49; PMID:24246642; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
J Neural Eng 2008; 5:221-31; PMID:18503105; http://dx.doi.org/ 10.1088/1741-2560/5/2/013 29.,Non-OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Tissue Eng 2006; 12:2777-2787; PMID:17518647; http://dx.doi.org/10.1089/ ten.2006.12.2777 30.,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
Biomaterials 2008; 29:3574-82; PMID:18533251; http://dx.doi.org/ 10.1016/j.biomaterials.2008.05.014 www.tandfonline.com e1005527-7 Biomatter,OADS,/arxiv_data1/oa_pdf/39/bc/kbim-05-01-1005527.PMC4581123.pdf
"Biologicalprocesses are complex and synergistic, and few studies aredevoted to explore this synergy through the development of © Vanessa Monta ~no-Machado, Pascale Chevallier, Diego Mantovani, and Emmanuel Pauthe *Correspondence to: Emmanuel Pauthe; Email: emmanuel.pauthe@u-cergy.fr Submitted: 02/13/2014; Revised: 04/30/2014; Accepted: 10/20/2014 http://dx.doi.org/10.4161/21592535.2014.979679 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Eur Heart J 2000; 21:662-7; PMID:10731404; http://dx.doi.org/10.1053/euhj.1999.1945 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Circulation 2004; 110:1226-30; PMID:15337693; http://dx.doi.org/10.1161/01.CIR.0000140721.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
EuroIntervention 2007; 2:309-14; PMID:19737710; http://dx.doi.org/10.4244/EIJV3I3A57 5.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Biomed Mater Res1992; 26:1259-75; PMID:1429748; http://dx.doi.org/ 10.1002/jbm.820261002 8.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Bio- chemistry 2004; 43:1724-35; PMID:14769050; http://dx.doi.org/10.1021/bi0347104 e979679-10 Volume 5 Issue 1 Biomatter,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Int J Biochem Cell Biol2006; 38:1547-60; PMID:16697243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biochim Biophys Acta 2002;1597:12-21; PMID:12009397; http://dx.doi.org/ 10.1016/S0167-4838(02)00271-6 13.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Colloid Surf B Biointerfaces 2008; 63:129-37; PMID:18249527;http://dx.doi.org/10.1016/j.colsurfb.2007.11.015 16.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Mac- romol Biosci 2007; 7:738-45; PMID:17457945; http://dx.doi.org/10.1002/mabi.200600267 17.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Blood 2006; 107:3555-63; PMID:16391013; http://dx.doi.org/10.1182/blood- 2005-10-4168 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Acta Biomater 2011; 7:3780-8; PMID:21704740; http://dx.doi.org/10.1016/j.actbio.2011.06.016 19.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials 1986; 7:252-6; PMID:3741959; http://dx.doi.org/10.1016/0142-9612(86)90045-1 21.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Materials 2010; 3:1515-32;http://dx.doi.org/10.3390/ma3031515 24.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials 2002; 23:1697-706; PMID:11922473; http://dx.doi.org/10.1016/S0142-9612(01)00297-6 25.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Macromol Biosci 2005; 5:829-39; PMID:16134089; http://dx.doi.org/10.1002/mabi.200500088 26.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials 2005; 26:7410-7; PMID:15998538; http://dx.doi.org/ 10.1016/j.biomaterials.2005.05.052 29.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials 2012; 33:1959-69; PMID:22154622; http://dx.doi.org/10.1016/j.biomaterials.2011.11.017 30.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Mater Sci-Mater Med 2012; 23:2761-72; PMID:22878726; http://dx.doi.org/10.1007/ s10856-012-4736-x 31.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials2009; 30:2276-83; PMID:19168214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Neurosurgery 2006; 59:812-21; PMID:17038945; http://dx.doi.org/10.1227/01.NEU.0000232836.66310.46 33.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Am J Cardiol 2000; 85:698-702;PMID:12000042; http://dx.doi.org/10.1016/S0002- 9149(99)00843-7 34.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Biomed Mater Res A 2013; 101A:413-20; PMID:22865832; http://dx.doi.org/10.1002/jbm.a.34339 36.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Vasc Surg 2011; 53:461-71; PMID:21129910; http://dx.doi.org/10.1016/j.jvs.2010.08.020 37.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Med Biol Eng 2011; 31:307-16; http://dx.doi.org/10.5405/jmbe.958 38.,Non-OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
Biomaterials 1989; 10:219-24; PMID:2525934; http://dx.doi.org/10.1016/0142-9612(89)90096-3 39.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
J Colloid Interface Sci 2012; 368:636-47; PMID:22172691; http://dx.doi.org/10.1016/j.jcis.2011.11.039 40.,OADS,/arxiv_data1/oa_pdf/9f/44/kbim-05-01-979679.PMC4581125.pdf
"In addition to the chemical composition, an “optimal” bone substitute material must also possess a speciﬁc combination ofphysical properties to support an optimal bone regeneration pro-cess by promoting the ingrowth of osteoblasts, endothelial cells © M Barbeck, M Dard, M Kokkinopoulou, J Markl, P Booms, RA Sader, CJ Kirkpatrick, and S Ghanaati *Correspondence to: M Barbeck; Email: mike.barbeck@kgu.deSubmitted: 03/02/2015; Revised: 05/11/2015; Accepted: 05/26/2015 http://dx.doi.org/10.1080/21592535.2015.1056943 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Appl Biomater 1991; 2(3):187-208;PMID:10149083; http://dx.doi.org/10.1002/ jab.770020307 2.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Bio- mater Appl 2008; 23(3):197-212; PMID:18996965; http://dx.doi.org/10.1177/0885328208096798 4.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Trauma2000; 48(1):179-86; PMID:10647592; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Materials 2010; 3(2):815-26;PMID:24710095; http://dx.doi.org/10.3390/ ma3020815 6.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomed Mater 2012; 7(1):015005; PMID:22287541; http://dx.doi.org/10.1088/1748-6041/7/1/015005 7.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res 1989; 23(8):883- 94; PMID:2777831; http://dx.doi.org/10.1002/ jbm.820230806 8.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Int J Appl Ceram Tech 2005; 2:184-99; PMID:16378638; http://dx.doi.org/ 10.1111/j.1744-7402.2005.02020.x 9.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res 2002; 63(4):408-12; PMID:12115748; http://dx.doi.org/10.1002/jbm.10259 10.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Acta Biomater 2008; 4(6):1904-15; PMID:18571999; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomaterials 2006; 27(30):5186-98; PMID:16790273; http://dx.doi.org/10.1016/j.biomaterials.2006.05.051 13.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Semin Immunol 2008; 20 (2):86-100; PMID:18162407; http://dx.doi.org/ 10.1016/j.smim.2007.11.004 14.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Acta Biomater 2010; 6(12):4476-87; PMID:20624495; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res 1998; 39:390-7; PMID:9468047; http://dx.doi.org/10.1002/(SICI)1097-4636(19980305)39:3%3c390::AID-JBM7 %3e3.0.CO;2-E 16.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Acta Biomater 2009; 5(1):338-45; PMID:18753024; http://dx.doi.org/ 10.1016/j.actbio.2008.07.023 17.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Periodontol 2006; 77(5):765-72; PMID:16671867; http://dx.doi.org/10.1902/jop.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Oral Implantol 2007; 33(5):267-76;PMID:17987858; http://dx.doi.org/10.1563/1548-1336 (2007)33%5b267:EOGSOT%5d2.0.CO;2 19.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res 1999; 46:103-11; PMID:10357141; http://dx.doi.org/10.1002/(SICI)1097-4636(199907)46:1%3c103:: AID-JBM12%3e3.0.CO;2-Z 20.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Osteoarthritis Cartilage1997; 5:145-51; PMID:9219677; http://dx.doi.org/ 10.1016/S1063-4584(97)80009-X 21.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
; http://dx.doi.org/10.1016/S8756- 3282(99)00137-4 22.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Cells Tissues Organs 2006; 182(2):79-88; http://dx.doi.org/ 10.1159/000093062 2 4 .,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomaterials 1991; 12(6):574-6; PMID:1663393; http://dx.doi.org/10.1016/0142- 9612(91)90054-E 26.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomaterials 2011; 32 (17):4067-75; PMID:21421269; http://dx.doi.org/ 10.1016/j.biomaterials.2011.02.039 27.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Periodontol 1984; 55(7):406-9; PMID:6086869; http://dx.doi.org/10.1902/jop.1984.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res B Appl Biomater 2013; 101(6):902-10; PMID:23362131;http://dx.doi.org/10.1002/jbm.b.32895 30.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomed Mater 2010; 5(2):25004; PMID:20208127; http://dx.doi.org/10.1088/1748-6041/5/2/025004 33.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
PMID:21784183; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
AnnMaxillofac Surg 2014 Jul-Dec; 4(2):150-7; PMID:25593863; http://dx.doi.org/10.4103/2231- 0746.147106 38.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
PLoS One 2014; 9(6):e101078; PMID:24971744; http://dx.doi.org/10.1371/journal.pone.0101078 39.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Biomed Mater Res Sympos 1971; 2:161; http://dx.doi.org/10.1002/jbm.820050613 42.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Pharm Res 2008; 25(8):1815-21; PMID:18373181; http://dx.doi.org/10.1007/s11095-008-9562-y 46.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
1988; 9:356-362; PMID:3214660; http://dx.doi.org/10.1016/0142- 9612(88)90033-6 47.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Annu Rev Mater Res 2001; 31:81-110; http://dx.doi.org/10.1146/annurev.matsci.31.1.81 48.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomaterials 2004; 25 (4):625-31; PMID:14607500; http://dx.doi.org/ 10.1016/S0142-9612(03)00571-4 49.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Bone Miner Res 2003; 18(9):1573-83; PMID:12968666; http://dx.doi.org/10.1359/jbmr.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Biomaterials 2012; 33(15):3792-802;PMID:22386919; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Int J Oral Sci 2012; 4(2):64-8; PMID:22722639; http://dx.doi.org/10.1038/ ijos.2012.33 53.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Exp Mol Pathol 2005; 79(2):126-35; PMID:16109404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Annu Rev Pathol 2012; 7:61-98; PMID:21910624; http://dx.doi.org/10.1146/annurev- pathol-011811-132445 55.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Curr Opin Hematol 2009; 16(1):53-7; PMID:19057205; http://dx.doi.org/10.1097/MOH.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Exp Hematol 1999; 27(8):1229-41; PMID:10428500; http://dx.doi.org/10.1016/S0301-472X(99)00061-2 57.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Bioessays 1998; 20(10):837-46; PMID:9819571; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Semin Cell Dev Biol 2002; 13 (4):285-92; PMID:12243728; http://dx.doi.org/ 10.1016/S1084952102000587 59.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Semin Cell Dev Biol 2008; 19(5):424-33; PMID:18768162; http://dx.doi.org/10.1016/j.semcdb.,OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
J Bone Miner Res 2000; 15(7):1337-45; PMID:10893682; http://dx.doi.org/10.1359/jbmr.2000.15.7.1337 www.tandfonline.com e1056943-13 Biomatter,Non-OADS,/arxiv_data1/oa_pdf/f4/07/kbim-05-01-1056943.PMC4581126.pdf
Available	from:	 http://www.iranicaonline.org/articles/gilan‑vi.,Non-OADS,/arxiv_data1/oa_pdf/d0/f6/ABR-4-160.PMC4581131.pdf
Available from: http://www.ohchr.org/EN/UDHR/Documents/ UDHR_Translations/eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.ohchr.org/ Documents/ProfessionalInterest/cescr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.nhp.gov.in/directory- services-and-regulations/committees-and-commissions/bhore- committee1946.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.un.org/millennium/declaration/ ares552e.htm.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.who.int/gho/publications/world_ health_statistics/EN_WHS2014_Part3.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.censusindia.gov.in/vital_statistics/ SRS_Based/Introduction.pdf.,OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://censusindia.gov.in/Vital_Statistics/ Summary_Report_Death_01_03.pdf.,OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.who.int/gho/publications/ world_health_statistics/EN_WHS2013_Full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://mospi.nic.in/Mopsi_New/ upload/nss_71st_ki_health_30june15.pdf [Last accessed on 2015  Jul 23].,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://uhc-india.org/uploads/RaoKD_ SituationAnalysisoftheHealthWorkforceinIndia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
http://nrhm.gov.in [Last accessed on  2015 Jul 23].,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://www.mohfw.nic.in/showfile.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://citation.allacademic.com/ meta/p_mla_apa_research_citation/4/1/0/4/8/p410489_index.,OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: http://citeseerx.ist.psu.edu/viewdoc/do wnload;jsessionid=EC46C47A2F544A5B40891B89DD75C3FA ?doi=10.1.1.198.8226&rep=rep1&type=pdf.,OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available from: https://www.oxfam.org/sites/www.oxfam.,Non-OADS,/arxiv_data1/oa_pdf/28/fc/IJCM-40-218.PMC4581140.pdf
Available at: http://apps.who.int/medicinedocs/en/d/Js21447en  [Last accessed on 2013 May 12].,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from:  http://apps.who.int/medicinedocs/documents/s17812en/ s17812en.pdf [Last accessed on 2013 May 05].,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available  from: http://www.eos-intelligence.com/perspectives/?p=36  [Last accessed on 2013 May 05].,OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available  from: http://nhsrcindia.org/pdf_files/resources_thematic/ Medicine_and_Technology/NHSRC_Contribution/Others/ Promoting_Rational_Drug_use_under_NRHM_NHSRC_WHO.,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from:  http://www.who.int/nha/country/ind/en/ [Last accessed on 2013  May 07].,OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from: http://articles.timesofindia.indiatimes.,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from: http://articles.economictimes.,Non-OADS,/arxiv_data1/oa_pdf/be/94/IJCM-40-223.PMC4581141.pdf
Available from: http://www.unicef.org/protection/57929_58008.,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available fro: http://wcd.nic.in/cma2006.,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available from: http://www.who.int/mediacentre/news/releases/2013/child_marriage_20130307/en/ [Last accessed on  2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available from: http://www.unicef.org/sowc07/docs/sowc07.pdf  [Last accessed on 2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available  from: http://www.unicef.org/india/Child_Marriage_Fact_Sheet_ Nov2011_final.pdf [Last accessed on 2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available  from: http://www.iussp.org/sites/default/files/event_call_for_ papers/IUSSP%20New.Extended%20Abstract%20ONE_0.pdf  [Last accessed on 2014 Aug 21].,OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available from: http://www.unicef.org/publications/ files/Early_Marriage_12.lo.pdf [Last accessed on 2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available from: http://www.icrw.org/files/publications/Too- Young-to-Wed-the-Lives-Rights-and-Health-of- Young-Married- Girls.pdf [Last accessed on 2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs364/en/  [Last accessed on 2014 Aug 21].,Non-OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available  from: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_13- en.pdf [Last accessed on 2014 Aug 21].,OADS,/arxiv_data1/oa_pdf/1b/d3/IJCM-40-246.PMC4581144.pdf
Available from: http://www.who.int/social_ determinants/tools/multimedia/alma_ata/en/ [Last updated on  2014 Aug 25 and Last cited on 2014 Aug 25].,OADS,/arxiv_data1/oa_pdf/d0/2c/IJCM-40-252.PMC4581145.pdf
Available  from: http://www.alz.org/downloads/Facts_Figures_2014.pdf.,OADS,/arxiv_data1/oa_pdf/24/f3/IJCM-40-258.PMC4581146.pdf
Available from: http://globocan.iarc.fr/Pages/ fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f0/2e/IJCM-40-264.PMC4581147.pdf
Available from:  http://mohfw.nic.in/WriteReadData/l892s/1455618937GATS%20 India.pdf [Last accessed on 2014 Dec 27].,Non-OADS,/arxiv_data1/oa_pdf/f0/2e/IJCM-40-264.PMC4581147.pdf
Available from: http://www.who.int/substance_abuse/ publications/global_alcohol_report/msb_gsr_2014_2.pdf [Last  accessed on 2014 Dec 27].,Non-OADS,/arxiv_data1/oa_pdf/f0/2e/IJCM-40-264.PMC4581147.pdf
Available from: http://www.seer.cancer.gov/popdata [Last  accessed on Dec 2014].,Non-OADS,/arxiv_data1/oa_pdf/f0/2e/IJCM-40-264.PMC4581147.pdf
Available from: http://fernandezresearch.com/2012/12/16/chronic-hypertension- in-pregnancy outcomes/ [Last accessed on 2014 March 10].,Non-OADS,/arxiv_data1/oa_pdf/bc/e2/IJCM-40-273.PMC4581149.pdf
Available from: http://www.who.int/cholera/publications/ OutbreakAssessment/en/ [Last accessed on 2013 Aug 25].,Non-OADS,/arxiv_data1/oa_pdf/6e/f4/IJCM-40-283.PMC4581152.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/vetreco-2014-000104).,Non-OADS,/arxiv_data1/oa_pdf/58/f9/vetreco-2014-000104.PMC4581345.pdf
"http://ec.europa.eu/health/files/eudralex/vol-5/consol_2004/dir_2001_02-dir_2004_28-cons_en.pdf Anonymous (2012) Hiérarchisation de 103 maladies animales présentes dans les filières ruminants, équidés, porcs, volailles et lapins en France métropolitaine.",Non-OADS,/arxiv_data1/oa_pdf/58/f9/vetreco-2014-000104.PMC4581345.pdf
Transcription 2014; 5:1 –5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Nature 2012; 489:101-8; PMID:22955620; http://dx.doi.org/10.1038/nature11233 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Annu Rev Microbiol1994; 48:713-42; PMID:7826024; http://dx.doi.org/ 10.1146/annurev.mi.48.100194.003433 5.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Annu Rev Genet 2010; 44:167-88; PMID:20707673;http://dx.doi.org/10.1146/annurev-genet-102209- 163523 6.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
EMBO J 2012; 31:4005-19; PMID: 22922465; http://dx.doi.org/10.1038/emboj.2012.229 7.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
RNA Biol 2014; 11:e00156-12; PMID:24922322;http://dx.doi.org/10.4161/rna.29299 8.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Science 2012; 335:1103-6; PMID: 22383849; http://dx.doi.org/10.1126/science.1206848 10.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Mol Biol Evol 2001; 18:1764-70; PMID:11504856; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
PLoS Genet 2006; 2:e185;PMID:17096598; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Mol Biol Evol 2003; 20:901-6; PMID: 12716998; http://dx.doi.org/10.1093/molbev/msg096 14.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Genes Dev 2012; 26:2621-33; PMID:23207917; http://dx.doi.org/10.1101/gad.196741.112 17.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Science 2014; 343:769-72; PMID: 24457212; http://dx.doi.org/10.1126/science.1248286 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
PLoS Genet 2012; 8: e1002841; PMID:22844254; http://dx.doi.org/10.1371/journal.pgen.1002841 20.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Proc Natl Acad Sci USA 2011; 108:20172- 7; PMID:22123973; http://dx.doi.org/10.1073/ pnas.1113521108 21.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Proc Natl Acad Sci USA 2014; 111:3134-9; PMID:24453212; http://dx.doi.org/ 10.1073/pnas.1315974111 22.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Mol Syst Biol 2012;8:583; PMID:22617957; http://dx.doi.org/10.1038/ msb.2012.11 23.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
PLoS Genet 2012; 8:e1002782; PMID:22761586; http://dx.doi.org/10.1371/journal.pgen.1002782 25.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Mol Cell 2013; 52:473-84; PMID:24267449; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Cold Spring HarbSymp Quant Biol 1974; 38:31-41; PMID:4598638; http://dx.doi.org/10.1101/SQB.1974.038.01.006 27.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
J Bacteriol 2012; 194:6046-55; PMID:22942248; http://dx.doi.org/ 10.1128/JB.00961-12 28.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Nat Biotechnol 2014; 32:453- 61; PMID:24811520; http://dx.doi.org/10.1038/nbt.,OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
Nat Rev Genet 2013; 14:880-93; PMID:24217315; http://dx.doi.org/ 10.1038/nrg3594 www.landesbioscience.com e944039-5 Transcription,Non-OADS,/arxiv_data1/oa_pdf/6a/15/ktrn-05-04-944039.PMC4581347.pdf
"9,10,17Based on extensive appar- ent structural homology, amino acid sequence alignments were generated, supporting the conclusion that sfactors, TFB and *Correspondence to: Zachary F Burton; Email:burton@cns.msu.edu Submitted: 08/19/2014; Revised: 09/11/2014; Accepted: 09/12/2014 http://dx.doi.org/10.4161/21541264.2014.967599 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id D index)31was used for homology threading to adapt the archaeal TFB-TBP-DNA structure (PDB 1AIS) to Sc TFIIB sequences andstructures.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
"After placing CLR/HTH 2, the B-linker was adjusted using the program Modeller (https://salilab.org/modeller/9.12/manual/) 32to connect the 2-CLR/HTH domains.",OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Sequences for archaeal TFB multiple alignments were collectedfrom the Uniprot database (http://www.uniprot.org/).,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Sequencesforsmultiple alignments were collected from the NCBI data- base (http://www.ncbi.nlm.nih.gov/) and aligned using the SDSC Biology Workbench tools (http://workbench.sdsc.edu/).,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Cold Spring Harbor Perspect biol 2014; 6:a016188;PMID:24691961; http://dx.doi.org/10.1101/ cshperspect.a016188 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Transcription 2014; 5:1-12; PMID:24802897; http://dx.doi.org/10.4161/trns.28674 3.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
J Struct Biol 2012; 179:299-319; PMID:22210308; http://dx.doi.org/10.1016/j.jsb.2011.12.013 5.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Annu Rev Microbiol 2014;68:357-76; PMID:25002089; http://dx.doi.org/10.1146/annurev- micro-092412-155737 6.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Ann Rev Microbiol 2013; 67:113-39; PMID:23768203; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Chem Rev 2013; 113:8331-49; PMID:24024741; http://dx.doi.org/10.1021/cr4002325 8 .,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Proc Natl Acad Sci U S A 1991; 88:9553-7; PMID:1946368; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Nature 2013; 493:437-40; PMID:23151482; http://dx.doi.org/10.1038/nature11715 10.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Sci- ence 2010; 327:206-9; PMID:19965383; http://dx.doi.org/10.1126/science.1182015 11.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
GeneDeve 1992; 6:1940-9; PMID:1398071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Biochim Biophys Acta 2013; 1829:265-73; PMID:22960599; http://dx.doi.org/10.1016/j.bbagrm.2012.08.003 14.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Sci 2004; 303:983-8; PMID:14963322; http://dx.doi.org/10.1126/ science.1090838 17.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Sci 2012; 338:1076-80; PMID:23086998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
"Acta crystallogrSect F, Struct Biol Cryst Commun 2013; 69:950-5; PMID:23989139; http://dx.doi.org/10.1107/ S1744309113020368 19.",OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Cell 2011; 147:1257-69; PMID: 22136875; http://dx.doi.org/10.1016/j.cell.2011.10.041 20.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
EMBO J 1997;16:4034-40; PMID:9233812; http://dx.doi.org/ 10.1093/emboj/16.13.4034 21.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Nucleic Acids Res 1986; 14:6745-63; PMID:3092189; http://dx.doi.org/10.1093/nar/ 14.16.6745 22.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Nat Struct Mol Biol 2014; 21:269-76; PMID:24531660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Curr Opin Struct Biol 2003; 13:31-9; PMID:12581657; http://dx.doi.org/10.1016/S0959-440X(02)00005-2 26.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Mol Cell 2002; 9:527-39; PMID:11931761; http://dx.doi.org/10.1016/S1097-2765(02)00470-7 27.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
Gene Dev 1998; 12:34-44; PMID:9420329; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
"Curr Pro-toc Bioinformatics / editoral board, Andreas D Baxevanis ; et al] 2006; Chapter 5:Unit 5.6; PMID:18428767; http://dx.doi.org/10.1002/0471250953.bi0506s15 33.",OADS,/arxiv_data1/oa_pdf/4e/af/ktrn-05-04-967599.PMC4581349.pdf
"cote@crhdq.ulaval.ca Submitted: 11/24/2014 Revised: 12/01/2014Accepted: 12/01/2014http://dx.doi.org/10.1080/21541264.2014.995571 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Cell 2013; 152:1237-51; PMID:23498934; http://dx.doi.org/10.1016/j.cell.2013.02.014 3.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
2011; Mol Cell 41:502-14; PMID:21362547; http://dx.doi.org/10.1016/j.molcel.2011.02.013 5.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Chem Rev 2013;113:8456-90; PMID:23952966; http://dx.doi.org/ 10.1021/cr400071f 6.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Mol Cell Biol 2002; 22:1298-306; PMID:11839797; http://dx.doi.org/10.1128/MCB.22.5.1298-1306.2002 7.,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Biol Chem 2003; 278: 8897-903;PMID:12511561; http://dx.doi.org/10.1074/jbc.M212 134200 9.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Genes Dev 2003; 17:654-63; PMID:12629047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Cell 2005; 123:581-92; PMID:16286007; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Cell 2005; 123:593-605; PMID:16286008;http://dx.doi.org/10.1016/j.cell.2005.10.025 13.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Nature 2012; 489:452-5;PMID:22914091; http://dx.doi.org/10.1038/nature 11326 14.,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Nature 1998; 394:498-502; PMID:9697775; http://dx.doi.org/10.1038/28886 15.,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Mol Cell 2000; 6:1297-307; PMID:11163204; http://dx.doi.org/10.1016/S1097-2765(00)00128-3 16.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
EMBO J 2004;23:2597-607; PMID:15175650; http://dx.doi.org/ 10.1038/sj.emboj.7600230 18.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
MolCell 2010; 39:234-46; PMID:20670892; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Mol Cell Biol 2009; 29:6473-87; PMID:19822662; http://dx.doi.org/10.1128/ MCB.01033-09 22.,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Biol Chem 2014; 289:32656-70; PMID:25301943; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Nat Struct Mol Biol 2012; 19:884-92; PMID:22922743; http://dx.doi.org/10.1038/nsmb.2312 25.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Biol Chem 2003; 278:42733-6; PMID:12963728; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Biol Chem 2010; 285:12803-12; PMID:20190278; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Nature 2013; 493:120-4; PMID:23160493; http://dx.doi.org/10.1038/nature11658 32.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Biol Chem 2009; 284:21127-31; PMID:19553677; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
J Cell Sci 2010; 123:1124-30; PMID:20332121; http://dx.doi.org/10.1242/jcs.060178 34.,OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Mol Cell Biol 2008; 28:2257-70; PMID:18212047; http://dx.doi.org/ 10.1128/MCB.01755-07 36.,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
Mol Cell Biol 2008; 28:2244-56; PMID:18212056; http://dx.doi.org/10.1128/MCB.01653-07 www.landesbioscience.com e995571-3 Transcription,Non-OADS,/arxiv_data1/oa_pdf/0a/dd/ktrn-05-05-995571.PMC4581353.pdf
"© Shun-ichi Sekine, Yuko Murayama, Vladimir Svetlov, Evgeny Nudler, and Shigeyuki Yokoyama*Correspondence to: Shun-ichi Sekine; Email: shunichi.sekine@riken.jp, Shigeyuki Yokoyama; Email: yokoyama@riken.jp Submitted: 04/14/2015Revised: 06/01/2015Accepted: 06/01/2015 http://dx.doi.org/10.1080/21541264.2015.1059922 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Structural basis of transcription: RNA polymerase II at 2.8 A/C14resolu- tion, Science 2001; 292, 1863-76; PMID:11313498; http://dx.doi.org/10.1126/science.1059493.",Non-OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Opening and closing of the bacterial RNA polymerase clamp, Science 2012; 337, 591-5; PMID:22859489; http://dx.doi.org/10.1126/ science.1218716.",Non-OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"2014 ;21, 794-802; PMID:25108353; http://dx.doi.org/10.1038/nsmb.2867.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Vassylyev DG, Vassylyeva MN, Zhang J, Palangat M, Artsimovitch I, Landick R. Structural basis for substrateloading in bacterial RNA polymerase, Nature 2007; 448, 163-8; PMID:17581591; http://dx.doi.org/ 10.1038/nature05931.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Cell 2015; 57, 408-21; PMID:25601758; http://dx.doi.org/10.1016/j.molcel.2014.12.014.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Structural basis for transcriptionelongation by bacterial RNA polymerase, Nature 2007; 448, 157-62; PMID:17581590; http://dx.doi.org/ 10.1038/nature05932.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Tagami S, Sekine SI, Yokoyama S. A novel conforma- tion of RNA polymerase sheds light on the mechanism of transcription, Transcription 2011; 2, 162-7; PMID:21922057; http://dx.doi.org/10.4161/ trns.2.4.16148.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Biol 2012; 22, 110-18;PMID:22155178; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Nudler E. RNA polymerase backtracking in gene regu- lation and genome instability, Cell 2012; 149, 1438- 45; PMID:22726433; http://dx.doi.org/10.1016/j.cell.2012.06.003.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Microbiol 2005; 55, 1315-24; PMID:15720542; http://dx.doi.org/10.1111/j.1365- 2958.2004.04481.x.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Laptenko O, Kim SS, Lee J, Starodubtseva M, Cava F, Berenguer J, Kong XP, Borukhov S. pH-dependentconformational switch activates the inhibitor of tran- scription elongation, EMBO J 2006; 25, 2131-41; PMID:16628221; http://dx.doi.org/10.1038/sj.emboj.7601094.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Struc- tural basis of transcriptional pausing in bacteria, Cell2013; 152, 431-41; PMID:23374340; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Roghanian M, Zenkin N, Yuzenkova Y. Bacterial global regulators DksA/ppGpp increase ﬁdelity of transcription, Nucleic Acids Res 2015; 43, 1529-36; PMID:25605801; http://dx.doi.org/10.1093/nar/gkv003.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Cell 2013; 50, 430-6; PMID:23623685; http://dx.doi.org/10.1016/j.molcel.2013.03.020.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Cell 2013; 50, 882-893; PMID:23769674; http://dx.doi.org/10.1016/ j.molcel.2013.05.015.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"The structure of bacterial RNA polymerase in complex with the essential transcription elongation fac-tor NusA, EMBO Rep 2009; 10, 997-1002; PMID:19680289; http://dx.doi.org/10.1038/ embor.2009.155.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Epshtein V, Kamarthapu V, McGary K, Svetlov V, Ueberheide B, Proshkin S, Mironov A, Nudler E.UvrD facilitates DNA repair by pulling RNA polymer- ase backwards, Nature 2014; 505, 372-77; PMID:24402227; http://dx.doi.org/10.1038/nature12928.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Epshtein V, Dutta D, Wade J, Nudler E. An allosteric mechanism of Rho-dependent transcription termina- tion, Nature 2010; 463, 245-9; PMID:20075920; http://dx.doi.org/10.1038/nature08669.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Cell Biol 2015; 16, 190-202;PMID:25650800; http://dx.doi.org/10.1038/ nrm3943.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"NandyMazumdar M, Artsimovitch I. Ubiquitous tran- scription factors display structural plasticity and diverse functions: NusG proteins - Shifting shapes and para-digms, BioEssays 2015; 37, 324-34; PMID:25640595; http://dx.doi.org/10.1002/bies.201400177.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Burmann BM, Knauer SH, Sevostyanova A, Schweimer K, Mooney RA, Landick R, Artsimovitch I, Rosch P. Anahelix to bbarrel domain switch transforms the transcription factor RfaH into a translation factor, Cell 2012; 150, 291-303; PMID:22817892; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Vassylyev DG, Sekine S, Laptenko O, Lee J, Vassylyeva MN, Borukhov S, Yokoyama S. Crystal structure of abacterial RNA polymerase holoenzyme at 2.6 A /C14resolu- tion, Nature 2002; 417, 712-9; PMID:12000971; http://dx.doi.org/10.1038/nature752.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Bridge helix and trigger loop perturba-tions generate superactive RNA polymerases, J. Biol 2008; 7, 40; PMID:19055851; http://dx.doi.org/ 10.1186/jbiol98.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Bar-Nahum G, Epshtein V, Ruckenstein AE, Raﬁkov R, Mustaev A, Nudler E. A ratchet mechanism of tran- scription elongation and its control, Cell 2005; 120, 183-93; PMID:15680325; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"Chem 2014; 289, 24549-59; PMID:24973216; http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/6e/d4/ktrn-06-03-1059922.PMC4581356.pdf
"© Jill Sergesketter Butler and Marek Napierala *Correspondence to: Jill Sergesketter Butler; Email: jsbutler@uab.edu; Marek Napierala; Email:mnapiera@uab.edu Submitted: 01/22/2015Accepted: 03/02/2015 http://dx.doi.org/10.1080/21541264.2015.1026538 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
PLoS One 2013; 8: e54710; PMID:23405090; http://dx.doi.org/10.1371/journal.pone.0054710 2.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Biofac- tors 2013;39:164-75; PMID:23233240; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Science 1996; 271: 1423-7; PMID:8596916; http://dx.doi.org/10.1126/ science.271.5254.1423 4.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nature 2003; 422:909-13; PMID:12712207; http://dx.doi.org/10.1038/nature01596 5.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nat Chem Biol 2006; 2:551-8; PMID:16921367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nucleic Acids Res 2008; 36:6056-65; PMID:18820300; http://dx.doi.org/10.1093/nar/gkn604 7.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Hum Mol Genet 2008; 17: 735-46; PMID:18045775; http://dx.doi.org/ 10.1093/hmg/ddm346 8.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Proc Natl Acad Sci U S A 2006; 103: 11497-502; PMID:16857735; http://dx.doi.org/10.1073/ pnas.0604939103 10.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
EMBO Mol Med 2010; 2:120-9; PMID:20373285;http://dx.doi.org/10.1002/emmm.201000064 11.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Ann Neurol 2014; 76: 522-8; PMID:25112975; http://dx.doi.org/10.1002/ana.24249 12.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
J Biol Chem 2010; 286: 4209- 15; PMID:21127046; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
PLoS Genet 2014; 10:e1004318; PMID:24787137; http://dx.doi.org/10.1371/journal.pgen.1004318 14.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nucleic Acids Res 2011; 39:8366-77; PMID:21745819; http://dx.doi.org/ 10.1093/nar/gkr54215.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nucleic Acids Res 2011; 39:1749-62; PMID:21051337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
PLoS Genet 2014; 10: e1004294; PMID:24743386; http://dx.doi.org/10.1371/journal.pgen.1004294 19.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nature 2014; 507:195-200; PMID:24598541; http://dx.doi.org/ 10.1038/nature13124 20.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nucleic Acids Res 2007; 35:5351-9;PMID:17693431; http://dx.doi.org/10.1093/nar/ gkm589 21.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Genes Dev 2014; 28:1384-96; PMID:24990962; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Nature 2014; 516: 436- 9; PMID:25296254; http://dx.doi.org/10.1038/ nature13787 23.,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Mol Cell 2011; 42:794-805;PMID:21700224; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Curr Opin Biotechnol 2011; 22:S16-S; http://dx.doi.org/10.1016/j.copbio.2011.05.010 25.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Mol Cell 2012; 48:254-65; PMID:22959270; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Genomics 2004; 83:373- 83; PMID:14962663; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
Mol Biology Evol 2009; 26:327-34; PMID:18984903; http://dx.doi.org/10.1093/molbev/msn249 36 Volume 6 Issue 2 Transcription,Non-OADS,/arxiv_data1/oa_pdf/43/47/ktrn-06-02-1026538.PMC4581357.pdf
"These resources, freely accessible athttp://lifefaculty.biu.ac.il/gershon-tamar/index.php/resources, facilitate the identi ﬁcation of core promoter elements as active contributors to gene expression.",OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
"Remarkably, the MTE, DPEand Bridge elements are exclusively dependent on the pres-ence of a functional initiator with a strict spacing *Correspondence to: Tamar Juven-Gershon; Email: tamar.gershon@biu.ac.il Submitted: 10/30/2014; Revised: 06/22/2015; Accepted: 06/24/2015 http://dx.doi.org/10.1080/21541264.2015.1067286 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
"29-35However, even available pro- grams that aim to identify core promoter elements, such as McPromoter36and Eukaryotic Core Promoter Predictor (YAPP, http://www.bioinformatics.org/yapp/cgi-bin/yapp.cgi), rarelyconsider the functional constraint of the strict spacing requiredby the Inr-dependent elements, namely, DPE, MTE, and Bridge.",Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
"GO terms analysis GO terms enrichment was assessed using the PANTHER classi- ﬁcation system 42(http://pantherdb.org/).43F o re a c he x a m i n e de l e - ment (TATA, dInr, DPE, MTE and dTCT), 5 distinct lists werecreated based on the CORE results- CAGE peaked, CAGE broad,CAGE unclassiﬁed, all CAGE tags and RNA-seq.",OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Cell Mol Life Sci 2007; 64:386-400; PMID:17171231; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Curr Opin Cell Biol 2008; 20:253-9; PMID:18436437; http://dx.doi.org/ 10.1016/j.ceb.2008.03.003 3.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Dev Biol 2010; 339:225-9;PMID:19682982; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Wiley Interd Rev Dev Biol 2012; 1:40- 51; PMID:23801666; http://dx.doi.org/10.1002/ wdev.21 5.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 2001; 15:2503-8; PMID:11581155; http://dx.doi.org/10.1101/ gad.937701 6.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Ann Rev Biochem 2003; 72:449-79; PMID:12651739; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
J Biol Chem 2007;282:14685-9; PMID:17395580; http://dx.doi.org/ 10.1074/jbc.R700012200 9.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Bio- chim Biophys Acta 2014; 1839:118-28;PMID:24275614; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Biochim Biophys Acta 2015; PMID:25934543; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nat Methods 2006; 3:917-22; PMID:17124735; http://dx.doi.org/10.1038/ nmeth937 12.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
J Biol Chem 2014; 289:11993-2004; PMID:24634215; http://dx.doi.org/10.1074/jbc.M114.55025113.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nucleus 2014; 5:298-303; PMID:25482118; http://dx.doi.org/10.4161/nucl.29838 14.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Transcription 2011; 2:201-6; PMID:22231114; http://dx.doi.org/10.4161/ trns.2.5.17271 16.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Trends BiochemSci 2013; 38:603-11; PMID:24120742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Cell 2013; 152:120-31; PMID:23332750; http://dx.doi.org/10.1016/j.cell.2012.12.005 20.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 1996; 10:711-24; PMID:8598298; http://dx.doi.org/10.1101/gad.10.6.711 21.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Mol Cell Biol 2001; 21:1593-602;PMID:11238896; http://dx.doi.org/10.1128/ MCB.21.5.1593-1602.2001 23.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Mol Cell Biol2010; 30:3471-9; PMID:20457814; http://dx.doi.org/ 10.1128/MCB.00053-10 24.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Mol Cell Biol 2000; 20:4754-64; PMID:10848601; http://dx.doi.org/10.1128/MCB.20.13.4754-4764.200025.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 2004; 18:1606-17; PMID:15231738; http://dx.doi.org/10.1101/gad.1193404 26.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Bioinformatics 2005; 21:1295-300; PMID:15572469; http://dx.doi.org/10.1093/bioinfor matics/bti172 27.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2008; 18:1-12; PMID:18032727; http://dx.doi.org/10.1101/gr.6831208 29.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Trends Genet 2001; 17:56-60;PMID:11173099; http://dx.doi.org/10.1016/S0168- 9525(00)02174-0 31.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Com- put Chem 1999; 23:191-207; PMID:10404615;http://dx.doi.org/10.1016/S0097-8485(99)00015-7 32.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
PLoS Genet 2011; 7:e1001274; PMID:21249180; http://dx.doi.org/10.1371/journal.pgen.1001274 33.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Bioinformatics 2008; 24:i24-31; PMID:18586720; http://dx.doi.org/ 10.1093/bioinformatics/btn172 35.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
PloS One 2013; 8:e54843; PMID:23437045; http://dx.doi.org/10.1371/journal.pone.0054843 36.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
34:5943-50; PMID:17068082; http://dx.doi.org/ 10.1093/nar/gkl608 37.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2013; 23:181-94; PMID:22990209; http://dx.doi.org/ 10.1101/gr.139881.112 38.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nucleic Acids Res 2012; 40:W104-9; PMID:22693218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 2008; 22:2823-30; PMID:18923080; http://dx.doi.org/10.1101/ gad.1698108 40.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2011; 21:182-92; PMID:21177961; http://dx.doi.org/ 10.1101/gr.112466.110 41.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Science 2010; 327:335-8; PMID:20007866; http://dx.doi.org/10.1126/science.1181421 42.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nat Protocols 2013; 8:1551-66; PMID:23868073; http://dx.doi.org/10.1038/ nprot.2013.092 43.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nucleic Acids Res 2013; 41:D377-86; PMID:23193289; http://dx.doi.org/10.1093/nar/gks1118 44.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 2005; 19:2418-23; PMID:16230532; http://dx.doi.org/10.1101/gad.342405 45.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genes Dev 1998; 12:34-44; PMID:9420329; http://dx.doi.org/ 10.1101/gad.12.1.34 46.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Chromosoma 2007; 116:417-29; PMID:17593382; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2007; 17:1898-908; PMID:17989259; http://dx.doi.org/10.1101/gr.6669607 48.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nature 2015; 518:556-9; PMID:25517091; http://dx.doi.org/10.1038/ nature13994 50.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
EMBO J 1999; 18:4835-45; PMID:10469661; http://dx.doi.org/ 10.1093/emboj/18.17.4835 51.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Mol Cell Biol 2007; 27:1844-58; PMID:17210644; http://dx.doi.org/10.1128/ MCB.01363-06 52.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Biol 2006; 7:R53;PMID:16827941; http://dx.doi.org/10.1186/gb-2006- 7-7-r53 53.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome biology 2002; 3:RESEARCH0087; PMID:12537576; http://dx.doi.org/10.1186/gb-2002- 3-12-research0087 54.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2007; 17:798-806; PMID:17567998; http://dx.doi.org/10.1101/gr.5754707 55.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
The EMBO J 2013; 32:1829-41; PMID:23708796; http://dx.doi.org/10.1038/emboj.2013.111 56.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Res 2007; 17:877-85; PMID:17179217; http://dx.doi.org/10.1101/ gr.5533506 59.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nat Rev Genet 2012; 13:840-52;PMID:23090257; http://dx.doi.org/10.1038/nrg3306 60.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Science 2008; 322:1845-8; PMID:19056941; http://dx.doi.org/10.1126/science.1162228 61.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Genome Biol 2009; 10:R73; PMID:19589141; http://dx.doi.org/10.1186/ gb-2009-10-7-r73 63.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nat Rev Genet 2014; 15:272-86;PMID:24614317; http://dx.doi.org/10.1038/nrg3682 64.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
2004; 306:636-40; PMID: 15499007; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Database (Oxford) 2011; 2011:bar023; PMID:21856757; http://dx.doi.org/10.1093/database/bar023 66.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nature 2014; 507:462-70;PMID:24670764; http://dx.doi.org/10.1038/ nature13182 67.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Nat Rev Genet 2007; 8:424-36; PMID:17486122; http://dx.doi.org/10.1038/nrg2026 68.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Cell 1989; 57:103-13;PMID:2467742; http://dx.doi.org/10.1016/0092- 8674(89)90176-1 71.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
PloS One 2009; 4:e5103; PMID:19337366; http://dx.doi.org/ 10.1371/journal.pone.0005103 73.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Proc Natl Acad Sci U S A 2000; 97:7172-7;PMID:10840054; http://dx.doi.org/10.1073/ pnas.120181197 74.,OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
Mol Cell Biol 2005; 25:9674-86; PMID:16227614; http://dx.doi.org/10.1128/ MCB.25.21.9674-9686.2005 50 Volume 6 Issue 3 Transcription,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ktrn-06-03-1067286.PMC4581360.pdf
"Therefore, on one hand splicing is reg- ulated by the speed of transcription, while on the other hand splicing itselfcan enforce a transient pausing/slowdownof the elongating polymerase.Keywords: chromatin and transcription, chromatin marks, co-trancriptional splic-ing, Eukaryotic transcription, PolII, splic-ing, transcription and RNA processing,transcription elongation © IBB PAS *Correspondence to: Szymon /C19Swie _zewski; Email: szymon.swiezewski@gmail.com Submitted: 03/17/2015Revised: 04/07/2015Accepted: 04/07/2015 http://dx.doi.org/10.1080/21541264.2015.1040146 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
F1000Prime Rep 2013; 5:9; PMID:23638305; http://dx.doi.org/10.12703/P5-9 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
RNA 2009; 15:1896-908; PMID:19656867; http://dx.doi.org/ 10.1261/rna.1714509 4.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Mol Cell 2003; 12:525-32;PMID:14536091; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Cell 2013; 154:775-88; PMID:23932120; http://dx.doi.org/ 10.1016/j.cell.2013.07.0336.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Genome Res 2011; 21:390-401; PMID:21163941; http://dx.doi.org/10.1101/ gr.111070.110 7.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
RNA 2003;9:993-1006; PMID:12869710; http://dx.doi.org/ 10.1261/rna.5390803 8.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
EMBO J 2015; 34:544-58; PMID:25568310; http://dx.doi.org/10.15252/ embj.201489478 9.,Non-OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Nat Rev Mol Cell Biol 2015; 16:167-77; PMID:25693130; http://dx.doi.org/10.1038/nrm3953 10.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Science 2013; 339:950-3; PMID:23430654; http://dx.doi.org/10.1126/ science.1229386 11.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Genome Biol 2014; 15:R69; PMID:24887486; http://dx.doi.org/10.1186/gb-2014-15-5-r69 12.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Nat Struct Mol Biol 2005; 13:22-9; http://dx.doi.org/ 10.1038/nsmb1030 14.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Nat Struct Mol Biol 2011; 18:337-44; PMID:21358630; http://dx.doi.org/ 10.1038/nsmb.1995 15.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Mol Cell 2010; 40:582-93; PMID:21095588; http://dx.doi.org/10.1016/j.molcel.2010.11.005 16.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Mol Cell 2013; 51:792-806; PMID:24035497; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Nat Struct Mol Biol 2015; 22:256-64; PMID:25664725; http://dx.doi.org/10.1038/nsmb.2959 18.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Mol Cell 2014; 53:779-90; PMID:24560925; http://dx.doi.org/10.1016/j.molcel.2014.01.017 19.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Cell 2011; 144:16-26; PMID:21215366; http://dx.doi.org/ 10.1016/j.cell.2010.11.056 20.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Mol Cell 2014; 54:156-65; PMID:24725596; http://dx.doi.org/10.1016/j.molcel.2014.03.026 22.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Genes Dev 2015; 29(7):696-701; [cited 2015 Mar 25]; Available from; PMID:25805848; http://dx.doi.org/ 10.1101/gad.258814.115 23.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
Cell 2013; 152:957-68; PMID:23415457; http://dx.doi.org/10.1016/j.cell.2013.01.046 25.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
RNA 1999; 5:1138-9; PMID:10496214; http://dx.doi.org/10.1017/S1355838299991379 26.,OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
RNA 2003; 9:618-30; PMID:12702820; http://dx.doi.org/10.1261/rna.5260303 www.tandfonline.com 39 Transcription,Non-OADS,/arxiv_data1/oa_pdf/d7/09/ktrn-06-02-1040146.PMC4581361.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cf/41/ijcp-08-2326.PMC4581362.pdf
"The Physico-Chemical Characteristics The physiochemical features, theoretical isoelectric  point (pI), molecular weight, total number of positive and negative residues, extinction coefficient, instabil - ity index, aliphatic index and grand average hydropathy of recombinant construct were analyzed by the Expasy ProtParam server (http://us.expasy .org/tools/protparam.html).",OADS,/arxiv_data1/oa_pdf/cf/41/ijcp-08-2326.PMC4581362.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.Dear Editor, Cancer prevention and treatment is one of the world - wide research priorities.",Non-OADS,/arxiv_data1/oa_pdf/ed/a4/ijcp-08-2316.PMC4581363.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a0/cc/ijcp-08-2333.PMC4581364.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/74/ac/ijcp-08-2334.PMC4581365.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/02/6d/ijcp-08-2332.PMC4581366.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7e/d7/ijcp-08-2330.PMC4581367.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a5/c3/ijcp-08-2329.PMC4581368.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9a/d7/ijcp-08-2328.PMC4581369.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/61/45/ijcp-08-2331.PMC4581370.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Com - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/ijcp-08-2327.PMC4581372.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/27/sfv053.PMC4581373.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/d5/sfv054.PMC4581374.pdf
"Chapter 10, Cancer report ( http://www.anzdata.org.au/ ) 10.",Non-OADS,/arxiv_data1/oa_pdf/f1/d5/sfv054.PMC4581374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/af/sfv055.PMC4581375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/04/sfv056.PMC4581376.pdf
Prospective calciphylaxis registries are recruiting patients also in the UK (UK Calciph ylaxis Study) (http://www.gmann.co.uk/website/trials/iccn/home.cfm ) and in Australia (Australian Calciphylaxis Registry) ( http://www.calci phylaxis.org.au ).,Non-OADS,/arxiv_data1/oa_pdf/56/04/sfv056.PMC4581376.pdf
The project received productive supportfrom all members of the ERA-EDTA scienti ﬁcw o r k i n gg r o u pCKD-MBD ( http://www.era-edtaworkinggroups.org/en-US/group/ ckd-mbd#sthash.bWA5EWIt.dpbs ).,Non-OADS,/arxiv_data1/oa_pdf/56/04/sfv056.PMC4581376.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/55/sfv057.PMC4581377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/11/sfv059.PMC4581378.pdf
http://www.cancer.gov/ drugdictionary/?CdrID=459751 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/11/sfv059.PMC4581378.pdf
"2012 http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm312920.htm (20 July 2012, date last accessed) 9.",Non-OADS,/arxiv_data1/oa_pdf/7b/11/sfv059.PMC4581378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/1f/sfv060.PMC4581379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/sfv061.PMC4581380.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/60/sfv062.PMC4581381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/61/sfv063.PMC4581382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/50/sfv064.PMC4581383.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/sfv066.PMC4581384.pdf
"NBTA report on Black, Asian and Minority Ethnic Organ Donation and Trans-plantation data 2013: http://www.nbta-uk.org.uk/wp-content/ uploads/2013/08/NBTA-Organ-data-report-update-July-2013.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/sfv066.PMC4581384.pdf
http://www.organdonation.nhs.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/sfv066.PMC4581384.pdf
"2011. http://www.organdonation.nhs.uk/ukt/statistics/ transplant_activity_report/current_activity_reports/ukt/nhs_ organ_donor_register.pdf (18 July 2012, date last accessed)628 |J.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/sfv066.PMC4581384.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/sfv067.PMC4581385.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/c6/2f/sfv068.PMC4581386.pdf
"Materials and methods Participants The present study is based on the Uppsala Longitudinal Study ofAdult Men ( http://www.pubcare.uu.se/ULSAM/ ), when partici- pants were 70 –71 years old (1991 –95;n= 1221).",Non-OADS,/arxiv_data1/oa_pdf/c6/2f/sfv068.PMC4581386.pdf
Supplementary data Supplementary data is available online at http://ndt.oxford journals.org.,OADS,/arxiv_data1/oa_pdf/c6/2f/sfv068.PMC4581386.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/93/dd/sfv069.PMC4581387.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/8d/sfv070.PMC4581388.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/2a/sfv071.PMC4581389.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/9e/sfv072.PMC4581390.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/a7/sfv074.PMC4581391.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/45/54/sfv075.PMC4581392.pdf
"Based on this unmet need, the STARMEN RCT (available at http://www.clinicaltrials.gov , NCT01955187) will compare the efﬁcacy and safety of sequential treatment with tacrolimus – rituximab versus steroids plus cyclophosphamide in nephrotic patients with primary MN [ 30].",Non-OADS,/arxiv_data1/oa_pdf/45/54/sfv075.PMC4581392.pdf
Available in: http://clinicaltrials.gov/ct2/ show/NCT01955187 31.,Non-OADS,/arxiv_data1/oa_pdf/45/54/sfv075.PMC4581392.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/ba/sfv076.PMC4581393.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/9a/sfv078.PMC4581394.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org.Table 4.,Non-OADS,/arxiv_data1/oa_pdf/db/9a/sfv078.PMC4581394.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/25/sfv085.PMC4581395.pdf
J Am Soc Nephrol 2013; 24: 26 –302.http://asn-online.org/about/ committees/committee.aspx?,Non-OADS,/arxiv_data1/oa_pdf/fc/25/sfv085.PMC4581395.pdf
"Clin Kidney J 2015; 8: 637 –644 5.http://www.c-kin.org www.c-kin.org (27 July 2015, date last accessed)Editorial Comment |631CLINICAL KIDNEY JOURNAL",Non-OADS,/arxiv_data1/oa_pdf/fc/25/sfv085.PMC4581395.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/fa/sfv088.PMC4581396.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/78/sfv092.PMC4581397.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/af/sfv095.PMC4581398.pdf
Primers and amplification conditions were derived from the  Genome Database ( http://www.ncbi.nlm.nih.gov) .,OADS,/arxiv_data1/oa_pdf/29/2b/mmr-12-04-5659.PMC4581739.pdf
"MeV software, version 4.7.4 ( http://www.tm4.",Non-OADS,/arxiv_data1/oa_pdf/10/6c/mmr-12-04-5647.PMC4581744.pdf
"In order to detect the target  genes of those miRNAs with different expression levels and  to evaluate their function, GO annotation was applied to the  target gene, according to the GO database ( http://www.geneon - tology.org/ ).",OADS,/arxiv_data1/oa_pdf/10/6c/mmr-12-04-5647.PMC4581744.pdf
The Limma package in R ( 32)   (http://www.bioconductor.org /packages /release /bioc/html/limma.html)   was used to identify the DEGs at the probe level between  the glaucoma samples and normal samples.,OADS,/arxiv_data1/oa_pdf/7a/8a/mmr-12-04-4829.PMC4581750.pdf
"Identification of the essential  oil constituents was completed based on the following: The  retention index (RI), determined with respect to a homologous  series of n -alkanes (C5-C28; PolyScience, Niles, IL, USA)  under the same experimental conditions; co -injection with  standards (Sigma -Aldrich) and standard isolates; identi - fication using an MS library [NIST 05 and Wiley; NIST/ EPA/NIH Mass Spectral Library with Search Program (data  version, NIST 11; software version 2.0g), a vailable online:   http://www.nist.gov/srd/nist1a.cfm]  and comparison with  previously reported MS data (28).",OADS,/arxiv_data1/oa_pdf/8f/5e/mmr-12-04-5762.PMC4581751.pdf
http://www.who .int/immuni - zation/documents/WHO_IVB_05.12/en/.,OADS,/arxiv_data1/oa_pdf/8f/5e/mmr-12-04-5762.PMC4581751.pdf
"The clinical stages of the tumors were  defined according to the National Comprehensive Cancer  Network Guidelines (http://www.nccn.org/; Version 1.2014 ,  Gastric Cancer).",Non-OADS,/arxiv_data1/oa_pdf/46/e8/mmr-12-04-5771.PMC4581752.pdf
Target genes of miR-21 were predicted  by PicTar  (http://pictar.mdc-berlin.de/cgi-bin/PicTar_verte - brate.cgi)  and Targetscan  (http://www.targetscan.org/) .,OADS,/arxiv_data1/oa_pdf/88/50/mmr-12-04-4917.PMC4581755.pdf
"According to the miRNA  sequence provided by miRBase, the two miRNA target  gene databases TargetScan ( http://www.targetscan.org /) and  RNA22 ( https: //cm.jefferson.edu /rna22 /) were used for the  prediction of the target genes of miR -26b (12).",OADS,/arxiv_data1/oa_pdf/55/6f/mmr-12-04-5753.PMC4581756.pdf
MOLECULAR MEDICINE REPORTS  12:  5753-5761 5755 model (complementary region) was predicted using RNA  mfold software ( http://mfold.rna.albany.edu /?q=mfold) .,OADS,/arxiv_data1/oa_pdf/55/6f/mmr-12-04-5753.PMC4581756.pdf
"A literature review of KRT17 gene muta - tions in SM pedigrees was performed through searches  of PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Ovid  Medline (http://ovidsp.tx.ovid.com/sp-3.16.0a/ovidweb.cgi),  EMBASE databases (www.embase.com) and China National  Knowledge Infrastructure (http://www.cnki.net/).",OADS,/arxiv_data1/oa_pdf/b4/c9/mmr-12-04-5072.PMC4581757.pdf
The DNA primers were designed according to Genbank  (http://www.ncbi.nlm.nih.gov/genbank/).,OADS,/arxiv_data1/oa_pdf/99/ef/mmr-12-04-4859.PMC4581758.pdf
miRWalk (http://www.umm.uni- heidelberg.de/apps/zmf/mirwalk/) was used to verify the  targets of miR -205.,OADS,/arxiv_data1/oa_pdf/13/9c/mmr-12-04-5715.PMC4581759.pdf
"In addition to its own algorithm, miRWalk  used eight additional computational algorithms - miRanda  (http://www.microrna.org/microrna/home.do), miRDB  (http://mirdb.org/miRDB/), RNA22 (https://cm.jefferson.edu/ rna22/), RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/ rnahybrid/submission.html), PITA (http://genie.weizmann.",OADS,/arxiv_data1/oa_pdf/13/9c/mmr-12-04-5715.PMC4581759.pdf
"ac.il/pubs/mir07/mir07_prediction.html), PICTAR (http:// pictar.mdc-berlin.de/), Diana-microT (http://diana.cslab.ece.",OADS,/arxiv_data1/oa_pdf/13/9c/mmr-12-04-5715.PMC4581759.pdf
ntua.gr/microT/) and TargetScan (http://www.targetscan.org/)  to predict the targets of the miRNAs.,OADS,/arxiv_data1/oa_pdf/13/9c/mmr-12-04-5715.PMC4581759.pdf
"Bioinformatics analysis with miRWalk  (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/)  was used to identify potential targets of miR -205, and from  these results, TP53INP1 was selected as a potential target  for further study.",OADS,/arxiv_data1/oa_pdf/13/9c/mmr-12-04-5715.PMC4581759.pdf
"Target genes of differentially expressed  miRNA were screened by combining TargetScan 5.1   (http://www.targetscan.org; Whitehead Institute for  Biomedical Research, Cambridge, MA, USA)  and  Pictar4way algorithms ( http://pictar.mdc-berlin.de; Center  for Comparative Functional Genomics and the Max Delbruck  Centrum, Berlin, Germany) .",OADS,/arxiv_data1/oa_pdf/c3/ee/mmr-12-04-4925.PMC4581765.pdf
"The software of Search Tool for the Retrieval of Interacting  Genes (STRING; http://string-db.org/ ) is a tool that could  cluster networks on demand, update on -screen previews  of structural information including homology models and  extensive data updates (13).",OADS,/arxiv_data1/oa_pdf/c3/ee/mmr-12-04-4925.PMC4581765.pdf
Cytoscape (http://cytoscape.org/)  is a popular  bioinformatics package for biological network visualization  and data integration (14).,OADS,/arxiv_data1/oa_pdf/c3/ee/mmr-12-04-4925.PMC4581765.pdf
"The  Biological Networks Gene Ontology tool (BiNGO;   http://www.psb.ugent.be/cbd/papers/BiNGO/ ), as a cytoscape  plugin, is an open -source Java tool to determine which Gene  Ontology (GO) terms are significantly overrepresented in  a set of genes (15).",OADS,/arxiv_data1/oa_pdf/c3/ee/mmr-12-04-4925.PMC4581765.pdf
"Web -based  Gene Set Enrichment Analysis Toolkit (WebGestalt;   http://www.webgestalt.org ) is composed of four modules: Gene  set management, information retrieval, organization /visu- alization and statistics, and shifted the study from ‘single  genes’ to ‘gene sets’ (16,17).",OADS,/arxiv_data1/oa_pdf/c3/ee/mmr-12-04-4925.PMC4581765.pdf
"The potential target genes of miRNAs  were predicted using the following online algorithms:  miRanda  (August 2010 release;  http://www.microrna.org/ ),  miRDB (MirTarget2_v4.0;  http://www.mirdb.org/miRDB/ ),  CLIP‑Seq (2012‑03‑28;  http://mirtarclip.mbc.nctu.edu.tw/ ) and  TargetScan  (version 6.2;  http://targetscan.org/ ).",OADS,/arxiv_data1/oa_pdf/61/1b/mmr-12-04-4877.PMC4581768.pdf
"Based on these predicted target genes, the signaling path - ways potentially regulated by miR -92a were analyzed using  the Kyoto Encyclopedia of Genes and Genomes (KEGG,  kobas2.0‑20120208;  http://www.genome.jp/kegg/)  database and  the possible function of miR -92a was predicted.Table I. Primer sequences for reverse transcription-quantitative polymerase chain reaction.",OADS,/arxiv_data1/oa_pdf/61/1b/mmr-12-04-4877.PMC4581768.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 261–267Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  261Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S8241 1rate and predictors of low serum ferritin levels  among healthy parturient women in enugu,  nigeria Fausta chioma J  emegoakor1 chukwuemeka anthony  iyoke1 hyginus Uzo ezegwui1 Frank Okechukwu ezugwu2 Odidika Ugochukwu  Umeora3 izuchukwu Obumneme  ibeagha4 1Department of Obstetrics and  gynaecology, University of nigeria  T eaching hospital, ituku-Ozalla,   2Department of Obstetrics and  gynaecology, enugu state University  T eaching hospital, Park lane,   enugu, 3Department of Obstetrics  and gynaecology, Federal T eaching  hospital, abakaliki, 4Department of  haematology, University of nigeria  T eaching hospital, ituku-Ozalla,    enugu, nigeria correspondence: Fausta chioma J  emegoakor   Department of Obstetrics and  gynaecology, University of nigeria  T eaching hospital, ituku-Ozalla,   enugu state, nigeria   T el +23 480 3688 8248   email faustay302@yahoo.co mBackground:  Low serum ferritin levels signify low iron stores and this could predispose to  iron deficiency anemia.",Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
"Available from: http://www.who.int/nutrition/publiications/ micronutrients/anaemia.iron deficiency/9789241596106.pd f. Accessed  October 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
Available from: http://www.emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/6d/jbm-6-261.PMC4581776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1497–1503Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1497OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8906 7history of falls, gait, balance, and fall risks in older  cancer survivors living in the community Min h huang Tracy shilling Kara A Miller Kristin smith Kayle laVictoire Physical Therapy Department, school  of health Professions and studies,   University of Michigan–Flint, Flint,   MI, UsAAbstract:  Older cancer survivors may be predisposed to falls because cancer-related sequelae  affect virtually all body systems.",Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
"Falls and fall-related injuries are serious problems in older adults.3 Older cancer  survivors may be predisposed to falls because cancer- and treatment-related side  effects impact virtually all body systems.2 Pain, fatigue, muscle weakness, vision  and cognitive impairments, difficulty with balance and walking can emerge while  a person is receiving cancer treatments or develop years after treatments have  completed.2,4–6 Decline in physical function after the cancer diagnosis is often  undetected or untreated.4 In a sample of Medicare and Medicaid recipients aged Correspondence: Min h huang Physical Therapy Department,  school of health Professions and  studies, University of Michigan–Flint,  2157 William s White Building, 303 east  Kearsley street, Flint, MI 48502, UsA email mhhuang@umflint.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Huang et al Running head recto: Falls, gait, balance, and falls risks in older cancer survivors DOI: http://dx.doi.org/10.2147/CIA.S89067",Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/7b/f1/cia-10-1497.PMC4581777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/3e/imcrj-8-193.PMC4581778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 193–197International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  193Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S8950 7Relapsing polychondritis with different types of  ocular inflammations Nana Furuya T oshiyuki Oshitari Jiro Y otsukura Takayuki Baba shuichi Yamamoto Department of Ophthalmology and  Visual science, Chiba University,   Graduate school of Medicine,   Chuo-ku, Chiba, Japan Correspondence: Toshiyuki Oshitari  Department of Ophthalmology and Visual  science, Chiba University, Graduate  school of Medicine, Inohana 1-8-1,  Chuo-ku, Chiba 260-8670, Japan   Tel +81 43 226 2124   Fax +81 43 224 4162   email Tarii@aol.co mAbstract:  We were presented with two cases of relapsing polychondritis (RP) associated with  different types of ocular inflammation.",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/imcrj-8-193.PMC4581778.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/imcrj-8-193.PMC4581778.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/3e/imcrj-8-193.PMC4581778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/0f/imcrj-8-199.PMC4581779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 199–203International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  199Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S8614 3Optical coherence tomography imaging of  chorioretinal folds associated with hypotony  maculopathy following pars plana vitrectomy Basil K Williams Jr Jonathan s Chang Harry W Flynn Jr Department of Ophthalmology,   Bascom Palmer eye Institute,   University of Miami Miller school   of Medicine, Miami, FL, Usa Correspondence: Basil K Williams Jr   Department of Ophthalmology,   Bascom Palmer eye Institute, University  of Miami Miller school of Medicine,   900 NW 17th street, Miami,   FL 33136, Usa   Tel +1 305 326 6000   Fax +1 305 326 6417   email b asilkwilliams@gmail.co mAbstract:  Chorioretinal folds may occur as a consequence of hypotony and can be a cause  of vision loss when associated with macular involvement.",Non-OADS,/arxiv_data1/oa_pdf/8c/0f/imcrj-8-199.PMC4581779.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/8c/0f/imcrj-8-199.PMC4581779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/0f/imcrj-8-199.PMC4581779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2415–2423Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2415OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9305 5anatomical and functional brain abnormalities in  unmedicated major depressive disorder Xiao Yang1,2,* Xiaojuan Ma3,* Mingli li1,2 Ye liu1 Jian Zhang1 Bin huang4 liansheng Zhao1,2 Wei Deng1,2 Tao li1,2 Xiaohong Ma1,2 1Psychiatric laboratory and  Department of Psychiatry, 2National  Key laboratory of Biotherapy, West  china hospital, sichuan University,  3chengdu First People’s hospital,  chengdu, 4Dong Feng Mao Jian  hospital, shiyan, People’s republic  of china *These authors contributed equally  to this workBackground:  Using magnetic resonance imaging (MRI) and resting-state functional magnetic  resonance imaging (rsfMRI) to explore the mechanism of brain structure and function in unmedi - cated patients with major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
"Some research has found that GMV  deficits in the frontal gyrus, temporal lobe, and insula were negatively correlated  with depressive symptoms or illness duration in MDD patients.12,13 The prefrontal correspondence: Xiaohong Ma Psychiatric laboratory and Department of  Psychiatry, West china hospital, sichuan  University, 37 guoxue alley, Wuhou,  chengdu, sichuan 610041, People’s  republic of china email maxiaohong@scu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Y ang et al Running head recto: Anatomical and functional brain abnormalities in MDD DOI: http://dx.doi.org/10.2147/NDT.S93055",Non-OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
image processing and analysis All structural data were processed using the DARTEL36  toolbox with the Statistical Parametric Mapping software package (SPM8; http://www.fil.ion.ucl.ac.uk/sp m).,OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
"The statistical results of ReHo were  corrected using the AlphaSim program, which is based on  Monte Carlo simulations ( http://afni.nimh.nih.gov/pub/dist/ doc/manual/AlphaSim.pd f).",OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/78/ndt-11-2415.PMC4581780.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2405–2414Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2405Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9047 3intractable and highly active relapsing multiple  sclerosis – role of alemtuzumab Divyanshu Dubey1 Christopher A Cano1 Olaf Stuve1–3 1Department of Neurology and  Neurotherapeutics, University of  T exas Southwestern Medical Center,   2Neurology Section, vA North T exas  Health Care System, Medical Service,   Dallas, TX, USA; 3Department of  Neurology, Klinikum rechts der isar,   T echnische Universität München,   Munich, GermanyAbstract:  Alemtuzumab is a humanized recombinant monoclonal antibody that was recently  approved by the US Food and Drug Administration and the European Medicines Agency for the  management of relapsing forms of multiple sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
"European Medicines Agency (EMA) defined patients with HARRMS as  treatment naïve patients with at least two disabling relapses in the last 1  year and at least  one gadolinium-enhancing lesion or significant increase in T2-lesion load.4,5 Patients  who have failed to respond to an adequate course of at least one disease-modifying ther - apy (DMT), presenting with at least one relapse in the previous year while on therapy  and at least nine T2-hyperintense lesions or at least one gadolinium-enhancing lesion,  were also characterized as having HARRMS.4–6 For these patients, most designated  MS centers currently adopt an approach of rapid and effective immunomodulation in  order to prevent aggressive disease progression and severe disability accumulation.7  Early initiation of effective immunotherapy is considered to be important in this group  of patients due to a narrow therapeutic window for anti-inflammatory agents.7–9 Most  of the conventional first-generation DMT may be ineffective in avoiding rapid accu - mulation of fixed disability.10–13Correspondence: Divyanshu Dubey Department of Neurology and  Neurotherapeutics, University of  Texas Southwestern Medical Center,  5323 Harry Hines Boulevard, Dallas,  TX, USA email divyanshudubey87@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Dubey et al Running head recto: Intractable and highly active relapsing MS DOI: http://dx.doi.org/10.2147/NDT.S90473",Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
Available from http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002202/ WC500104528.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
Available from http://www.nationalmssociety.,Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
"Available from http://www.worldpharmanews.com/genzyme/1529- genzyme-details-market-potential-of-alemtuzumab-for-ms. Accessed  August 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/54/3d/ndt-11-2405.PMC4581781.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1487–1495Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1487OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7962 5effects of exercise intensity on postexercise  hypotension after resistance training session  in overweight hypertensive patients Paula Andréa M Cavalcante,1,2  roberta l rica,1,2 Alexandre l  evangelista,1,3 Andrey J serra,3,4  Aylton Figueira Jr,1,2 Francisco  luciano Pontes  Jr,5 lon  Kilgore,6 Julien s Baker,6 Danilo  s Bocalini1,2 1Translational Physiology laboratory,   2Postgraduate Program in Physical  education and Aging science, são Judas  Tadeu University (UsJT), 3Department  of Physical education, 4Postgraduate  Program in Biophotonics Applied to  health sciences, nove de Julho University  (UnInOVe), 5Department of gerontology  of Arts, science and humanities school,   são Paulo University, são Paulo, Brazil;   6Institute of Clinical exercise and health  science, University of the West of scotland,   hamilton, lanarkshire, scotlandAbstract:  Among all nonpharmacological treatments, aerobic or resistance training (RT) has  been indicated as a significantly important strategy to control hypertension.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
"Among these diseases,  hypertension will be the most prevalent increasing progressively with age especially  among women.6 It is estimated that hypertension affects approximately 55.3% of  women between 60 and 74 years and 60.7% in those of more than 75 years.5 The first-line therapy to reduce the impact of hypertension on health is frequently  drug therapy; however, lifestyle modifications that include decreasing sodium and fat  in the diet, avoidance of smoking and alcohol consumption, and frequent participation Correspondence: Danilo s Bocalini Translational Physiology laboratory,  Postgraduate Program in Physical education  and Aging science, são Judas Tadeu University  (UsJT) – rua Ary Barroso, n ° 68, apto 105,  Torre 1, CeP 09790-240, Ferrazópolis, são  Bernardo do Campo, são Paulo, Brazil email bocaliniht@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Cavalcante et al Running head recto: Resistance training on postexercise hypotension DOI: http://dx.doi.org/10.2147/CIA.S79625 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
Or use: http://youtu.be/vOkPNrgoqd 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1c/be/cia-10-1487.PMC4581782.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/0e/ndt-11-2391.PMC4581783.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2391–2404Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2391OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9096 6an innovative intervention for the treatment of  cognitive impairment– emisymmetric bilateral  stimulation improves cognitive functions in  alzheimer’s disease and mild cognitive impairment:  an open-label study Fabio guerriero,1–3  emanuele Botarelli,3 gianni  Mele,3 lorenzo Polo,3  Daniele Zoncu,3 Paolo  renati,3,4 carmelo sgarlata,1   Marco rollone,2 giovanni  ricevuti,1,2 Niccolo  Maurizi,1 Matthew Francis,1  Mariangela rondanelli,5  simone Perna,5 Davide  guido,2,6 Piero Mannu3 1Department of internal Medicine and  Medical Therapy, section of geriatrics,   University of Pavia, Pavia, italy;   2agency for elderly People services,   santa Margherita hospital, Pavia, italy;   3ambra elektron, italian association  of Biophysics for the study of  electromagnetic Fields in Medicine,   4alberto sorti research institute,   Medicine and Metamolecular Biology,   T urin, italy; 5Department of Public  health, experimental and Forensic  Medicine, section of human Nutrition,   endocrinology and Nutrition Unit,   6Department of Public health,   experimental and Forensic Medicine,   Biostatistics and clinical epidemiology  Unit, University of Pavia, Pavia, italyBackground and aims:  In the last decade, the development of different methods of brain stimulation  by electromagnetic fields (EMF) provides a promising therapeutic tool for subjects with impaired  cognitive functions.",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/ndt-11-2391.PMC4581783.pdf
"Keywords:  pulsed electromagnetic fields, cognitive decline, Alzheimer’s disease, Emisym - metric bilateral stimulation Introduction The increasing mean age of the population, and as a consequence the aging-related  incidence of neurocognitive disorders such as dementia, highlights the need for new,  highly effective, therapeutic strategies.correspondence: Fabio guerriero  Department of internal Medicine and  Medical Therapy, section of geriatrics,  University of Pavia, via emilia 12, Pavia  27100, italy Tel +39 03 8238 1772 Fax +39 03 8238 1217 email fabio_guerriero@yahoo.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Guerriero et al Running head recto: Innovative brain stimulation by electromagnetic fields for cognitive decline DOI: http://dx.doi.org/10.2147/NDT.S90966",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/ndt-11-2391.PMC4581783.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/ndt-11-2391.PMC4581783.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/0e/ndt-11-2391.PMC4581783.pdf
RefFinder ( http://www.leonxie.com/refer - encegene.php?,Non-OADS,/arxiv_data1/oa_pdf/e0/c4/mmr-12-04-5633.PMC4581798.pdf
The Linear  Models for Microarray Analysis package (http://www.bio   conductor.org/packages/release/bioc/html/limma.html) (17) in  R language was used to screen for the DEGs between the NPC  and control tissue samples.,OADS,/arxiv_data1/oa_pdf/63/fa/mmr-12-04-4975.PMC4581807.pdf
Two-way hierarchical  clustering analysis was performed for the identified DEGs  using the pheatmap package in R language (http://cran.fhcrc.,OADS,/arxiv_data1/oa_pdf/63/fa/mmr-12-04-4975.PMC4581807.pdf
"To identify the hub proteins in the present study,  the Search Tool for the Retrieval of Interacting Gene s (22)  online database (http://string-db.org/) was used to construct  a PPI network using the proteins encoded by the DEGs.",OADS,/arxiv_data1/oa_pdf/63/fa/mmr-12-04-4975.PMC4581807.pdf
Using the sequence of the YAP gene  (NM_006106) from GenBank ( http://www.ncbi.nlm.nih.gov/ gene/?,OADS,/arxiv_data1/oa_pdf/42/09/mmr-12-04-4867.PMC4581809.pdf
The sjTGR dimer was assembled using PISA  (http://www.ebi.ac.uk /msd- srv/prot_int /pistart.html ) (15).,Non-OADS,/arxiv_data1/oa_pdf/65/95/mmr-12-04-5787.PMC4581810.pdf
"Spectra were interpreted manually and /or  with the Sequest ™ v. B22 software ( Thermo Finnigan, San  Jose, CA, USA ) and MS /MS MASCOT error tolerant search  engine  (http://www.matrixscience.com)  (20).",OADS,/arxiv_data1/oa_pdf/58/26/mmr-12-04-5737.PMC4581812.pdf
"The final PAP -S1aci model, which consists of  261 amino -acid residues, 1 N-linked GlcNAc and 464  water molecules, exhibits good geometry as determined by  MolProbity  (http://molprobity.biochem.duke.edu/)  (24).",OADS,/arxiv_data1/oa_pdf/58/26/mmr-12-04-5737.PMC4581812.pdf
"Structural superpo - sitions were performed with LSQKAB (26), as implemented  in the CCP4 suite software (http://www.ccp4.ac.uk)  (27).",OADS,/arxiv_data1/oa_pdf/58/26/mmr-12-04-5737.PMC4581812.pdf
"DeLano  Scientific, Palo Alto, USA 2002. http://www.pymol.org.",Non-OADS,/arxiv_data1/oa_pdf/58/26/mmr-12-04-5737.PMC4581812.pdf
"Three sequences of siRNA  oligonucleotides targeting HOXB7 synthesized by Shanghai  Genepharma Co., Ltd. were identified and matched with  the following HOXB7 cDNA sequences obtained from  GenBank through a BLAST search ( http://blast.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/82/09/mmr-12-04-4901.PMC4581815.pdf
Differentially expressed genes were categorized in Gene  Ontology groups using the DAVID tool (http://david.abcc.,OADS,/arxiv_data1/oa_pdf/0c/79/mmr-12-04-5049.PMC4581816.pdf
A microarray dataset for NPC (GSE12452) was retrieved  from the GEO database ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/5f/e8/mmr-12-04-4909.PMC4581822.pdf
The present  study  performed drug gene and miRNA target prediction  using a Web‑based gene set analysis toolkit (WebGestalt;  http://bioinfo.vanderbilt.edu /webgestalt /analysis.php) (26).,OADS,/arxiv_data1/oa_pdf/29/99/mmr-12-04-4947.PMC4581825.pdf
Pathway  analysis is a type of functional analysis that maps genes to  Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways   (http://www.genome .jp/kegg/pathway.html).,OADS,/arxiv_data1/oa_pdf/7c/bc/mmr-12-04-5807.PMC4581826.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d8/54/134_2015_Article_3903.PMC4582073.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Interna- tional License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/90/86/134_2015_Article_4029.PMC4582074.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Interna- tional License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/df/0e/134_2015_Article_4016.PMC4582078.pdf
"Editorial http://dx.doi.org/10.5213/inj.2015.19.3.131 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Implantable Bladder Sensors for Long-term Monitoring of  Bladder Volume Su Jin Kim    Department of Urology, The Catholic University of Korea School of Medicine, Seoul, Korea E-mail: hygeia@catholic.ac.kr Int Neurourol J 2015;19:131-131",Non-OADS,/arxiv_data1/oa_pdf/b6/f0/inj-19-3-131.PMC4582082.pdf
"Int  Neurourol J 2015;19:142-50.Editorial http://dx.doi.org/10.5213/inj.2015.19.3.132 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Interleukin-33 as a Potential Therapeutic Target for Interstitial  Cystitis: New Perspectives on Mast Cell Regulation Min Soo Choo    Department of Urology, Hallym University College of Medicine, Chuncheon, Korea E-mail: snuhuro@gmail.com  Int Neurourol J 2015;19:132-132",Non-OADS,/arxiv_data1/oa_pdf/f9/94/inj-19-3-132.PMC4582083.pdf
"Copyright © 2015 Korean Continence SocietyCorresponding author:  Y eun-Ho Joung     http://orcid.org/0000-0003-2365-2805 Department of Electronics and Control Engineering, Hanbat National  University, 125 Dongseo-daero, Yuseong-gu, Daejeon 34158, Korea E-mail: yeunho@gmail.com / Tel: +82-42-821-1166 / Fax: +82-42-821-1164 Submitted:  August 5, 2015 / Accepted after revision:  August 19, 2015INTRODUCTION   Urinary incontinence (UI) is not only caused by peripheral   nerve/spinal cord injury but also other factors such as excessive  alcohol intake, pregnancy, childbirth, bladder tumor/cancer, and  an enlarged prostate.",Non-OADS,/arxiv_data1/oa_pdf/9b/3e/inj-19-3-133.PMC4582084.pdf
"Even though this method grants  the accuracy needed for monitoring urine volume/pressure, it is Review Article http://dx.doi.org/10.5213/inj.2015.19.3.133 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL The loss of urinary bladder control/sensation, also known as urinary incontinence (UI), is a common clinical problem in au - tistic children, diabetics, and the elderly.",Non-OADS,/arxiv_data1/oa_pdf/9b/3e/inj-19-3-133.PMC4582084.pdf
"www.einj.org Copyright © 2015 Korean Continence SocietyCorresponding author:  Y oung Hyo Kim     http://orcid.org/0000-0002-3623-1770 Department of Otorhinolaryngology-Head and Neck Surgery, Inha University  Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon  22332, Korea E-mail: inhaorl@inha.ac.kr / Tel: +82-32-890-2437 / Fax: +82-32-890-3580 Submitted:  August 12, 2015 / Accepted:  September 4, 2015INTRODUCTION The Role of IL-33 and Mast Cells in the Immune Response Interleukin (IL) 33 is a member of the IL-1 superfamily and has  molecular properties similar to those of related cytokines such  as IL-1 and IL-18 [1].",Non-OADS,/arxiv_data1/oa_pdf/b1/60/inj-19-3-142.PMC4582085.pdf
"Consequently, it is quite probable that IL-33 induces and Review Article http://dx.doi.org/10.5213/inj.2015.19.3.142 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Interleukin (IL) 33, a member of the IL-1 superfamily, is an “alarmin” protein and is secreted in its active form from damaged  cells undergoing necrotic cell death.",Non-OADS,/arxiv_data1/oa_pdf/b1/60/inj-19-3-142.PMC4582085.pdf
http://dx.doi.org/10.1016/j.ejphar.2015.04.047.,OADS,/arxiv_data1/oa_pdf/b1/60/inj-19-3-142.PMC4582085.pdf
"Copyright © 2015 Korean Continence SocietyCorresponding author:  Limin Liao     http://orcid.org/0000-0002-7092-6576 Department of Urology, China Rehabilitation Research Center, Capital Medical   University, No.",Non-OADS,/arxiv_data1/oa_pdf/bb/94/inj-19-3-151.PMC4582086.pdf
"10, Jiaomen Beilu, Beijing 100068, China E-mail: lmliao@263.net / Tel: +86-13-311268064 / Fax: +86-10-67570492  Co-Corresponding Author : Jean Jacques Wyndaele     http://orcid.org/0000-0002-0879-6854 Department of Urology, Antwerp University, 10 Wilrijkstraat, 2650 Edegem,  Antwerp, Belgium E-mail: wyndaelejj@skynet.be / Tel: +32-3821-3511 / Fax: +32-3821-4479 Submitted:  July 12, 2015 / Accepted:  August 27, 2015INTRODUCTION Overactive bladder (OAB) symptoms include frequency, ur - gency, and incontinence and are difficult to manage with medi -cation alone [1,2].",Non-OADS,/arxiv_data1/oa_pdf/bb/94/inj-19-3-151.PMC4582086.pdf
"Currently, a tined lead elec -Original Article http://dx.doi.org/10.5213/inj.2015.19.3.151 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To investigate the inhibitory effect and possible mechanism of intraurethral stimulation on overactive bladder  (OAB) induced by acetic acid irritation.",Non-OADS,/arxiv_data1/oa_pdf/bb/94/inj-19-3-151.PMC4582086.pdf
"www.einj.org Copyright © 2015 Korean Continence SocietyCorresponding author:  Chong Koo Sul      http://orcid.org/0000-0002-7225-1496 Department of Urology, Chungnam National University Hospital, Chungnam  National University School of Medicine, 282 Munhwa-ro, Jung-gu,   Daejeon 35015, Korea E-mail: snowman@cnu.ac.kr / Tel: +82-42-280-7776 / Fax: +82-42-257-0966 Submitted:  June 11, 2015 / Accepted after revision:  July 27, 2015INTRODUCTION Patients with interstitial cystitis (IC) or painful bladder syn - drome (PBS) exhibit urinary urgency, frequency, and suprapubic and pelvic pain related to bladder filling [1,2].",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/inj-19-3-158.PMC4582087.pdf
"Bladder  inflammation, urethra stimulus in the lower urinary tract, me - chanical bulging within the uterus or vagina, and urethral occlu -Original Article http://dx.doi.org/10.5213/inj.2015.19.3.158 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The aim of this study was to evaluate changes in expressions of neuregulin (NRG)1 and erbB2 tyrosine kinase  (ErbB2) in bladders of rats with cyclophosphamide (CYP)-induced interstitial cystitis (IC).",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/inj-19-3-158.PMC4582087.pdf
Elife 2015;4. http://dx.doi.org/10.7554/ eLife.05871.,Non-OADS,/arxiv_data1/oa_pdf/f9/b5/inj-19-3-158.PMC4582087.pdf
"www.einj.org Copyright © 2015 Korean Continence SocietyCorresponding author:  Ayla Eser     http://orcid.org/0000-0002-7897-3481 Department of Obstetrics and Gynecology, Turgut Ozal University School of  Medicine, Hosdere Cad.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/inj-19-3-164.PMC4582088.pdf
"The etiology of POP is complex and multifactorial, and epide -Original Article http://dx.doi.org/10.5213/inj.2015.19.3.164 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 1-51 INJ INTERNATIONAL  NEUROUROLOGY JOURNALVolume 19, Number 3  September 2015 Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Pelvic organ prolapse is a multifactorial disorder in which extracellular matrix defects are implicated.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/inj-19-3-164.PMC4582088.pdf
"Copyright © 2015 Korean Continence SocietyCorresponding author:  Hann-Chorng Kuo     http://orcid.org/0000-0001-7165-4771 Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi  University, No.",Non-OADS,/arxiv_data1/oa_pdf/b6/1d/inj-19-3-171.PMC4582089.pdf
